id,entrez_id,go,name,go_type
1,47,5524,ATP binding,F
2,47,3878,ATP citrate synthase activity,F
3,47,3878,ATP citrate synthase activity,F
4,47,48037,cofactor binding,F
5,47,46872,metal ion binding,F
6,47,5515,protein binding,F
7,47,6085,acetyl-CoA biosynthetic process,P
8,47,6695,cholesterol biosynthetic process,P
9,47,6101,citrate metabolic process,P
10,47,6633,fatty acid biosynthetic process,P
11,47,8610,lipid biosynthetic process,P
12,47,35338,long-chain fatty-acyl-CoA biosynthetic process,P
13,47,43312,neutrophil degranulation,P
14,47,6107,oxaloacetate metabolic process,P
15,47,31325,positive regulation of cellular metabolic process,P
16,47,35578,azurophil granule lumen,C
17,47,9346,citrate lyase complex,C
18,47,5829,cytosol,C
19,47,5829,cytosol,C
20,47,5829,cytosol,C
21,47,70062,extracellular exosome,C
22,47,5576,extracellular region,C
23,47,1904813,ficolin-1-rich granule lumen,C
24,47,16020,membrane,C
25,47,5654,nucleoplasm,C
26,47,5886,plasma membrane,C
27,22848,35612,AP-2 adaptor complex binding,F
28,22848,5524,ATP binding,F
29,22848,5112,Notch binding,F
30,22848,5515,protein binding,F
31,22848,4674,protein serine/threonine kinase activity,F
32,22848,4674,protein serine/threonine kinase activity,F
33,22848,4674,protein serine/threonine kinase activity,F
34,22848,6897,endocytosis,P
35,22848,61024,membrane organization,P
36,22848,45747,positive regulation of Notch signaling pathway,P
37,22848,46777,protein autophosphorylation,P
38,22848,6468,protein phosphorylation,P
39,22848,50821,protein stabilization,P
40,22848,2000369,regulation of clathrin-dependent endocytosis,P
41,22848,2000369,regulation of clathrin-dependent endocytosis,P
42,22848,32880,regulation of protein localization,P
43,22848,31252,cell leading edge,C
44,22848,5905,clathrin-coated pit,C
45,22848,30136,clathrin-coated vesicle,C
46,22848,5737,cytoplasm,C
47,22848,5829,cytosol,C
48,22848,19897,extrinsic component of plasma membrane,C
49,22848,43195,terminal bouton,C
50,51225,42802,identical protein binding,F
51,51225,5515,protein binding,F
52,51225,6928,movement of cell or subcellular component,P
53,51225,18108,peptidyl-tyrosine phosphorylation,P
54,51225,30334,regulation of cell migration,P
55,51225,5737,cytoplasm,C
56,51225,5737,cytoplasm,C
57,51225,5622,intracellular,C
58,51225,30027,lamellipodium,C
59,51225,16020,membrane,C
60,203054,5515,protein binding,F
61,203054,4674,protein serine/threonine kinase activity,F
62,203054,6468,protein phosphorylation,P
63,203054,16021,integral component of membrane,C
64,231,4032,alditol:NADP+ 1-oxidoreductase activity,F
65,231,4033,aldo-keto reductase (NADP) activity,F
66,231,9055,electron carrier activity,F
67,231,43795,glyceraldehyde oxidoreductase activity,F
68,231,6700,C21-steroid hormone biosynthetic process,P
69,231,5975,carbohydrate metabolic process,P
70,231,70301,cellular response to hydrogen peroxide,P
71,231,97238,cellular response to methylglyoxal,P
72,231,1901653,cellular response to peptide,P
73,231,44597,daunorubicin metabolic process,P
74,231,44598,doxorubicin metabolic process,P
75,231,46370,fructose biosynthetic process,P
76,231,72061,inner medullary collecting duct development,P
77,231,60135,maternal process involved in female pregnancy,P
78,231,18931,naphthalene metabolic process,P
79,231,43066,negative regulation of apoptotic process,P
80,231,42415,norepinephrine metabolic process,P
81,231,55114,oxidation-reduction process,P
82,231,46427,positive regulation of JAK-STAT cascade,P
83,231,48661,positive regulation of smooth muscle cell proliferation,P
84,231,35809,regulation of urine volume,P
85,231,3091,renal water homeostasis,P
86,231,6950,response to stress,P
87,231,97066,response to thyroid hormone,P
88,231,9414,response to water deprivation,P
89,231,6061,sorbitol biosynthetic process,P
90,231,31098,stress-activated protein kinase signaling cascade,P
91,231,1894,tissue homeostasis,P
92,231,43220,Schmidt-Lanterman incisure,C
93,231,97454,Schwann cell microvillus,C
94,231,32838,cell projection cytoplasm,C
95,231,5829,cytosol,C
96,231,5829,cytosol,C
97,231,70062,extracellular exosome,C
98,231,5615,extracellular space,C
99,231,42629,mast cell granule,C
100,231,5654,nucleoplasm,C
101,231,33010,paranodal junction,C
102,231,48471,perinuclear region of cytoplasm,C
103,183,8083,growth factor activity,F
104,183,5179,hormone activity,F
105,183,5179,hormone activity,F
106,183,5515,protein binding,F
107,183,4867,serine-type endopeptidase inhibitor activity,F
108,183,31702,type 1 angiotensin receptor binding,F
109,183,31703,type 2 angiotensin receptor binding,F
110,183,70371,ERK1 and ERK2 cascade,P
111,183,7186,G-protein coupled receptor signaling pathway,P
112,183,7199,G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger,P
113,183,7202,activation of phospholipase C activity,P
114,183,7568,aging,P
115,183,2003,angiotensin maturation,P
116,183,3051,angiotensin-mediated drinking behavior,P
117,183,14824,artery smooth muscle contraction,P
118,183,1974,blood vessel remodeling,P
119,183,35411,catenin import into nucleus,P
120,183,61049,cell growth involved in cardiac muscle cell development,P
121,183,7166,cell surface receptor signaling pathway,P
122,183,7267,cell-cell signaling,P
123,183,71260,cellular response to mechanical stimulus,P
124,183,6883,cellular sodium ion homeostasis,P
125,183,50663,cytokine secretion,P
126,183,7565,female pregnancy,P
127,183,48144,fibroblast proliferation,P
128,183,1822,kidney development,P
129,183,34374,low-density lipoprotein particle remodeling,P
130,183,16525,negative regulation of angiogenesis,P
131,183,30308,negative regulation of cell growth,P
132,183,10951,negative regulation of endopeptidase activity,P
133,183,51387,negative regulation of neurotrophin TRK receptor signaling pathway,P
134,183,34104,negative regulation of tissue remodeling,P
135,183,7263,nitric oxide mediated signal transduction,P
136,183,7200,phospholipase C-activating G-protein coupled receptor signaling pathway,P
137,183,1905589,positive regulation of L-arginine import across plasma membrane,P
138,183,1905010,positive regulation of L-lysine import across plasma membrane,P
139,183,33864,positive regulation of NAD(P)H oxidase activity,P
140,183,51092,positive regulation of NF-kappaB transcription factor activity,P
141,183,45777,positive regulation of blood pressure,P
142,183,90190,positive regulation of branching involved in ureteric bud morphogenesis,P
143,183,10666,positive regulation of cardiac muscle cell apoptotic process,P
144,183,10613,positive regulation of cardiac muscle hypertrophy,P
145,183,32270,positive regulation of cellular protein metabolic process,P
146,183,10873,positive regulation of cholesterol esterification,P
147,183,1819,positive regulation of cytokine production,P
148,183,7204,positive regulation of cytosolic calcium ion concentration,P
149,183,10595,positive regulation of endothelial cell migration,P
150,183,45742,positive regulation of epidermal growth factor receptor signaling pathway,P
151,183,3331,positive regulation of extracellular matrix constituent secretion,P
152,183,2001238,positive regulation of extrinsic apoptotic signaling pathway,P
153,183,48146,positive regulation of fibroblast proliferation,P
154,183,1903598,positive regulation of gap junction assembly,P
155,183,2001275,positive regulation of glucose import in response to insulin stimulus,P
156,183,50729,positive regulation of inflammatory response,P
157,183,10744,positive regulation of macrophage derived foam cell differentiation,P
158,183,45429,positive regulation of nitric oxide biosynthetic process,P
159,183,50731,positive regulation of peptidyl-tyrosine phosphorylation,P
160,183,14068,positive regulation of phosphatidylinositol 3-kinase signaling,P
161,183,61098,positive regulation of protein tyrosine kinase activity,P
162,183,2000379,positive regulation of reactive oxygen species metabolic process,P
163,183,35815,positive regulation of renal sodium excretion,P
164,183,32930,positive regulation of superoxide anion generation,P
165,183,45893,"positive regulation of transcription, DNA-templated",P
166,183,1904754,positive regulation of vascular associated smooth muscle cell migration,P
167,183,1904707,positive regulation of vascular smooth muscle cell proliferation,P
168,183,8217,regulation of blood pressure,P
169,183,2034,regulation of blood vessel diameter by renin-angiotensin,P
170,183,2016,regulation of blood volume by renin-angiotensin,P
171,183,51924,regulation of calcium ion transport,P
172,183,1903779,regulation of cardiac conduction,P
173,183,1558,regulation of cell growth,P
174,183,42127,regulation of cell proliferation,P
175,183,1901201,regulation of extracellular matrix assembly,P
176,183,2027,regulation of heart rate,P
177,183,48169,regulation of long-term neuronal synaptic plasticity,P
178,183,14061,regulation of norepinephrine secretion,P
179,183,2019,regulation of renal output by angiotensin,P
180,183,35813,regulation of renal sodium excretion,P
181,183,51969,regulation of transmission of nerve impulse,P
182,183,19229,regulation of vasoconstriction,P
183,183,3014,renal system process,P
184,183,2018,renin-angiotensin regulation of aldosterone production,P
185,183,14873,response to muscle activity involved in regulation of muscle adaptation,P
186,183,48659,smooth muscle cell proliferation,P
187,183,51403,stress-activated MAPK cascade,P
188,183,70471,uterine smooth muscle contraction,P
189,183,42311,vasodilation,P
190,183,72562,blood microparticle,C
191,183,5829,cytosol,C
192,183,70062,extracellular exosome,C
193,183,5576,extracellular region,C
194,183,5576,extracellular region,C
195,183,5615,extracellular space,C
196,183,5615,extracellular space,C
197,183,5615,extracellular space,C
198,207,71889,14-3-3 protein binding,F
199,207,5524,ATP binding,F
200,207,5524,ATP binding,F
201,207,32794,GTPase activating protein binding,F
202,207,19899,enzyme binding,F
203,207,42802,identical protein binding,F
204,207,16301,kinase activity,F
205,207,30235,nitric-oxide synthase regulator activity,F
206,207,5547,"phosphatidylinositol-3,4,5-trisphosphate binding",F
207,207,43325,"phosphatidylinositol-3,4-bisphosphate binding",F
208,207,5515,protein binding,F
209,207,5080,protein kinase C binding,F
210,207,4672,protein kinase activity,F
211,207,51721,protein phosphatase 2A binding,F
212,207,4674,protein serine/threonine kinase activity,F
213,207,4674,protein serine/threonine kinase activity,F
214,207,4674,protein serine/threonine kinase activity,F
215,207,4712,protein serine/threonine/tyrosine kinase activity,F
216,207,7186,G-protein coupled receptor signaling pathway,P
217,207,82,G1/S transition of mitotic cell cycle,P
218,207,7249,I-kappaB kinase/NF-kappaB signaling,P
219,207,38061,NIK/NF-kappaB signaling,P
220,207,31295,T cell costimulation,P
221,207,31929,TOR signaling,P
222,207,6924,activation-induced cell death of T cells,P
223,207,7568,aging,P
224,207,43276,anoikis,P
225,207,8637,apoptotic mitochondrial changes,P
226,207,30154,cell differentiation,P
227,207,30030,cell projection organization,P
228,207,8283,cell proliferation,P
229,207,6464,cellular protein modification process,P
230,207,6974,cellular response to DNA damage stimulus,P
231,207,71276,cellular response to cadmium ion,P
232,207,71364,cellular response to epidermal growth factor stimulus,P
233,207,97011,cellular response to granulocyte macrophage colony-stimulating factor stimulus,P
234,207,71456,cellular response to hypoxia,P
235,207,32869,cellular response to insulin stimulus,P
236,207,32869,cellular response to insulin stimulus,P
237,207,71260,cellular response to mechanical stimulus,P
238,207,1990090,cellular response to nerve growth factor stimulus,P
239,207,71407,cellular response to organic cyclic compound,P
240,207,71380,cellular response to prostaglandin E stimulus,P
241,207,34614,cellular response to reactive oxygen species,P
242,207,35924,cellular response to vascular endothelial growth factor stimulus,P
243,207,99565,"chemical synaptic transmission, postsynaptic",P
244,207,31018,endocrine pancreas development,P
245,207,72655,establishment of protein localization to mitochondrion,P
246,207,97194,execution phase of apoptosis,P
247,207,7281,germ cell development,P
248,207,42593,glucose homeostasis,P
249,207,6006,glucose metabolic process,P
250,207,15758,glucose transport,P
251,207,5978,glycogen biosynthetic process,P
252,207,60709,glycogen cell differentiation involved in embryonic placenta development,P
253,207,30212,hyaluronan metabolic process,P
254,207,6954,inflammatory response,P
255,207,8286,insulin receptor signaling pathway,P
256,207,48009,insulin-like growth factor receptor signaling pathway,P
257,207,35655,interleukin-18-mediated signaling pathway,P
258,207,35556,intracellular signal transduction,P
259,207,60716,labyrinthine layer blood vessel development,P
260,207,31663,lipopolysaccharide-mediated signaling pathway,P
261,207,72656,maintenance of protein location in mitochondrion,P
262,207,60644,mammary gland epithelial cell differentiation,P
263,207,1893,maternal placenta development,P
264,207,61024,membrane organization,P
265,207,46329,negative regulation of JNK cascade,P
266,207,43066,negative regulation of apoptotic process,P
267,207,10507,negative regulation of autophagy,P
268,207,45792,negative regulation of cell size,P
269,207,43154,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,P
270,207,10951,negative regulation of endopeptidase activity,P
271,207,2001240,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,P
272,207,31999,negative regulation of fatty acid beta-oxidation,P
273,207,10629,negative regulation of gene expression,P
274,207,16242,negative regulation of macroautophagy,P
275,207,1901215,negative regulation of neuron death,P
276,207,1902176,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,P
277,207,10748,negative regulation of plasma membrane long-chain fatty acid transport,P
278,207,6469,negative regulation of protein kinase activity,P
279,207,6469,negative regulation of protein kinase activity,P
280,207,100002,negative regulation of protein kinase activity by protein phosphorylation,P
281,207,45861,negative regulation of proteolysis,P
282,207,90201,negative regulation of release of cytochrome c from mitochondria,P
283,207,6809,nitric oxide biosynthetic process,P
284,207,1649,osteoblast differentiation,P
285,207,18105,peptidyl-serine phosphorylation,P
286,207,18105,peptidyl-serine phosphorylation,P
287,207,18107,peptidyl-threonine phosphorylation,P
288,207,32287,peripheral nervous system myelin maintenance,P
289,207,14065,phosphatidylinositol 3-kinase signaling,P
290,207,48015,phosphatidylinositol-mediated signaling,P
291,207,16310,phosphorylation,P
292,207,30168,platelet activation,P
293,207,1903721,positive regulation of I-kappaB phosphorylation,P
294,207,43065,positive regulation of apoptotic process,P
295,207,43536,positive regulation of blood vessel endothelial cell migration,P
296,207,30307,positive regulation of cell growth,P
297,207,32270,positive regulation of cellular protein metabolic process,P
298,207,31659,positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,P
299,207,32079,positive regulation of endodeoxyribonuclease activity,P
300,207,1938,positive regulation of endothelial cell proliferation,P
301,207,45742,positive regulation of epidermal growth factor receptor signaling pathway,P
302,207,90004,positive regulation of establishment of protein localization to plasma membrane,P
303,207,45600,positive regulation of fat cell differentiation,P
304,207,10763,positive regulation of fibroblast migration,P
305,207,46326,positive regulation of glucose import,P
306,207,10907,positive regulation of glucose metabolic process,P
307,207,45725,positive regulation of glycogen biosynthetic process,P
308,207,45725,positive regulation of glycogen biosynthetic process,P
309,207,46889,positive regulation of lipid biosynthetic process,P
310,207,45429,positive regulation of nitric oxide biosynthetic process,P
311,207,51000,positive regulation of nitric-oxide synthase activity,P
312,207,46622,positive regulation of organ growth,P
313,207,33138,positive regulation of peptidyl-serine phosphorylation,P
314,207,32436,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,P
315,207,1900182,positive regulation of protein localization to nucleus,P
316,207,1934,positive regulation of protein phosphorylation,P
317,207,51091,positive regulation of sequence-specific DNA binding transcription factor activity,P
318,207,48661,positive regulation of smooth muscle cell proliferation,P
319,207,10765,positive regulation of sodium ion transport,P
320,207,45944,positive regulation of transcription from RNA polymerase II promoter,P
321,207,45893,"positive regulation of transcription, DNA-templated",P
322,207,45907,positive regulation of vasoconstriction,P
323,207,46777,protein autophosphorylation,P
324,207,30163,protein catabolic process,P
325,207,60,"protein import into nucleus, translocation",P
326,207,43491,protein kinase B signaling,P
327,207,6468,protein phosphorylation,P
328,207,16567,protein ubiquitination,P
329,207,1901976,regulation of cell cycle checkpoint,P
330,207,30334,regulation of cell migration,P
331,207,30334,regulation of cell migration,P
332,207,5979,regulation of glycogen biosynthetic process,P
333,207,43488,regulation of mRNA stability,P
334,207,31641,regulation of myelination,P
335,207,10975,regulation of neuron projection development,P
336,207,50999,regulation of nitric-oxide synthase activity,P
337,207,14066,regulation of phosphatidylinositol 3-kinase signaling,P
338,207,1901796,regulation of signal transduction by p53 class mediator,P
339,207,6417,regulation of translation,P
340,207,70141,response to UV-A,P
341,207,34405,response to fluid shear stress,P
342,207,32094,response to food,P
343,207,60416,response to growth hormone,P
344,207,9408,response to heat,P
345,207,1990418,response to insulin-like growth factor stimulus,P
346,207,6979,response to oxidative stress,P
347,207,7165,signal transduction,P
348,207,21510,spinal cord development,P
349,207,51146,striated muscle cell differentiation,P
350,207,6412,translation,P
351,207,5911,cell-cell junction,C
352,207,36064,ciliary basal body,C
353,207,5737,cytoplasm,C
354,207,5737,cytoplasm,C
355,207,5737,cytoplasm,C
356,207,5829,cytosol,C
357,207,5829,cytosol,C
358,207,15630,microtubule cytoskeleton,C
359,207,5739,mitochondrion,C
360,207,5654,nucleoplasm,C
361,207,5634,nucleus,C
362,207,5634,nucleus,C
363,207,5886,plasma membrane,C
364,207,5886,plasma membrane,C
365,207,98794,postsynapse,C
366,207,43234,protein complex,C
367,207,5819,spindle,C
368,207,31982,vesicle,C
369,247,50473,arachidonate 15-lipoxygenase activity,F
370,247,50473,arachidonate 15-lipoxygenase activity,F
371,247,36403,arachidonate 8(S)-lipoxygenase activity,F
372,247,5509,calcium ion binding,F
373,247,5506,iron ion binding,F
374,247,16165,linoleate 13S-lipoxygenase activity,F
375,247,8289,lipid binding,F
376,247,6915,apoptotic process,P
377,247,19369,arachidonic acid metabolic process,P
378,247,51122,hepoxilin biosynthetic process,P
379,247,43651,linoleic acid metabolic process,P
380,247,6629,lipid metabolic process,P
381,247,19372,lipoxygenase pathway,P
382,247,45786,negative regulation of cell cycle,P
383,247,30336,negative regulation of cell migration,P
384,247,8285,negative regulation of cell proliferation,P
385,247,8285,negative regulation of cell proliferation,P
386,247,45926,negative regulation of growth,P
387,247,55114,oxidation-reduction process,P
388,247,90197,positive regulation of chemokine secretion,P
389,247,45618,positive regulation of keratinocyte differentiation,P
390,247,10744,positive regulation of macrophage derived foam cell differentiation,P
391,247,35360,positive regulation of peroxisome proliferator activated receptor signaling pathway,P
392,247,30850,prostate gland development,P
393,247,30856,regulation of epithelial cell differentiation,P
394,247,5856,cytoskeleton,C
395,247,5829,cytosol,C
396,247,5829,cytosol,C
397,247,70062,extracellular exosome,C
398,247,19898,extrinsic component of membrane,C
399,247,5622,intracellular,C
400,247,16020,membrane,C
401,247,5634,nucleus,C
402,247,5886,plasma membrane,C
403,367,51117,ATPase binding,F
404,367,3677,DNA binding,F
405,367,70974,POU domain binding,F
406,367,978,RNA polymerase II core promoter proximal region sequence-specific DNA binding,F
407,367,4879,"RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding",F
408,367,1085,RNA polymerase II transcription factor binding,F
409,367,5497,androgen binding,F
410,367,5497,androgen binding,F
411,367,4882,androgen receptor activity,F
412,367,4882,androgen receptor activity,F
413,367,4882,androgen receptor activity,F
414,367,4882,androgen receptor activity,F
415,367,8013,beta-catenin binding,F
416,367,8013,beta-catenin binding,F
417,367,8013,beta-catenin binding,F
418,367,3682,chromatin binding,F
419,367,19899,enzyme binding,F
420,367,5515,protein binding,F
421,367,46983,protein dimerization activity,F
422,367,5102,receptor binding,F
423,367,5496,steroid binding,F
424,367,3700,"transcription factor activity, sequence-specific DNA binding",F
425,367,3700,"transcription factor activity, sequence-specific DNA binding",F
426,367,8134,transcription factor binding,F
427,367,44212,transcription regulatory region DNA binding,F
428,367,1077,"transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding",F
429,367,8270,zinc ion binding,F
430,367,33327,Leydig cell differentiation,P
431,367,60520,activation of prostate induction by androgen receptor signaling pathway,P
432,367,30521,androgen receptor signaling pathway,P
433,367,48645,animal organ formation,P
434,367,16049,cell growth,P
435,367,8283,cell proliferation,P
436,367,7267,cell-cell signaling,P
437,367,71383,cellular response to steroid hormone stimulus,P
438,367,71394,cellular response to testosterone stimulus,P
439,367,60742,epithelial cell differentiation involved in prostate gland development,P
440,367,3382,epithelial cell morphogenesis,P
441,367,1701,in utero embryonic development,P
442,367,30522,intracellular receptor signaling pathway,P
443,367,60599,lateral sprouting involved in mammary gland duct morphogenesis,P
444,367,48808,male genitalia morphogenesis,P
445,367,19102,male somatic sex determination,P
446,367,60749,mammary gland alveolus development,P
447,367,60571,morphogenesis of an epithelial fold,P
448,367,35264,multicellular organism growth,P
449,367,8285,negative regulation of cell proliferation,P
450,367,50680,negative regulation of epithelial cell proliferation,P
451,367,2001237,negative regulation of extrinsic apoptotic signaling pathway,P
452,367,45720,negative regulation of integrin biosynthetic process,P
453,367,122,negative regulation of transcription from RNA polymerase II promoter,P
454,367,43410,positive regulation of MAPK cascade,P
455,367,51092,positive regulation of NF-kappaB transcription factor activity,P
456,367,45597,positive regulation of cell differentiation,P
457,367,8284,positive regulation of cell proliferation,P
458,367,60769,positive regulation of epithelial cell proliferation involved in prostate gland development,P
459,367,10628,positive regulation of gene expression,P
460,367,43568,positive regulation of insulin-like growth factor receptor signaling pathway,P
461,367,45726,positive regulation of integrin biosynthetic process,P
462,367,33148,positive regulation of intracellular estrogen receptor signaling pathway,P
463,367,42327,positive regulation of phosphorylation,P
464,367,45944,positive regulation of transcription from RNA polymerase II promoter,P
465,367,45944,positive regulation of transcription from RNA polymerase II promoter,P
466,367,45945,positive regulation of transcription from RNA polymerase III promoter,P
467,367,45893,"positive regulation of transcription, DNA-templated",P
468,367,30850,prostate gland development,P
469,367,60740,prostate gland epithelium morphogenesis,P
470,367,60736,prostate gland growth,P
471,367,16579,protein deubiquitination,P
472,367,51259,protein oligomerization,P
473,367,50790,regulation of catalytic activity,P
474,367,48638,regulation of developmental growth,P
475,367,90003,regulation of establishment of protein localization to plasma membrane,P
476,367,3073,regulation of systemic arterial blood pressure,P
477,367,72520,seminiferous tubule development,P
478,367,7548,sex differentiation,P
479,367,7165,signal transduction,P
480,367,7338,single fertilization,P
481,367,7283,spermatogenesis,P
482,367,60748,tertiary branching involved in mammary gland duct morphogenesis,P
483,367,6367,transcription initiation from RNA polymerase II promoter,P
484,367,6351,"transcription, DNA-templated",P
485,367,6810,transport,P
486,367,5737,cytoplasm,C
487,367,5829,cytosol,C
488,367,790,nuclear chromatin,C
489,367,16607,nuclear speck,C
490,367,5654,nucleoplasm,C
491,367,5634,nucleus,C
492,367,5886,plasma membrane,C
493,367,43234,protein complex,C
494,10095,51015,actin filament binding,F
495,10095,5200,structural constituent of cytoskeleton,F
496,10095,34314,Arp2/3 complex-mediated actin nucleation,P
497,10095,38096,Fc-gamma receptor signaling pathway involved in phagocytosis,P
498,10095,48013,ephrin receptor signaling pathway,P
499,10095,6928,movement of cell or subcellular component,P
500,10095,32355,response to estradiol,P
501,10095,43627,response to estrogen,P
502,10095,5885,Arp2/3 protein complex,C
503,10095,15629,actin cytoskeleton,C
504,10095,5829,cytosol,C
505,10095,70062,extracellular exosome,C
506,10095,5925,focal adhesion,C
507,10095,36284,tubulobulbar complex,C
508,25842,3682,chromatin binding,F
509,25842,42393,histone binding,F
510,25842,5515,protein binding,F
511,25842,6281,DNA repair,P
512,25842,6335,DNA replication-dependent nucleosome assembly,P
513,25842,6336,DNA replication-independent nucleosome assembly,P
514,25842,16569,covalent chromatin modification,P
515,25842,42692,muscle cell differentiation,P
516,25842,31936,negative regulation of chromatin silencing,P
517,25842,6334,nucleosome assembly,P
518,25842,1649,osteoblast differentiation,P
519,25842,6351,"transcription, DNA-templated",P
520,25842,790,nuclear chromatin,C
521,25842,5654,nucleoplasm,C
522,25842,5654,nucleoplasm,C
523,25842,5634,nucleus,C
524,25842,5634,nucleus,C
525,25842,43234,protein complex,C
526,444,5509,calcium ion binding,F
527,444,9055,electron carrier activity,F
528,444,4597,peptide-aspartate beta-dioxygenase activity,F
529,444,5515,protein binding,F
530,444,8307,structural constituent of muscle,F
531,444,5198,structural molecule activity,F
532,444,97202,activation of cysteine-type endopeptidase activity,P
533,444,60325,face morphogenesis,P
534,444,34220,ion transmembrane transport,P
535,444,35108,limb morphogenesis,P
536,444,6936,muscle contraction,P
537,444,8285,negative regulation of cell proliferation,P
538,444,55114,oxidation-reduction process,P
539,444,60021,palate development,P
540,444,7389,pattern specification process,P
541,444,42264,peptidyl-aspartic acid hydroxylation,P
542,444,45862,positive regulation of proteolysis,P
543,444,1903779,regulation of cardiac conduction,P
544,444,1901879,regulation of protein depolymerization,P
545,444,31647,regulation of protein stability,P
546,444,32541,cortical endoplasmic reticulum,C
547,444,5783,endoplasmic reticulum,C
548,444,5789,endoplasmic reticulum membrane,C
549,444,5789,endoplasmic reticulum membrane,C
550,444,16021,integral component of membrane,C
551,444,5886,plasma membrane,C
552,444,16529,sarcoplasmic reticulum,C
553,444,33017,sarcoplasmic reticulum membrane,C
554,55729,16887,ATPase activity,F
555,55729,5515,protein binding,F
556,55729,3714,transcription corepressor activity,F
557,55729,6306,DNA methylation,P
558,55729,122,negative regulation of transcription from RNA polymerase II promoter,P
559,55729,45892,"negative regulation of transcription, DNA-templated",P
560,55729,45893,"positive regulation of transcription, DNA-templated",P
561,55729,45898,regulation of RNA polymerase II transcriptional preinitiation complex assembly,P
562,55729,6351,"transcription, DNA-templated",P
563,55729,16032,viral process,P
564,55729,5829,cytosol,C
565,55729,16604,nuclear body,C
566,55729,5654,nucleoplasm,C
567,55729,5654,nucleoplasm,C
568,55729,5634,nucleus,C
569,55729,5667,transcription factor complex,C
570,472,16303,1-phosphatidylinositol-3-kinase activity,F
571,472,5524,ATP binding,F
572,472,3677,DNA binding,F
573,472,4677,DNA-dependent protein kinase activity,F
574,472,47485,protein N-terminus binding,F
575,472,5515,protein binding,F
576,472,32403,protein complex binding,F
577,472,46983,protein dimerization activity,F
578,472,4674,protein serine/threonine kinase activity,F
579,472,4674,protein serine/threonine kinase activity,F
580,472,6975,DNA damage induced protein phosphorylation,P
581,472,6975,DNA damage induced protein phosphorylation,P
582,472,6977,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest",P
583,472,729,DNA double-strand break processing,P
584,472,6260,DNA replication,P
585,472,731,DNA synthesis involved in DNA repair,P
586,472,33151,V(D)J recombination,P
587,472,7420,brain development,P
588,472,7050,cell cycle arrest,P
589,472,6974,cellular response to DNA damage stimulus,P
590,472,6974,cellular response to DNA damage stimulus,P
591,472,71481,cellular response to X-ray,P
592,472,71480,cellular response to gamma radiation,P
593,472,71500,cellular response to nitrosative stress,P
594,472,8340,determination of adult lifespan,P
595,472,724,double-strand break repair via homologous recombination,P
596,472,6303,double-strand break repair via nonhomologous end joining,P
597,472,97694,establishment of RNA localization to telomere,P
598,472,97695,establishment of macromolecular complex localization to telomere,P
599,472,7143,female meiotic nuclear division,P
600,472,7507,heart development,P
601,472,71044,histone mRNA catabolic process,P
602,472,2377,immunoglobulin production,P
603,472,8630,intrinsic apoptotic signaling pathway in response to DNA damage,P
604,472,42159,lipoprotein catabolic process,P
605,472,7140,male meiotic nuclear division,P
606,472,45141,meiotic telomere clustering,P
607,472,7094,mitotic spindle assembly checkpoint,P
608,472,35264,multicellular organism growth,P
609,472,30889,negative regulation of B cell proliferation,P
610,472,1904262,negative regulation of TORC1 signaling,P
611,472,1904354,negative regulation of telomere capping,P
612,472,51402,neuron apoptotic process,P
613,472,48599,oocyte development,P
614,472,1541,ovarian follicle development,P
615,472,36289,peptidyl-serine autophosphorylation,P
616,472,18105,peptidyl-serine phosphorylation,P
617,472,36092,phosphatidylinositol-3-phosphate biosynthetic process,P
618,472,43517,"positive regulation of DNA damage response, signal transduction by p53 class mediator",P
619,472,43065,positive regulation of apoptotic process,P
620,472,33129,positive regulation of histone phosphorylation,P
621,472,43525,positive regulation of neuron apoptotic process,P
622,472,1904884,positive regulation of telomerase catalytic core complex assembly,P
623,472,32212,positive regulation of telomere maintenance via telomerase,P
624,472,1904358,positive regulation of telomere maintenance via telomere lengthening,P
625,472,9791,post-embryonic development,P
626,472,2331,pre-B cell allelic exclusion,P
627,472,46777,protein autophosphorylation,P
628,472,46777,protein autophosphorylation,P
629,472,6468,protein phosphorylation,P
630,472,6468,protein phosphorylation,P
631,472,7131,reciprocal meiotic recombination,P
632,472,42981,regulation of apoptotic process,P
633,472,10506,regulation of autophagy,P
634,472,1900034,regulation of cellular response to heat,P
635,472,1901796,regulation of signal transduction by p53 class mediator,P
636,472,51972,regulation of telomerase activity,P
637,472,32210,regulation of telomere maintenance via telomerase,P
638,472,90399,replicative senescence,P
639,472,1666,response to hypoxia,P
640,472,10212,response to ionizing radiation,P
641,472,7165,signal transduction,P
642,472,72434,signal transduction involved in mitotic G2 DNA damage checkpoint,P
643,472,1756,somitogenesis,P
644,472,732,strand displacement,P
645,472,48538,thymus development,P
646,472,1990391,DNA repair complex,C
647,472,781,"chromosome, telomeric region",C
648,472,31410,cytoplasmic vesicle,C
649,472,784,"nuclear chromosome, telomeric region",C
650,472,5654,nucleoplasm,C
651,472,5634,nucleus,C
652,472,5819,spindle,C
653,6790,5524,ATP binding,F
654,6790,35174,histone serine kinase activity,F
655,6790,5515,protein binding,F
656,6790,46982,protein heterodimerization activity,F
657,6790,4672,protein kinase activity,F
658,6790,19901,protein kinase binding,F
659,6790,4674,protein serine/threonine kinase activity,F
660,6790,4674,protein serine/threonine kinase activity,F
661,6790,4712,protein serine/threonine/tyrosine kinase activity,F
662,6790,31625,ubiquitin protein ligase binding,F
663,6790,6977,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest",P
664,6790,86,G2/M transition of mitotic cell cycle,P
665,6790,31145,anaphase-promoting complex-dependent catabolic process,P
666,6790,9948,anterior/posterior axis specification,P
667,6790,51301,cell division,P
668,6790,51642,centrosome localization,P
669,6790,35404,histone-serine phosphorylation,P
670,6790,97421,liver regeneration,P
671,6790,278,mitotic cell cycle,P
672,6790,7100,mitotic centrosome separation,P
673,6790,7052,mitotic spindle organization,P
674,6790,10972,negative regulation of G2/M transition of mitotic cell cycle,P
675,6790,43066,negative regulation of apoptotic process,P
676,6790,32091,negative regulation of protein binding,P
677,6790,1990138,neuron projection extension,P
678,6790,45840,positive regulation of mitotic nuclear division,P
679,6790,1900195,positive regulation of oocyte maturation,P
680,6790,32436,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,P
681,6790,46777,protein autophosphorylation,P
682,6790,71539,protein localization to centrosome,P
683,6790,6468,protein phosphorylation,P
684,6790,42787,protein ubiquitination involved in ubiquitin-dependent protein catabolic process,P
685,6790,46605,regulation of centrosome cycle,P
686,6790,32465,regulation of cytokinesis,P
687,6790,31647,regulation of protein stability,P
688,6790,1901796,regulation of signal transduction by p53 class mediator,P
689,6790,9611,response to wounding,P
690,6790,7057,spindle assembly involved in female meiosis I,P
691,6790,7051,spindle organization,P
692,6790,43203,axon hillock,C
693,6790,5814,centriole,C
694,6790,5813,centrosome,C
695,6790,5813,centrosome,C
696,6790,32133,chromosome passenger complex,C
697,6790,5929,cilium,C
698,6790,780,"condensed nuclear chromosome, centromeric region",C
699,6790,5829,cytosol,C
700,6790,5829,cytosol,C
701,6790,42585,germinal vesicle,C
702,6790,72687,meiotic spindle,C
703,6790,15630,microtubule cytoskeleton,C
704,6790,30496,midbody,C
705,6790,97431,mitotic spindle pole,C
706,6790,5654,nucleoplasm,C
707,6790,5634,nucleus,C
708,6790,48471,perinuclear region of cytoplasm,C
709,6790,45120,pronucleus,C
710,6790,5819,spindle,C
711,6790,5876,spindle microtubule,C
712,6790,51233,spindle midzone,C
713,6790,31616,spindle pole centrosome,C
714,558,5524,ATP binding,F
715,558,32036,myosin heavy chain binding,F
716,558,43548,phosphatidylinositol 3-kinase binding,F
717,558,1786,phosphatidylserine binding,F
718,558,5515,protein binding,F
719,558,46982,protein heterodimerization activity,F
720,558,4713,protein tyrosine kinase activity,F
721,558,4714,transmembrane receptor protein tyrosine kinase activity,F
722,558,1618,virus receptor activity,F
723,558,31100,animal organ regeneration,P
724,558,43277,apoptotic cell clearance,P
725,558,1974,blood vessel remodeling,P
726,558,48469,cell maturation,P
727,558,31668,cellular response to extracellular stimulus,P
728,558,70301,cellular response to hydrogen peroxide,P
729,558,35457,cellular response to interferon-alpha,P
730,558,71222,cellular response to lipopolysaccharide,P
731,558,97028,dendritic cell differentiation,P
732,558,34101,erythrocyte homeostasis,P
733,558,21885,forebrain cell migration,P
734,558,6954,inflammatory response,P
735,558,45087,innate immune response,P
736,558,1779,natural killer cell differentiation,P
737,558,2000669,negative regulation of dendritic cell apoptotic process,P
738,558,32689,negative regulation of interferon-gamma production,P
739,558,51250,negative regulation of lymphocyte activation,P
740,558,43524,negative regulation of neuron apoptotic process,P
741,558,32720,negative regulation of tumor necrosis factor production,P
742,558,1764,neuron migration,P
743,558,97350,neutrophil clearance,P
744,558,42698,ovulation cycle,P
745,558,18108,peptidyl-tyrosine phosphorylation,P
746,558,6909,phagocytosis,P
747,558,30168,platelet activation,P
748,558,1961,positive regulation of cytokine-mediated signaling pathway,P
749,558,32825,positive regulation of natural killer cell differentiation,P
750,558,48549,positive regulation of pinocytosis,P
751,558,51897,positive regulation of protein kinase B signaling,P
752,558,43491,protein kinase B signaling,P
753,558,32940,secretion by cell,P
754,558,7165,signal transduction,P
755,558,7283,spermatogenesis,P
756,558,34446,substrate adhesion-dependent cell spreading,P
757,558,60068,vagina development,P
758,558,48010,vascular endothelial growth factor receptor signaling pathway,P
759,558,46718,viral entry into host cell,P
760,558,9986,cell surface,C
761,558,70062,extracellular exosome,C
762,558,5615,extracellular space,C
763,558,44228,host cell surface,C
764,558,5887,integral component of plasma membrane,C
765,558,5622,intracellular,C
766,558,5886,plasma membrane,C
767,9531,774,adenyl-nucleotide exchange factor activity,F
768,9531,774,adenyl-nucleotide exchange factor activity,F
769,9531,45296,cadherin binding,F
770,9531,51087,chaperone binding,F
771,9531,5515,protein binding,F
772,9531,32403,protein complex binding,F
773,9531,7420,brain development,P
774,9531,34605,cellular response to heat,P
775,9531,71260,cellular response to mechanical stimulus,P
776,9531,97192,extrinsic apoptotic signaling pathway in absence of ligand,P
777,9531,8625,extrinsic apoptotic signaling pathway via death domain receptors,P
778,9531,43066,negative regulation of apoptotic process,P
779,9531,10664,negative regulation of striated muscle cell apoptotic process,P
780,9531,97201,negative regulation of transcription from RNA polymerase II promoter in response to stress,P
781,9531,46827,positive regulation of protein export from nucleus,P
782,9531,42993,positive regulation of transcription factor import into nucleus,P
783,9531,6457,protein folding,P
784,9531,50821,protein stabilization,P
785,9531,50790,regulation of catalytic activity,P
786,9531,1900034,regulation of cellular response to heat,P
787,9531,21510,spinal cord development,P
788,9531,30018,Z disc,C
789,9531,5737,cytoplasm,C
790,9531,5829,cytosol,C
791,9531,5829,cytosol,C
792,9531,43005,neuron projection,C
793,9531,5634,nucleus,C
794,9531,5886,plasma membrane,C
795,8553,70888,E-box binding,F
796,8553,43426,MRF binding,F
797,8553,1102,RNA polymerase II activating transcription factor binding,F
798,8553,981,"RNA polymerase II transcription factor activity, sequence-specific DNA binding",F
799,8553,43425,bHLH transcription factor binding,F
800,8553,5515,protein binding,F
801,8553,19904,protein domain specific binding,F
802,8553,46982,protein heterodimerization activity,F
803,8553,42803,protein homodimerization activity,F
804,8553,3714,transcription corepressor activity,F
805,8553,3705,"transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding",F
806,8553,3700,"transcription factor activity, sequence-specific DNA binding",F
807,8553,1078,"transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding",F
808,8553,1191,"transcriptional repressor activity, RNA polymerase II transcription factor binding",F
809,8553,32922,circadian regulation of gene expression,P
810,8553,43153,entrainment of circadian clock by photoperiod,P
811,8553,43433,negative regulation of sequence-specific DNA binding transcription factor activity,P
812,8553,122,negative regulation of transcription from RNA polymerase II promoter,P
813,8553,45892,"negative regulation of transcription, DNA-templated",P
814,8553,6355,"regulation of transcription, DNA-templated",P
815,8553,6351,"transcription, DNA-templated",P
816,8553,5737,cytoplasm,C
817,8553,16604,nuclear body,C
818,8553,5634,nucleus,C
819,8553,5634,nucleus,C
820,604,977,RNA polymerase II regulatory region sequence-specific DNA binding,F
821,604,31490,chromatin DNA binding,F
822,604,3682,chromatin binding,F
823,604,42802,identical protein binding,F
824,604,1161,intronic transcription regulatory region sequence-specific DNA binding,F
825,604,46872,metal ion binding,F
826,604,5515,protein binding,F
827,604,43565,sequence-specific DNA binding,F
828,604,3700,"transcription factor activity, sequence-specific DNA binding",F
829,604,1227,"transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding",F
830,604,30183,B cell differentiation,P
831,604,7266,Rho protein signal transduction,P
832,604,30036,actin cytoskeleton organization,P
833,604,902,cell morphogenesis,P
834,604,6974,cellular response to DNA damage stimulus,P
835,604,48821,erythrocyte development,P
836,604,2467,germinal center formation,P
837,604,6954,inflammatory response,P
838,604,2903,negative regulation of B cell apoptotic process,P
839,604,45746,negative regulation of Notch signaling pathway,P
840,604,35024,negative regulation of Rho protein signal transduction,P
841,604,45629,negative regulation of T-helper 2 cell differentiation,P
842,604,30308,negative regulation of cell growth,P
843,604,8285,negative regulation of cell proliferation,P
844,604,1953,negative regulation of cell-matrix adhesion,P
845,604,2000773,negative regulation of cellular senescence,P
846,604,48294,negative regulation of isotype switching to IgE isotypes,P
847,604,32764,negative regulation of mast cell cytokine production,P
848,604,1903464,negative regulation of mitotic cell cycle DNA replication,P
849,604,122,negative regulation of transcription from RNA polymerase II promoter,P
850,604,45892,"negative regulation of transcription, DNA-templated",P
851,604,45892,"negative regulation of transcription, DNA-templated",P
852,604,30890,positive regulation of B cell proliferation,P
853,604,43065,positive regulation of apoptotic process,P
854,604,51272,positive regulation of cellular component movement,P
855,604,31065,positive regulation of histone deacetylation,P
856,604,45666,positive regulation of neuron differentiation,P
857,604,45591,positive regulation of regulatory T cell differentiation,P
858,604,60,"protein import into nucleus, translocation",P
859,604,43087,regulation of GTPase activity,P
860,604,42981,regulation of apoptotic process,P
861,604,42127,regulation of cell proliferation,P
862,604,2634,regulation of germinal center formation,P
863,604,50776,regulation of immune response,P
864,604,50727,regulation of inflammatory response,P
865,604,43380,regulation of memory T cell differentiation,P
866,604,7283,spermatogenesis,P
867,604,6351,"transcription, DNA-templated",P
868,604,42092,type 2 immune response,P
869,604,5794,Golgi apparatus,C
870,604,5654,nucleoplasm,C
871,604,5654,nucleoplasm,C
872,604,5634,nucleus,C
873,604,5657,replication fork,C
874,640,5524,ATP binding,F
875,640,4715,non-membrane spanning protein tyrosine kinase activity,F
876,640,5515,protein binding,F
877,640,4713,protein tyrosine kinase activity,F
878,640,5102,receptor binding,F
879,640,50853,B cell receptor signaling pathway,P
880,640,30154,cell differentiation,P
881,640,16477,cell migration,P
882,640,45087,innate immune response,P
883,640,35556,intracellular signal transduction,P
884,640,38083,peptidyl-tyrosine autophosphorylation,P
885,640,32024,positive regulation of insulin secretion,P
886,640,42127,regulation of cell proliferation,P
887,640,7169,transmembrane receptor protein tyrosine kinase signaling pathway,P
888,640,31234,extrinsic component of cytoplasmic side of plasma membrane,C
889,644,4074,biliverdin reductase activity,F
890,644,4074,biliverdin reductase activity,F
891,644,5515,protein binding,F
892,644,8270,zinc ion binding,F
893,644,42167,heme catabolic process,P
894,644,55114,oxidation-reduction process,P
895,644,5829,cytosol,C
896,644,5829,cytosol,C
897,644,70062,extracellular exosome,C
898,648,71535,RING-like zinc finger domain binding,F
899,648,1990841,promoter-specific chromatin binding,F
900,648,5515,protein binding,F
901,648,8270,zinc ion binding,F
902,648,16569,covalent chromatin modification,P
903,648,30097,hemopoiesis,P
904,648,45814,"negative regulation of gene expression, epigenetic",P
905,648,122,negative regulation of transcription from RNA polymerase II promoter,P
906,648,48146,positive regulation of fibroblast proliferation,P
907,648,51443,positive regulation of ubiquitin-protein transferase activity,P
908,648,10468,regulation of gene expression,P
909,648,7379,segment specification,P
910,648,6351,"transcription, DNA-templated",P
911,648,35102,PRC1 complex,C
912,648,31519,PcG protein complex,C
913,648,5829,cytosol,C
914,648,16604,nuclear body,C
915,648,5654,nucleoplasm,C
916,648,5634,nucleus,C
917,648,151,ubiquitin ligase complex,C
918,673,5524,ATP binding,F
919,673,4709,MAP kinase kinase kinase activity,F
920,673,5509,calcium ion binding,F
921,673,42802,identical protein binding,F
922,673,31434,mitogen-activated protein kinase kinase binding,F
923,673,5515,protein binding,F
924,673,46982,protein heterodimerization activity,F
925,673,4672,protein kinase activity,F
926,673,4674,protein serine/threonine kinase activity,F
927,673,31267,small GTPase binding,F
928,673,43369,"CD4-positive or CD8-positive, alpha-beta T cell lineage commitment",P
929,673,43367,"CD4-positive, alpha-beta T cell differentiation",P
930,673,165,MAPK cascade,P
931,673,50852,T cell receptor signaling pathway,P
932,673,186,activation of MAPKK activity,P
933,673,9887,animal organ morphogenesis,P
934,673,30154,cell differentiation,P
935,673,71277,cellular response to calcium ion,P
936,673,35690,cellular response to drug,P
937,673,1990090,cellular response to nerve growth factor stimulus,P
938,673,90150,establishment of protein localization to membrane,P
939,673,60324,face development,P
940,673,15758,glucose transport,P
941,673,60323,head morphogenesis,P
942,673,60291,long-term synaptic potentiation,P
943,673,2318,myeloid progenitor cell differentiation,P
944,673,43066,negative regulation of apoptotic process,P
945,673,2000352,negative regulation of endothelial cell apoptotic process,P
946,673,10764,negative regulation of fibroblast migration,P
947,673,43524,negative regulation of neuron apoptotic process,P
948,673,9968,negative regulation of signal transduction,P
949,673,2000301,negative regulation of synaptic vesicle exocytosis,P
950,673,70374,positive regulation of ERK1 and ERK2 cascade,P
951,673,48680,positive regulation of axon regeneration,P
952,673,50772,positive regulation of axonogenesis,P
953,673,10628,positive regulation of gene expression,P
954,673,33138,positive regulation of peptidyl-serine phosphorylation,P
955,673,51496,positive regulation of stress fiber assembly,P
956,673,1900026,positive regulation of substrate adhesion-dependent cell spreading,P
957,673,51291,protein heterooligomerization,P
958,673,6468,protein phosphorylation,P
959,673,45580,regulation of T cell differentiation,P
960,673,42127,regulation of cell proliferation,P
961,673,51591,response to cAMP,P
962,673,43434,response to peptide hormone,P
963,673,35019,somatic stem cell population maintenance,P
964,673,48538,thymus development,P
965,673,30878,thyroid gland development,P
966,673,8542,visual learning,P
967,673,44297,cell body,C
968,673,5829,cytosol,C
969,673,5829,cytosol,C
970,673,5622,intracellular,C
971,673,43231,intracellular membrane-bounded organelle,C
972,673,5739,mitochondrion,C
973,673,43005,neuron projection,C
974,673,5634,nucleus,C
975,673,5886,plasma membrane,C
976,673,5886,plasma membrane,C
977,29117,42393,histone binding,F
978,29117,70577,lysine-acetylated histone binding,F
979,29117,2039,p53 binding,F
980,29117,5515,protein binding,F
981,29117,3713,transcription coactivator activity,F
982,29117,3714,transcription corepressor activity,F
983,29117,3714,transcription corepressor activity,F
984,29117,8134,transcription factor binding,F
985,29117,44212,transcription regulatory region DNA binding,F
986,29117,16055,Wnt signaling pathway,P
987,29117,7049,cell cycle,P
988,29117,2000134,negative regulation of G1/S transition of mitotic cell cycle,P
989,29117,8285,negative regulation of cell proliferation,P
990,29117,45892,"negative regulation of transcription, DNA-templated",P
991,29117,35066,positive regulation of histone acetylation,P
992,29117,45893,"positive regulation of transcription, DNA-templated",P
993,29117,1901796,regulation of signal transduction by p53 class mediator,P
994,29117,6357,regulation of transcription from RNA polymerase II promoter,P
995,29117,6351,"transcription, DNA-templated",P
996,29117,90544,BAF-type complex,C
997,29117,5737,cytoplasm,C
998,29117,5829,cytosol,C
999,29117,5654,nucleoplasm,C
1000,29117,5654,nucleoplasm,C
1001,29117,5634,nucleus,C
1002,672,3677,DNA binding,F
1003,672,3723,RNA binding,F
1004,672,50681,androgen receptor binding,F
1005,672,3684,damaged DNA binding,F
1006,672,19899,enzyme binding,F
1007,672,5515,protein binding,F
1008,672,3713,transcription coactivator activity,F
1009,672,44212,transcription regulatory region DNA binding,F
1010,672,15631,tubulin binding,F
1011,672,31625,ubiquitin protein ligase binding,F
1012,672,4842,ubiquitin-protein transferase activity,F
1013,672,8270,zinc ion binding,F
1014,672,6978,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator",P
1015,672,729,DNA double-strand break processing,P
1016,672,6260,DNA replication,P
1017,672,731,DNA synthesis involved in DNA repair,P
1018,672,31572,G2 DNA damage checkpoint,P
1019,672,30521,androgen receptor signaling pathway,P
1020,672,6915,apoptotic process,P
1021,672,6974,cellular response to DNA damage stimulus,P
1022,672,71681,cellular response to indole-3-methanol,P
1023,672,71356,cellular response to tumor necrosis factor,P
1024,672,7098,centrosome cycle,P
1025,672,43009,chordate embryonic development,P
1026,672,7059,chromosome segregation,P
1027,672,9048,dosage compensation by inactivation of X chromosome,P
1028,672,6302,double-strand break repair,P
1029,672,6302,double-strand break repair,P
1030,672,724,double-strand break repair via homologous recombination,P
1031,672,6303,double-strand break repair via nonhomologous end joining,P
1032,672,6633,fatty acid biosynthetic process,P
1033,672,8630,intrinsic apoptotic signaling pathway in response to DNA damage,P
1034,672,44818,mitotic G2/M transition checkpoint,P
1035,672,46600,negative regulation of centriole replication,P
1036,672,1902042,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,P
1037,672,45717,negative regulation of fatty acid biosynthetic process,P
1038,672,51572,negative regulation of histone H3-K4 methylation,P
1039,672,51573,negative regulation of histone H3-K9 methylation,P
1040,672,35067,negative regulation of histone acetylation,P
1041,672,33147,negative regulation of intracellular estrogen receptor signaling pathway,P
1042,672,2000378,negative regulation of reactive oxygen species metabolic process,P
1043,672,45892,"negative regulation of transcription, DNA-templated",P
1044,672,45739,positive regulation of DNA repair,P
1045,672,45766,positive regulation of angiogenesis,P
1046,672,71158,positive regulation of cell cycle arrest,P
1047,672,10628,positive regulation of gene expression,P
1048,672,51571,positive regulation of histone H3-K4 methylation,P
1049,672,2000617,positive regulation of histone H3-K9 acetylation,P
1050,672,51574,positive regulation of histone H3-K9 methylation,P
1051,672,2000620,positive regulation of histone H4-K16 acetylation,P
1052,672,70512,positive regulation of histone H4-K20 methylation,P
1053,672,35066,positive regulation of histone acetylation,P
1054,672,31398,positive regulation of protein ubiquitination,P
1055,672,45944,positive regulation of transcription from RNA polymerase II promoter,P
1056,672,45944,positive regulation of transcription from RNA polymerase II promoter,P
1057,672,45893,"positive regulation of transcription, DNA-templated",P
1058,672,45893,"positive regulation of transcription, DNA-templated",P
1059,672,45893,"positive regulation of transcription, DNA-templated",P
1060,672,10575,positive regulation of vascular endothelial growth factor production,P
1061,672,6301,postreplication repair,P
1062,672,85020,protein K6-linked ubiquitination,P
1063,672,51865,protein autoubiquitination,P
1064,672,16579,protein deubiquitination,P
1065,672,16567,protein ubiquitination,P
1066,672,44030,regulation of DNA methylation,P
1067,672,42981,regulation of apoptotic process,P
1068,672,42127,regulation of cell proliferation,P
1069,672,6349,regulation of gene expression by genetic imprinting,P
1070,672,1901796,regulation of signal transduction by p53 class mediator,P
1071,672,6357,regulation of transcription from RNA polymerase II promoter,P
1072,672,6359,regulation of transcription from RNA polymerase III promoter,P
1073,672,43627,response to estrogen,P
1074,672,10212,response to ionizing radiation,P
1075,672,732,strand displacement,P
1076,672,6351,"transcription, DNA-templated",P
1077,672,70531,BRCA1-A complex,C
1078,672,31436,BRCA1-BARD1 complex,C
1079,672,5694,chromosome,C
1080,672,5737,cytoplasm,C
1081,672,8274,gamma-tubulin ring complex,C
1082,672,30529,intracellular ribonucleoprotein complex,C
1083,672,800,lateral element,C
1084,672,5654,nucleoplasm,C
1085,672,5634,nucleus,C
1086,672,5886,plasma membrane,C
1087,672,43234,protein complex,C
1088,672,151,ubiquitin ligase complex,C
1089,10950,5515,protein binding,F
1090,10950,8285,negative regulation of cell proliferation,P
1091,10950,45930,negative regulation of mitotic cell cycle,P
1092,10950,5737,cytoplasm,C
1093,280636,3723,RNA binding,F
1094,857,51117,ATPase binding,F
1095,857,48365,Rac GTPase binding,F
1096,857,15485,cholesterol binding,F
1097,857,19899,enzyme binding,F
1098,857,42802,identical protein binding,F
1099,857,70320,inward rectifier potassium channel inhibitor activity,F
1100,857,44325,ion channel binding,F
1101,857,50998,nitric-oxide synthase binding,F
1102,857,5113,patched binding,F
1103,857,16504,peptidase activator activity,F
1104,857,5515,protein binding,F
1105,857,30674,"protein binding, bridging",F
1106,857,32947,protein complex scaffold,F
1107,857,46982,protein heterodimerization activity,F
1108,857,19901,protein kinase binding,F
1109,857,5102,receptor binding,F
1110,857,5198,structural molecule activity,F
1111,857,165,MAPK cascade,P
1112,857,31295,T cell costimulation,P
1113,857,1525,angiogenesis,P
1114,857,86098,angiotensin-activated signaling pathway involved in heart process,P
1115,857,97190,apoptotic signaling pathway,P
1116,857,1904886,beta-catenin destruction complex disassembly,P
1117,857,55074,calcium ion homeostasis,P
1118,857,6816,calcium ion transport,P
1119,857,70836,caveola assembly,P
1120,857,70836,caveola assembly,P
1121,857,70836,caveola assembly,P
1122,857,72584,caveolin-mediated endocytosis,P
1123,857,6874,cellular calcium ion homeostasis,P
1124,857,71360,cellular response to exogenous dsRNA,P
1125,857,71455,cellular response to hyperoxia,P
1126,857,71375,cellular response to peptide hormone stimulus,P
1127,857,71560,cellular response to transforming growth factor beta stimulus,P
1128,857,42632,cholesterol homeostasis,P
1129,857,42632,cholesterol homeostasis,P
1130,857,30301,cholesterol transport,P
1131,857,188,inactivation of MAPK activity,P
1132,857,7595,lactation,P
1133,857,50900,leukocyte migration,P
1134,857,19915,lipid storage,P
1135,857,32507,maintenance of protein location in cell,P
1136,857,30879,mammary gland development,P
1137,857,60056,mammary gland involution,P
1138,857,51899,membrane depolarization,P
1139,857,46426,negative regulation of JAK-STAT cascade,P
1140,857,43409,negative regulation of MAPK cascade,P
1141,857,2000811,negative regulation of anoikis,P
1142,857,90090,negative regulation of canonical Wnt signaling pathway,P
1143,857,1960,negative regulation of cytokine-mediated signaling pathway,P
1144,857,1937,negative regulation of endothelial cell proliferation,P
1145,857,30857,negative regulation of epithelial cell differentiation,P
1146,857,60546,negative regulation of necroptotic process,P
1147,857,45019,negative regulation of nitric oxide biosynthetic process,P
1148,857,51001,negative regulation of nitric-oxide synthase activity,P
1149,857,33137,negative regulation of peptidyl-serine phosphorylation,P
1150,857,1900085,negative regulation of peptidyl-tyrosine autophosphorylation,P
1151,857,48550,negative regulation of pinocytosis,P
1152,857,1901380,negative regulation of potassium ion transmembrane transport,P
1153,857,32091,negative regulation of protein binding,P
1154,857,61099,negative regulation of protein tyrosine kinase activity,P
1155,857,31397,negative regulation of protein ubiquitination,P
1156,857,122,negative regulation of transcription from RNA polymerase II promoter,P
1157,857,30512,negative regulation of transforming growth factor beta receptor signaling pathway,P
1158,857,33484,nitric oxide homeostasis,P
1159,857,1903071,positive regulation of ER-associated ubiquitin-dependent protein catabolic process,P
1160,857,10524,positive regulation of calcium ion transport into cytosol,P
1161,857,90263,positive regulation of canonical Wnt signaling pathway,P
1162,857,43085,positive regulation of catalytic activity,P
1163,857,60355,positive regulation of cell adhesion molecule production,P
1164,857,2001238,positive regulation of extrinsic apoptotic signaling pathway,P
1165,857,1903598,positive regulation of gap junction assembly,P
1166,857,10628,positive regulation of gene expression,P
1167,857,2001244,positive regulation of intrinsic apoptotic signaling pathway,P
1168,857,10952,positive regulation of peptidase activity,P
1169,857,33138,positive regulation of peptidyl-serine phosphorylation,P
1170,857,32092,positive regulation of protein binding,P
1171,857,31398,positive regulation of protein ubiquitination,P
1172,857,34141,positive regulation of toll-like receptor 3 signaling pathway,P
1173,857,45907,positive regulation of vasoconstriction,P
1174,857,10608,posttranscriptional regulation of gene expression,P
1175,857,51260,protein homooligomerization,P
1176,857,8104,protein localization,P
1177,857,1903361,protein localization to basolateral plasma membrane,P
1178,857,44860,protein localization to plasma membrane raft,P
1179,857,31623,receptor internalization,P
1180,857,2000286,receptor internalization involved in canonical Wnt signaling pathway,P
1181,857,19065,receptor-mediated endocytosis of virus by host cell,P
1182,857,30193,regulation of blood coagulation,P
1183,857,98909,regulation of cardiac muscle cell action potential involved in regulation of contraction,P
1184,857,1901844,regulation of cell communication by electrical coupling involved in cardiac conduction,P
1185,857,51480,regulation of cytosolic calcium ion concentration,P
1186,857,2000535,regulation of entry of bacterium into host cell,P
1187,857,19217,regulation of fatty acid metabolic process,P
1188,857,86091,regulation of heart rate by cardiac conduction,P
1189,857,1901979,regulation of inward rectifier potassium channel activity,P
1190,857,98903,regulation of membrane repolarization during action potential,P
1191,857,50999,regulation of nitric-oxide synthase activity,P
1192,857,52547,regulation of peptidase activity,P
1193,857,1900027,regulation of ruffle assembly,P
1194,857,6940,regulation of smooth muscle contraction,P
1195,857,3057,regulation of the force of heart contraction by chemical signal,P
1196,857,98911,regulation of ventricular cardiac muscle cell action potential,P
1197,857,9617,response to bacterium,P
1198,857,51592,response to calcium ion,P
1199,857,43627,response to estrogen,P
1200,857,1666,response to hypoxia,P
1201,857,2931,response to ischemia,P
1202,857,32570,response to progesterone,P
1203,857,7519,skeletal muscle tissue development,P
1204,857,6641,triglyceride metabolic process,P
1205,857,1570,vasculogenesis,P
1206,857,42310,vasoconstriction,P
1207,857,16050,vesicle organization,P
1208,857,139,Golgi membrane,C
1209,857,139,Golgi membrane,C
1210,857,34098,VCP-NPL4-UFD1 AAA ATPase complex,C
1211,857,2080,acrosomal membrane,C
1212,857,5901,caveola,C
1213,857,5938,cell cortex,C
1214,857,5929,cilium,C
1215,857,31410,cytoplasmic vesicle,C
1216,857,31901,early endosome membrane,C
1217,857,30666,endocytic vesicle membrane,C
1218,857,5783,endoplasmic reticulum,C
1219,857,5789,endoplasmic reticulum membrane,C
1220,857,5768,endosome,C
1221,857,5925,focal adhesion,C
1222,857,5925,focal adhesion,C
1223,857,5887,integral component of plasma membrane,C
1224,857,5622,intracellular,C
1225,857,5811,lipid particle,C
1226,857,16020,membrane,C
1227,857,45121,membrane raft,C
1228,857,48471,perinuclear region of cytoplasm,C
1229,857,48471,perinuclear region of cytoplasm,C
1230,857,5886,plasma membrane,C
1231,857,5886,plasma membrane,C
1232,857,43234,protein complex,C
1233,23492,5515,protein binding,F
1234,23492,16569,covalent chromatin modification,P
1235,23492,122,negative regulation of transcription from RNA polymerase II promoter,P
1236,23492,6351,"transcription, DNA-templated",P
1237,23492,35102,PRC1 complex,C
1238,23492,31519,PcG protein complex,C
1239,23492,5829,cytosol,C
1240,23492,790,nuclear chromatin,C
1241,23492,5654,nucleoplasm,C
1242,23492,5634,nucleus,C
1243,57332,35064,methylated histone binding,F
1244,57332,5515,protein binding,F
1245,57332,3727,single-stranded RNA binding,F
1246,57332,97027,ubiquitin-protein transferase activator activity,F
1247,57332,70301,cellular response to hydrogen peroxide,P
1248,57332,16574,histone ubiquitination,P
1249,57332,122,negative regulation of transcription from RNA polymerase II promoter,P
1250,57332,45739,positive regulation of DNA repair,P
1251,57332,8284,positive regulation of cell proliferation,P
1252,57332,32967,positive regulation of collagen biosynthetic process,P
1253,57332,50790,regulation of catalytic activity,P
1254,57332,6351,"transcription, DNA-templated",P
1255,57332,35102,PRC1 complex,C
1256,57332,31519,PcG protein complex,C
1257,57332,792,heterochromatin,C
1258,57332,790,nuclear chromatin,C
1259,57332,5654,nucleoplasm,C
1260,57332,5654,nucleoplasm,C
1261,57332,5634,nucleus,C
1262,595,16538,cyclin-dependent protein serine/threonine kinase regulator activity,F
1263,595,19899,enzyme binding,F
1264,595,42826,histone deacetylase binding,F
1265,595,70064,proline-rich region binding,F
1266,595,5515,protein binding,F
1267,595,32403,protein complex binding,F
1268,595,4672,protein kinase activity,F
1269,595,19901,protein kinase binding,F
1270,595,3714,transcription corepressor activity,F
1271,595,8134,transcription factor binding,F
1272,595,82,G1/S transition of mitotic cell cycle,P
1273,595,82,G1/S transition of mitotic cell cycle,P
1274,595,33327,Leydig cell differentiation,P
1275,595,60070,canonical Wnt signaling pathway,P
1276,595,51301,cell division,P
1277,595,6974,cellular response to DNA damage stimulus,P
1278,595,30968,endoplasmic reticulum unfolded protein response,P
1279,595,45444,fat cell differentiation,P
1280,595,7595,lactation,P
1281,595,97421,liver regeneration,P
1282,595,60749,mammary gland alveolus development,P
1283,595,33598,mammary gland epithelial cell proliferation,P
1284,595,31571,mitotic G1 DNA damage checkpoint,P
1285,595,30178,negative regulation of Wnt signaling pathway,P
1286,595,71157,negative regulation of cell cycle arrest,P
1287,595,30857,negative regulation of epithelial cell differentiation,P
1288,595,122,negative regulation of transcription from RNA polymerase II promoter,P
1289,595,10971,positive regulation of G2/M transition of mitotic cell cycle,P
1290,595,45787,positive regulation of cell cycle,P
1291,595,45737,positive regulation of cyclin-dependent protein serine/threonine kinase activity,P
1292,595,33601,positive regulation of mammary gland epithelial cell proliferation,P
1293,595,1934,positive regulation of protein phosphorylation,P
1294,595,6468,protein phosphorylation,P
1295,595,320,re-entry into mitotic cell cycle,P
1296,595,70141,response to UV-A,P
1297,595,10165,response to X-ray,P
1298,595,51592,response to calcium ion,P
1299,595,51412,response to corticosterone,P
1300,595,42493,response to drug,P
1301,595,32355,response to estradiol,P
1302,595,43627,response to estrogen,P
1303,595,45471,response to ethanol,P
1304,595,10039,response to iron ion,P
1305,595,44321,response to leptin,P
1306,595,32026,response to magnesium ion,P
1307,595,10243,response to organonitrogen compound,P
1308,595,33197,response to vitamin E,P
1309,595,6351,"transcription, DNA-templated",P
1310,595,5923,bicellular tight junction,C
1311,595,307,cyclin-dependent protein kinase holoenzyme complex,C
1312,595,5829,cytosol,C
1313,595,5622,intracellular,C
1314,595,16020,membrane,C
1315,595,5654,nucleoplasm,C
1316,595,5654,nucleoplasm,C
1317,595,5634,nucleus,C
1318,595,17053,transcriptional repressor complex,C
1319,983,5524,ATP binding,F
1320,983,30544,Hsp70 protein binding,F
1321,983,8353,RNA polymerase II carboxy-terminal domain kinase activity,F
1322,983,3682,chromatin binding,F
1323,983,30332,cyclin binding,F
1324,983,30332,cyclin binding,F
1325,983,97472,cyclin-dependent protein kinase activity,F
1326,983,4693,cyclin-dependent protein serine/threonine kinase activity,F
1327,983,4693,cyclin-dependent protein serine/threonine kinase activity,F
1328,983,4693,cyclin-dependent protein serine/threonine kinase activity,F
1329,983,35173,histone kinase activity,F
1330,983,5515,protein binding,F
1331,983,4672,protein kinase activity,F
1332,983,4674,protein serine/threonine kinase activity,F
1333,983,4674,protein serine/threonine kinase activity,F
1334,983,6977,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest",P
1335,983,6281,DNA repair,P
1336,983,6260,DNA replication,P
1337,983,82,G1/S transition of mitotic cell cycle,P
1338,983,86,G2/M transition of mitotic cell cycle,P
1339,983,90166,Golgi disassembly,P
1340,983,187,activation of MAPK activity,P
1341,983,31145,anaphase-promoting complex-dependent catabolic process,P
1342,983,31100,animal organ regeneration,P
1343,983,6915,apoptotic process,P
1344,983,7569,cell aging,P
1345,983,51301,cell division,P
1346,983,16477,cell migration,P
1347,983,8283,cell proliferation,P
1348,983,70301,cellular response to hydrogen peroxide,P
1349,983,7098,centrosome cycle,P
1350,983,30261,chromosome condensation,P
1351,983,97711,ciliary basal body docking,P
1352,983,30855,epithelial cell differentiation,P
1353,983,16572,histone phosphorylation,P
1354,983,226,microtubule cytoskeleton organization,P
1355,983,7095,mitotic G2 DNA damage checkpoint,P
1356,983,44772,mitotic cell cycle phase transition,P
1357,983,7077,mitotic nuclear envelope disassembly,P
1358,983,43066,negative regulation of apoptotic process,P
1359,983,51436,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,P
1360,983,18105,peptidyl-serine phosphorylation,P
1361,983,18107,peptidyl-threonine phosphorylation,P
1362,983,45740,positive regulation of DNA replication,P
1363,983,10971,positive regulation of G2/M transition of mitotic cell cycle,P
1364,983,60045,positive regulation of cardiac muscle cell proliferation,P
1365,983,10628,positive regulation of gene expression,P
1366,983,1905448,positive regulation of mitochondrial ATP synthesis coupled electron transport,P
1367,983,33160,"positive regulation of protein import into nucleus, translocation",P
1368,983,1900182,positive regulation of protein localization to nucleus,P
1369,983,51437,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,P
1370,983,7344,pronuclear fusion,P
1371,983,43161,proteasome-mediated ubiquitin-dependent protein catabolic process,P
1372,983,6461,protein complex assembly,P
1373,983,34501,protein localization to kinetochore,P
1374,983,6468,protein phosphorylation,P
1375,983,42787,protein ubiquitination involved in ubiquitin-dependent protein catabolic process,P
1376,983,14038,regulation of Schwann cell differentiation,P
1377,983,45995,regulation of embryonic development,P
1378,983,10468,regulation of gene expression,P
1379,983,51445,regulation of meiotic cell cycle,P
1380,983,7346,regulation of mitotic cell cycle,P
1381,983,83,regulation of transcription involved in G1/S transition of mitotic cell cycle,P
1382,983,51439,regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,P
1383,983,14823,response to activity,P
1384,983,14075,response to amine,P
1385,983,48678,response to axon injury,P
1386,983,46686,response to cadmium ion,P
1387,983,46688,response to copper ion,P
1388,983,42493,response to drug,P
1389,983,45471,response to ethanol,P
1390,983,14070,response to organic cyclic compound,P
1391,983,9636,response to toxic substance,P
1392,983,55015,ventricular cardiac muscle cell development,P
1393,983,5813,centrosome,C
1394,983,97125,cyclin B1-CDK1 complex,C
1395,983,307,cyclin-dependent protein kinase holoenzyme complex,C
1396,983,5829,cytosol,C
1397,983,5829,cytosol,C
1398,983,70062,extracellular exosome,C
1399,983,16020,membrane,C
1400,983,30496,midbody,C
1401,983,5759,mitochondrial matrix,C
1402,983,5739,mitochondrion,C
1403,983,72686,mitotic spindle,C
1404,983,784,"nuclear chromosome, telomeric region",C
1405,983,5654,nucleoplasm,C
1406,983,5634,nucleus,C
1407,983,5876,spindle microtubule,C
1408,5129,5524,ATP binding,F
1409,5129,4693,cyclin-dependent protein serine/threonine kinase activity,F
1410,5129,5515,protein binding,F
1411,5129,4674,protein serine/threonine kinase activity,F
1412,5129,6468,protein phosphorylation,P
1413,5129,5575,cellular_component,C
1414,5129,5737,cytoplasm,C
1415,5129,5634,nucleus,C
1416,8099,70182,DNA polymerase binding,F
1417,8099,5515,protein binding,F
1418,8099,6261,DNA-dependent DNA replication,P
1419,8099,7049,cell cycle,P
1420,8099,1934,positive regulation of protein phosphorylation,P
1421,8099,5829,cytosol,C
1422,8099,5654,nucleoplasm,C
1423,8099,5634,nucleus,C
1424,8099,48471,perinuclear region of cytoplasm,C
1425,1021,5524,ATP binding,F
1426,1021,98770,FBXO family protein binding,F
1427,1021,30332,cyclin binding,F
1428,1021,4693,cyclin-dependent protein serine/threonine kinase activity,F
1429,1021,5515,protein binding,F
1430,1021,82,G1/S transition of mitotic cell cycle,P
1431,1021,14002,astrocyte development,P
1432,1021,7050,cell cycle arrest,P
1433,1021,43697,cell dedifferentiation,P
1434,1021,51301,cell division,P
1435,1021,1904628,cellular response to phorbol 13-acetate 12-myristate,P
1436,1021,21542,dentate gyrus development,P
1437,1021,48699,generation of neurons,P
1438,1021,42063,gliogenesis,P
1439,1021,21670,lateral ventricle development,P
1440,1021,45786,negative regulation of cell cycle,P
1441,1021,45596,negative regulation of cell differentiation,P
1442,1021,8285,negative regulation of cell proliferation,P
1443,1021,2000773,negative regulation of cellular senescence,P
1444,1021,50680,negative regulation of epithelial cell proliferation,P
1445,1021,45656,negative regulation of monocyte differentiation,P
1446,1021,45638,negative regulation of myeloid cell differentiation,P
1447,1021,45668,negative regulation of osteoblast differentiation,P
1448,1021,1954,positive regulation of cell-matrix adhesion,P
1449,1021,48146,positive regulation of fibroblast proliferation,P
1450,1021,6468,protein phosphorylation,P
1451,1021,10389,regulation of G2/M transition of mitotic cell cycle,P
1452,1021,2000145,regulation of cell motility,P
1453,1021,45646,regulation of erythrocyte differentiation,P
1454,1021,10468,regulation of gene expression,P
1455,1021,10468,regulation of gene expression,P
1456,1021,9615,response to virus,P
1457,1021,7165,signal transduction,P
1458,1021,3323,type B pancreatic cell development,P
1459,1021,5813,centrosome,C
1460,1021,307,cyclin-dependent protein kinase holoenzyme complex,C
1461,1021,5737,cytoplasm,C
1462,1021,5829,cytosol,C
1463,1021,5829,cytosol,C
1464,1021,5654,nucleoplasm,C
1465,1021,5634,nucleus,C
1466,1021,1726,ruffle,C
1467,1019,5524,ATP binding,F
1468,1019,30332,cyclin binding,F
1469,1019,4693,cyclin-dependent protein serine/threonine kinase activity,F
1470,1019,16538,cyclin-dependent protein serine/threonine kinase regulator activity,F
1471,1019,5515,protein binding,F
1472,1019,32403,protein complex binding,F
1473,1019,82,G1/S transition of mitotic cell cycle,P
1474,1019,60612,adipose tissue development,P
1475,1019,31100,animal organ regeneration,P
1476,1019,51301,cell division,P
1477,1019,32869,cellular response to insulin stimulus,P
1478,1019,71353,cellular response to interleukin-4,P
1479,1019,1904637,cellular response to ionomycin,P
1480,1019,71222,cellular response to lipopolysaccharide,P
1481,1019,1904628,cellular response to phorbol 13-acetate 12-myristate,P
1482,1019,7623,circadian rhythm,P
1483,1019,2088,lens development in camera-type eye,P
1484,1019,7275,multicellular organism development,P
1485,1019,71157,negative regulation of cell cycle arrest,P
1486,1019,10971,positive regulation of G2/M transition of mitotic cell cycle,P
1487,1019,43065,positive regulation of apoptotic process,P
1488,1019,45787,positive regulation of cell cycle,P
1489,1019,8284,positive regulation of cell proliferation,P
1490,1019,45793,positive regulation of cell size,P
1491,1019,48146,positive regulation of fibroblast proliferation,P
1492,1019,45727,positive regulation of translation,P
1493,1019,6468,protein phosphorylation,P
1494,1019,10468,regulation of gene expression,P
1495,1019,46626,regulation of insulin receptor signaling pathway,P
1496,1019,46890,regulation of lipid biosynthetic process,P
1497,1019,50994,regulation of lipid catabolic process,P
1498,1019,40014,regulation of multicellular organism growth,P
1499,1019,45859,regulation of protein kinase activity,P
1500,1019,42493,response to drug,P
1501,1019,55093,response to hyperoxia,P
1502,1019,10288,response to lead ion,P
1503,1019,10033,response to organic substance,P
1504,1019,33574,response to testosterone,P
1505,1019,9636,response to toxic substance,P
1506,1019,7165,signal transduction,P
1507,1019,5923,bicellular tight junction,C
1508,1019,785,chromatin,C
1509,1019,97129,cyclin D2-CDK4 complex,C
1510,1019,307,cyclin-dependent protein kinase holoenzyme complex,C
1511,1019,5829,cytosol,C
1512,1019,5829,cytosol,C
1513,1019,31965,nuclear membrane,C
1514,1019,5730,nucleolus,C
1515,1019,5654,nucleoplasm,C
1516,1019,5634,nucleus,C
1517,1019,48471,perinuclear region of cytoplasm,C
1518,1019,5667,transcription factor complex,C
1519,1026,30332,cyclin binding,F
1520,1026,19912,cyclin-dependent protein kinase activating kinase activity,F
1521,1026,4861,cyclin-dependent protein serine/threonine kinase inhibitor activity,F
1522,1026,46872,metal ion binding,F
1523,1026,5515,protein binding,F
1524,1026,32403,protein complex binding,F
1525,1026,19901,protein kinase binding,F
1526,1026,4860,protein kinase inhibitor activity,F
1527,1026,31625,ubiquitin protein ligase binding,F
1528,1026,6977,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest",P
1529,1026,6977,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest",P
1530,1026,6978,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator",P
1531,1026,82,G1/S transition of mitotic cell cycle,P
1532,1026,82,G1/S transition of mitotic cell cycle,P
1533,1026,86,G2/M transition of mitotic cell cycle,P
1534,1026,7265,Ras protein signal transduction,P
1535,1026,31100,animal organ regeneration,P
1536,1026,7050,cell cycle arrest,P
1537,1026,7050,cell cycle arrest,P
1538,1026,6974,cellular response to DNA damage stimulus,P
1539,1026,71493,cellular response to UV-B,P
1540,1026,34198,cellular response to amino acid starvation,P
1541,1026,31668,cellular response to extracellular stimulus,P
1542,1026,71480,cellular response to gamma radiation,P
1543,1026,34605,cellular response to heat,P
1544,1026,71479,cellular response to ionizing radiation,P
1545,1026,90398,cellular senescence,P
1546,1026,60574,intestinal epithelial cell maturation,P
1547,1026,97193,intrinsic apoptotic signaling pathway,P
1548,1026,42771,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,P
1549,1026,71850,mitotic cell cycle arrest,P
1550,1026,2000134,negative regulation of G1/S transition of mitotic cell cycle,P
1551,1026,43066,negative regulation of apoptotic process,P
1552,1026,30308,negative regulation of cell growth,P
1553,1026,8285,negative regulation of cell proliferation,P
1554,1026,8285,negative regulation of cell proliferation,P
1555,1026,1904030,negative regulation of cyclin-dependent protein kinase activity,P
1556,1026,45736,negative regulation of cyclin-dependent protein serine/threonine kinase activity,P
1557,1026,10629,negative regulation of gene expression,P
1558,1026,42326,negative regulation of phosphorylation,P
1559,1026,30890,positive regulation of B cell proliferation,P
1560,1026,1904031,positive regulation of cyclin-dependent protein kinase activity,P
1561,1026,48146,positive regulation of fibroblast proliferation,P
1562,1026,43068,positive regulation of programmed cell death,P
1563,1026,45860,positive regulation of protein kinase activity,P
1564,1026,2000379,positive regulation of reactive oxygen species metabolic process,P
1565,1026,50821,protein stabilization,P
1566,1026,2000278,regulation of DNA biosynthetic process,P
1567,1026,79,regulation of cyclin-dependent protein serine/threonine kinase activity,P
1568,1026,33158,"regulation of protein import into nucleus, translocation",P
1569,1026,6357,regulation of transcription from RNA polymerase II promoter,P
1570,1026,90399,replicative senescence,P
1571,1026,10165,response to X-ray,P
1572,1026,46685,response to arsenic-containing substance,P
1573,1026,51412,response to corticosterone,P
1574,1026,42493,response to drug,P
1575,1026,55093,response to hyperoxia,P
1576,1026,10243,response to organonitrogen compound,P
1577,1026,9636,response to toxic substance,P
1578,1026,90400,stress-induced premature senescence,P
1579,1026,70557,PCNA-p21 complex,C
1580,1026,307,cyclin-dependent protein kinase holoenzyme complex,C
1581,1026,5829,cytosol,C
1582,1026,16604,nuclear body,C
1583,1026,5730,nucleolus,C
1584,1026,5654,nucleoplasm,C
1585,1026,5654,nucleoplasm,C
1586,1026,5634,nucleus,C
1587,1026,48471,perinuclear region of cytoplasm,C
1588,1026,43234,protein complex,C
1589,1028,4861,cyclin-dependent protein serine/threonine kinase inhibitor activity,F
1590,1028,5515,protein binding,F
1591,1028,32403,protein complex binding,F
1592,1028,4860,protein kinase inhibitor activity,F
1593,1028,30325,adrenal gland development,P
1594,1028,7568,aging,P
1595,1028,43010,camera-type eye development,P
1596,1028,7050,cell cycle arrest,P
1597,1028,55123,digestive system development,P
1598,1028,60669,embryonic placenta morphogenesis,P
1599,1028,71514,genetic imprinting,P
1600,1028,1822,kidney development,P
1601,1028,35264,multicellular organism growth,P
1602,1028,30099,myeloid cell differentiation,P
1603,1028,1904030,negative regulation of cyclin-dependent protein kinase activity,P
1604,1028,50680,negative regulation of epithelial cell proliferation,P
1605,1028,33673,negative regulation of kinase activity,P
1606,1028,42326,negative regulation of phosphorylation,P
1607,1028,71901,negative regulation of protein serine/threonine kinase activity,P
1608,1028,122,negative regulation of transcription from RNA polymerase II promoter,P
1609,1028,45892,"negative regulation of transcription, DNA-templated",P
1610,1028,42551,neuron maturation,P
1611,1028,45893,"positive regulation of transcription, DNA-templated",P
1612,1028,30511,positive regulation of transforming growth factor beta receptor signaling pathway,P
1613,1028,7096,regulation of exit from mitosis,P
1614,1028,1902746,regulation of lens fiber cell differentiation,P
1615,1028,1501,skeletal system development,P
1616,1028,60065,uterus development,P
1617,1028,5737,cytoplasm,C
1618,1028,5634,nucleus,C
1619,1027,30544,Hsp70 protein binding,F
1620,1027,51087,chaperone binding,F
1621,1027,30332,cyclin binding,F
1622,1027,4861,cyclin-dependent protein serine/threonine kinase inhibitor activity,F
1623,1027,5515,protein binding,F
1624,1027,32403,protein complex binding,F
1625,1027,19901,protein kinase binding,F
1626,1027,4860,protein kinase inhibitor activity,F
1627,1027,19903,protein phosphatase binding,F
1628,1027,5072,"transforming growth factor beta receptor, cytoplasmic mediator activity",F
1629,1027,6977,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest",P
1630,1027,82,G1/S transition of mitotic cell cycle,P
1631,1027,82,G1/S transition of mitotic cell cycle,P
1632,1027,7219,Notch signaling pathway,P
1633,1027,48102,autophagic cell death,P
1634,1027,7050,cell cycle arrest,P
1635,1027,71236,cellular response to antibiotic,P
1636,1027,71285,cellular response to lithium ion,P
1637,1027,71407,cellular response to organic cyclic compound,P
1638,1027,48839,inner ear development,P
1639,1027,71850,mitotic cell cycle arrest,P
1640,1027,43066,negative regulation of apoptotic process,P
1641,1027,30308,negative regulation of cell growth,P
1642,1027,8285,negative regulation of cell proliferation,P
1643,1027,8285,negative regulation of cell proliferation,P
1644,1027,51271,negative regulation of cellular component movement,P
1645,1027,1904030,negative regulation of cyclin-dependent protein kinase activity,P
1646,1027,45736,negative regulation of cyclin-dependent protein serine/threonine kinase activity,P
1647,1027,60770,negative regulation of epithelial cell proliferation involved in prostate gland development,P
1648,1027,33673,negative regulation of kinase activity,P
1649,1027,45930,negative regulation of mitotic cell cycle,P
1650,1027,42326,negative regulation of phosphorylation,P
1651,1027,45892,"negative regulation of transcription, DNA-templated",P
1652,1027,1904706,negative regulation of vascular smooth muscle cell proliferation,P
1653,1027,1890,placenta development,P
1654,1027,45787,positive regulation of cell cycle,P
1655,1027,10942,positive regulation of cell death,P
1656,1027,8284,positive regulation of cell proliferation,P
1657,1027,45737,positive regulation of cyclin-dependent protein serine/threonine kinase activity,P
1658,1027,31116,positive regulation of microtubule polymerization,P
1659,1027,45732,positive regulation of protein catabolic process,P
1660,1027,6813,potassium ion transport,P
1661,1027,79,regulation of cyclin-dependent protein serine/threonine kinase activity,P
1662,1027,7096,regulation of exit from mitosis,P
1663,1027,1902746,regulation of lens fiber cell differentiation,P
1664,1027,43200,response to amino acid,P
1665,1027,46686,response to cadmium ion,P
1666,1027,42493,response to drug,P
1667,1027,32355,response to estradiol,P
1668,1027,9749,response to glucose,P
1669,1027,1666,response to hypoxia,P
1670,1027,43434,response to peptide hormone,P
1671,1027,7605,sensory perception of sound,P
1672,1027,31464,Cul4A-RING E3 ubiquitin ligase complex,C
1673,1027,5737,cytoplasm,C
1674,1027,5829,cytosol,C
1675,1027,5768,endosome,C
1676,1027,43231,intracellular membrane-bounded organelle,C
1677,1027,5654,nucleoplasm,C
1678,1027,5634,nucleus,C
1679,1027,43234,protein complex,C
1680,1029,51059,NF-kappaB binding,F
1681,1029,3723,RNA binding,F
1682,1029,4861,cyclin-dependent protein serine/threonine kinase inhibitor activity,F
1683,1029,5515,protein binding,F
1684,1029,19901,protein kinase binding,F
1685,1029,82,G1/S transition of mitotic cell cycle,P
1686,1029,7265,Ras protein signal transduction,P
1687,1029,7050,cell cycle arrest,P
1688,1029,7050,cell cycle arrest,P
1689,1029,90398,cellular senescence,P
1690,1029,32088,negative regulation of NF-kappaB transcription factor activity,P
1691,1029,30308,negative regulation of cell growth,P
1692,1029,8285,negative regulation of cell proliferation,P
1693,1029,8285,negative regulation of cell proliferation,P
1694,1029,1953,negative regulation of cell-matrix adhesion,P
1695,1029,45736,negative regulation of cyclin-dependent protein serine/threonine kinase activity,P
1696,1029,42326,negative regulation of phosphorylation,P
1697,1029,45892,"negative regulation of transcription, DNA-templated",P
1698,1029,2000774,positive regulation of cellular senescence,P
1699,1029,2000111,positive regulation of macrophage apoptotic process,P
1700,1029,34393,positive regulation of smooth muscle cell apoptotic process,P
1701,1029,90399,replicative senescence,P
1702,1029,35986,senescence-associated heterochromatin focus assembly,P
1703,1029,5737,cytoplasm,C
1704,1029,5829,cytosol,C
1705,1029,5634,nucleus,C
1706,1029,35985,senescence-associated heterochromatin focus,C
1707,55602,3723,RNA binding,F
1708,55602,2039,p53 binding,F
1709,55602,5515,protein binding,F
1710,55602,6974,cellular response to DNA damage stimulus,P
1711,55602,30308,negative regulation of cell growth,P
1712,55602,30307,positive regulation of cell growth,P
1713,55602,9967,positive regulation of signal transduction,P
1714,55602,31647,regulation of protein stability,P
1715,55602,1652,granular component,C
1716,55602,5730,nucleolus,C
1717,55602,5654,nucleoplasm,C
1718,1030,4861,cyclin-dependent protein serine/threonine kinase inhibitor activity,F
1719,1030,4861,cyclin-dependent protein serine/threonine kinase inhibitor activity,F
1720,1030,5515,protein binding,F
1721,1030,19901,protein kinase binding,F
1722,1030,86,G2/M transition of mitotic cell cycle,P
1723,1030,7050,cell cycle arrest,P
1724,1030,31668,cellular response to extracellular stimulus,P
1725,1030,31670,cellular response to nutrient,P
1726,1030,30219,megakaryocyte differentiation,P
1727,1030,7093,mitotic cell cycle checkpoint,P
1728,1030,2000134,negative regulation of G1/S transition of mitotic cell cycle,P
1729,1030,8285,negative regulation of cell proliferation,P
1730,1030,50680,negative regulation of epithelial cell proliferation,P
1731,1030,42326,negative regulation of phosphorylation,P
1732,1030,71901,negative regulation of protein serine/threonine kinase activity,P
1733,1030,45944,positive regulation of transcription from RNA polymerase II promoter,P
1734,1030,30511,positive regulation of transforming growth factor beta receptor signaling pathway,P
1735,1030,79,regulation of cyclin-dependent protein serine/threonine kinase activity,P
1736,1030,48536,spleen development,P
1737,1030,5737,cytoplasm,C
1738,1030,5829,cytosol,C
1739,1030,5634,nucleus,C
1740,1058,3677,DNA binding,F
1741,1058,3682,chromatin binding,F
1742,1058,5515,protein binding,F
1743,1058,46982,protein heterodimerization activity,F
1744,1058,34080,CENP-A containing nucleosome assembly,P
1745,1058,132,establishment of mitotic spindle orientation,P
1746,1058,51382,kinetochore assembly,P
1747,1058,281,mitotic cytokinesis,P
1748,1058,71459,"protein localization to chromosome, centromeric region",P
1749,1058,7062,sister chromatid cohesion,P
1750,1058,16032,viral process,P
1751,1058,775,"chromosome, centromeric region",C
1752,1058,939,condensed chromosome inner kinetochore,C
1753,1058,778,condensed nuclear chromosome kinetochore,C
1754,1058,780,"condensed nuclear chromosome, centromeric region",C
1755,1058,5829,cytosol,C
1756,1058,788,nuclear nucleosome,C
1757,1058,31618,nuclear pericentric heterochromatin,C
1758,1058,5654,nucleoplasm,C
1759,1058,5634,nucleus,C
1760,1051,3677,DNA binding,F
1761,1051,978,RNA polymerase II core promoter proximal region sequence-specific DNA binding,F
1762,1051,979,RNA polymerase II core promoter sequence-specific DNA binding,F
1763,1051,977,RNA polymerase II regulatory region sequence-specific DNA binding,F
1764,1051,3682,chromatin binding,F
1765,1051,35259,glucocorticoid receptor binding,F
1766,1051,35035,histone acetyltransferase binding,F
1767,1051,42826,histone deacetylase binding,F
1768,1051,19900,kinase binding,F
1769,1051,5515,protein binding,F
1770,1051,46982,protein heterodimerization activity,F
1771,1051,42803,protein homodimerization activity,F
1772,1051,3705,"transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding",F
1773,1051,3700,"transcription factor activity, sequence-specific DNA binding",F
1774,1051,8134,transcription factor binding,F
1775,1051,1077,"transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding",F
1776,1051,44389,ubiquitin-like protein ligase binding,F
1777,1051,6953,acute-phase response,P
1778,1051,50873,brown fat cell differentiation,P
1779,1051,71230,cellular response to amino acid stimulus,P
1780,1051,71347,cellular response to interleukin-1,P
1781,1051,71222,cellular response to lipopolysaccharide,P
1782,1051,71407,cellular response to organic cyclic compound,P
1783,1051,42742,defense response to bacterium,P
1784,1051,1892,embryonic placenta development,P
1785,1051,72574,hepatocyte proliferation,P
1786,1051,6955,immune response,P
1787,1051,6954,inflammatory response,P
1788,1051,70059,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,P
1789,1051,97421,liver regeneration,P
1790,1051,60644,mammary gland epithelial cell differentiation,P
1791,1051,33598,mammary gland epithelial cell proliferation,P
1792,1051,7613,memory,P
1793,1051,42130,negative regulation of T cell proliferation,P
1794,1051,43524,negative regulation of neuron apoptotic process,P
1795,1051,45892,"negative regulation of transcription, DNA-templated",P
1796,1051,30182,neuron differentiation,P
1797,1051,1541,ovarian follicle development,P
1798,1051,45600,positive regulation of fat cell differentiation,P
1799,1051,32753,positive regulation of interleukin-4 production,P
1800,1051,45669,positive regulation of osteoblast differentiation,P
1801,1051,45944,positive regulation of transcription from RNA polymerase II promoter,P
1802,1051,1990440,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,P
1803,1051,45408,regulation of interleukin-6 biosynthetic process,P
1804,1051,45670,regulation of osteoclast differentiation,P
1805,1051,60850,regulation of transcription involved in cell fate commitment,P
1806,1051,6355,"regulation of transcription, DNA-templated",P
1807,1051,34976,response to endoplasmic reticulum stress,P
1808,1051,6366,transcription from RNA polymerase II promoter,P
1809,1051,36488,CHOP-C/EBP complex,C
1810,1051,779,"condensed chromosome, centromeric region",C
1811,1051,5737,cytoplasm,C
1812,1051,790,nuclear chromatin,C
1813,1051,16363,nuclear matrix,C
1814,1051,5654,nucleoplasm,C
1815,1051,5654,nucleoplasm,C
1816,1051,5634,nucleus,C
1817,1111,5524,ATP binding,F
1818,1111,35402,histone kinase activity (H3-T11 specific),F
1819,1111,16301,kinase activity,F
1820,1111,5515,protein binding,F
1821,1111,19904,protein domain specific binding,F
1822,1111,4672,protein kinase activity,F
1823,1111,4674,protein serine/threonine kinase activity,F
1824,1111,4674,protein serine/threonine kinase activity,F
1825,1111,77,DNA damage checkpoint,P
1826,1111,77,DNA damage checkpoint,P
1827,1111,6975,DNA damage induced protein phosphorylation,P
1828,1111,6281,DNA repair,P
1829,1111,6260,DNA replication,P
1830,1111,31572,G2 DNA damage checkpoint,P
1831,1111,7049,cell cycle,P
1832,1111,6974,cellular response to DNA damage stimulus,P
1833,1111,71260,cellular response to mechanical stimulus,P
1834,1111,48096,chromatin-mediated maintenance of transcription,P
1835,1111,35407,histone H3-T11 phosphorylation,P
1836,1111,35556,intracellular signal transduction,P
1837,1111,45839,negative regulation of mitotic nuclear division,P
1838,1111,18107,peptidyl-threonine phosphorylation,P
1839,1111,45787,positive regulation of cell cycle,P
1840,1111,10569,regulation of double-strand break repair via homologous recombination,P
1841,1111,2000615,regulation of histone H3-K9 acetylation,P
1842,1111,46602,regulation of mitotic centrosome separation,P
1843,1111,1901796,regulation of signal transduction by p53 class mediator,P
1844,1111,10767,regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage,P
1845,1111,90399,replicative senescence,P
1846,1111,5813,centrosome,C
1847,1111,785,chromatin,C
1848,1111,781,"chromosome, telomeric region",C
1849,1111,794,condensed nuclear chromosome,C
1850,1111,5737,cytoplasm,C
1851,1111,5737,cytoplasm,C
1852,1111,5829,cytosol,C
1853,1111,5615,extracellular space,C
1854,1111,43231,intracellular membrane-bounded organelle,C
1855,1111,5654,nucleoplasm,C
1856,1111,5654,nucleoplasm,C
1857,1111,5634,nucleus,C
1858,1111,43234,protein complex,C
1859,1152,5524,ATP binding,F
1860,1152,4111,creatine kinase activity,F
1861,1152,4111,creatine kinase activity,F
1862,1152,5515,protein binding,F
1863,1152,31625,ubiquitin protein ligase binding,F
1864,1152,30644,cellular chloride ion homeostasis,P
1865,1152,21549,cerebellum development,P
1866,1152,6600,creatine metabolic process,P
1867,1152,16310,phosphorylation,P
1868,1152,21762,substantia nigra development,P
1869,1152,5829,cytosol,C
1870,1152,5829,cytosol,C
1871,1152,30425,dendrite,C
1872,1152,70062,extracellular exosome,C
1873,1152,5615,extracellular space,C
1874,1152,5739,mitochondrion,C
1875,1152,43209,myelin sheath,C
1876,1152,43025,neuronal cell body,C
1877,1152,5634,nucleus,C
1878,64506,35925,mRNA 3'-UTR AU-rich region binding,F
1879,64506,3730,mRNA 3'-UTR binding,F
1880,64506,46872,metal ion binding,F
1881,64506,43022,ribosome binding,F
1882,64506,8135,"translation factor activity, RNA binding",F
1883,64506,900,"translation repressor activity, nucleic acid binding",F
1884,64506,900,"translation repressor activity, nucleic acid binding",F
1885,64506,71230,cellular response to amino acid stimulus,P
1886,64506,71456,cellular response to hypoxia,P
1887,64506,32869,cellular response to insulin stimulus,P
1888,64506,71222,cellular response to lipopolysaccharide,P
1889,64506,6397,mRNA processing,P
1890,64506,51028,mRNA transport,P
1891,64506,8285,negative regulation of cell proliferation,P
1892,64506,2000766,negative regulation of cytoplasmic translation,P
1893,64506,30335,positive regulation of cell migration,P
1894,64506,10976,positive regulation of neuron projection development,P
1895,64506,51770,positive regulation of nitric-oxide synthase biosynthetic process,P
1896,64506,45727,positive regulation of translation,P
1897,64506,6412,translation,P
1898,64506,932,P-body,C
1899,64506,30054,cell junction,C
1900,64506,5813,centrosome,C
1901,64506,5737,cytoplasm,C
1902,64506,5737,cytoplasm,C
1903,64506,30425,dendrite,C
1904,64506,30426,growth cone,C
1905,64506,1990124,messenger ribonucleoprotein complex,C
1906,64506,43005,neuron projection,C
1907,64506,43025,neuronal cell body,C
1908,64506,5634,nucleus,C
1909,64506,5634,nucleus,C
1910,64506,48471,perinuclear region of cytoplasm,C
1911,64506,14069,postsynaptic density,C
1912,64506,45211,postsynaptic membrane,C
1913,64506,45202,synapse,C
1914,1452,5524,ATP binding,F
1915,1452,16301,kinase activity,F
1916,1452,5515,protein binding,F
1917,1452,4672,protein kinase activity,F
1918,1452,4672,protein kinase activity,F
1919,1452,4674,protein serine/threonine kinase activity,F
1920,1452,4674,protein serine/threonine kinase activity,F
1921,1452,4674,protein serine/threonine kinase activity,F
1922,1452,7030,Golgi organization,P
1923,1452,16055,Wnt signaling pathway,P
1924,1452,16055,Wnt signaling pathway,P
1925,1452,1904885,beta-catenin destruction complex assembly,P
1926,1452,1904886,beta-catenin destruction complex disassembly,P
1927,1452,7049,cell cycle,P
1928,1452,51301,cell division,P
1929,1452,7166,cell surface receptor signaling pathway,P
1930,1452,45104,intermediate filament cytoskeleton organization,P
1931,1452,90090,negative regulation of canonical Wnt signaling pathway,P
1932,1452,18105,peptidyl-serine phosphorylation,P
1933,1452,18105,peptidyl-serine phosphorylation,P
1934,1452,6909,phagocytosis,P
1935,1452,32436,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,P
1936,1452,43161,proteasome-mediated ubiquitin-dependent protein catabolic process,P
1937,1452,6468,protein phosphorylation,P
1938,1452,1904424,regulation of GTP binding,P
1939,1452,8360,regulation of cell shape,P
1940,1452,7165,signal transduction,P
1941,1452,30877,beta-catenin destruction complex,C
1942,1452,5813,centrosome,C
1943,1452,5929,cilium,C
1944,1452,777,condensed chromosome kinetochore,C
1945,1452,5829,cytosol,C
1946,1452,5829,cytosol,C
1947,1452,45095,keratin filament,C
1948,1452,5847,mRNA cleavage and polyadenylation specificity factor complex,C
1949,1452,16020,membrane,C
1950,1452,16607,nuclear speck,C
1951,8727,51015,actin filament binding,F
1952,8727,45296,cadherin binding,F
1953,8727,5515,protein binding,F
1954,8727,7266,Rho protein signal transduction,P
1955,8727,7155,cell adhesion,P
1956,8727,5856,cytoskeleton,C
1957,8727,5829,cytosol,C
1958,8727,5886,plasma membrane,C
1959,1457,5524,ATP binding,F
1960,1457,51879,Hsp90 protein binding,F
1961,1457,16301,kinase activity,F
1962,1457,47485,protein N-terminus binding,F
1963,1457,5515,protein binding,F
1964,1457,4674,protein serine/threonine kinase activity,F
1965,1457,4674,protein serine/threonine kinase activity,F
1966,1457,4674,protein serine/threonine kinase activity,F
1967,1457,16055,Wnt signaling pathway,P
1968,1457,6915,apoptotic process,P
1969,1457,61077,chaperone-mediated protein folding,P
1970,1457,71174,mitotic spindle checkpoint,P
1971,1457,43154,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,P
1972,1457,18107,peptidyl-threonine phosphorylation,P
1973,1457,6656,phosphatidylcholine biosynthetic process,P
1974,1457,30177,positive regulation of Wnt signaling pathway,P
1975,1457,30307,positive regulation of cell growth,P
1976,1457,8284,positive regulation of cell proliferation,P
1977,1457,45732,positive regulation of protein catabolic process,P
1978,1457,6457,protein folding,P
1979,1457,6468,protein phosphorylation,P
1980,1457,1901796,regulation of signal transduction by p53 class mediator,P
1981,1457,6355,"regulation of transcription, DNA-templated",P
1982,1457,48511,rhythmic process,P
1983,1457,7165,signal transduction,P
1984,1457,6351,"transcription, DNA-templated",P
1985,1457,16581,NuRD complex,C
1986,1457,31519,PcG protein complex,C
1987,1457,16580,Sin3 complex,C
1988,1457,5829,cytosol,C
1989,1457,5654,nucleoplasm,C
1990,1457,5654,nucleoplasm,C
1991,1457,5634,nucleus,C
1992,1457,5886,plasma membrane,C
1993,1457,5956,protein kinase CK2 complex,C
1994,2919,45236,CXCR chemokine receptor binding,F
1995,2919,8009,chemokine activity,F
1996,2919,8047,enzyme activator activity,F
1997,2919,8083,growth factor activity,F
1998,2919,5102,receptor binding,F
1999,2919,7186,G-protein coupled receptor signaling pathway,P
2000,2919,30036,actin cytoskeleton organization,P
2001,2919,60326,cell chemotaxis,P
2002,2919,8283,cell proliferation,P
2003,2919,70098,chemokine-mediated signaling pathway,P
2004,2919,6935,chemotaxis,P
2005,2919,6955,immune response,P
2006,2919,6954,inflammatory response,P
2007,2919,35556,intracellular signal transduction,P
2008,2919,8285,negative regulation of cell proliferation,P
2009,2919,7399,nervous system development,P
2010,2919,43312,neutrophil degranulation,P
2011,2919,43085,positive regulation of catalytic activity,P
2012,2919,90023,positive regulation of neutrophil chemotaxis,P
2013,2919,32496,response to lipopolysaccharide,P
2014,2919,7165,signal transduction,P
2015,2919,5576,extracellular region,C
2016,2919,5615,extracellular space,C
2017,2919,35580,specific granule lumen,C
2018,2919,1904724,tertiary granule lumen,C
2019,3491,50840,extracellular matrix binding,F
2020,3491,8201,heparin binding,F
2021,3491,5520,insulin-like growth factor binding,F
2022,3491,5178,integrin binding,F
2023,3491,9653,anatomical structure morphogenesis,P
2024,1643,3677,DNA binding,F
2025,3491,3278,apoptotic process involved in heart morphogenesis,P
2026,3491,60413,atrial septum morphogenesis,P
2027,1643,3684,damaged DNA binding,F
2028,3491,3181,atrioventricular valve morphogenesis,P
2029,1643,5515,protein binding,F
2030,3491,8283,cell proliferation,P
2031,1643,32403,protein complex binding,F
2032,3491,6935,chemotaxis,P
2033,1643,4842,ubiquitin-protein transferase activity,F
2034,3491,60591,chondroblast differentiation,P
2035,1643,6281,DNA repair,P
2036,3491,60710,chorio-allantoic fusion,P
2037,1643,70914,UV-damage excision repair,P
2038,1643,70911,global genome nucleotide-excision repair,P
2039,3491,30198,extracellular matrix organization,P
2040,3491,2041,intussusceptive angiogenesis,P
2041,1643,35518,histone H2A monoubiquitination,P
2042,3491,60716,labyrinthine layer blood vessel development,P
2043,1643,6289,nucleotide-excision repair,P
2044,3491,43066,negative regulation of apoptotic process,P
2045,1643,715,"nucleotide-excision repair, DNA damage recognition",P
2046,3491,1649,osteoblast differentiation,P
2047,1643,717,"nucleotide-excision repair, DNA duplex unwinding",P
2048,3491,30513,positive regulation of BMP signaling pathway,P
2049,1643,33683,"nucleotide-excision repair, DNA incision",P
2050,3491,61036,positive regulation of cartilage development,P
2051,1643,6295,"nucleotide-excision repair, DNA incision, 3'-to lesion",P
2052,3491,30335,positive regulation of cell migration,P
2053,1643,6296,"nucleotide-excision repair, DNA incision, 5'-to lesion",P
2054,3491,10811,positive regulation of cell-substrate adhesion,P
2055,1643,6294,"nucleotide-excision repair, preincision complex assembly",P
2056,3491,2000304,positive regulation of ceramide biosynthetic process,P
2057,1643,6293,"nucleotide-excision repair, preincision complex stabilization",P
2058,3491,43280,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,P
2059,1643,51865,protein autoubiquitination,P
2060,3491,45669,positive regulation of osteoblast differentiation,P
2061,1643,16579,protein deubiquitination,P
2062,3491,33690,positive regulation of osteoblast proliferation,P
2063,1643,209,protein polyubiquitination,P
2064,3491,10518,positive regulation of phospholipase activity,P
2065,1643,6290,pyrimidine dimer repair,P
2066,3491,45860,positive regulation of protein kinase activity,P
2067,1643,9411,response to UV,P
2068,3491,1934,positive regulation of protein phosphorylation,P
2069,1643,31465,Cul4B-RING E3 ubiquitin ligase complex,C
2070,3491,45944,positive regulation of transcription from RNA polymerase II promoter,P
2071,1643,30054,cell junction,C
2072,3491,72593,reactive oxygen species metabolic process,P
2073,1643,5654,nucleoplasm,C
2074,3491,70372,regulation of ERK1 and ERK2 cascade,P
2075,1643,5654,nucleoplasm,C
2076,3491,1558,regulation of cell growth,P
2077,1643,43234,protein complex,C
2078,3491,3281,ventricular septum development,P
2079,3491,44319,"wound healing, spreading of cells",P
2080,3491,31012,extracellular matrix,C
2081,3491,5615,extracellular space,C
2082,7913,3677,DNA binding,F
2083,7913,3723,RNA binding,F
2084,7913,3682,chromatin binding,F
2085,7913,42393,histone binding,F
2086,7913,6338,chromatin remodeling,P
2087,7913,16569,covalent chromatin modification,P
2088,7913,45815,"positive regulation of gene expression, epigenetic",P
2089,7913,2000779,regulation of double-strand break repair,P
2090,7913,2001032,regulation of double-strand break repair via nonhomologous end joining,P
2091,7913,6357,regulation of transcription from RNA polymerase II promoter,P
2092,7913,7165,signal transduction,P
2093,7913,6366,transcription from RNA polymerase II promoter,P
2094,7913,19079,viral genome replication,P
2095,7913,43292,contractile fiber,C
2096,7913,5654,nucleoplasm,C
2097,7913,5634,nucleus,C
2098,54487,3725,double-stranded RNA binding,F
2099,54487,20037,heme binding,F
2100,54487,46872,metal ion binding,F
2101,54487,70878,primary miRNA binding,F
2102,54487,5515,protein binding,F
2103,54487,42803,protein homodimerization activity,F
2104,54487,4525,ribonuclease III activity,F
2105,54487,90502,"RNA phosphodiester bond hydrolysis, endonucleolytic",P
2106,54487,31047,gene silencing by RNA,P
2107,54487,31053,primary miRNA processing,P
2108,54487,72091,regulation of stem cell proliferation,P
2109,54487,5737,cytoplasm,C
2110,54487,70877,microprocessor complex,C
2111,54487,5730,nucleolus,C
2112,54487,5654,nucleoplasm,C
2113,54487,5634,nucleus,C
2114,1718,246,delta24(24-1) sterol reductase activity,F
2115,1718,50614,delta24-sterol reductase activity,F
2116,1718,19899,enzyme binding,F
2117,1718,50660,flavin adenine dinucleotide binding,F
2118,1718,16614,"oxidoreductase activity, acting on CH-OH group of donors",F
2119,1718,16628,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor",F
2120,1718,42605,peptide antigen binding,F
2121,1718,7265,Ras protein signal transduction,P
2122,1718,42987,amyloid precursor protein catabolic process,P
2123,1718,6915,apoptotic process,P
2124,1718,7050,cell cycle arrest,P
2125,1718,6695,cholesterol biosynthetic process,P
2126,1718,6695,cholesterol biosynthetic process,P
2127,1718,33489,cholesterol biosynthetic process via desmosterol,P
2128,1718,33490,cholesterol biosynthetic process via lathosterol,P
2129,1718,30539,male genitalia development,P
2130,1718,61024,membrane organization,P
2131,1718,43066,negative regulation of apoptotic process,P
2132,1718,8285,negative regulation of cell proliferation,P
2133,1718,43154,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,P
2134,1718,55114,oxidation-reduction process,P
2135,1718,31639,plasminogen activation,P
2136,1718,8104,protein localization,P
2137,1718,1901214,regulation of neuron death,P
2138,1718,9725,response to hormone,P
2139,1718,6979,response to oxidative stress,P
2140,1718,43588,skin development,P
2141,1718,9888,tissue development,P
2142,1718,139,Golgi membrane,C
2143,1718,5856,cytoskeleton,C
2144,1718,5829,cytosol,C
2145,1718,5783,endoplasmic reticulum,C
2146,1718,5789,endoplasmic reticulum membrane,C
2147,1718,5789,endoplasmic reticulum membrane,C
2148,1718,16021,integral component of membrane,C
2149,1718,16020,membrane,C
2150,1718,5634,nucleus,C
2151,1746,977,RNA polymerase II regulatory region sequence-specific DNA binding,F
2152,1746,3682,chromatin binding,F
2153,1746,5515,protein binding,F
2154,1746,3727,single-stranded RNA binding,F
2155,1746,3700,"transcription factor activity, sequence-specific DNA binding",F
2156,1746,1228,"transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding",F
2157,1746,7420,brain development,P
2158,1746,48755,branching morphogenesis of a nerve,P
2159,1660,5524,ATP binding,F
2160,1746,51216,cartilage development,P
2161,1660,4003,ATP-dependent DNA helicase activity,F
2162,1746,21893,cerebral cortex GABAergic interneuron fate commitment,P
2163,1660,4004,ATP-dependent RNA helicase activity,F
2164,1746,48701,embryonic cranial skeleton morphogenesis,P
2165,1660,3677,DNA binding,F
2166,1746,21766,hippocampus development,P
2167,1660,3723,RNA binding,F
2168,1746,45746,negative regulation of Notch signaling pathway,P
2169,1660,3724,RNA helicase activity,F
2170,1746,48715,negative regulation of oligodendrocyte differentiation,P
2171,1660,1085,RNA polymerase II transcription factor binding,F
2172,1746,46533,negative regulation of photoreceptor cell differentiation,P
2173,1660,5515,protein binding,F
2174,1746,122,negative regulation of transcription from RNA polymerase II promoter,P
2175,1660,70934,CRD-mediated mRNA stabilization,P
2176,1746,42475,odontogenesis of dentin-containing tooth,P
2177,1660,32508,DNA duplex unwinding,P
2178,1746,21772,olfactory bulb development,P
2179,1660,6396,RNA processing,P
2180,1746,1902871,positive regulation of amacrine cell differentiation,P
2181,1660,398,"mRNA splicing, via spliceosome",P
2182,1746,45597,positive regulation of cell differentiation,P
2183,1660,1649,osteoblast differentiation,P
2184,1746,45944,positive regulation of transcription from RNA polymerase II promoter,P
2185,1660,32481,positive regulation of type I interferon production,P
2186,1660,1903608,protein localization to cytoplasmic stress granule,P
2187,1746,9954,proximal/distal pattern formation,P
2188,1660,48511,rhythmic process,P
2189,1746,21882,regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment,P
2190,1660,70937,CRD-mediated mRNA stability complex,C
2191,1746,21544,subpallium development,P
2192,1746,6366,transcription from RNA polymerase II promoter,P
2193,1660,5813,centrosome,C
2194,1746,5634,nucleus,C
2195,1660,5737,cytoplasm,C
2196,1660,36464,cytoplasmic ribonucleoprotein granule,C
2197,1660,5829,cytosol,C
2198,1660,30529,intracellular ribonucleoprotein complex,C
2199,1660,16020,membrane,C
2200,1660,97165,nuclear stress granule,C
2201,1660,5730,nucleolus,C
2202,1660,5654,nucleoplasm,C
2203,1660,5654,nucleoplasm,C
2204,1660,5634,nucleus,C
2205,84661,42800,histone methyltransferase activity (H3-K4 specific),F
2206,84661,18024,histone-lysine N-methyltransferase activity,F
2207,84661,42802,identical protein binding,F
2208,84661,5515,protein binding,F
2209,84661,42803,protein homodimerization activity,F
2210,84661,6348,chromatin silencing at telomere,P
2211,84661,16197,endosomal transport,P
2212,84661,51568,histone H3-K4 methylation,P
2213,84661,6351,"transcription, DNA-templated",P
2214,84661,5794,Golgi apparatus,C
2215,84661,44666,MLL3/4 complex,C
2216,84661,48188,Set1C/COMPASS complex,C
2217,84661,781,"chromosome, telomeric region",C
2218,84661,35097,histone methyltransferase complex,C
2219,84661,5654,nucleoplasm,C
2220,84661,5654,nucleoplasm,C
2221,84661,5634,nucleus,C
2222,84661,5802,trans-Golgi network,C
2223,1845,33549,MAP kinase phosphatase activity,F
2224,1845,16791,phosphatase activity,F
2225,1845,19901,protein kinase binding,F
2226,1845,4725,protein tyrosine phosphatase activity,F
2227,1845,4725,protein tyrosine phosphatase activity,F
2228,1845,8138,protein tyrosine/serine/threonine phosphatase activity,F
2229,1845,8138,protein tyrosine/serine/threonine phosphatase activity,F
2230,1845,16311,dephosphorylation,P
2231,1845,1701,in utero embryonic development,P
2232,1845,188,inactivation of MAPK activity,P
2233,1845,70373,negative regulation of ERK1 and ERK2 cascade,P
2234,1845,46329,negative regulation of JNK cascade,P
2235,1845,46329,negative regulation of JNK cascade,P
2236,1845,43409,negative regulation of MAPK cascade,P
2237,1845,50868,negative regulation of T cell activation,P
2238,1845,50860,negative regulation of T cell receptor signaling pathway,P
2239,1845,35335,peptidyl-tyrosine dephosphorylation,P
2240,1845,45931,positive regulation of mitotic cell cycle,P
2241,1845,5829,cytosol,C
2242,1845,70062,extracellular exosome,C
2243,1845,1772,immunological synapse,C
2244,80824,17017,MAP kinase tyrosine/serine/threonine phosphatase activity,F
2245,1845,5654,nucleoplasm,C
2246,80824,16791,phosphatase activity,F
2247,1845,5654,nucleoplasm,C
2248,80824,4721,phosphoprotein phosphatase activity,F
2249,1845,5634,nucleus,C
2250,80824,4725,protein tyrosine phosphatase activity,F
2251,80824,45204,MAPK export from nucleus,P
2252,80824,45209,"MAPK phosphatase export from nucleus, leptomycin B sensitive",P
2253,80824,16311,dephosphorylation,P
2254,80824,16311,dephosphorylation,P
2255,80824,188,inactivation of MAPK activity,P
2256,80824,35335,peptidyl-tyrosine dephosphorylation,P
2257,80824,5737,cytoplasm,C
2258,80824,31410,cytoplasmic vesicle,C
2259,80824,5829,cytosol,C
2260,80824,5654,nucleoplasm,C
2261,80824,5634,nucleus,C
2262,1869,3677,DNA binding,F
2263,1869,3677,DNA binding,F
2264,1869,1047,core promoter binding,F
2265,1869,5515,protein binding,F
2266,1869,46983,protein dimerization activity,F
2267,1869,19901,protein kinase binding,F
2268,1869,43565,sequence-specific DNA binding,F
2269,1869,3700,"transcription factor activity, sequence-specific DNA binding",F
2270,1869,3700,"transcription factor activity, sequence-specific DNA binding",F
2271,1869,8134,transcription factor binding,F
2272,1869,77,DNA damage checkpoint,P
2273,1869,6977,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest",P
2274,1869,43276,anoikis,P
2275,1869,71398,cellular response to fatty acid,P
2276,1869,71456,cellular response to hypoxia,P
2277,1869,1990090,cellular response to nerve growth factor stimulus,P
2278,1869,71466,cellular response to xenobiotic stimulus,P
2279,1869,30900,forebrain development,P
2280,1869,72332,intrinsic apoptotic signaling pathway by p53 class mediator,P
2281,1869,8630,intrinsic apoptotic signaling pathway in response to DNA damage,P
2282,1869,1990086,lens fiber cell apoptotic process,P
2283,1869,48255,mRNA stabilization,P
2284,1869,43392,negative regulation of DNA binding,P
2285,1869,45599,negative regulation of fat cell differentiation,P
2286,1869,70345,negative regulation of fat cell proliferation,P
2287,1869,122,negative regulation of transcription from RNA polymerase II promoter,P
2288,1869,71930,negative regulation of transcription involved in G1/S transition of mitotic cell cycle,P
2289,1869,45892,"negative regulation of transcription, DNA-templated",P
2290,1869,45892,"negative regulation of transcription, DNA-templated",P
2291,1869,48146,positive regulation of fibroblast proliferation,P
2292,1869,10628,positive regulation of gene expression,P
2293,1869,1900740,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,P
2294,1869,45944,positive regulation of transcription from RNA polymerase II promoter,P
2295,1869,45893,"positive regulation of transcription, DNA-templated",P
2296,1869,45893,"positive regulation of transcription, DNA-templated",P
2297,1869,2000045,regulation of G1/S transition of mitotic cell cycle,P
2298,1869,6355,"regulation of transcription, DNA-templated",P
2299,1869,7283,spermatogenesis,P
2300,1869,6351,"transcription, DNA-templated",P
2301,1869,35189,Rb-E2F complex,C
2302,1869,5813,centrosome,C
2303,1869,5739,mitochondrion,C
2304,1869,790,nuclear chromatin,C
2305,1869,5654,nucleoplasm,C
2306,1869,5654,nucleoplasm,C
2307,1869,5634,nucleus,C
2308,26298,3677,DNA binding,F
2309,26298,3677,DNA binding,F
2310,26298,978,RNA polymerase II core promoter proximal region sequence-specific DNA binding,F
2311,26298,3700,"transcription factor activity, sequence-specific DNA binding",F
2312,26298,1077,"transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding",F
2313,26298,8283,cell proliferation,P
2314,26298,30855,epithelial cell differentiation,P
2315,26298,50673,epithelial cell proliferation,P
2316,26298,7275,multicellular organism development,P
2317,26298,45944,positive regulation of transcription from RNA polymerase II promoter,P
2318,26298,45893,"positive regulation of transcription, DNA-templated",P
2319,26298,6366,transcription from RNA polymerase II promoter,P
2320,26298,5794,Golgi apparatus,C
2321,26298,5654,nucleoplasm,C
2322,26298,5634,nucleus,C
2323,26298,5634,nucleus,C
2324,2021,4536,deoxyribonuclease activity,F
2325,2021,4519,endonuclease activity,F
2326,2021,46872,metal ion binding,F
2327,2021,3676,nucleic acid binding,F
2328,2021,5515,protein binding,F
2329,2021,6310,DNA recombination,P
2330,2021,7568,aging,P
2331,2021,6309,apoptotic DNA fragmentation,P
2332,2021,71277,cellular response to calcium ion,P
2333,2021,71333,cellular response to glucose stimulus,P
2334,2021,71456,cellular response to hypoxia,P
2335,2021,1701,in utero embryonic development,P
2336,2021,36475,neuron death in response to oxidative stress,P
2337,2021,1902512,positive regulation of apoptotic DNA fragmentation,P
2338,2021,1901300,positive regulation of hydrogen peroxide-mediated programmed cell death,P
2339,2021,46677,response to antibiotic,P
2340,2021,32355,response to estradiol,P
2341,2021,9612,response to mechanical stimulus,P
2342,2021,34612,response to tumor necrosis factor,P
2343,2021,5829,cytosol,C
2344,2021,5739,mitochondrion,C
2345,2021,5634,nucleus,C
2346,2021,43204,perikaryon,C
2347,2042,5524,ATP binding,F
2348,2042,5004,GPI-linked ephrin receptor activity,F
2349,2042,5515,protein binding,F
2350,2042,7155,cell adhesion,P
2351,2042,16477,cell migration,P
2352,2042,71300,cellular response to retinoic acid,P
2353,2042,48013,ephrin receptor signaling pathway,P
2354,2042,48013,ephrin receptor signaling pathway,P
2355,2042,97156,fasciculation of motor neuron axon,P
2356,2042,97155,fasciculation of sensory neuron axon,P
2357,2042,18108,peptidyl-tyrosine phosphorylation,P
2358,2042,10976,positive regulation of neuron projection development,P
2359,2042,43087,regulation of GTPase activity,P
2360,2042,32956,regulation of actin cytoskeleton organization,P
2361,2042,10717,regulation of epithelial to mesenchymal transition,P
2362,2042,51893,regulation of focal adhesion assembly,P
2363,2042,70507,regulation of microtubule cytoskeleton organization,P
2364,2042,5769,early endosome,C
2365,2042,5576,extracellular region,C
2366,2042,5887,integral component of plasma membrane,C
2367,2042,5886,plasma membrane,C
2368,54206,5096,GTPase activator activity,F
2369,54206,17124,SH3 domain binding,F
2370,54206,5515,protein binding,F
2371,54206,19901,protein kinase binding,F
2372,54206,31267,small GTPase binding,F
2373,54206,71474,cellular hyperosmotic response,P
2374,54206,71549,cellular response to dexamethasone stimulus,P
2375,54206,71364,cellular response to epidermal growth factor stimulus,P
2376,54206,32869,cellular response to insulin stimulus,P
2377,54206,36120,cellular response to platelet-derived growth factor stimulus,P
2378,54206,48286,lung alveolus development,P
2379,54206,60428,lung epithelium development,P
2380,54206,60426,lung vasculature development,P
2381,54206,70373,negative regulation of ERK1 and ERK2 cascade,P
2382,54206,1903243,negative regulation of cardiac muscle hypertrophy in response to stress,P
2383,54206,32966,negative regulation of collagen biosynthetic process,P
2384,54206,7175,negative regulation of epidermal growth factor-activated receptor activity,P
2385,54206,7175,negative regulation of epidermal growth factor-activated receptor activity,P
2386,54206,32691,negative regulation of interleukin-1 beta production,P
2387,54206,31953,negative regulation of protein autophosphorylation,P
2388,54206,42536,negative regulation of tumor necrosis factor biosynthetic process,P
2389,54206,43547,positive regulation of GTPase activity,P
2390,54206,45616,regulation of keratinocyte differentiation,P
2391,54206,45616,regulation of keratinocyte differentiation,P
2392,54206,61469,regulation of type B pancreatic cell proliferation,P
2393,54206,6950,response to stress,P
2394,2113,3677,DNA binding,F
2395,54206,43589,skin morphogenesis,P
2396,54206,5737,cytoplasm,C
2397,2113,978,RNA polymerase II core promoter proximal region sequence-specific DNA binding,F
2398,54206,5829,cytosol,C
2399,2113,35035,histone acetyltransferase binding,F
2400,54206,31234,extrinsic component of cytoplasmic side of plasma membrane,C
2401,54206,31234,extrinsic component of cytoplasmic side of plasma membrane,C
2402,2113,42802,identical protein binding,F
2403,54206,5634,nucleus,C
2404,2113,5515,protein binding,F
2405,2113,982,"transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding",F
2406,2113,3700,"transcription factor activity, sequence-specific DNA binding",F
2407,2113,8134,transcription factor binding,F
2408,2113,1077,"transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding",F
2409,2113,30578,PML body organization,P
2410,2113,60055,angiogenesis involved in wound healing,P
2411,2113,48870,cell motility,P
2412,2113,70301,cellular response to hydrogen peroxide,P
2413,2113,44849,estrous cycle,P
2414,2113,7565,female pregnancy,P
2415,2113,21854,hypothalamus development,P
2416,2113,6955,immune response,P
2417,2113,8285,negative regulation of cell proliferation,P
2418,2113,50728,negative regulation of inflammatory response,P
2419,2113,21983,pituitary gland development,P
2420,2113,45766,positive regulation of angiogenesis,P
2421,2113,8284,positive regulation of cell proliferation,P
2422,2113,51272,positive regulation of cellular component movement,P
2423,2113,10595,positive regulation of endothelial cell migration,P
2424,2113,45648,positive regulation of erythrocyte differentiation,P
2425,2113,50729,positive regulation of inflammatory response,P
2426,2113,1904996,positive regulation of leukocyte adhesion to vascular endothelial cell,P
2427,2113,45944,positive regulation of transcription from RNA polymerase II promoter,P
2428,2113,45893,"positive regulation of transcription, DNA-templated",P
2429,2113,61614,pri-miRNA transcription from RNA polymerase II promoter,P
2430,2113,45765,regulation of angiogenesis,P
2431,2113,10715,regulation of extracellular matrix disassembly,P
2432,2113,32355,response to estradiol,P
2433,2113,1666,response to hypoxia,P
2434,2113,70555,response to interleukin-1,P
2435,2113,34616,response to laminar fluid shear stress,P
2436,2113,9612,response to mechanical stimulus,P
2437,2113,5737,cytoplasm,C
2438,2113,5654,nucleoplasm,C
2439,2113,5654,nucleoplasm,C
2440,2113,5634,nucleus,C
2441,2113,5667,transcription factor complex,C
2442,2114,3677,DNA binding,F
2443,2114,978,RNA polymerase II core promoter proximal region sequence-specific DNA binding,F
2444,2114,35259,glucocorticoid receptor binding,F
2445,2114,5515,protein binding,F
2446,2114,19904,protein domain specific binding,F
2447,2114,3700,"transcription factor activity, sequence-specific DNA binding",F
2448,2114,1078,"transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding",F
2449,2114,30154,cell differentiation,P
2450,2114,1712,ectodermal cell fate commitment,P
2451,2114,7498,mesoderm development,P
2452,2114,122,negative regulation of transcription from RNA polymerase II promoter,P
2453,2114,45944,positive regulation of transcription from RNA polymerase II promoter,P
2454,2114,45893,"positive regulation of transcription, DNA-templated",P
2455,2114,90009,primitive streak formation,P
2456,2114,1501,skeletal system development,P
2457,2114,6351,"transcription, DNA-templated",P
2458,2114,5829,cytosol,C
2459,2114,5654,nucleoplasm,C
2460,2114,5654,nucleoplasm,C
2461,2114,5634,nucleus,C
2462,2114,5886,plasma membrane,C
2463,2130,3723,RNA binding,F
2464,2130,5516,calmodulin binding,F
2465,2130,42802,identical protein binding,F
2466,2130,5515,protein binding,F
2467,2130,8270,zinc ion binding,F
2468,2130,6355,"regulation of transcription, DNA-templated",P
2469,2130,6351,"transcription, DNA-templated",P
2470,2130,5737,cytoplasm,C
2471,2130,5730,nucleolus,C
2472,2130,5634,nucleus,C
2473,2130,5886,plasma membrane,C
2474,10922,5524,ATP binding,F
2475,10922,33867,Fas-activated serine/threonine kinase activity,F
2476,10922,3723,RNA binding,F
2477,10922,5515,protein binding,F
2478,10922,4674,protein serine/threonine kinase activity,F
2479,10922,97190,apoptotic signaling pathway,P
2480,10922,6468,protein phosphorylation,P
2481,10922,43484,regulation of RNA splicing,P
2482,10922,43484,regulation of RNA splicing,P
2483,10922,5759,mitochondrial matrix,C
2484,2146,3677,DNA binding,F
2485,2146,979,RNA polymerase II core promoter sequence-specific DNA binding,F
2486,2146,31490,chromatin DNA binding,F
2487,2146,3682,chromatin binding,F
2488,2146,1047,core promoter binding,F
2489,2146,42054,histone methyltransferase activity,F
2490,2146,42054,histone methyltransferase activity,F
2491,2146,46976,histone methyltransferase activity (H3-K27 specific),F
2492,2146,46976,histone methyltransferase activity (H3-K27 specific),F
2493,2146,18024,histone-lysine N-methyltransferase activity,F
2494,2146,18024,histone-lysine N-methyltransferase activity,F
2495,2146,70878,primary miRNA binding,F
2496,2146,1990841,promoter-specific chromatin binding,F
2497,2146,5515,protein binding,F
2498,2146,16279,protein-lysine N-methyltransferase activity,F
2499,2146,43021,ribonucleoprotein complex binding,F
2500,2146,6306,DNA methylation,P
2501,2146,70314,G1 to G0 transition,P
2502,2146,14898,cardiac muscle hypertrophy in response to stress,P
2503,2146,70301,cellular response to hydrogen peroxide,P
2504,2146,35984,cellular response to trichostatin A,P
2505,2146,21695,cerebellar cortex development,P
2506,2146,6325,chromatin organization,P
2507,2146,36333,hepatocyte homeostasis,P
2508,2146,21766,hippocampus development,P
2509,2146,70734,histone H3-K27 methylation,P
2510,2146,98532,histone H3-K27 trimethylation,P
2511,2146,16571,histone methylation,P
2512,2146,97421,liver regeneration,P
2513,2146,2000134,negative regulation of G1/S transition of mitotic cell cycle,P
2514,2146,45605,negative regulation of epidermal cell differentiation,P
2515,2146,45814,"negative regulation of gene expression, epigenetic",P
2516,2146,45814,"negative regulation of gene expression, epigenetic",P
2517,2146,45814,"negative regulation of gene expression, epigenetic",P
2518,2146,48387,negative regulation of retinoic acid receptor signaling pathway,P
2519,2146,43433,negative regulation of sequence-specific DNA binding transcription factor activity,P
2520,2146,51154,negative regulation of striated muscle cell differentiation,P
2521,2146,34244,negative regulation of transcription elongation from RNA polymerase II promoter,P
2522,2146,122,negative regulation of transcription from RNA polymerase II promoter,P
2523,2146,45892,"negative regulation of transcription, DNA-templated",P
2524,2146,43547,positive regulation of GTPase activity,P
2525,2146,43406,positive regulation of MAP kinase activity,P
2526,2146,1900006,positive regulation of dendrite development,P
2527,2146,10718,positive regulation of epithelial to mesenchymal transition,P
2528,2146,71902,positive regulation of protein serine/threonine kinase activity,P
2529,2146,71168,protein localization to chromatin,P
2530,2146,42127,regulation of cell proliferation,P
2531,2146,42752,regulation of circadian rhythm,P
2532,2146,14013,regulation of gliogenesis,P
2533,2146,6355,"regulation of transcription, DNA-templated",P
2534,2146,32355,response to estradiol,P
2535,2146,1904772,response to tetrachloromethane,P
2536,2146,48511,rhythmic process,P
2537,2146,14834,skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration,P
2538,2146,6351,"transcription, DNA-templated",P
2539,2146,35098,ESC/E(Z) complex,C
2540,2146,5737,cytoplasm,C
2541,2146,790,nuclear chromatin,C
2542,2146,5654,nucleoplasm,C
2543,2146,5634,nucleus,C
2544,2146,45120,pronucleus,C
2545,79791,30332,cyclin binding,F
2546,79791,4842,ubiquitin-protein transferase activity,F
2547,79791,4842,ubiquitin-protein transferase activity,F
2548,79791,31146,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,P
2549,79791,31145,anaphase-promoting complex-dependent catabolic process,P
2550,79791,6974,cellular response to DNA damage stimulus,P
2551,79791,31571,mitotic G1 DNA damage checkpoint,P
2552,79791,50775,positive regulation of dendrite morphogenesis,P
2553,79791,2001224,positive regulation of neuron migration,P
2554,79791,209,protein polyubiquitination,P
2555,79791,19005,SCF ubiquitin ligase complex,C
2556,79791,5813,centrosome,C
2557,79791,5829,cytosol,C
2558,79791,43025,neuronal cell body,C
2559,2353,70412,R-SMAD binding,F
2560,2353,1102,RNA polymerase II activating transcription factor binding,F
2561,2353,978,RNA polymerase II core promoter proximal region sequence-specific DNA binding,F
2562,2353,979,RNA polymerase II core promoter sequence-specific DNA binding,F
2563,2353,3682,chromatin binding,F
2564,2353,5515,protein binding,F
2565,2353,46982,protein heterodimerization activity,F
2566,2353,3700,"transcription factor activity, sequence-specific DNA binding",F
2567,2353,8134,transcription factor binding,F
2568,2353,44212,transcription regulatory region DNA binding,F
2569,2353,1077,"transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding",F
2570,2353,1190,"transcriptional activator activity, RNA polymerase II transcription factor binding",F
2571,2353,6306,DNA methylation,P
2572,2353,38095,Fc-epsilon receptor signaling pathway,P
2573,2353,60395,SMAD protein signal transduction,P
2574,2353,7568,aging,P
2575,2353,71276,cellular response to cadmium ion,P
2576,2353,71277,cellular response to calcium ion,P
2577,2353,31668,cellular response to extracellular stimulus,P
2578,2353,32870,cellular response to hormone stimulus,P
2579,2353,34614,cellular response to reactive oxygen species,P
2580,2353,34614,cellular response to reactive oxygen species,P
2581,2353,1661,conditioned taste aversion,P
2582,2353,7565,female pregnancy,P
2583,2353,6954,inflammatory response,P
2584,2353,7399,nervous system development,P
2585,2353,45672,positive regulation of osteoclast differentiation,P
2586,2353,1902895,positive regulation of pri-miRNA transcription from RNA polymerase II promoter,P
2587,2353,45944,positive regulation of transcription from RNA polymerase II promoter,P
2588,2353,45944,positive regulation of transcription from RNA polymerase II promoter,P
2589,2353,45944,positive regulation of transcription from RNA polymerase II promoter,P
2590,2353,45893,"positive regulation of transcription, DNA-templated",P
2591,2353,45893,"positive regulation of transcription, DNA-templated",P
2592,2305,981,"RNA polymerase II transcription factor activity, sequence-specific DNA binding",F
2593,2353,51090,regulation of sequence-specific DNA binding transcription factor activity,P
2594,2305,5515,protein binding,F
2595,2353,6357,regulation of transcription from RNA polymerase II promoter,P
2596,2305,19901,protein kinase binding,F
2597,2353,51591,response to cAMP,P
2598,2305,43565,sequence-specific DNA binding,F
2599,2353,9409,response to cold,P
2600,2305,6978,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator",P
2601,2353,51412,response to corticosterone,P
2602,2305,6281,DNA repair,P
2603,2305,86,G2/M transition of mitotic cell cycle,P
2604,2353,34097,response to cytokine,P
2605,2305,86,G2/M transition of mitotic cell cycle,P
2606,2353,42493,response to drug,P
2607,2305,90344,negative regulation of cell aging,P
2608,2353,9629,response to gravity,P
2609,2305,32873,negative regulation of stress-activated MAPK cascade,P
2610,2353,35902,response to immobilization stress,P
2611,2305,122,negative regulation of transcription from RNA polymerase II promoter,P
2612,2353,9416,response to light stimulus,P
2613,2305,45892,"negative regulation of transcription, DNA-templated",P
2614,2353,32496,response to lipopolysaccharide,P
2615,2305,8284,positive regulation of cell proliferation,P
2616,2305,2000781,positive regulation of double-strand break repair,P
2617,2353,35994,response to muscle stretch,P
2618,2305,45944,positive regulation of transcription from RNA polymerase II promoter,P
2619,2353,32570,response to progesterone,P
2620,2305,45944,positive regulation of transcription from RNA polymerase II promoter,P
2621,2353,9636,response to toxic substance,P
2622,2305,45893,"positive regulation of transcription, DNA-templated",P
2623,2305,46578,regulation of Ras protein signal transduction,P
2624,2353,35914,skeletal muscle cell differentiation,P
2625,2305,51726,regulation of cell cycle,P
2626,2353,30431,sleep,P
2627,2305,71156,regulation of cell cycle arrest,P
2628,2353,6366,transcription from RNA polymerase II promoter,P
2629,2305,2000377,regulation of reactive oxygen species metabolic process,P
2630,2353,7179,transforming growth factor beta receptor signaling pathway,P
2631,2305,6351,"transcription, DNA-templated",P
2632,2305,5654,nucleoplasm,C
2633,2353,5829,cytosol,C
2634,2305,5634,nucleus,C
2635,2353,5783,endoplasmic reticulum,C
2636,2353,16020,membrane,C
2637,2353,43005,neuron projection,C
2638,2353,5654,nucleoplasm,C
2639,2353,5654,nucleoplasm,C
2640,2353,5634,nucleus,C
2641,2353,32993,protein-DNA complex,C
2642,2353,35976,transcription factor AP-1 complex,C
2643,2353,35976,transcription factor AP-1 complex,C
2644,2309,3677,DNA binding,F
2645,2309,8013,beta-catenin binding,F
2646,2309,31490,chromatin DNA binding,F
2647,2309,1047,core promoter binding,F
2648,2309,5515,protein binding,F
2649,2309,19901,protein kinase binding,F
2650,2309,43565,sequence-specific DNA binding,F
2651,2309,1221,transcription cofactor binding,F
2652,2309,3700,"transcription factor activity, sequence-specific DNA binding",F
2653,2309,1228,"transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding",F
2654,2309,1227,"transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding",F
2655,2309,30330,"DNA damage response, signal transduction by p53 class mediator",P
2656,2309,7568,aging,P
2657,2309,1547,antral ovarian follicle growth,P
2658,2309,48854,brain morphogenesis,P
2659,2309,1904646,cellular response to beta-amyloid,P
2660,2309,71386,cellular response to corticosterone stimulus,P
2661,2309,71333,cellular response to glucose stimulus,P
2662,2309,71456,cellular response to hypoxia,P
2663,2309,1990090,cellular response to nerve growth factor stimulus,P
2664,2309,34599,cellular response to oxidative stress,P
2665,2309,97192,extrinsic apoptotic signaling pathway in absence of ligand,P
2666,2309,1544,initiation of primordial ovarian follicle growth,P
2667,2309,90090,negative regulation of canonical Wnt signaling pathway,P
2668,2309,45665,negative regulation of neuron differentiation,P
2669,2309,122,negative regulation of transcription from RNA polymerase II promoter,P
2670,2309,122,negative regulation of transcription from RNA polymerase II promoter,P
2671,2309,97150,neuronal stem cell population maintenance,P
2672,2309,1556,oocyte maturation,P
2673,2309,1542,ovulation from ovarian follicle,P
2674,2309,43065,positive regulation of apoptotic process,P
2675,2309,2000353,positive regulation of endothelial cell apoptotic process,P
2676,2309,45648,positive regulation of erythrocyte differentiation,P
2677,2309,1901300,positive regulation of hydrogen peroxide-mediated programmed cell death,P
2678,2309,43525,positive regulation of neuron apoptotic process,P
2679,2309,1903428,positive regulation of reactive oxygen species biosynthetic process,P
2680,2309,45944,positive regulation of transcription from RNA polymerase II promoter,P
2681,2309,45893,"positive regulation of transcription, DNA-templated",P
2682,2309,2000177,regulation of neural precursor cell proliferation,P
2683,2309,6357,regulation of transcription from RNA polymerase II promoter,P
2684,2309,6417,regulation of translation,P
2685,2309,71548,response to dexamethasone,P
2686,2309,42493,response to drug,P
2687,2309,31667,response to nutrient levels,P
2688,2309,1990785,response to water-immersion restraint stress,P
2689,2309,6366,transcription from RNA polymerase II promoter,P
2690,2309,33209,tumor necrosis factor-mediated signaling pathway,P
2691,2309,5737,cytoplasm,C
2692,2309,5829,cytosol,C
2693,2309,5829,cytosol,C
2694,2309,16020,membrane,C
2695,2309,5739,mitochondrion,C
2696,2309,5654,nucleoplasm,C
2697,2309,5654,nucleoplasm,C
2698,2309,5634,nucleus,C
2699,8087,2151,G-quadruplex RNA binding,F
2700,8087,3723,RNA binding,F
2701,8087,33592,RNA strand annealing activity,F
2702,8087,3730,mRNA 3'-UTR binding,F
2703,8087,3729,mRNA binding,F
2704,8087,5515,protein binding,F
2705,8087,46982,protein heterodimerization activity,F
2706,8087,42803,protein homodimerization activity,F
2707,8087,6915,apoptotic process,P
2708,8087,30154,cell differentiation,P
2709,8087,7517,muscle organ development,P
2710,8087,17148,negative regulation of translation,P
2711,8087,2000637,positive regulation of gene silencing by miRNA,P
2712,8087,30424,axon,C
2713,8087,43034,costamere,C
2714,8087,5737,cytoplasm,C
2715,8087,5829,cytosol,C
2716,8087,43197,dendritic spine,C
2717,8087,16020,membrane,C
2718,8087,5730,nucleolus,C
2719,8087,48471,perinuclear region of cytoplasm,C
2720,8087,5844,polysome,C
2721,8087,35770,ribonucleoprotein granule,C
2722,2539,50661,NADP binding,F
2723,2539,5536,glucose binding,F
2724,2539,5536,glucose binding,F
2725,2539,4345,glucose-6-phosphate dehydrogenase activity,F
2726,2539,4345,glucose-6-phosphate dehydrogenase activity,F
2727,2539,4345,glucose-6-phosphate dehydrogenase activity,F
2728,2539,42802,identical protein binding,F
2729,2539,5515,protein binding,F
2730,2539,42803,protein homodimerization activity,F
2731,2539,6739,NADP metabolic process,P
2732,2539,6740,NADPH regeneration,P
2733,2539,34599,cellular response to oxidative stress,P
2734,2539,6695,cholesterol biosynthetic process,P
2735,2539,43249,erythrocyte maturation,P
2736,2539,51156,glucose 6-phosphate metabolic process,P
2737,2539,51156,glucose 6-phosphate metabolic process,P
2738,2539,6006,glucose metabolic process,P
2739,2539,6749,glutathione metabolic process,P
2740,2539,6629,lipid metabolic process,P
2741,2539,61052,negative regulation of cell growth involved in cardiac muscle cell development,P
2742,2539,10734,negative regulation of protein glutathionylation,P
2743,2539,2000378,negative regulation of reactive oxygen species metabolic process,P
2744,2539,55114,oxidation-reduction process,P
2745,2539,19322,pentose biosynthetic process,P
2746,2539,6098,pentose-phosphate shunt,P
2747,2539,6098,pentose-phosphate shunt,P
2748,2539,9051,"pentose-phosphate shunt, oxidative branch",P
2749,2539,1904879,positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,P
2750,2539,43523,regulation of neuron apoptotic process,P
2751,2539,45471,response to ethanol,P
2752,2539,32094,response to food,P
2753,2539,10041,response to iron(III) ion,P
2754,2539,14070,response to organic cyclic compound,P
2755,2539,46390,ribose phosphate biosynthetic process,P
2756,2539,21762,substantia nigra development,P
2757,2539,5737,cytoplasm,C
2758,2539,9898,cytoplasmic side of plasma membrane,C
2759,2539,5829,cytosol,C
2760,2539,5829,cytosol,C
2761,2539,70062,extracellular exosome,C
2762,2539,16020,membrane,C
2763,2539,5634,nucleus,C
2764,2597,51287,NAD binding,F
2765,2597,50661,NADP binding,F
2766,2597,97718,disordered domain specific binding,F
2767,2597,4365,glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity,F
2768,2597,4365,glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity,F
2769,2597,4365,glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity,F
2770,2597,42802,identical protein binding,F
2771,2597,8017,microtubule binding,F
2772,2597,35605,peptidyl-cysteine S-nitrosylase activity,F
2773,2597,5515,protein binding,F
2774,2597,61621,canonical glycolysis,P
2775,2597,71346,cellular response to interferon-gamma,P
2776,2597,6094,gluconeogenesis,P
2777,2597,226,microtubule cytoskeleton organization,P
2778,2597,17148,negative regulation of translation,P
2779,2597,17148,negative regulation of translation,P
2780,2597,51402,neuron apoptotic process,P
2781,2597,35606,peptidyl-cysteine S-trans-nitrosylation,P
2782,2597,50821,protein stabilization,P
2783,2597,16241,regulation of macroautophagy,P
2784,2597,97452,GAIT complex,C
2785,2597,5737,cytoplasm,C
2786,2597,5737,cytoplasm,C
2787,2597,5829,cytosol,C
2788,2597,5829,cytosol,C
2789,2597,5829,cytosol,C
2790,2597,70062,extracellular exosome,C
2791,2597,31012,extracellular matrix,C
2792,2597,43231,intracellular membrane-bounded organelle,C
2793,2597,30529,intracellular ribonucleoprotein complex,C
2794,2597,5811,lipid particle,C
2795,2597,16020,membrane,C
2796,2597,15630,microtubule cytoskeleton,C
2797,2597,31965,nuclear membrane,C
2798,2597,5634,nucleus,C
2799,2597,5634,nucleus,C
2800,2597,48471,perinuclear region of cytoplasm,C
2801,2597,5886,plasma membrane,C
2802,2597,31982,vesicle,C
2803,56287,3674,molecular_function,F
2804,56287,7586,digestion,P
2805,56287,51781,positive regulation of cell division,P
2806,56287,42127,regulation of cell proliferation,P
2807,56287,5575,cellular_component,C
2808,56287,5615,extracellular space,C
2809,2626,3677,DNA binding,F
2810,2626,3677,DNA binding,F
2811,2626,51525,NFAT protein binding,F
2812,2626,977,RNA polymerase II regulatory region sequence-specific DNA binding,F
2813,2626,1085,RNA polymerase II transcription factor binding,F
2814,2626,33613,activating transcription factor binding,F
2815,2626,3682,chromatin binding,F
2816,2626,70410,co-SMAD binding,F
2817,2626,1158,enhancer sequence-specific DNA binding,F
2818,2626,5515,protein binding,F
2819,2626,19901,protein kinase binding,F
2820,2626,43565,sequence-specific DNA binding,F
2821,2626,3713,transcription coactivator activity,F
2822,2626,1076,"transcription factor activity, RNA polymerase II transcription factor binding",F
2823,2626,3700,"transcription factor activity, sequence-specific DNA binding",F
2824,2626,8134,transcription factor binding,F
2825,2626,44212,transcription regulatory region DNA binding,F
2826,2626,1228,"transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding",F
2827,2626,8270,zinc ion binding,F
2828,2626,60413,atrial septum morphogenesis,P
2829,2626,3289,atrial septum primum morphogenesis,P
2830,2626,3290,atrial septum secundum morphogenesis,P
2831,2626,7596,blood coagulation,P
2832,2626,3215,cardiac right ventricle morphogenesis,P
2833,2626,3208,cardiac ventricle morphogenesis,P
2834,2626,61049,cell growth involved in cardiac muscle cell development,P
2835,2626,7267,cell-cell signaling,P
2836,2626,71333,cellular response to glucose stimulus,P
2837,2626,48617,embryonic foregut morphogenesis,P
2838,2626,35054,embryonic heart tube anterior/posterior pattern specification,P
2839,2626,3197,endocardial cushion development,P
2840,2626,3197,endocardial cushion development,P
2841,2626,7492,endoderm development,P
2842,2626,1947,heart looping,P
2843,2626,60575,intestinal epithelial cell differentiation,P
2844,2626,8584,male gonad development,P
2845,2626,8584,male gonad development,P
2846,2626,10507,negative regulation of autophagy,P
2847,2626,30513,positive regulation of BMP signaling pathway,P
2848,2626,45766,positive regulation of angiogenesis,P
2849,2626,51891,positive regulation of cardioblast differentiation,P
2850,2626,45944,positive regulation of transcription from RNA polymerase II promoter,P
2851,2626,45944,positive regulation of transcription from RNA polymerase II promoter,P
2852,2626,45893,"positive regulation of transcription, DNA-templated",P
2853,2626,45893,"positive regulation of transcription, DNA-templated",P
2854,2626,10575,positive regulation of vascular endothelial growth factor production,P
2855,2626,86004,regulation of cardiac muscle cell contraction,P
2856,2626,6355,"regulation of transcription, DNA-templated",P
2857,2626,42493,response to drug,P
2858,2626,9612,response to mechanical stimulus,P
2859,2626,33189,response to vitamin A,P
2860,2626,6366,transcription from RNA polymerase II promoter,P
2861,2626,60290,transdifferentiation,P
2862,2626,3281,ventricular septum development,P
2863,2626,90575,RNA polymerase II transcription factor complex,C
2864,2626,16604,nuclear body,C
2865,2626,5654,nucleoplasm,C
2866,2626,5634,nucleus,C
2867,2626,5634,nucleus,C
2868,2626,5634,nucleus,C
2869,2791,3924,GTPase activity,F
2870,2791,4871,signal transducer activity,F
2871,2791,7186,G-protein coupled receptor signaling pathway,P
2872,2791,71377,cellular response to glucagon stimulus,P
2873,2791,7165,signal transduction,P
2874,2791,5834,heterotrimeric G-protein complex,C
2875,2791,5886,plasma membrane,C
2876,2720,4565,beta-galactosidase activity,F
2877,2720,4565,beta-galactosidase activity,F
2878,2720,4565,beta-galactosidase activity,F
2879,2720,4308,exo-alpha-sialidase activity,F
2880,2720,16936,galactoside binding,F
2881,2720,5515,protein binding,F
2882,2720,44262,cellular carbohydrate metabolic process,P
2883,2720,19388,galactose catabolic process,P
2884,2720,6027,glycosaminoglycan catabolic process,P
2885,2720,6687,glycosphingolipid metabolic process,P
2886,2720,42340,keratan sulfate catabolic process,P
2887,2720,43312,neutrophil degranulation,P
2888,2720,5794,Golgi apparatus,C
2889,2720,35578,azurophil granule lumen,C
2890,2720,5737,cytoplasm,C
2891,2720,70062,extracellular exosome,C
2892,2720,5576,extracellular region,C
2893,2720,5615,extracellular space,C
2894,2720,1904813,ficolin-1-rich granule lumen,C
2895,2720,43231,intracellular membrane-bounded organelle,C
2896,2720,43202,lysosomal lumen,C
2897,2720,48471,perinuclear region of cytoplasm,C
2898,2720,5773,vacuole,C
2899,2870,5524,ATP binding,F
2900,2870,4703,G-protein coupled receptor kinase activity,F
2901,2870,47696,beta-adrenergic receptor kinase activity,F
2902,2870,47696,beta-adrenergic receptor kinase activity,F
2903,2870,47696,beta-adrenergic receptor kinase activity,F
2904,2870,5515,protein binding,F
2905,2870,16055,Wnt signaling pathway,P
2906,2870,6468,protein phosphorylation,P
2907,2870,8277,regulation of G-protein coupled receptor protein signaling pathway,P
2908,2870,16020,membrane,C
2909,2870,5886,plasma membrane,C
2910,9759,32041,NAD-dependent histone deacetylase activity (H3-K14 specific),F
2911,9759,1025,RNA polymerase III transcription factor binding,F
2912,9759,33613,activating transcription factor binding,F
2913,9759,3682,chromatin binding,F
2914,9759,1047,core promoter binding,F
2915,9759,4407,histone deacetylase activity,F
2916,9759,42826,histone deacetylase binding,F
2917,9759,30955,potassium ion binding,F
2918,9759,5515,protein binding,F
2919,9759,33558,protein deacetylase activity,F
2920,9759,19901,protein kinase binding,F
2921,9759,70491,repressing transcription factor binding,F
2922,9759,43565,sequence-specific DNA binding,F
2923,9759,3714,transcription corepressor activity,F
2924,9759,8134,transcription factor binding,F
2925,9759,44212,transcription regulatory region DNA binding,F
2926,3065,32041,NAD-dependent histone deacetylase activity (H3-K14 specific),F
2927,9759,8270,zinc ion binding,F
2928,9759,42113,B cell activation,P
2929,3065,51059,NF-kappaB binding,F
2930,9759,30183,B cell differentiation,P
2931,3065,978,RNA polymerase II core promoter proximal region sequence-specific DNA binding,F
2932,9759,14898,cardiac muscle hypertrophy in response to stress,P
2933,3065,980,RNA polymerase II distal enhancer sequence-specific DNA binding,F
2934,9759,71260,cellular response to mechanical stimulus,P
2935,9759,71374,cellular response to parathyroid hormone stimulus,P
2936,3065,1103,RNA polymerase II repressing transcription factor binding,F
2937,9759,71356,cellular response to tumor necrosis factor,P
2938,9759,6338,chromatin remodeling,P
2939,3065,1106,RNA polymerase II transcription corepressor activity,F
2940,9759,70932,histone H3 deacetylation,P
2941,9759,70933,histone H4 deacetylation,P
2942,3065,1085,RNA polymerase II transcription factor binding,F
2943,9759,16575,histone deacetylation,P
2944,3065,33613,activating transcription factor binding,F
2945,9759,16575,histone deacetylation,P
2946,9759,6954,inflammatory response,P
2947,3065,1047,core promoter binding,F
2948,9759,8285,negative regulation of cell proliferation,P
2949,3065,1046,core promoter sequence-specific DNA binding,F
2950,9759,45820,negative regulation of glycolytic process,P
2951,3065,19213,deacetylase activity,F
2952,9759,10832,negative regulation of myotube differentiation,P
2953,3065,19899,enzyme binding,F
2954,9759,45668,negative regulation of osteoblast differentiation,P
2955,3065,4407,histone deacetylase activity,F
2956,9759,1902894,negative regulation of pri-miRNA transcription from RNA polymerase II promoter,P
2957,3065,4407,histone deacetylase activity,F
2958,9759,43433,negative regulation of sequence-specific DNA binding transcription factor activity,P
2959,3065,4407,histone deacetylase activity,F
2960,9759,122,negative regulation of transcription from RNA polymerase II promoter,P
2961,3065,42826,histone deacetylase binding,F
2962,9759,122,negative regulation of transcription from RNA polymerase II promoter,P
2963,3065,31492,nucleosomal DNA binding,F
2964,9759,122,negative regulation of transcription from RNA polymerase II promoter,P
2965,3065,2039,p53 binding,F
2966,9759,45892,"negative regulation of transcription, DNA-templated",P
2967,3065,47485,protein N-terminus binding,F
2968,9759,45892,"negative regulation of transcription, DNA-templated",P
2969,3065,5515,protein binding,F
2970,9759,7399,nervous system development,P
2971,3065,33558,protein deacetylase activity,F
2972,9759,2076,osteoblast development,P
2973,3065,33558,protein deacetylase activity,F
2974,9759,34983,peptidyl-lysine deacetylation,P
2975,3065,70491,repressing transcription factor binding,F
2976,9759,8284,positive regulation of cell proliferation,P
2977,3065,3700,"transcription factor activity, sequence-specific DNA binding",F
2978,9759,10592,positive regulation of lamellipodium assembly,P
2979,3065,8134,transcription factor binding,F
2980,9759,43525,positive regulation of neuron apoptotic process,P
2981,3065,8134,transcription factor binding,F
2982,9759,33235,positive regulation of protein sumoylation,P
2983,3065,44212,transcription regulatory region DNA binding,F
2984,9759,1903428,positive regulation of reactive oxygen species biosynthetic process,P
2985,9759,51091,positive regulation of sequence-specific DNA binding transcription factor activity,P
2986,3065,976,transcription regulatory region sequence-specific DNA binding,F
2987,9759,14911,positive regulation of smooth muscle cell migration,P
2988,3065,43044,ATP-dependent chromatin remodeling,P
2989,9759,48661,positive regulation of smooth muscle cell proliferation,P
2990,3065,1904837,beta-catenin-TCF complex assembly,P
2991,3065,7596,blood coagulation,P
2992,9759,45944,positive regulation of transcription from RNA polymerase II promoter,P
2993,3065,6325,chromatin organization,P
2994,9759,45944,positive regulation of transcription from RNA polymerase II promoter,P
2995,3065,6338,chromatin remodeling,P
2996,9759,45893,"positive regulation of transcription, DNA-templated",P
2997,3065,32922,circadian regulation of gene expression,P
2998,9759,6476,protein deacetylation,P
2999,9759,10882,regulation of cardiac muscle contraction by calcium ion signaling,P
3000,3065,42733,embryonic digit morphogenesis,P
3001,9759,40029,"regulation of gene expression, epigenetic",P
3002,9759,43393,regulation of protein binding,P
3003,3065,9913,epidermal cell differentiation,P
3004,9759,48742,regulation of skeletal muscle fiber development,P
3005,3065,61029,eyelid development in camera-type eye,P
3006,9759,14894,response to denervation involved in regulation of muscle adaptation,P
3007,3065,61198,fungiform papilla formation,P
3008,3065,60789,hair follicle placode formation,P
3009,9759,42493,response to drug,P
3010,3065,70932,histone H3 deacetylation,P
3011,9759,70555,response to interleukin-1,P
3012,3065,70933,histone H4 deacetylation,P
3013,9759,1501,skeletal system development,P
3014,3065,16575,histone deacetylation,P
3015,9759,6351,"transcription, DNA-templated",P
3016,3065,6346,methylation-dependent chromatin silencing,P
3017,9759,31672,A band,C
3018,3065,43922,negative regulation by host of viral transcription,P
3019,9759,30018,Z disc,C
3020,3065,60766,negative regulation of androgen receptor signaling pathway,P
3021,9759,42641,actomyosin,C
3022,3065,43066,negative regulation of apoptotic process,P
3023,3065,90090,negative regulation of canonical Wnt signaling pathway,P
3024,9759,5737,cytoplasm,C
3025,9759,5829,cytosol,C
3026,3065,10629,negative regulation of gene expression,P
3027,3065,10832,negative regulation of myotube differentiation,P
3028,9759,118,histone deacetylase complex,C
3029,3065,122,negative regulation of transcription from RNA polymerase II promoter,P
3030,9759,31594,neuromuscular junction,C
3031,3065,122,negative regulation of transcription from RNA polymerase II promoter,P
3032,9759,5654,nucleoplasm,C
3033,3065,122,negative regulation of transcription from RNA polymerase II promoter,P
3034,9759,5634,nucleus,C
3035,3065,122,negative regulation of transcription from RNA polymerase II promoter,P
3036,9759,43234,protein complex,C
3037,3065,45892,"negative regulation of transcription, DNA-templated",P
3038,9759,17053,transcriptional repressor complex,C
3039,3065,45892,"negative regulation of transcription, DNA-templated",P
3040,3065,42475,odontogenesis of dentin-containing tooth,P
3041,3065,8284,positive regulation of cell proliferation,P
3042,3065,10870,positive regulation of receptor biosynthetic process,P
3043,3065,45944,positive regulation of transcription from RNA polymerase II promoter,P
3044,3065,45893,"positive regulation of transcription, DNA-templated",P
3045,3065,6476,protein deacetylation,P
3046,3065,1901796,regulation of signal transduction by p53 class mediator,P
3047,3065,6351,"transcription, DNA-templated",P
3048,3065,16032,viral process,P
3049,3065,16581,NuRD complex,C
3050,3065,16580,Sin3 complex,C
3051,3065,785,chromatin,C
3052,3065,5737,cytoplasm,C
3053,3065,5829,cytosol,C
3054,3065,118,histone deacetylase complex,C
3055,3065,790,nuclear chromatin,C
3056,3065,5654,nucleoplasm,C
3057,3065,5654,nucleoplasm,C
3058,3065,5634,nucleus,C
3059,3065,43234,protein complex,C
3060,220296,7155,cell adhesion,P
3061,220296,7050,cell cycle arrest,P
3062,220296,34613,cellular protein localization,P
3063,220296,40008,regulation of growth,P
3064,220296,30424,axon,C
3065,220296,5911,cell-cell junction,C
3066,220296,5737,cytoplasm,C
3067,220296,16021,integral component of membrane,C
3068,55355,3677,DNA binding,F
3069,55355,42393,histone binding,F
3070,55355,42393,histone binding,F
3071,55355,42802,identical protein binding,F
3072,55355,5515,protein binding,F
3073,55355,34080,CENP-A containing nucleosome assembly,P
3074,55355,34080,CENP-A containing nucleosome assembly,P
3075,55355,7049,cell cycle,P
3076,55355,7059,chromosome segregation,P
3077,55355,51101,regulation of DNA binding,P
3078,55355,43254,regulation of protein complex assembly,P
3079,55355,775,"chromosome, centromeric region",C
3080,55355,777,condensed chromosome kinetochore,C
3081,55355,5829,cytosol,C
3082,55355,5739,mitochondrion,C
3083,55355,5730,nucleolus,C
3084,55355,5654,nucleoplasm,C
3085,55355,5634,nucleus,C
3086,3096,3677,DNA binding,F
3087,3096,980,RNA polymerase II distal enhancer sequence-specific DNA binding,F
3088,3096,46872,metal ion binding,F
3089,3096,5515,protein binding,F
3090,3096,43565,sequence-specific DNA binding,F
3091,3096,44212,transcription regulatory region DNA binding,F
3092,3096,1206,"transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding",F
3093,3096,7275,multicellular organism development,P
3094,3096,122,negative regulation of transcription from RNA polymerase II promoter,P
3095,3096,7165,signal transduction,P
3096,3096,6366,transcription from RNA polymerase II promoter,P
3097,3096,5739,mitochondrion,C
3098,3096,16604,nuclear body,C
3099,3096,5654,nucleoplasm,C
3100,3096,5634,nucleus,C
3101,3101,5524,ATP binding,F
3102,3101,8865,fructokinase activity,F
3103,3101,4340,glucokinase activity,F
3104,3101,4340,glucokinase activity,F
3105,3101,5536,glucose binding,F
3106,3101,4396,hexokinase activity,F
3107,3101,19158,mannokinase activity,F
3108,3101,61621,canonical glycolysis,P
3109,3101,46835,carbohydrate phosphorylation,P
3110,3101,1678,cellular glucose homeostasis,P
3111,3101,51156,glucose 6-phosphate metabolic process,P
3112,3101,15758,glucose transport,P
3113,3101,6096,glycolytic process,P
3114,3101,43312,neutrophil degranulation,P
3115,3101,5829,cytosol,C
3116,3101,5829,cytosol,C
3117,3101,5576,extracellular region,C
3118,3101,1904813,ficolin-1-rich granule lumen,C
3119,3101,5739,mitochondrion,C
3120,3101,34774,secretory granule lumen,C
3121,3146,19958,C-X-C chemokine binding,F
3122,3146,8301,"DNA binding, bending",F
3123,3146,8301,"DNA binding, bending",F
3124,3146,70182,DNA polymerase binding,F
3125,3146,50786,RAGE receptor binding,F
3126,3146,3723,RNA binding,F
3127,3146,405,bubble DNA binding,F
3128,3146,42056,chemoattractant activity,F
3129,3146,5125,cytokine activity,F
3130,3146,3684,damaged DNA binding,F
3131,3146,3684,damaged DNA binding,F
3132,3146,3690,double-stranded DNA binding,F
3133,3146,400,four-way junction DNA binding,F
3134,3146,1530,lipopolysaccharide binding,F
3135,3146,16829,lyase activity,F
3136,3146,1786,phosphatidylserine binding,F
3137,3146,5515,protein binding,F
3138,3146,70491,repressing transcription factor binding,F
3139,3146,3697,single-stranded DNA binding,F
3140,3146,97100,supercoiled DNA binding,F
3141,3146,3700,"transcription factor activity, sequence-specific DNA binding",F
3142,3146,8134,transcription factor binding,F
3143,3146,32392,DNA geometric change,P
3144,3146,51103,DNA ligation involved in DNA repair,P
3145,3146,6310,DNA recombination,P
3146,3146,6265,DNA topological change,P
3147,3146,35711,T-helper 1 cell activation,P
3148,3146,45063,T-helper 1 cell differentiation,P
3149,3146,33151,V(D)J recombination,P
3150,3146,2218,activation of innate immune response,P
3151,3146,6309,apoptotic DNA fragmentation,P
3152,3146,43277,apoptotic cell clearance,P
3153,3146,6914,autophagy,P
3154,3146,2407,dendritic cell chemotaxis,P
3155,3146,6954,inflammatory response,P
3156,3146,2437,inflammatory response to antigenic stimulus,P
3157,3146,45087,innate immune response,P
3158,3146,1773,myeloid dendritic cell activation,P
3159,3146,43371,"negative regulation of CD4-positive, alpha-beta T cell differentiation",P
3160,3146,17055,negative regulation of RNA polymerase II transcriptional preinitiation complex assembly,P
3161,3146,43537,negative regulation of blood vessel endothelial cell migration,P
3162,3146,32689,negative regulation of interferon-gamma production,P
3163,3146,122,negative regulation of transcription from RNA polymerase II promoter,P
3164,3146,31175,neuron projection development,P
3165,3146,97350,neutrophil clearance,P
3166,3146,43312,neutrophil degranulation,P
3167,3146,50918,positive chemotaxis,P
3168,3146,43388,positive regulation of DNA binding,P
3169,3146,51106,positive regulation of DNA ligation,P
3170,3146,70374,positive regulation of ERK1 and ERK2 cascade,P
3171,3146,46330,positive regulation of JNK cascade,P
3172,3146,43410,positive regulation of MAPK cascade,P
3173,3146,42104,positive regulation of activated T cell proliferation,P
3174,3146,43065,positive regulation of apoptotic process,P
3175,3146,43280,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,P
3176,3146,7204,positive regulation of cytosolic calcium ion concentration,P
3177,3146,2001200,positive regulation of dendritic cell differentiation,P
3178,3146,50716,positive regulation of interleukin-1 secretion,P
3179,3146,32733,positive regulation of interleukin-10 production,P
3180,3146,32735,positive regulation of interleukin-12 production,P
3181,3146,2000778,positive regulation of interleukin-6 secretion,P
3182,3146,32425,positive regulation of mismatch repair,P
3183,3146,90026,positive regulation of monocyte chemotaxis,P
3184,3146,34165,positive regulation of toll-like receptor 9 signaling pathway,P
3185,3146,45944,positive regulation of transcription from RNA polymerase II promoter,P
3186,3146,2840,regulation of T cell mediated immune response to tumor cell,P
3187,3146,10506,regulation of autophagy,P
3188,3146,32072,regulation of restriction endodeoxyribonuclease activity,P
3189,3146,2643,regulation of tolerance induction,P
3190,3146,6357,regulation of transcription from RNA polymerase II promoter,P
3191,3146,2224,toll-like receptor signaling pathway,P
3192,3146,1990774,tumor necrosis factor secretion,P
3193,3265,19003,GDP binding,F
3194,3146,9986,cell surface,C
3195,3265,5525,GTP binding,F
3196,3146,793,condensed chromosome,C
3197,3265,5525,GTP binding,F
3198,3146,5793,endoplasmic reticulum-Golgi intermediate compartment,C
3199,3265,3924,GTPase activity,F
3200,3146,5768,endosome,C
3201,3265,3924,GTPase activity,F
3202,3146,5576,extracellular region,C
3203,3265,8022,protein C-terminus binding,F
3204,3146,5615,extracellular space,C
3205,3265,5515,protein binding,F
3206,3146,1904813,ficolin-1-rich granule lumen,C
3207,3265,38128,ERBB2 signaling pathway,P
3208,3146,5654,nucleoplasm,C
3209,3265,38095,Fc-epsilon receptor signaling pathway,P
3210,3146,5634,nucleus,C
3211,3265,165,MAPK cascade,P
3212,3146,5886,plasma membrane,C
3213,3265,7265,Ras protein signal transduction,P
3214,3146,34774,secretory granule lumen,C
3215,3265,7265,Ras protein signal transduction,P
3216,3146,17053,transcriptional repressor complex,C
3217,3265,50852,T cell receptor signaling pathway,P
3218,3265,42088,T-helper 1 type immune response,P
3219,3265,9887,animal organ morphogenesis,P
3220,3265,7411,axon guidance,P
3221,3265,7050,cell cycle arrest,P
3222,3265,7050,cell cycle arrest,P
3223,3265,8283,cell proliferation,P
3224,3265,7166,cell surface receptor signaling pathway,P
3225,3265,71480,cellular response to gamma radiation,P
3226,3265,90398,cellular senescence,P
3227,3265,6935,chemotaxis,P
3228,3265,42832,defense response to protozoan,P
3229,3265,6897,endocytosis,P
3230,3265,48013,ephrin receptor signaling pathway,P
3231,3265,7173,epidermal growth factor receptor signaling pathway,P
3232,3265,97193,intrinsic apoptotic signaling pathway,P
3233,3265,50900,leukocyte migration,P
3234,3265,7093,mitotic cell cycle checkpoint,P
3235,3265,34260,negative regulation of GTPase activity,P
3236,3265,8285,negative regulation of cell proliferation,P
3237,3265,10629,negative regulation of gene expression,P
3238,3265,43524,negative regulation of neuron apoptotic process,P
3239,3265,45740,positive regulation of DNA replication,P
3240,3265,70374,positive regulation of ERK1 and ERK2 cascade,P
3241,3265,43547,positive regulation of GTPase activity,P
3242,3265,46330,positive regulation of JNK cascade,P
3243,3265,43406,positive regulation of MAP kinase activity,P
3244,3265,43410,positive regulation of MAPK cascade,P
3245,3265,46579,positive regulation of Ras protein signal transduction,P
3246,3265,2000251,positive regulation of actin cytoskeleton reorganization,P
3247,3265,30335,positive regulation of cell migration,P
3248,3265,8284,positive regulation of cell proliferation,P
3249,3265,50679,positive regulation of epithelial cell proliferation,P
3250,3265,32729,positive regulation of interferon-gamma production,P
3251,3265,2000630,positive regulation of miRNA metabolic process,P
3252,3265,1934,positive regulation of protein phosphorylation,P
3253,3265,1900029,positive regulation of ruffle assembly,P
3254,3265,45944,positive regulation of transcription from RNA polymerase II promoter,P
3255,3265,90303,positive regulation of wound healing,P
3256,3265,51291,protein heterooligomerization,P
3257,3265,48169,regulation of long-term neuronal synaptic plasticity,P
3258,3265,35900,response to isolation stress,P
3259,3265,7165,signal transduction,P
3260,3265,2223,stimulatory C-type lectin receptor signaling pathway,P
3261,3265,5794,Golgi apparatus,C
3262,3265,139,Golgi membrane,C
3263,3265,5737,cytoplasm,C
3264,3265,5829,cytosol,C
3265,3265,5634,nucleus,C
3266,3265,48471,perinuclear region of cytoplasm,C
3267,3265,5886,plasma membrane,C
3268,3265,5886,plasma membrane,C
3269,3309,5524,ATP binding,F
3270,3309,16887,ATPase activity,F
3271,3309,16887,ATPase activity,F
3272,3309,45296,cadherin binding,F
3273,3309,5509,calcium ion binding,F
3274,3309,51087,chaperone binding,F
3275,3309,19899,enzyme binding,F
3276,3309,1948,glycoprotein binding,F
3277,3309,51787,misfolded protein binding,F
3278,3309,5515,protein binding,F
3279,3309,19904,protein domain specific binding,F
3280,3309,43022,ribosome binding,F
3281,3309,31625,ubiquitin protein ligase binding,F
3282,3309,51082,unfolded protein binding,F
3283,3309,36500,ATF6-mediated unfolded protein response,P
3284,3309,6983,ER overload response,P
3285,3309,36498,IRE1-mediated unfolded protein response,P
3286,3309,36499,PERK-mediated unfolded protein response,P
3287,3309,6987,activation of signaling protein activity involved in unfolded protein response,P
3288,3309,71236,cellular response to antibiotic,P
3289,3309,71320,cellular response to cAMP,P
3290,3309,71277,cellular response to calcium ion,P
3291,3309,35690,cellular response to drug,P
3292,3309,42149,cellular response to glucose starvation,P
3293,3309,71353,cellular response to interleukin-4,P
3294,3309,71287,cellular response to manganese ion,P
3295,3309,1990090,cellular response to nerve growth factor stimulus,P
3296,3309,21680,cerebellar Purkinje cell layer development,P
3297,3309,21589,cerebellum structural organization,P
3298,3309,30968,endoplasmic reticulum unfolded protein response,P
3299,3309,35437,maintenance of protein localization in endoplasmic reticulum,P
3300,3309,43066,negative regulation of apoptotic process,P
3301,3309,43066,negative regulation of apoptotic process,P
3302,3309,90074,negative regulation of protein homodimerization activity,P
3303,3309,30512,negative regulation of transforming growth factor beta receptor signaling pathway,P
3304,3309,51402,neuron apoptotic process,P
3305,3309,30182,neuron differentiation,P
3306,3309,30335,positive regulation of cell migration,P
3307,3309,10976,positive regulation of neuron projection development,P
3308,3309,31398,positive regulation of protein ubiquitination,P
3309,3309,1990440,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,P
3310,3309,34975,protein folding in endoplasmic reticulum,P
3311,3309,1903891,regulation of ATF6-mediated unfolded protein response,P
3312,3309,1903894,regulation of IRE1-mediated unfolded protein response,P
3313,3309,1903897,regulation of PERK-mediated unfolded protein response,P
3314,3309,60904,regulation of protein folding in endoplasmic reticulum,P
3315,3309,42220,response to cocaine,P
3316,3309,1904313,response to methamphetamine hydrochloride,P
3317,3309,9314,response to radiation,P
3318,3309,97501,stress response to metal ion,P
3319,3309,21762,substantia nigra development,P
3320,3309,1901998,toxin transport,P
3321,3309,30433,ubiquitin-dependent ERAD pathway,P
3322,3309,8180,COP9 signalosome,C
3323,3309,9986,cell surface,C
3324,3309,5783,endoplasmic reticulum,C
3325,3309,5783,endoplasmic reticulum,C
3326,3309,5783,endoplasmic reticulum,C
3327,3309,34663,endoplasmic reticulum chaperone complex,C
3328,3309,5788,endoplasmic reticulum lumen,C
3329,3309,5789,endoplasmic reticulum membrane,C
3330,3309,5793,endoplasmic reticulum-Golgi intermediate compartment,C
3331,3309,70062,extracellular exosome,C
3332,3309,31012,extracellular matrix,C
3333,3309,5925,focal adhesion,C
3334,3309,30176,integral component of endoplasmic reticulum membrane,C
3335,3309,42470,melanosome,C
3336,3309,16020,membrane,C
3337,3309,30496,midbody,C
3338,3309,5739,mitochondrion,C
3339,3309,43209,myelin sheath,C
3340,3309,5634,nucleus,C
3341,3309,5634,nucleus,C
3342,3309,5886,plasma membrane,C
3343,3309,5790,smooth endoplasmic reticulum,C
3344,3316,8047,enzyme activator activity,F
3345,3316,5515,protein binding,F
3346,3316,43085,positive regulation of catalytic activity,P
3347,3316,9408,response to heat,P
3348,3316,6986,response to unfolded protein,P
3349,3316,5737,cytoplasm,C
3350,3316,5829,cytosol,C
3351,3316,5634,nucleus,C
3352,3397,70628,proteasome binding,F
3353,3397,8022,protein C-terminus binding,F
3354,3397,47485,protein N-terminus binding,F
3355,3397,5515,protein binding,F
3356,3397,42803,protein homodimerization activity,F
3357,3397,43621,protein self-association,F
3358,3397,3700,"transcription factor activity, sequence-specific DNA binding",F
3359,3397,8134,transcription factor binding,F
3360,3397,30509,BMP signaling pathway,P
3361,3397,1525,angiogenesis,P
3362,3397,43534,blood vessel endothelial cell migration,P
3363,3397,48514,blood vessel morphogenesis,P
3364,3397,7420,brain development,P
3365,3397,36164,cell-abiotic substrate adhesion,P
3366,3397,1903351,cellular response to dopamine,P
3367,3397,71364,cellular response to epidermal growth factor stimulus,P
3368,3397,1990090,cellular response to nerve growth factor stimulus,P
3369,3397,1901653,cellular response to peptide,P
3370,3397,7623,circadian rhythm,P
3371,3397,32963,collagen metabolic process,P
3372,3397,1886,endothelial cell morphogenesis,P
3373,3397,7507,heart development,P
3374,3397,60425,lung morphogenesis,P
3375,3397,60426,lung vasculature development,P
3376,3397,1903026,negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding,P
3377,3397,43066,negative regulation of apoptotic process,P
3378,3397,50774,negative regulation of dendrite morphogenesis,P
3379,3397,45602,negative regulation of endothelial cell differentiation,P
3380,3397,45668,negative regulation of osteoblast differentiation,P
3381,3397,90074,negative regulation of protein homodimerization activity,P
3382,3397,43433,negative regulation of sequence-specific DNA binding transcription factor activity,P
3383,3397,10621,negative regulation of transcription by transcription factor localization,P
3384,3397,122,negative regulation of transcription from RNA polymerase II promoter,P
3385,3397,45892,"negative regulation of transcription, DNA-templated",P
3386,3397,30182,neuron differentiation,P
3387,3397,32233,positive regulation of actin filament bundle assembly,P
3388,3397,50679,positive regulation of epithelial cell proliferation,P
3389,3397,10628,positive regulation of gene expression,P
3390,3397,31648,protein destabilization,P
3391,3397,43408,regulation of MAPK cascade,P
3392,3397,45765,regulation of angiogenesis,P
3393,3397,46677,response to antibiotic,P
3394,3397,6351,"transcription, DNA-templated",P
3395,3397,7179,transforming growth factor beta receptor signaling pathway,P
3396,3397,5794,Golgi apparatus,C
3397,3397,5813,centrosome,C
3398,3397,5654,nucleoplasm,C
3399,3397,5654,nucleoplasm,C
3400,3397,5634,nucleus,C
3401,3400,1085,RNA polymerase II transcription factor binding,F
3402,3400,5515,protein binding,F
3403,3400,46983,protein dimerization activity,F
3404,3400,3714,transcription corepressor activity,F
3405,3400,82,G1/S transition of mitotic cell cycle,P
3406,3400,34613,cellular protein localization,P
3407,3400,22010,central nervous system myelination,P
3408,3400,21895,cerebral cortex neuron differentiation,P
3409,3400,7623,circadian rhythm,P
3410,3400,45444,fat cell differentiation,P
3411,3400,21766,hippocampus development,P
3412,3400,48712,negative regulation of astrocyte differentiation,P
3413,3400,45599,negative regulation of fat cell differentiation,P
3414,3400,45665,negative regulation of neuron differentiation,P
3415,3400,48715,negative regulation of oligodendrocyte differentiation,P
3416,3400,122,negative regulation of transcription from RNA polymerase II promoter,P
3417,3400,45892,"negative regulation of transcription, DNA-templated",P
3418,3400,7405,neuroblast proliferation,P
3419,3400,8284,positive regulation of cell proliferation,P
3420,3400,45669,positive regulation of osteoblast differentiation,P
3421,3400,45944,positive regulation of transcription from RNA polymerase II promoter,P
3422,3400,60740,prostate gland epithelium morphogenesis,P
3423,3400,60741,prostate gland stromal morphogenesis,P
3424,3400,6357,regulation of transcription from RNA polymerase II promoter,P
3425,3400,61682,seminal vesicle morphogenesis,P
3426,3400,6351,"transcription, DNA-templated",P
3427,3400,5737,cytoplasm,C
3428,3400,5634,nucleus,C
3429,3400,5634,nucleus,C
3430,3484,31994,insulin-like growth factor I binding,F
3431,3484,31995,insulin-like growth factor II binding,F
3432,3484,5520,insulin-like growth factor binding,F
3433,3484,5515,protein binding,F
3434,3484,5102,receptor binding,F
3435,3484,36499,PERK-mediated unfolded protein response,P
3436,3484,7568,aging,P
3437,3484,44267,cellular protein metabolic process,P
3438,3484,8286,insulin receptor signaling pathway,P
3439,3484,90090,negative regulation of canonical Wnt signaling pathway,P
3440,3484,30307,positive regulation of cell growth,P
3441,3484,43567,regulation of insulin-like growth factor receptor signaling pathway,P
3442,3484,7165,signal transduction,P
3443,3484,42246,tissue regeneration,P
3444,3484,5794,Golgi apparatus,C
3445,3484,5576,extracellular region,C
3446,3484,5615,extracellular space,C
3447,3458,5125,cytokine activity,F
3448,3458,5133,interferon-gamma receptor binding,F
3449,3458,2302,"CD8-positive, alpha-beta T cell differentiation involved in immune response",P
3450,3458,50852,T cell receptor signaling pathway,P
3451,3458,2250,adaptive immune response,P
3452,3458,19882,antigen processing and presentation,P
3453,3458,6915,apoptotic process,P
3454,3458,7050,cell cycle arrest,P
3455,3458,7166,cell surface receptor signaling pathway,P
3456,3458,71351,cellular response to interleukin-18,P
3457,3458,71222,cellular response to lipopolysaccharide,P
3458,3458,42742,defense response to bacterium,P
3459,3458,42832,defense response to protozoan,P
3460,3458,51607,defense response to virus,P
3461,3458,30968,endoplasmic reticulum unfolded protein response,P
3462,3458,97191,extrinsic apoptotic signaling pathway,P
3463,3458,6959,humoral immune response,P
3464,3458,60333,interferon-gamma-mediated signaling pathway,P
3465,3458,60333,interferon-gamma-mediated signaling pathway,P
3466,3458,6928,movement of cell or subcellular component,P
3467,3458,30857,negative regulation of epithelial cell differentiation,P
3468,3458,48147,negative regulation of fibroblast proliferation,P
3469,3458,10629,negative regulation of gene expression,P
3470,3458,72125,negative regulation of glomerular mesangial cell proliferation,P
3471,3458,44130,negative regulation of growth of symbiont in host,P
3472,3458,32700,negative regulation of interleukin-17 production,P
3473,3458,31642,negative regulation of myelination,P
3474,3458,48662,negative regulation of smooth muscle cell proliferation,P
3475,3458,122,negative regulation of transcription from RNA polymerase II promoter,P
3476,3458,45892,"negative regulation of transcription, DNA-templated",P
3477,3458,1781,neutrophil apoptotic process,P
3478,3458,30593,neutrophil chemotaxis,P
3479,3458,32834,"positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response",P
3480,3458,45348,positive regulation of MHC class II biosynthetic process,P
3481,3458,42102,positive regulation of T cell proliferation,P
3482,3458,10508,positive regulation of autophagy,P
3483,3458,60559,positive regulation of calcidiol 1-monooxygenase activity,P
3484,3458,8284,positive regulation of cell proliferation,P
3485,3458,45080,positive regulation of chemokine biosynthetic process,P
3486,3458,1904798,positive regulation of core promoter binding,P
3487,3458,10634,positive regulation of epithelial cell migration,P
3488,3458,90004,positive regulation of establishment of protein localization to plasma membrane,P
3489,3458,1903543,positive regulation of exosomal secretion,P
3490,3458,60550,"positive regulation of fructose 1,6-bisphosphate 1-phosphatase activity",P
3491,3458,60552,"positive regulation of fructose 1,6-bisphosphate metabolic process",P
3492,3458,10628,positive regulation of gene expression,P
3493,3458,50718,positive regulation of interleukin-1 beta secretion,P
3494,3458,45084,positive regulation of interleukin-12 biosynthetic process,P
3495,3458,32735,positive regulation of interleukin-12 production,P
3496,3458,32747,positive regulation of interleukin-23 production,P
3497,3458,45410,positive regulation of interleukin-6 biosynthetic process,P
3498,3458,48304,positive regulation of isotype switching to IgG isotypes,P
3499,3458,51712,positive regulation of killing of cells of other organism,P
3500,3458,51044,positive regulation of membrane protein ectodomain proteolysis,P
3501,3458,45666,positive regulation of neuron differentiation,P
3502,3458,45429,positive regulation of nitric oxide biosynthetic process,P
3503,3458,45672,positive regulation of osteoclast differentiation,P
3504,3458,33141,positive regulation of peptidyl-serine phosphorylation of STAT protein,P
3505,3458,33141,positive regulation of peptidyl-serine phosphorylation of STAT protein,P
3506,3458,31334,positive regulation of protein complex assembly,P
3507,3458,90312,positive regulation of protein deacetylation,P
3508,3458,33160,"positive regulation of protein import into nucleus, translocation",P
3509,3458,1934,positive regulation of protein phosphorylation,P
3510,3458,71902,positive regulation of protein serine/threonine kinase activity,P
3511,3458,34393,positive regulation of smooth muscle cell apoptotic process,P
3512,3458,32224,"positive regulation of synaptic transmission, cholinergic",P
3513,3458,45944,positive regulation of transcription from RNA polymerase II promoter,P
3514,3458,2000309,positive regulation of tumor necrosis factor (ligand) superfamily member 11 production,P
3515,3458,32760,positive regulation of tumor necrosis factor production,P
3516,3458,60557,positive regulation of vitamin D biosynthetic process,P
3517,3458,60,"protein import into nucleus, translocation",P
3518,3458,50691,regulation of defense response to virus by host,P
3519,3458,60251,regulation of glial cell proliferation,P
3520,3458,2000345,regulation of hepatocyte proliferation,P
3521,3458,50796,regulation of insulin secretion,P
3522,3458,60334,regulation of interferon-gamma-mediated signaling pathway,P
3523,3458,98908,regulation of neuronal action potential,P
3524,3458,10835,regulation of protein ADP-ribosylation,P
3525,3458,2026,regulation of the force of heart contraction,P
3526,3458,42493,response to drug,P
3527,3458,9615,response to virus,P
3528,3458,50954,sensory perception of mechanical stimulus,P
3529,3458,5737,cytoplasm,C
3530,3458,9897,external side of plasma membrane,C
3531,3458,5576,extracellular region,C
3532,3458,5576,extracellular region,C
3533,3458,5615,extracellular space,C
3534,3458,43005,neuron projection,C
3535,3458,43204,perikaryon,C
3536,3486,1968,fibronectin binding,F
3537,3486,31994,insulin-like growth factor I binding,F
3538,3486,31995,insulin-like growth factor II binding,F
3539,3486,5520,insulin-like growth factor binding,F
3540,3486,46872,metal ion binding,F
3541,3486,5515,protein binding,F
3542,3486,8160,protein tyrosine phosphatase activator activity,F
3543,3486,6915,apoptotic process,P
3544,3486,44267,cellular protein metabolic process,P
3545,3486,8285,negative regulation of cell proliferation,P
3546,3486,1933,negative regulation of protein phosphorylation,P
3547,3486,9968,negative regulation of signal transduction,P
3548,3486,14912,negative regulation of smooth muscle cell migration,P
3549,3486,48662,negative regulation of smooth muscle cell proliferation,P
3550,3486,1649,osteoblast differentiation,P
3551,3486,43410,positive regulation of MAPK cascade,P
3552,3486,43065,positive regulation of apoptotic process,P
3553,3486,43085,positive regulation of catalytic activity,P
3554,3486,43568,positive regulation of insulin-like growth factor receptor signaling pathway,P
3555,3486,45663,positive regulation of myoblast differentiation,P
3556,3486,6468,protein phosphorylation,P
3557,3486,42981,regulation of apoptotic process,P
3558,3486,1558,regulation of cell growth,P
3559,3486,10906,regulation of glucose metabolic process,P
3560,3486,43567,regulation of insulin-like growth factor receptor signaling pathway,P
3561,3486,44342,type B pancreatic cell proliferation,P
3562,3486,70062,extracellular exosome,C
3563,3486,5576,extracellular region,C
3564,3486,5576,extracellular region,C
3565,3486,5615,extracellular space,C
3566,3486,16942,insulin-like growth factor binding protein complex,C
3567,3486,42567,insulin-like growth factor ternary complex,C
3568,3486,5634,nucleus,C
3569,3489,31994,insulin-like growth factor I binding,F
3570,3489,31995,insulin-like growth factor II binding,F
3571,3489,31995,insulin-like growth factor II binding,F
3572,3489,5102,receptor binding,F
3573,3489,44267,cellular protein metabolic process,P
3574,3489,90090,negative regulation of canonical Wnt signaling pathway,P
3575,3489,8285,negative regulation of cell proliferation,P
3576,3488,1968,fibronectin binding,F
3577,3489,1558,regulation of cell growth,P
3578,3488,31994,insulin-like growth factor I binding,F
3579,3489,43567,regulation of insulin-like growth factor receptor signaling pathway,P
3580,3488,31995,insulin-like growth factor II binding,F
3581,3489,7165,signal transduction,P
3582,3488,5515,protein binding,F
3583,3489,5794,Golgi apparatus,C
3584,3488,7568,aging,P
3585,3489,70062,extracellular exosome,C
3586,3488,44267,cellular protein metabolic process,P
3587,3489,5576,extracellular region,C
3588,3488,71320,cellular response to cAMP,P
3589,3489,5615,extracellular space,C
3590,3488,71407,cellular response to organic cyclic compound,P
3591,3489,42568,insulin-like growth factor binary complex,C
3592,3488,7565,female pregnancy,P
3593,3488,42593,glucose homeostasis,P
3594,3488,6006,glucose metabolic process,P
3595,3488,31069,hair follicle morphogenesis,P
3596,3488,35556,intracellular signal transduction,P
3597,3488,48286,lung alveolus development,P
3598,3488,60056,mammary gland involution,P
3599,3488,30336,negative regulation of cell migration,P
3600,3488,45926,negative regulation of growth,P
3601,3488,43569,negative regulation of insulin-like growth factor receptor signaling pathway,P
3602,3488,1901862,negative regulation of muscle tissue development,P
3603,3488,45668,negative regulation of osteoblast differentiation,P
3604,3488,1904205,negative regulation of skeletal muscle hypertrophy,P
3605,3488,14912,negative regulation of smooth muscle cell migration,P
3606,3488,48662,negative regulation of smooth muscle cell proliferation,P
3607,3488,17148,negative regulation of translation,P
3608,3488,1649,osteoblast differentiation,P
3609,3488,43568,positive regulation of insulin-like growth factor receptor signaling pathway,P
3610,3488,51897,positive regulation of protein kinase B signaling,P
3611,3488,1558,regulation of cell growth,P
3612,3488,10906,regulation of glucose metabolic process,P
3613,3488,60416,response to growth hormone,P
3614,3488,7165,signal transduction,P
3615,3488,51146,striated muscle cell differentiation,P
3616,3488,44342,type B pancreatic cell proliferation,P
3617,3488,5576,extracellular region,C
3618,3488,5576,extracellular region,C
3619,3488,16942,insulin-like growth factor binding protein complex,C
3620,3488,42567,insulin-like growth factor ternary complex,C
3621,3488,5622,intracellular,C
3622,3552,5507,copper ion binding,F
3623,3552,5125,cytokine activity,F
3624,3552,5149,interleukin-1 receptor binding,F
3625,3552,5515,protein binding,F
3626,3552,6915,apoptotic process,P
3627,3552,8283,cell proliferation,P
3628,3552,34605,cellular response to heat,P
3629,3552,2248,connective tissue replacement involved in inflammatory response wound healing,P
3630,3552,19221,cytokine-mediated signaling pathway,P
3631,3552,35234,ectopic germ cell programmed cell death,P
3632,3552,97192,extrinsic apoptotic signaling pathway in absence of ligand,P
3633,3552,1660,fever generation,P
3634,3552,6955,immune response,P
3635,3552,6954,inflammatory response,P
3636,3552,70498,interleukin-1-mediated signaling pathway,P
3637,3552,8285,negative regulation of cell proliferation,P
3638,3552,2001240,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,P
3639,3552,45766,positive regulation of angiogenesis,P
3640,3552,51781,positive regulation of cell division,P
3641,3552,50715,positive regulation of cytokine secretion,P
3642,3552,10628,positive regulation of gene expression,P
3643,3552,45086,positive regulation of interleukin-2 biosynthetic process,P
3644,3552,32755,positive regulation of interleukin-6 production,P
3645,3552,45840,positive regulation of mitotic nuclear division,P
3646,3552,71639,positive regulation of monocyte chemotactic protein-1 production,P
3647,3552,2000391,positive regulation of neutrophil extravasation,P
3648,3552,50714,positive regulation of protein secretion,P
3649,3552,45944,positive regulation of transcription from RNA polymerase II promoter,P
3650,3552,10575,positive regulation of vascular endothelial growth factor production,P
3651,3552,46688,response to copper ion,P
3652,3552,5829,cytosol,C
3653,3552,5576,extracellular region,C
3654,3552,5615,extracellular space,C
3655,3552,5615,extracellular space,C
3656,3576,8009,chemokine activity,F
3657,3576,8009,chemokine activity,F
3658,3576,5153,interleukin-8 receptor binding,F
3659,3576,5515,protein binding,F
3660,3576,7186,G-protein coupled receptor signaling pathway,P
3661,3576,36499,PERK-mediated unfolded protein response,P
3662,3576,1525,angiogenesis,P
3663,3576,19722,calcium-mediated signaling,P
3664,3576,7050,cell cycle arrest,P
3665,3576,44344,cellular response to fibroblast growth factor stimulus,P
3666,3576,71347,cellular response to interleukin-1,P
3667,3576,71222,cellular response to lipopolysaccharide,P
3668,3576,71356,cellular response to tumor necrosis factor,P
3669,3576,70098,chemokine-mediated signaling pathway,P
3670,3576,6935,chemotaxis,P
3671,3576,48566,embryonic digestive tract development,P
3672,3576,6955,immune response,P
3673,3576,50930,induction of positive chemotaxis,P
3674,3576,6954,inflammatory response,P
3675,3576,35556,intracellular signal transduction,P
3676,3576,6928,movement of cell or subcellular component,P
3677,3576,45744,negative regulation of G-protein coupled receptor protein signaling pathway,P
3678,3576,8285,negative regulation of cell proliferation,P
3679,3576,42119,neutrophil activation,P
3680,3576,42119,neutrophil activation,P
3681,3576,30593,neutrophil chemotaxis,P
3682,3576,30593,neutrophil chemotaxis,P
3683,3576,45766,positive regulation of angiogenesis,P
3684,3576,90023,positive regulation of neutrophil chemotaxis,P
3685,3576,31623,receptor internalization,P
3686,3576,30155,regulation of cell adhesion,P
3687,3576,2000535,regulation of entry of bacterium into host cell,P
3688,3576,45091,regulation of single stranded viral RNA replication via double stranded DNA intermediate,P
3689,3576,34976,response to endoplasmic reticulum stress,P
3690,3576,2237,response to molecule of bacterial origin,P
3691,3576,7165,signal transduction,P
3692,3576,5576,extracellular region,C
3693,3576,5615,extracellular space,C
3694,3576,5622,intracellular,C
3695,3621,35064,methylated histone binding,F
3696,3621,5515,protein binding,F
3697,3621,8270,zinc ion binding,F
3698,3621,7049,cell cycle,P
3699,3621,30308,negative regulation of cell growth,P
3700,3621,8285,negative regulation of cell proliferation,P
3701,3621,10941,regulation of cell death,P
3702,3621,5634,nucleus,C
3703,3622,3677,DNA binding,F
3704,3622,3682,chromatin binding,F
3705,3622,35064,methylated histone binding,F
3706,3622,35091,phosphatidylinositol binding,F
3707,3622,5515,protein binding,F
3708,3622,32403,protein complex binding,F
3709,3622,8270,zinc ion binding,F
3710,3622,16569,covalent chromatin modification,P
3711,3622,30317,flagellated sperm motility,P
3712,3622,48133,male germ-line stem cell asymmetric division,P
3713,3622,7141,male meiosis I,P
3714,3622,8285,negative regulation of cell proliferation,P
3715,3622,1902166,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,P
3716,3622,31065,positive regulation of histone deacetylation,P
3717,3622,45893,"positive regulation of transcription, DNA-templated",P
3718,3622,30511,positive regulation of transforming growth factor beta receptor signaling pathway,P
3719,3622,2000772,regulation of cellular senescence,P
3720,3622,40008,regulation of growth,P
3721,3622,2001020,regulation of response to DNA damage stimulus,P
3722,3622,6355,"regulation of transcription, DNA-templated",P
3723,3622,72520,seminiferous tubule development,P
3724,3622,7165,signal transduction,P
3725,3622,7286,spermatid development,P
3726,3622,7283,spermatogenesis,P
3727,3622,6351,"transcription, DNA-templated",P
3728,3622,16602,CCAAT-binding factor complex,C
3729,3622,5794,Golgi apparatus,C
3730,3622,16580,Sin3 complex,C
3731,3622,5829,cytosol,C
3732,3622,5654,nucleoplasm,C
3733,3622,5654,nucleoplasm,C
3734,3622,5634,nucleus,C
3735,3622,5634,nucleus,C
3736,3622,5886,plasma membrane,C
3737,3665,3677,DNA binding,F
3738,3665,979,RNA polymerase II core promoter sequence-specific DNA binding,F
3739,3665,5515,protein binding,F
3740,3665,982,"transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding",F
3741,3665,39530,MDA-5 signaling pathway,P
3742,3665,35666,TRIF-dependent toll-like receptor signaling pathway,P
3743,3665,6974,cellular response to DNA damage stimulus,P
3744,3665,19043,establishment of viral latency,P
3745,3665,16064,immunoglobulin mediated immune response,P
3746,3665,45087,innate immune response,P
3747,3665,32607,interferon-alpha production,P
3748,3665,32608,interferon-beta production,P
3749,3665,60333,interferon-gamma-mediated signaling pathway,P
3750,3665,2000110,negative regulation of macrophage apoptotic process,P
3751,3665,122,negative regulation of transcription from RNA polymerase II promoter,P
3752,3665,32727,positive regulation of interferon-alpha production,P
3753,3665,32727,positive regulation of interferon-alpha production,P
3754,3665,32728,positive regulation of interferon-beta production,P
3755,3665,32728,positive regulation of interferon-beta production,P
3756,3665,45944,positive regulation of transcription from RNA polymerase II promoter,P
3757,3665,45893,"positive regulation of transcription, DNA-templated",P
3758,3665,32481,positive regulation of type I interferon production,P
3759,3665,60340,positive regulation of type I interferon-mediated signaling pathway,P
3760,3665,34124,regulation of MyD88-dependent toll-like receptor signaling pathway,P
3761,3665,34127,regulation of MyD88-independent toll-like receptor signaling pathway,P
3762,3665,2819,regulation of adaptive immune response,P
3763,3665,50776,regulation of immune response,P
3764,3665,45655,regulation of monocyte differentiation,P
3765,3665,32479,regulation of type I interferon production,P
3766,3665,9615,response to virus,P
3767,3665,6366,transcription from RNA polymerase II promoter,P
3768,3665,45351,type I interferon biosynthetic process,P
3769,3665,60337,type I interferon signaling pathway,P
3770,3665,5737,cytoplasm,C
3771,3665,5829,cytosol,C
3772,3665,5829,cytosol,C
3773,3665,10008,endosome membrane,C
3774,3665,5654,nucleoplasm,C
3775,3665,5654,nucleoplasm,C
3776,3665,5634,nucleus,C
3777,3691,1664,G-protein coupled receptor binding,F
3778,3691,31994,insulin-like growth factor I binding,F
3779,3691,38132,neuregulin binding,F
3780,3691,5515,protein binding,F
3781,3691,4872,receptor activity,F
3782,3691,97186,amelogenesis,P
3783,3691,6914,autophagy,P
3784,3691,7155,cell adhesion,P
3785,3691,48870,cell motility,P
3786,3691,7160,cell-matrix adhesion,P
3787,3691,48565,digestive tract development,P
3788,3691,30198,extracellular matrix organization,P
3789,3691,31581,hemidesmosome assembly,P
3790,3691,31581,hemidesmosome assembly,P
3791,3691,31581,hemidesmosome assembly,P
3792,3691,7229,integrin-mediated signaling pathway,P
3793,3691,48333,mesodermal cell differentiation,P
3794,3691,35878,nail development,P
3795,3691,72001,renal system development,P
3796,3691,9611,response to wounding,P
3797,3691,43588,skin development,P
3798,3691,30054,cell junction,C
3799,3691,31252,cell leading edge,C
3800,3691,9986,cell surface,C
3801,3691,70062,extracellular exosome,C
3802,3691,30056,hemidesmosome,C
3803,3691,8305,integrin complex,C
3804,3691,5634,nucleus,C
3805,3691,5886,plasma membrane,C
3806,3691,5886,plasma membrane,C
3807,3691,43235,receptor complex,C
3808,3707,5524,ATP binding,F
3809,3707,5516,calmodulin binding,F
3810,3707,8440,"inositol-1,4,5-trisphosphate 3-kinase activity",F
3811,3707,8440,"inositol-1,4,5-trisphosphate 3-kinase activity",F
3812,3707,5515,protein binding,F
3813,3707,165,MAPK cascade,P
3814,3707,7166,cell surface receptor signaling pathway,P
3815,3707,71277,cellular response to calcium ion,P
3816,3707,35726,common myeloid progenitor cell proliferation,P
3817,3707,43647,inositol phosphate metabolic process,P
3818,3707,32957,inositol trisphosphate metabolic process,P
3819,3707,2262,myeloid cell homeostasis,P
3820,3707,45638,negative regulation of myeloid cell differentiation,P
3821,3707,33030,negative regulation of neutrophil apoptotic process,P
3822,3707,46579,positive regulation of Ras protein signal transduction,P
3823,3707,46638,positive regulation of alpha-beta T cell differentiation,P
3824,3707,45059,positive thymic T cell selection,P
3825,3707,1932,regulation of protein phosphorylation,P
3826,3707,7165,signal transduction,P
3827,3707,5829,cytosol,C
3828,3707,16020,membrane,C
3829,3707,5634,nucleus,C
3830,50618,5089,Rho guanyl-nucleotide exchange factor activity,F
3831,50618,5070,SH3/SH2 adaptor activity,F
3832,50618,5509,calcium ion binding,F
3833,50618,5515,protein binding,F
3834,50618,6897,endocytosis,P
3835,50618,43547,positive regulation of GTPase activity,P
3836,50618,1903861,positive regulation of dendrite extension,P
3837,50618,9967,positive regulation of signal transduction,P
3838,50618,35023,regulation of Rho protein signal transduction,P
3839,50618,5813,centrosome,C
3840,50618,5737,cytoplasm,C
3841,50618,70062,extracellular exosome,C
3842,3768,15467,G-protein activated inward rectifier potassium channel activity,F
3843,3768,5242,inward rectifier potassium channel activity,F
3844,3768,61337,cardiac conduction,P
3845,3768,6936,muscle contraction,P
3846,3768,10107,potassium ion import,P
3847,3768,6813,potassium ion transport,P
3848,3768,51289,protein homotetramerization,P
3849,3768,8016,regulation of heart contraction,P
3850,3768,34765,regulation of ion transmembrane transport,P
3851,3768,5887,integral component of plasma membrane,C
3852,3768,31224,intrinsic component of membrane,C
3853,3768,5886,plasma membrane,C
3854,9682,32452,histone demethylase activity,F
3855,9682,51864,histone demethylase activity (H3-K36 specific),F
3856,9682,35064,methylated histone binding,F
3857,9682,5515,protein binding,F
3858,9682,31625,ubiquitin protein ligase binding,F
3859,9682,8270,zinc ion binding,F
3860,9682,14898,cardiac muscle hypertrophy in response to stress,P
3861,9682,70544,histone H3-K36 demethylation,P
3862,9682,16577,histone demethylation,P
3863,9682,48712,negative regulation of astrocyte differentiation,P
3864,9682,10507,negative regulation of autophagy,P
3865,9682,60548,negative regulation of cell death,P
3866,9682,10629,negative regulation of gene expression,P
3867,9682,1900113,negative regulation of histone H3-K9 trimethylation,P
3868,9682,45892,"negative regulation of transcription, DNA-templated",P
3869,9682,55114,oxidation-reduction process,P
3870,9682,10628,positive regulation of gene expression,P
3871,9682,45666,positive regulation of neuron differentiation,P
3872,9682,31667,response to nutrient levels,P
3873,9682,6351,"transcription, DNA-templated",P
3874,9682,16032,viral process,P
3875,9682,5829,cytosol,C
3876,9682,1650,fibrillar center,C
3877,9682,5654,nucleoplasm,C
3878,9682,5634,nucleus,C
3879,9682,5721,pericentric heterochromatin,C
3880,10765,3677,DNA binding,F
3881,10765,32452,histone demethylase activity,F
3882,10765,32453,histone demethylase activity (H3-K4 specific),F
3883,10765,34648,histone demethylase activity (H3-dimethyl-K4 specific),F
3884,10765,34647,histone demethylase activity (H3-trimethyl-K4 specific),F
3885,10765,34647,histone demethylase activity (H3-trimethyl-K4 specific),F
3886,10765,16706,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors",F
3887,10765,5515,protein binding,F
3888,10765,1990837,sequence-specific double-stranded DNA binding,F
3889,10765,3714,transcription corepressor activity,F
3890,10765,3700,"transcription factor activity, sequence-specific DNA binding",F
3891,10765,8270,zinc ion binding,F
3892,10765,60444,branching involved in mammary gland duct morphogenesis,P
3893,10765,44344,cellular response to fibroblast growth factor stimulus,P
3894,10765,34720,histone H3-K4 demethylation,P
3895,10765,34721,"histone H3-K4 demethylation, trimethyl-H3-K4-specific",P
3896,10765,70306,lens fiber cell differentiation,P
3897,10765,60763,mammary duct terminal end bud growth,P
3898,10765,45892,"negative regulation of transcription, DNA-templated",P
3899,10765,55114,oxidation-reduction process,P
3900,10765,10628,positive regulation of gene expression,P
3901,10765,33601,positive regulation of mammary gland epithelial cell proliferation,P
3902,10765,9791,post-embryonic development,P
3903,10765,2000864,regulation of estradiol secretion,P
3904,10765,6357,regulation of transcription from RNA polymerase II promoter,P
3905,10765,60992,response to fungicide,P
3906,10765,48511,rhythmic process,P
3907,10765,7338,single fertilization,P
3908,10765,6351,"transcription, DNA-templated",P
3909,10765,61038,uterus morphogenesis,P
3910,10765,5829,cytosol,C
3911,10765,5654,nucleoplasm,C
3912,10765,5634,nucleus,C
3913,57650,45296,cadherin binding,F
3914,57650,5515,protein binding,F
3915,57650,2000179,positive regulation of neural precursor cell proliferation,P
3916,57650,7283,spermatogenesis,P
3917,57650,5737,cytoplasm,C
3918,57650,5829,cytosol,C
3919,57650,16021,integral component of membrane,C
3920,57650,5886,plasma membrane,C
3921,9365,16303,1-phosphatidylinositol-3-kinase activity,F
3922,9365,5088,Ras guanyl-nucleotide exchange factor activity,F
3923,9365,8422,beta-glucosidase activity,F
3924,9365,4566,beta-glucuronidase activity,F
3925,9365,17134,fibroblast growth factor binding,F
3926,9365,5104,fibroblast growth factor receptor binding,F
3927,9365,5179,hormone activity,F
3928,9365,46934,"phosphatidylinositol-4,5-bisphosphate 3-kinase activity",F
3929,9365,4871,signal transducer activity,F
3930,9365,5499,vitamin D binding,F
3931,9365,165,MAPK cascade,P
3932,9365,7568,aging,P
3933,9365,55074,calcium ion homeostasis,P
3934,9365,5975,carbohydrate metabolic process,P
3935,9365,6112,energy reserve metabolic process,P
3936,9365,8543,fibroblast growth factor receptor signaling pathway,P
3937,9365,8543,fibroblast growth factor receptor signaling pathway,P
3938,9365,1901657,glycosyl compound metabolic process,P
3939,9365,8286,insulin receptor signaling pathway,P
3940,9365,46854,phosphatidylinositol phosphorylation,P
3941,9365,36092,phosphatidylinositol-3-phosphate biosynthetic process,P
3942,9365,48015,phosphatidylinositol-mediated signaling,P
3943,9365,43547,positive regulation of GTPase activity,P
3944,9365,90080,positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway,P
3945,9365,30501,positive regulation of bone mineralization,P
3946,9365,14066,regulation of phosphatidylinositol 3-kinase signaling,P
3947,9365,16324,apical plasma membrane,C
3948,9365,70062,extracellular exosome,C
3949,9365,5576,extracellular region,C
3950,9365,5615,extracellular space,C
3951,9365,5887,integral component of plasma membrane,C
3952,9365,5622,intracellular,C
3953,9365,5886,plasma membrane,C
3954,283455,5524,ATP binding,F
3955,283455,46872,metal ion binding,F
3956,283455,4672,protein kinase activity,F
3957,283455,4674,protein serine/threonine kinase activity,F
3958,283455,4871,signal transducer activity,F
3959,283455,7265,Ras protein signal transduction,P
3960,283455,19722,calcium-mediated signaling,P
3961,283455,43410,positive regulation of MAPK cascade,P
3962,283455,6468,protein phosphorylation,P
3963,283455,5829,cytosol,C
3964,283455,5886,plasma membrane,C
3965,9113,5524,ATP binding,F
3966,9113,30331,estrogen receptor binding,F
3967,9113,287,magnesium ion binding,F
3968,9113,5515,protein binding,F
3969,9113,19901,protein kinase binding,F
3970,9113,4674,protein serine/threonine kinase activity,F
3971,9113,4674,protein serine/threonine kinase activity,F
3972,9113,82,G1/S transition of mitotic cell cycle,P
3973,9113,86,G2/M transition of mitotic cell cycle,P
3974,9113,51301,cell division,P
3975,9113,51220,cytoplasmic sequestering of protein,P
3976,9113,35329,hippo signaling,P
3977,9113,35329,hippo signaling,P
3978,9113,9755,hormone-mediated signaling pathway,P
3979,9113,1827,inner cell mass cell fate commitment,P
3980,9113,1828,inner cell mass cellular morphogenesis,P
3981,9113,30216,keratinocyte differentiation,P
3982,9113,60644,mammary gland epithelial cell differentiation,P
3983,9113,90090,negative regulation of canonical Wnt signaling pathway,P
3984,9113,45736,negative regulation of cyclin-dependent protein serine/threonine kinase activity,P
3985,9113,43065,positive regulation of apoptotic process,P
3986,9113,33138,positive regulation of peptidyl-serine phosphorylation,P
3987,9113,6468,protein phosphorylation,P
3988,9113,30833,regulation of actin filament polymerization,P
3989,9113,33146,regulation of intracellular estrogen receptor signaling pathway,P
3990,9113,46620,regulation of organ growth,P
3991,9113,43254,regulation of protein complex assembly,P
3992,9113,2000058,regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process,P
3993,9113,819,sister chromatid segregation,P
3994,9113,5829,cytosol,C
3995,9113,5815,microtubule organizing center,C
3996,9113,922,spindle pole,C
3997,123169,1990269,RNA polymerase II C-terminal domain phosphoserine binding,F
3998,123169,5515,protein binding,F
3999,123169,16055,Wnt signaling pathway,P
4000,123169,1904837,beta-catenin-TCF complex assembly,P
4001,123169,1711,endodermal cell fate commitment,P
4002,123169,33523,histone H2B ubiquitination,P
4003,123169,10390,histone monoubiquitination,P
4004,123169,6378,mRNA polyadenylation,P
4005,123169,45638,negative regulation of myeloid cell differentiation,P
4006,123169,31442,positive regulation of mRNA 3'-end processing,P
4007,123169,32968,positive regulation of transcription elongation from RNA polymerase II promoter,P
4008,123169,45944,positive regulation of transcription from RNA polymerase II promoter,P
4009,123169,16567,protein ubiquitination,P
4010,123169,19827,stem cell population maintenance,P
4011,123169,6368,transcription elongation from RNA polymerase II promoter,P
4012,123169,6366,transcription from RNA polymerase II promoter,P
4013,123169,16593,Cdc73/Paf1 complex,C
4014,123169,5813,centrosome,C
4015,123169,1650,fibrillar center,C
4016,123169,5654,nucleoplasm,C
4017,123169,5654,nucleoplasm,C
4018,3958,19863,IgE binding,F
4019,3958,3723,RNA binding,F
4020,3958,30246,carbohydrate binding,F
4021,3958,42056,chemoattractant activity,F
4022,3958,43236,laminin binding,F
4023,3958,5515,protein binding,F
4024,3958,8380,RNA splicing,P
4025,3958,48245,eosinophil chemotaxis,P
4026,3958,30855,epithelial cell differentiation,P
4027,3958,45087,innate immune response,P
4028,3958,6397,mRNA processing,P
4029,3958,48246,macrophage chemotaxis,P
4030,3958,2548,monocyte chemotaxis,P
4031,3958,71674,mononuclear cell migration,P
4032,3958,2001189,negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,P
4033,3958,50860,negative regulation of T cell receptor signaling pathway,P
4034,3958,45806,negative regulation of endocytosis,P
4035,3958,2001237,negative regulation of extrinsic apoptotic signaling pathway,P
4036,3958,2000521,negative regulation of immunological synapse formation,P
4037,3958,30593,neutrophil chemotaxis,P
4038,3958,43312,neutrophil degranulation,P
4039,3958,50918,positive chemotaxis,P
4040,3958,90280,positive regulation of calcium ion import,P
4041,3958,2001200,positive regulation of dendritic cell differentiation,P
4042,3958,71677,positive regulation of mononuclear cell migration,P
4043,3958,70232,regulation of T cell apoptotic process,P
4044,3958,42129,regulation of T cell proliferation,P
4045,3958,1902041,regulation of extrinsic apoptotic signaling pathway via death domain receptors,P
4046,3958,5737,cytoplasm,C
4047,3958,70062,extracellular exosome,C
4048,3958,31012,extracellular matrix,C
4049,3958,5615,extracellular space,C
4050,3958,101003,ficolin-1-rich granule membrane,C
4051,3958,1772,immunological synapse,C
4052,3958,16020,membrane,C
4053,3958,5743,mitochondrial inner membrane,C
4054,3958,5634,nucleus,C
4055,3958,5886,plasma membrane,C
4056,3958,30667,secretory granule membrane,C
4057,3958,5681,spliceosomal complex,C
4058,51474,51015,actin filament binding,F
4059,51474,3785,actin monomer binding,F
4060,51474,45296,cadherin binding,F
4061,51474,5515,protein binding,F
4062,51474,8270,zinc ion binding,F
4063,51474,51017,actin filament bundle assembly,P
4064,51474,30835,negative regulation of actin filament depolymerization,P
4065,51474,31529,ruffle organization,P
4066,51474,15629,actin cytoskeleton,C
4067,51474,5903,brush border,C
4068,51474,32154,cleavage furrow,C
4069,51474,5737,cytoplasm,C
4070,51474,5925,focal adhesion,C
4071,51474,1725,stress fiber,C
4072,3984,5524,ATP binding,F
4073,3984,31072,heat shock protein binding,F
4074,3984,5515,protein binding,F
4075,3984,46982,protein heterodimerization activity,F
4076,3984,4672,protein kinase activity,F
4077,3984,4674,protein serine/threonine kinase activity,F
4078,3984,4674,protein serine/threonine kinase activity,F
4079,3984,4871,signal transducer activity,F
4080,3984,8270,zinc ion binding,F
4081,3984,38096,Fc-gamma receptor signaling pathway involved in phagocytosis,P
4082,3984,7266,Rho protein signal transduction,P
4083,3984,30036,actin cytoskeleton organization,P
4084,3984,51444,negative regulation of ubiquitin-protein transferase activity,P
4085,3984,7399,nervous system development,P
4086,3984,32233,positive regulation of actin filament bundle assembly,P
4087,3984,45773,positive regulation of axon extension,P
4088,3984,51496,positive regulation of stress fiber assembly,P
4089,3984,6468,protein phosphorylation,P
4090,3984,6468,protein phosphorylation,P
4091,3984,7165,signal transduction,P
4092,3984,5794,Golgi apparatus,C
4093,3984,5737,cytoplasm,C
4094,3984,5829,cytosol,C
4095,3984,5829,cytosol,C
4096,3984,5925,focal adhesion,C
4097,3984,16020,membrane,C
4098,3984,43005,neuron projection,C
4099,3984,43005,neuron projection,C
4100,3984,16607,nuclear speck,C
4101,3984,5634,nucleus,C
4102,4101,42826,histone deacetylase binding,F
4103,4101,5515,protein binding,F
4104,4101,70491,repressing transcription factor binding,F
4105,4101,31625,ubiquitin protein ligase binding,F
4106,4101,44257,cellular protein catabolic process,P
4107,4101,90398,cellular senescence,P
4108,4101,1901984,negative regulation of protein acetylation,P
4109,4101,33234,negative regulation of protein sumoylation,P
4110,4101,122,negative regulation of transcription from RNA polymerase II promoter,P
4111,4101,51443,positive regulation of ubiquitin-protein transferase activity,P
4112,4101,72331,signal transduction by p53 class mediator,P
4113,4101,6351,"transcription, DNA-templated",P
4114,4101,16605,PML body,C
4115,4101,5634,nucleus,C
4116,4116,3723,RNA binding,F
4117,4116,5515,protein binding,F
4118,4116,6405,RNA export from nucleus,P
4119,4116,31124,mRNA 3'-end processing,P
4120,4116,6406,mRNA export from nucleus,P
4121,4116,398,"mRNA splicing, via spliceosome",P
4122,4116,398,"mRNA splicing, via spliceosome",P
4123,4116,184,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay",P
4124,4116,184,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay",P
4125,4116,184,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay",P
4126,4116,381,"regulation of alternative mRNA splicing, via spliceosome",P
4127,4116,6417,regulation of translation,P
4128,4116,6369,termination of RNA polymerase II transcription,P
4129,4116,71013,catalytic step 2 spliceosome,C
4130,4116,5737,cytoplasm,C
4131,4116,35145,exon-exon junction complex,C
4132,4116,16607,nuclear speck,C
4133,4116,5654,nucleoplasm,C
4134,4116,5634,nucleus,C
4135,4085,42802,identical protein binding,F
4136,4085,5515,protein binding,F
4137,4085,42803,protein homodimerization activity,F
4138,4085,31145,anaphase-promoting complex-dependent catabolic process,P
4139,4085,51301,cell division,P
4140,4085,7093,mitotic cell cycle checkpoint,P
4141,4085,7093,mitotic cell cycle checkpoint,P
4142,4085,70,mitotic sister chromatid segregation,P
4143,4085,7094,mitotic spindle assembly checkpoint,P
4144,4085,43066,negative regulation of apoptotic process,P
4145,4085,45930,negative regulation of mitotic cell cycle,P
4146,4085,42177,negative regulation of protein catabolic process,P
4147,4085,1904667,negative regulation of ubiquitin protein ligase activity,P
4148,4085,51436,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,P
4149,4085,90267,positive regulation of mitotic cell cycle spindle assembly checkpoint,P
4150,4085,51437,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,P
4151,4085,43161,proteasome-mediated ubiquitin-dependent protein catabolic process,P
4152,4085,42787,protein ubiquitination involved in ubiquitin-dependent protein catabolic process,P
4153,4085,7062,sister chromatid cohesion,P
4154,4085,777,condensed chromosome kinetochore,C
4155,4085,5829,cytosol,C
4156,4085,5829,cytosol,C
4157,4085,776,kinetochore,C
4158,4085,776,kinetochore,C
4159,4085,72686,mitotic spindle,C
4160,4085,5643,nuclear pore,C
4161,4085,5654,nucleoplasm,C
4162,4085,5634,nucleus,C
4163,4085,48471,perinuclear region of cytoplasm,C
4164,4085,922,spindle pole,C
4165,55110,3723,RNA binding,F
4166,55110,5515,protein binding,F
4167,55110,6405,RNA export from nucleus,P
4168,55110,8380,RNA splicing,P
4169,55110,31124,mRNA 3'-end processing,P
4170,55110,6406,mRNA export from nucleus,P
4171,55110,398,"mRNA splicing, via spliceosome",P
4172,55110,184,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay",P
4173,55110,184,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay",P
4174,55110,6369,termination of RNA polymerase II transcription,P
4175,55110,71013,catalytic step 2 spliceosome,C
4176,55110,35145,exon-exon junction complex,C
4177,55110,43025,neuronal cell body,C
4178,55110,5654,nucleoplasm,C
4179,5604,5524,ATP binding,F
4180,5604,4708,MAP kinase kinase activity,F
4181,5604,8022,protein C-terminus binding,F
4182,5604,47485,protein N-terminus binding,F
4183,5604,5515,protein binding,F
4184,5604,4672,protein kinase activity,F
4185,5604,43539,protein serine/threonine kinase activator activity,F
4186,5604,4674,protein serine/threonine kinase activity,F
4187,5604,4712,protein serine/threonine/tyrosine kinase activity,F
4188,5604,4713,protein tyrosine kinase activity,F
4189,5604,4728,"signal transducer, downstream of receptor, with protein tyrosine phosphatase activity",F
4190,5604,4702,"signal transducer, downstream of receptor, with serine/threonine kinase activity",F
4191,5604,60020,Bergmann glial cell differentiation,P
4192,5604,70371,ERK1 and ERK2 cascade,P
4193,5604,165,MAPK cascade,P
4194,5604,187,activation of MAPK activity,P
4195,5604,187,activation of MAPK activity,P
4196,5604,7050,cell cycle arrest,P
4197,5604,48870,cell motility,P
4198,5604,90398,cellular senescence,P
4199,5604,21697,cerebellar cortex formation,P
4200,5604,6935,chemotaxis,P
4201,5604,60502,epithelial cell proliferation involved in lung morphogenesis,P
4202,5604,60324,face development,P
4203,5604,7507,heart development,P
4204,5604,30216,keratinocyte differentiation,P
4205,5604,60711,labyrinthine layer development,P
4206,5604,6928,movement of cell or subcellular component,P
4207,5604,8285,negative regulation of cell proliferation,P
4208,5604,10629,negative regulation of gene expression,P
4209,5604,30182,neuron differentiation,P
4210,5604,18108,peptidyl-tyrosine phosphorylation,P
4211,5604,60674,placenta blood vessel development,P
4212,5604,70374,positive regulation of ERK1 and ERK2 cascade,P
4213,5604,50772,positive regulation of axonogenesis,P
4214,5604,10628,positive regulation of gene expression,P
4215,5604,1903800,positive regulation of production of miRNAs involved in gene silencing by miRNA,P
4216,5604,71902,positive regulation of protein serine/threonine kinase activity,P
4217,5604,45893,"positive regulation of transcription, DNA-templated",P
4218,5604,35897,proteolysis in other organism,P
4219,5604,90170,regulation of Golgi inheritance,P
4220,5604,48679,regulation of axon regeneration,P
4221,5604,2000641,regulation of early endosome to late endosome transport,P
4222,5604,32872,regulation of stress-activated MAPK cascade,P
4223,5604,7165,signal transduction,P
4224,5604,48538,thymus development,P
4225,5604,30878,thyroid gland development,P
4226,5604,60440,trachea formation,P
4227,5604,5794,Golgi apparatus,C
4228,5604,5829,cytosol,C
4229,5604,5829,cytosol,C
4230,5604,5769,early endosome,C
4231,5604,5783,endoplasmic reticulum,C
4232,5604,70062,extracellular exosome,C
4233,5604,5925,focal adhesion,C
4234,5604,5770,late endosome,C
4235,5604,5815,microtubule organizing center,C
4236,5604,5739,mitochondrion,C
4237,5604,5634,nucleus,C
4238,5604,5886,plasma membrane,C
4239,5604,5886,plasma membrane,C
4240,5606,5524,ATP binding,F
4241,5606,4708,MAP kinase kinase activity,F
4242,5606,5515,protein binding,F
4243,5606,19901,protein kinase binding,F
4244,5606,4713,protein tyrosine kinase activity,F
4245,5606,4702,"signal transducer, downstream of receptor, with serine/threonine kinase activity",F
4246,5606,165,MAPK cascade,P
4247,5606,187,activation of MAPK activity,P
4248,5606,60048,cardiac muscle contraction,P
4249,5606,6954,inflammatory response,P
4250,5606,18108,peptidyl-tyrosine phosphorylation,P
4251,5606,45860,positive regulation of protein kinase activity,P
4252,5606,45893,"positive regulation of transcription, DNA-templated",P
4253,5606,35897,proteolysis in other organism,P
4254,5606,42035,regulation of cytokine biosynthetic process,P
4255,5606,7165,signal transduction,P
4256,5606,5737,cytoplasm,C
4257,5606,5829,cytosol,C
4258,5606,16020,membrane,C
4259,5606,5654,nucleoplasm,C
4260,5605,5524,ATP binding,F
4261,5605,4708,MAP kinase kinase activity,F
4262,5605,30165,PDZ domain binding,F
4263,5605,46872,metal ion binding,F
4264,5605,5515,protein binding,F
4265,5605,43539,protein serine/threonine kinase activator activity,F
4266,5605,4674,protein serine/threonine kinase activity,F
4267,5605,4712,protein serine/threonine/tyrosine kinase activity,F
4268,5605,4713,protein tyrosine kinase activity,F
4269,5605,97110,scaffold protein binding,F
4270,5605,4702,"signal transducer, downstream of receptor, with serine/threonine kinase activity",F
4271,5605,70371,ERK1 and ERK2 cascade,P
4272,5605,165,MAPK cascade,P
4273,5605,187,activation of MAPK activity,P
4274,5605,10629,negative regulation of gene expression,P
4275,5605,36289,peptidyl-serine autophosphorylation,P
4276,5605,18108,peptidyl-tyrosine phosphorylation,P
4277,5605,70374,positive regulation of ERK1 and ERK2 cascade,P
4278,5605,1903800,positive regulation of production of miRNAs involved in gene silencing by miRNA,P
4279,5605,71902,positive regulation of protein serine/threonine kinase activity,P
4280,5605,45893,"positive regulation of transcription, DNA-templated",P
4281,5605,35897,proteolysis in other organism,P
4282,5605,90170,regulation of Golgi inheritance,P
4283,5605,2000641,regulation of early endosome to late endosome transport,P
4284,5605,32872,regulation of stress-activated MAPK cascade,P
4285,5605,5794,Golgi apparatus,C
4286,5605,5794,Golgi apparatus,C
4287,5605,5911,cell-cell junction,C
4288,5605,9898,cytoplasmic side of plasma membrane,C
4289,5605,5829,cytosol,C
4290,5605,5829,cytosol,C
4291,5605,5769,early endosome,C
4292,5605,5783,endoplasmic reticulum,C
4293,5605,5576,extracellular region,C
4294,5605,5925,focal adhesion,C
4295,5605,5770,late endosome,C
4296,5605,5874,microtubule,C
4297,5605,5739,mitochondrion,C
4298,5605,5634,nucleus,C
4299,5605,48471,perinuclear region of cytoplasm,C
4300,5605,5778,peroxisomal membrane,C
4301,5605,5886,plasma membrane,C
4302,5608,5524,ATP binding,F
4303,5608,4708,MAP kinase kinase activity,F
4304,5608,4708,MAP kinase kinase activity,F
4305,5608,5515,protein binding,F
4306,5608,19901,protein kinase binding,F
4307,5608,4674,protein serine/threonine kinase activity,F
4308,5608,4713,protein tyrosine kinase activity,F
4309,5608,4702,"signal transducer, downstream of receptor, with serine/threonine kinase activity",F
4310,5608,6975,DNA damage induced protein phosphorylation,P
4311,5608,165,MAPK cascade,P
4312,5608,187,activation of MAPK activity,P
4313,5608,6915,apoptotic process,P
4314,5608,60048,cardiac muscle contraction,P
4315,5608,7050,cell cycle arrest,P
4316,5608,72709,cellular response to sorbitol,P
4317,5608,70423,nucleotide-binding oligomerization domain containing signaling pathway,P
4318,5608,22602,ovulation cycle process,P
4319,5608,18108,peptidyl-tyrosine phosphorylation,P
4320,5608,43065,positive regulation of apoptotic process,P
4321,5608,51770,positive regulation of nitric-oxide synthase biosynthetic process,P
4322,5608,32308,positive regulation of prostaglandin secretion,P
4323,5608,35897,proteolysis in other organism,P
4324,5608,6355,"regulation of transcription, DNA-templated",P
4325,5608,42493,response to drug,P
4326,5608,2931,response to ischemia,P
4327,5608,7165,signal transduction,P
4328,5608,6351,"transcription, DNA-templated",P
4329,5608,5737,cytoplasm,C
4330,5608,5856,cytoskeleton,C
4331,5608,5829,cytosol,C
4332,5608,5829,cytosol,C
4333,5608,5654,nucleoplasm,C
4334,5608,5634,nucleus,C
4335,9064,5524,ATP binding,F
4336,9064,4709,MAP kinase kinase kinase activity,F
4337,9064,287,magnesium ion binding,F
4338,9064,7257,activation of JUN kinase activity,P
4339,9064,186,activation of MAPKK activity,P
4340,9064,6468,protein phosphorylation,P
4341,9064,7165,signal transduction,P
4342,9064,5622,intracellular,C
4343,5609,5524,ATP binding,F
4344,5609,4708,MAP kinase kinase activity,F
4345,5609,19899,enzyme binding,F
4346,5609,287,magnesium ion binding,F
4347,5609,5515,protein binding,F
4348,5609,19901,protein kinase binding,F
4349,5609,19903,protein phosphatase binding,F
4350,5609,4713,protein tyrosine kinase activity,F
4351,5609,4702,"signal transducer, downstream of receptor, with serine/threonine kinase activity",F
4352,5609,38095,Fc-epsilon receptor signaling pathway,P
4353,5609,7254,JNK cascade,P
4354,5609,7257,activation of JUN kinase activity,P
4355,5609,6915,apoptotic process,P
4356,5609,18108,peptidyl-tyrosine phosphorylation,P
4357,5609,51973,positive regulation of telomerase activity,P
4358,5609,1904355,positive regulation of telomere capping,P
4359,5609,32212,positive regulation of telomere maintenance via telomerase,P
4360,5609,35897,proteolysis in other organism,P
4361,5609,9411,response to UV,P
4362,5609,9408,response to heat,P
4363,5609,6970,response to osmotic stress,P
4364,5609,34612,response to tumor necrosis factor,P
4365,5609,7165,signal transduction,P
4366,5609,51403,stress-activated MAPK cascade,P
4367,5609,5737,cytoplasm,C
4368,5609,5737,cytoplasm,C
4369,5609,5829,cytosol,C
4370,5609,5634,nucleus,C
4371,6885,5524,ATP binding,F
4372,6885,4709,MAP kinase kinase kinase activity,F
4373,6885,4709,MAP kinase kinase kinase activity,F
4374,6885,42802,identical protein binding,F
4375,6885,287,magnesium ion binding,F
4376,6885,5515,protein binding,F
4377,6885,4672,protein kinase activity,F
4378,6885,4674,protein serine/threonine kinase activity,F
4379,6885,4674,protein serine/threonine kinase activity,F
4380,11184,5524,ATP binding,F
4381,6885,97110,scaffold protein binding,F
4382,6885,38095,Fc-epsilon receptor signaling pathway,P
4383,11184,8349,MAP kinase kinase kinase kinase activity,F
4384,6885,7249,I-kappaB kinase/NF-kappaB signaling,P
4385,11184,5515,protein binding,F
4386,6885,7252,I-kappaB phosphorylation,P
4387,11184,4672,protein kinase activity,F
4388,6885,7254,JNK cascade,P
4389,6885,7254,JNK cascade,P
4390,11184,4674,protein serine/threonine kinase activity,F
4391,6885,2755,MyD88-dependent toll-like receptor signaling pathway,P
4392,6885,50852,T cell receptor signaling pathway,P
4393,11184,7257,activation of JUN kinase activity,P
4394,6885,50852,T cell receptor signaling pathway,P
4395,11184,185,activation of MAPKKK activity,P
4396,6885,7223,"Wnt signaling pathway, calcium modulating pathway",P
4397,11184,8283,cell proliferation,P
4398,6885,187,activation of MAPK activity,P
4399,11184,35556,intracellular signal transduction,P
4400,6885,187,activation of MAPK activity,P
4401,11184,18105,peptidyl-serine phosphorylation,P
4402,6885,186,activation of MAPKK activity,P
4403,11184,46777,protein autophosphorylation,P
4404,6885,7250,activation of NF-kappaB-inducing kinase activity,P
4405,11184,6468,protein phosphorylation,P
4406,6885,43276,anoikis,P
4407,11184,6950,response to stress,P
4408,6885,43966,histone H3 acetylation,P
4409,6885,70423,nucleotide-binding oligomerization domain containing signaling pathway,P
4410,11184,5737,cytoplasm,C
4411,6885,43123,positive regulation of I-kappaB kinase/NF-kappaB signaling,P
4412,11184,16020,membrane,C
4413,6885,43507,positive regulation of JUN kinase activity,P
4414,6885,43507,positive regulation of JUN kinase activity,P
4415,6885,51092,positive regulation of NF-kappaB transcription factor activity,P
4416,6885,50870,positive regulation of T cell activation,P
4417,6885,2726,positive regulation of T cell cytokine production,P
4418,6885,32743,positive regulation of interleukin-2 production,P
4419,6885,16239,positive regulation of macroautophagy,P
4420,6885,16579,protein deubiquitination,P
4421,6885,2223,stimulatory C-type lectin receptor signaling pathway,P
4422,6885,51403,stress-activated MAPK cascade,P
4423,6885,6351,"transcription, DNA-templated",P
4424,6885,7179,transforming growth factor beta receptor signaling pathway,P
4425,6885,5671,Ada2/Gcn5/Ada3 transcription activator complex,C
4426,6885,8385,IkappaB kinase complex,C
4427,6885,5829,cytosol,C
4428,6885,10008,endosome membrane,C
4429,6885,5634,nucleus,C
4430,6885,5886,plasma membrane,C
4431,6300,5524,ATP binding,F
4432,6300,4707,MAP kinase activity,F
4433,6300,287,magnesium ion binding,F
4434,6300,5515,protein binding,F
4435,6300,4674,protein serine/threonine kinase activity,F
4436,6300,4674,protein serine/threonine kinase activity,F
4437,6300,6975,DNA damage induced protein phosphorylation,P
4438,6300,165,MAPK cascade,P
4439,6300,7050,cell cycle arrest,P
4440,6300,35556,intracellular signal transduction,P
4441,6300,7517,muscle organ development,P
4442,6300,45445,myoblast differentiation,P
4443,6300,18105,peptidyl-serine phosphorylation,P
4444,6300,18105,peptidyl-serine phosphorylation,P
4445,6300,51149,positive regulation of muscle cell differentiation,P
4446,6300,10952,positive regulation of peptidase activity,P
4447,6300,10468,regulation of gene expression,P
4448,6300,6355,"regulation of transcription, DNA-templated",P
4449,6300,7165,signal transduction,P
4450,6300,6351,"transcription, DNA-templated",P
4451,6300,48010,vascular endothelial growth factor receptor signaling pathway,P
4452,6300,5737,cytoplasm,C
4453,6300,5829,cytosol,C
4454,6300,5739,mitochondrion,C
4455,6300,5654,nucleoplasm,C
4456,6300,5634,nucleus,C
4457,8550,5524,ATP binding,F
4458,8550,4708,MAP kinase kinase activity,F
4459,8550,9931,calcium-dependent protein serine/threonine kinase activity,F
4460,8550,5516,calmodulin binding,F
4461,8550,4683,calmodulin-dependent protein kinase activity,F
4462,8550,2039,p53 binding,F
4463,8550,5515,protein binding,F
4464,8550,4674,protein serine/threonine kinase activity,F
4465,8550,4674,protein serine/threonine kinase activity,F
4466,8550,4674,protein serine/threonine kinase activity,F
4467,8550,165,MAPK cascade,P
4468,8550,7265,Ras protein signal transduction,P
4469,8550,187,activation of MAPK activity,P
4470,8550,7166,cell surface receptor signaling pathway,P
4471,8550,32007,negative regulation of TOR signaling,P
4472,8550,18105,peptidyl-serine phosphorylation,P
4473,8550,51973,positive regulation of telomerase activity,P
4474,8550,1904355,positive regulation of telomere capping,P
4475,8550,32212,positive regulation of telomere maintenance via telomerase,P
4476,8550,46777,protein autophosphorylation,P
4477,8550,1901796,regulation of signal transduction by p53 class mediator,P
4478,8550,6417,regulation of translation,P
4479,8550,7165,signal transduction,P
4480,8550,90400,stress-induced premature senescence,P
4481,8550,5737,cytoplasm,C
4482,8550,5829,cytosol,C
4483,8550,5829,cytosol,C
4484,8550,5654,nucleoplasm,C
4485,8550,5654,nucleoplasm,C
4486,54708,51020,GTPase binding,F
4487,8550,5634,nucleus,C
4488,54708,5515,protein binding,F
4489,54708,4842,ubiquitin-protein transferase activity,F
4490,54708,4842,ubiquitin-protein transferase activity,F
4491,54708,8270,zinc ion binding,F
4492,54708,90344,negative regulation of cell aging,P
4493,54708,90141,positive regulation of mitochondrial fission,P
4494,54708,51865,protein autoubiquitination,P
4495,54708,70585,protein localization to mitochondrion,P
4496,54708,209,protein polyubiquitination,P
4497,54708,90140,regulation of mitochondrial fission,P
4498,54708,5783,endoplasmic reticulum,C
4499,54708,5789,endoplasmic reticulum membrane,C
4500,54708,16021,integral component of membrane,C
4501,54708,16020,membrane,C
4502,54708,5741,mitochondrial outer membrane,C
4503,54708,5739,mitochondrion,C
4504,1432,5524,ATP binding,F
4505,1432,4707,MAP kinase activity,F
4506,1432,4708,MAP kinase kinase activity,F
4507,1432,51525,NFAT protein binding,F
4508,1432,19899,enzyme binding,F
4509,1432,48273,mitogen-activated protein kinase p38 binding,F
4510,1432,5515,protein binding,F
4511,1432,19903,protein phosphatase binding,F
4512,1432,4674,protein serine/threonine kinase activity,F
4513,1432,70935,3'-UTR-mediated mRNA stabilization,P
4514,1432,77,DNA damage checkpoint,P
4515,1432,7265,Ras protein signal transduction,P
4516,1432,187,activation of MAPK activity,P
4517,1432,1525,angiogenesis,P
4518,1432,6915,apoptotic process,P
4519,1432,1502,cartilage condensation,P
4520,1432,902,cell morphogenesis,P
4521,1432,7166,cell surface receptor signaling pathway,P
4522,1432,71479,cellular response to ionizing radiation,P
4523,1432,71222,cellular response to lipopolysaccharide,P
4524,1432,35924,cellular response to vascular endothelial growth factor stimulus,P
4525,1432,98586,cellular response to virus,P
4526,1432,6935,chemotaxis,P
4527,1432,2062,chondrocyte differentiation,P
4528,1432,19395,fatty acid oxidation,P
4529,1432,6006,glucose metabolic process,P
4530,1432,35556,intracellular signal transduction,P
4531,1432,31663,lipopolysaccharide-mediated signaling pathway,P
4532,1432,6928,movement of cell or subcellular component,P
4533,1432,14835,myoblast differentiation involved in skeletal muscle regeneration,P
4534,1432,90090,negative regulation of canonical Wnt signaling pathway,P
4535,1432,43312,neutrophil degranulation,P
4536,1432,30316,osteoclast differentiation,P
4537,1432,38066,p38MAPK cascade,P
4538,1432,18105,peptidyl-serine phosphorylation,P
4539,1432,1890,placenta development,P
4540,1432,43536,positive regulation of blood vessel endothelial cell migration,P
4541,1432,90336,positive regulation of brown fat cell differentiation,P
4542,1432,60045,positive regulation of cardiac muscle cell proliferation,P
4543,1432,31281,positive regulation of cyclase activity,P
4544,1432,2741,positive regulation of cytokine secretion involved in immune response,P
4545,1432,45648,positive regulation of erythrocyte differentiation,P
4546,1432,10628,positive regulation of gene expression,P
4547,1432,46326,positive regulation of glucose import,P
4548,1432,2001184,positive regulation of interleukin-12 secretion,P
4549,1432,10759,positive regulation of macrophage chemotaxis,P
4550,1432,1905050,positive regulation of metallopeptidase activity,P
4551,1432,51149,positive regulation of muscle cell differentiation,P
4552,1432,45663,positive regulation of myoblast differentiation,P
4553,1432,1901741,positive regulation of myoblast fusion,P
4554,1432,10831,positive regulation of myotube differentiation,P
4555,1432,42307,positive regulation of protein import into nucleus,P
4556,1432,2000379,positive regulation of reactive oxygen species metabolic process,P
4557,1432,45944,positive regulation of transcription from RNA polymerase II promoter,P
4558,1432,1900015,regulation of cytokine production involved in inflammatory response,P
4559,1432,30278,regulation of ossification,P
4560,1432,51090,regulation of sequence-specific DNA binding transcription factor activity,P
4561,1432,1901796,regulation of signal transduction by p53 class mediator,P
4562,1432,6357,regulation of transcription from RNA polymerase II promoter,P
4563,1432,32495,response to muramyl dipeptide,P
4564,1432,35994,response to muscle stretch,P
4565,1432,7165,signal transduction,P
4566,1432,42770,signal transduction in response to DNA damage,P
4567,1432,7519,skeletal muscle tissue development,P
4568,1432,90400,stress-induced premature senescence,P
4569,1432,51146,striated muscle cell differentiation,P
4570,1432,6351,"transcription, DNA-templated",P
4571,1432,7178,transmembrane receptor protein serine/threonine kinase signaling pathway,P
4572,1432,48010,vascular endothelial growth factor receptor signaling pathway,P
4573,1432,48010,vascular endothelial growth factor receptor signaling pathway,P
4574,1432,5737,cytoplasm,C
4575,1432,5737,cytoplasm,C
4576,1432,5829,cytosol,C
4577,1432,70062,extracellular exosome,C
4578,1432,5576,extracellular region,C
4579,1432,1904813,ficolin-1-rich granule lumen,C
4580,1432,5739,mitochondrion,C
4581,1432,16607,nuclear speck,C
4582,1432,5654,nucleoplasm,C
4583,1432,5634,nucleus,C
4584,1432,5634,nucleus,C
4585,1432,34774,secretory granule lumen,C
4586,1432,922,spindle pole,C
4587,22983,5524,ATP binding,F
4588,22983,287,magnesium ion binding,F
4589,22983,5515,protein binding,F
4590,22983,4674,protein serine/threonine kinase activity,F
4591,22983,4674,protein serine/threonine kinase activity,F
4592,22983,7010,cytoskeleton organization,P
4593,22983,7010,cytoskeleton organization,P
4594,22983,35556,intracellular signal transduction,P
4595,22983,35556,intracellular signal transduction,P
4596,22983,18105,peptidyl-serine phosphorylation,P
4597,22983,6468,protein phosphorylation,P
4598,22983,5737,cytoplasm,C
4599,22983,5856,cytoskeleton,C
4600,22983,5622,intracellular,C
4601,22983,5886,plasma membrane,C
4602,4145,5524,ATP binding,F
4603,4145,4715,non-membrane spanning protein tyrosine kinase activity,F
4604,4145,5515,protein binding,F
4605,4145,4713,protein tyrosine kinase activity,F
4606,4145,5102,receptor binding,F
4607,4145,38128,ERBB2 signaling pathway,P
4608,4145,30154,cell differentiation,P
4609,4145,8283,cell proliferation,P
4610,4145,45087,innate immune response,P
4611,4145,7498,mesoderm development,P
4612,4145,38083,peptidyl-tyrosine autophosphorylation,P
4613,4145,8284,positive regulation of cell proliferation,P
4614,4145,6468,protein phosphorylation,P
4615,4145,7169,transmembrane receptor protein tyrosine kinase signaling pathway,P
4616,4145,5829,cytosol,C
4617,4145,31234,extrinsic component of cytoplasmic side of plasma membrane,C
4618,4170,51434,BH3 domain binding,F
4619,4170,5515,protein binding,F
4620,4170,15266,protein channel activity,F
4621,4170,46982,protein heterodimerization activity,F
4622,4170,8637,apoptotic mitochondrial changes,P
4623,4170,1709,cell fate determination,P
4624,4170,19725,cellular homeostasis,P
4625,4170,97192,extrinsic apoptotic signaling pathway in absence of ligand,P
4626,4170,8630,intrinsic apoptotic signaling pathway in response to DNA damage,P
4627,4170,7275,multicellular organism development,P
4628,4170,2000811,negative regulation of anoikis,P
4629,4170,43066,negative regulation of apoptotic process,P
4630,4170,10507,negative regulation of autophagy,P
4631,4170,2001240,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,P
4632,4170,1903378,positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,P
4633,4170,71806,protein transmembrane transport,P
4634,4170,2001020,regulation of response to DNA damage stimulus,P
4635,4170,34097,response to cytokine,P
4636,4170,97136,Bcl-2 family protein complex,C
4637,4170,5737,cytoplasm,C
4638,4170,5829,cytosol,C
4639,4170,5829,cytosol,C
4640,4170,16021,integral component of membrane,C
4641,4170,16020,membrane,C
4642,4170,16020,membrane,C
4643,4170,5759,mitochondrial matrix,C
4644,4170,5741,mitochondrial outer membrane,C
4645,4170,5739,mitochondrion,C
4646,4170,5654,nucleoplasm,C
4647,4170,5634,nucleus,C
4648,4190,30060,L-malate dehydrogenase activity,F
4649,4190,30060,L-malate dehydrogenase activity,F
4650,4190,51287,NAD binding,F
4651,4190,47860,diiodophenylpyruvate reductase activity,F
4652,4190,4470,malic enzyme activity,F
4653,4190,5515,protein binding,F
4654,4190,6734,NADH metabolic process,P
4655,4190,6094,gluconeogenesis,P
4656,4190,6108,malate metabolic process,P
4657,4190,6107,oxaloacetate metabolic process,P
4658,4190,6099,tricarboxylic acid cycle,P
4659,4190,5829,cytosol,C
4660,4190,5829,cytosol,C
4661,4190,70062,extracellular exosome,C
4662,4190,5615,extracellular space,C
4663,4190,5739,mitochondrion,C
4664,4190,43209,myelin sheath,C
4665,10445,2151,G-quadruplex RNA binding,F
4666,10445,46972,histone acetyltransferase activity (H4-K16 specific),F
4667,10445,43995,histone acetyltransferase activity (H4-K5 specific),F
4668,10445,43996,histone acetyltransferase activity (H4-K8 specific),F
4669,10445,34046,poly(G) binding,F
4670,10445,8266,poly(U) RNA binding,F
4671,10445,5515,protein binding,F
4672,10445,6310,DNA recombination,P
4673,10445,6281,DNA repair,P
4674,10445,6464,cellular protein modification process,P
4675,10445,43984,histone H4-K16 acetylation,P
4676,10445,43981,histone H4-K5 acetylation,P
4677,10445,43982,histone H4-K8 acetylation,P
4678,10445,1904751,positive regulation of protein localization to nucleolus,P
4679,10445,16579,protein deubiquitination,P
4680,10445,6355,"regulation of transcription, DNA-templated",P
4681,10445,6351,"transcription, DNA-templated",P
4682,10445,31011,Ino80 complex,C
4683,10445,71339,MLL1 complex,C
4684,10445,5737,cytoplasm,C
4685,10445,30425,dendrite,C
4686,10445,5783,endoplasmic reticulum,C
4687,10445,123,histone acetyltransferase complex,C
4688,10445,5730,nucleolus,C
4689,10445,5654,nucleoplasm,C
4690,10445,5654,nucleoplasm,C
4691,10445,5634,nucleus,C
4692,10445,43204,perikaryon,C
4693,10445,5844,polysome,C
4694,4204,3677,DNA binding,F
4695,4204,3723,RNA binding,F
4696,4204,3682,chromatin binding,F
4697,4204,10385,double-stranded methylated DNA binding,F
4698,4204,42826,histone deacetylase binding,F
4699,4204,3729,mRNA binding,F
4700,4204,8327,methyl-CpG binding,F
4701,4204,47485,protein N-terminus binding,F
4702,4204,5515,protein binding,F
4703,4204,19904,protein domain specific binding,F
4704,4204,35197,siRNA binding,F
4705,4204,3714,transcription corepressor activity,F
4706,4204,8134,transcription factor binding,F
4707,4204,1078,"transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding",F
4708,4204,8344,adult locomotory behavior,P
4709,4204,1662,behavioral fear response,P
4710,4204,32048,cardiolipin metabolic process,P
4711,4204,50432,catecholamine secretion,P
4712,4204,6576,cellular biogenic amine metabolic process,P
4713,4204,21549,cerebellum development,P
4714,4204,6342,chromatin silencing,P
4715,4204,16358,dendrite development,P
4716,4204,60079,excitatory postsynaptic potential,P
4717,4204,8211,glucocorticoid metabolic process,P
4718,4204,6541,glutamine metabolic process,P
4719,4204,16573,histone acetylation,P
4720,4204,16571,histone methylation,P
4721,4204,6020,inositol metabolic process,P
4722,4204,7616,long-term memory,P
4723,4204,60291,long-term synaptic potentiation,P
4724,4204,6122,"mitochondrial electron transport, ubiquinol to cytochrome c",P
4725,4204,7052,mitotic spindle organization,P
4726,4204,35067,negative regulation of histone acetylation,P
4727,4204,31061,negative regulation of histone methylation,P
4728,4204,43524,negative regulation of neuron apoptotic process,P
4729,4204,51151,negative regulation of smooth muscle cell differentiation,P
4730,4204,122,negative regulation of transcription from RNA polymerase II promoter,P
4731,4204,2000820,negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation,P
4732,4204,45892,"negative regulation of transcription, DNA-templated",P
4733,4204,1976,neurological system process involved in regulation of systemic arterial blood pressure,P
4734,4204,42551,neuron maturation,P
4735,4204,9405,pathogenesis,P
4736,4204,46470,phosphatidylcholine metabolic process,P
4737,4204,10971,positive regulation of G2/M transition of mitotic cell cycle,P
4738,4204,8284,positive regulation of cell proliferation,P
4739,4204,1900114,positive regulation of histone H3-K9 trimethylation,P
4740,4204,90063,positive regulation of microtubule nucleation,P
4741,4204,51965,positive regulation of synapse assembly,P
4742,4204,45893,"positive regulation of transcription, DNA-templated",P
4743,4204,9791,post-embryonic development,P
4744,4204,19230,proprioception,P
4745,4204,8104,protein localization,P
4746,4204,6349,regulation of gene expression by genetic imprinting,P
4747,4204,2087,regulation of respiratory gaseous exchange by neurological system process,P
4748,4204,7585,respiratory gaseous exchange,P
4749,4204,1666,response to hypoxia,P
4750,4204,19233,sensory perception of pain,P
4751,4204,35176,social behavior,P
4752,4204,1964,startle response,P
4753,4204,7416,synapse assembly,P
4754,4204,6351,"transcription, DNA-templated",P
4755,4204,21591,ventricular system development,P
4756,4204,8542,visual learning,P
4757,4204,5813,centrosome,C
4758,4204,5829,cytosol,C
4759,4204,5615,extracellular space,C
4760,4204,930,gamma-tubulin complex,C
4761,4204,792,heterochromatin,C
4762,4204,5739,mitochondrion,C
4763,4204,5634,nucleus,C
4764,4204,98794,postsynapse,C
4765,126308,46872,metal ion binding,F
4766,126308,5622,intracellular,C
4767,4318,5518,collagen binding,F
4768,4318,4175,endopeptidase activity,F
4769,4318,4175,endopeptidase activity,F
4770,4318,42802,identical protein binding,F
4771,4318,4222,metalloendopeptidase activity,F
4772,4318,4222,metalloendopeptidase activity,F
4773,4318,8237,metallopeptidase activity,F
4774,4318,5515,protein binding,F
4775,4318,4252,serine-type endopeptidase activity,F
4776,4318,4252,serine-type endopeptidase activity,F
4777,4318,8270,zinc ion binding,F
4778,4318,71276,cellular response to cadmium ion,P
4779,4318,34614,cellular response to reactive oxygen species,P
4780,4318,30574,collagen catabolic process,P
4781,4318,7566,embryo implantation,P
4782,4318,35987,endodermal cell differentiation,P
4783,4318,48013,ephrin receptor signaling pathway,P
4784,4318,22617,extracellular matrix disassembly,P
4785,4318,50900,leukocyte migration,P
4786,4318,30225,macrophage differentiation,P
4787,4318,43066,negative regulation of apoptotic process,P
4788,4318,2001258,negative regulation of cation channel activity,P
4789,4318,2001268,negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,P
4790,4318,2001243,negative regulation of intrinsic apoptotic signaling pathway,P
4791,4318,43312,neutrophil degranulation,P
4792,4318,1503,ossification,P
4793,4318,43388,positive regulation of DNA binding,P
4794,4318,30335,positive regulation of cell migration,P
4795,4318,45742,positive regulation of epidermal growth factor receptor signaling pathway,P
4796,4318,51549,positive regulation of keratinocyte migration,P
4797,4318,1934,positive regulation of protein phosphorylation,P
4798,4318,1900122,positive regulation of receptor binding,P
4799,4318,90200,positive regulation of release of cytochrome c from mitochondria,P
4800,4318,1904707,positive regulation of vascular smooth muscle cell proliferation,P
4801,4318,6508,proteolysis,P
4802,4318,1501,skeletal system development,P
4803,4318,70062,extracellular exosome,C
4804,4318,5576,extracellular region,C
4805,4318,5615,extracellular space,C
4806,4318,1904813,ficolin-1-rich granule lumen,C
4807,4318,5578,proteinaceous extracellular matrix,C
4808,4318,1904724,tertiary granule lumen,C
4809,23515,3723,RNA binding,F
4810,23515,8270,zinc ion binding,F
4811,23515,7569,cell aging,P
4812,23515,51457,maintenance of protein location in nucleus,P
4813,23515,51457,maintenance of protein location in nucleus,P
4814,23515,48147,negative regulation of fibroblast proliferation,P
4815,23515,18105,peptidyl-serine phosphorylation,P
4816,23515,9791,post-embryonic development,P
4817,23515,6468,protein phosphorylation,P
4818,23515,50821,protein stabilization,P
4819,23515,16032,viral process,P
4820,23515,16605,PML body,C
4821,23515,16363,nuclear matrix,C
4822,23515,5654,nucleoplasm,C
4823,10608,3677,DNA binding,F
4824,10608,5515,protein binding,F
4825,10608,46983,protein dimerization activity,F
4826,10608,3714,transcription corepressor activity,F
4827,10608,8285,negative regulation of cell proliferation,P
4828,10608,122,negative regulation of transcription from RNA polymerase II promoter,P
4829,10608,6351,"transcription, DNA-templated",P
4830,10608,5634,nucleus,C
4831,4598,5524,ATP binding,F
4832,4598,42802,identical protein binding,F
4833,4598,4496,mevalonate kinase activity,F
4834,4598,4496,mevalonate kinase activity,F
4835,4598,4496,mevalonate kinase activity,F
4836,4598,5515,protein binding,F
4837,4598,6695,cholesterol biosynthetic process,P
4838,4598,6695,cholesterol biosynthetic process,P
4839,4598,19287,"isopentenyl diphosphate biosynthetic process, mevalonate pathway",P
4840,4598,19287,"isopentenyl diphosphate biosynthetic process, mevalonate pathway",P
4841,4598,8299,isoprenoid biosynthetic process,P
4842,4598,50728,negative regulation of inflammatory response,P
4843,4598,16310,phosphorylation,P
4844,4598,5829,cytosol,C
4845,4598,5829,cytosol,C
4846,4598,70062,extracellular exosome,C
4847,4598,5777,peroxisome,C
4848,4609,3677,DNA binding,F
4849,4609,3677,DNA binding,F
4850,4609,70888,E-box binding,F
4851,4609,978,RNA polymerase II core promoter proximal region sequence-specific DNA binding,F
4852,4609,33613,activating transcription factor binding,F
4853,4609,5515,protein binding,F
4854,4609,32403,protein complex binding,F
4855,4609,46983,protein dimerization activity,F
4856,4609,70491,repressing transcription factor binding,F
4857,4609,3700,"transcription factor activity, sequence-specific DNA binding",F
4858,4609,8134,transcription factor binding,F
4859,4609,1077,"transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding",F
4860,4609,70371,ERK1 and ERK2 cascade,P
4861,4609,82,G1/S transition of mitotic cell cycle,P
4862,4609,165,MAPK cascade,P
4863,4609,7219,Notch signaling pathway,P
4864,4609,1904837,beta-catenin-TCF complex assembly,P
4865,4609,1658,branching involved in ureteric bud morphogenesis,P
4866,4609,60070,canonical Wnt signaling pathway,P
4867,4609,7050,cell cycle arrest,P
4868,4609,6879,cellular iron ion homeostasis,P
4869,4609,6974,cellular response to DNA damage stimulus,P
4870,4609,34644,cellular response to UV,P
4871,4609,35690,cellular response to drug,P
4872,4609,71456,cellular response to hypoxia,P
4873,4609,6338,chromatin remodeling,P
4874,4609,51276,chromosome organization,P
4875,4609,6112,energy reserve metabolic process,P
4876,4609,44346,fibroblast apoptotic process,P
4877,4609,43066,negative regulation of apoptotic process,P
4878,4609,51782,negative regulation of cell division,P
4879,4609,48147,negative regulation of fibroblast proliferation,P
4880,4609,45656,negative regulation of monocyte differentiation,P
4881,4609,32873,negative regulation of stress-activated MAPK cascade,P
4882,4609,122,negative regulation of transcription from RNA polymerase II promoter,P
4883,4609,15671,oxygen transport,P
4884,4609,2000573,positive regulation of DNA biosynthetic process,P
4885,4609,8284,positive regulation of cell proliferation,P
4886,4609,43280,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,P
4887,4609,50679,positive regulation of epithelial cell proliferation,P
4888,4609,48146,positive regulation of fibroblast proliferation,P
4889,4609,48146,positive regulation of fibroblast proliferation,P
4890,4609,10628,positive regulation of gene expression,P
4891,4609,10628,positive regulation of gene expression,P
4892,4609,2053,positive regulation of mesenchymal cell proliferation,P
4893,4609,90096,positive regulation of metanephric cap mesenchymal cell proliferation,P
4894,4609,2001022,positive regulation of response to DNA damage stimulus,P
4895,4609,51973,positive regulation of telomerase activity,P
4896,4609,45944,positive regulation of transcription from RNA polymerase II promoter,P
4897,4609,45944,positive regulation of transcription from RNA polymerase II promoter,P
4898,4609,45944,positive regulation of transcription from RNA polymerase II promoter,P
4899,4609,45893,"positive regulation of transcription, DNA-templated",P
4900,4609,45893,"positive regulation of transcription, DNA-templated",P
4901,4609,16579,protein deubiquitination,P
4902,4609,32986,protein-DNA complex disassembly,P
4903,4609,10468,regulation of gene expression,P
4904,4609,32204,regulation of telomere maintenance,P
4905,4609,6357,regulation of transcription from RNA polymerase II promoter,P
4906,4609,42493,response to drug,P
4907,4609,10332,response to gamma radiation,P
4908,4609,70848,response to growth factor,P
4909,4609,6366,transcription from RNA polymerase II promoter,P
4910,4609,5829,cytosol,C
4911,4609,5730,nucleolus,C
4912,4609,5654,nucleoplasm,C
4913,4609,5654,nucleoplasm,C
4914,4609,5634,nucleus,C
4915,4609,43234,protein complex,C
4916,4638,5524,ATP binding,F
4917,4638,3779,actin binding,F
4918,4638,5516,calmodulin binding,F
4919,4638,46872,metal ion binding,F
4920,4638,4687,myosin light chain kinase activity,F
4921,4638,5515,protein binding,F
4922,4638,60414,aorta smooth muscle tissue morphogenesis,P
4923,4638,32060,bleb assembly,P
4924,4638,71476,cellular hypotonic response,P
4925,4638,6936,muscle contraction,P
4926,4638,51928,positive regulation of calcium ion transport,P
4927,4638,30335,positive regulation of cell migration,P
4928,4638,90303,positive regulation of wound healing,P
4929,4638,6468,protein phosphorylation,P
4930,4638,6939,smooth muscle contraction,P
4931,4638,6939,smooth muscle contraction,P
4932,4638,14820,tonic smooth muscle contraction,P
4933,4638,32154,cleavage furrow,C
4934,4638,5737,cytoplasm,C
4935,4638,5829,cytosol,C
4936,4638,70062,extracellular exosome,C
4937,4638,30027,lamellipodium,C
4938,4638,1725,stress fiber,C
4939,65220,5524,ATP binding,F
4940,65220,3951,NAD+ kinase activity,F
4941,65220,3951,NAD+ kinase activity,F
4942,65220,46872,metal ion binding,F
4943,65220,5515,protein binding,F
4944,65220,46034,ATP metabolic process,P
4945,65220,19674,NAD metabolic process,P
4946,65220,6741,NADP biosynthetic process,P
4947,65220,16310,phosphorylation,P
4948,65220,5829,cytosol,C
4949,79923,3677,DNA binding,F
4950,79923,5515,protein binding,F
4951,79923,43565,sequence-specific DNA binding,F
4952,79923,3714,transcription corepressor activity,F
4953,79923,3700,"transcription factor activity, sequence-specific DNA binding",F
4954,79923,30154,cell differentiation,P
4955,79923,8283,cell proliferation,P
4956,79923,1714,endodermal cell fate specification,P
4957,79923,1903507,negative regulation of nucleic acid-templated transcription,P
4958,79923,45944,positive regulation of transcription from RNA polymerase II promoter,P
4959,79923,45595,regulation of cell differentiation,P
4960,79923,10468,regulation of gene expression,P
4961,79923,6355,"regulation of transcription, DNA-templated",P
4962,79923,35019,somatic stem cell population maintenance,P
4963,79923,35019,somatic stem cell population maintenance,P
4964,79923,19827,stem cell population maintenance,P
4965,79923,6351,"transcription, DNA-templated",P
4966,79923,5730,nucleolus,C
4967,79923,5654,nucleoplasm,C
4968,79923,5634,nucleus,C
4969,79923,5634,nucleus,C
4970,10397,17137,Rab GTPase binding,F
4971,10397,45296,cadherin binding,F
4972,10397,43015,gamma-tubulin binding,F
4973,10397,8017,microtubule binding,F
4974,10397,5515,protein binding,F
4975,10397,30330,"DNA damage response, signal transduction by p53 class mediator",P
4976,10397,71456,cellular response to hypoxia,P
4977,10397,45576,mast cell activation,P
4978,10397,8285,negative regulation of cell proliferation,P
4979,10397,32287,peripheral nervous system myelin maintenance,P
4980,10397,90232,positive regulation of spindle checkpoint,P
4981,10397,42981,regulation of apoptotic process,P
4982,10397,10038,response to metal ion,P
4983,10397,5913,cell-cell adherens junction,C
4984,10397,5813,centrosome,C
4985,10397,5737,cytoplasm,C
4986,10397,5829,cytosol,C
4987,10397,5829,cytosol,C
4988,10397,70062,extracellular exosome,C
4989,10397,5874,microtubule,C
4990,10397,15630,microtubule cytoskeleton,C
4991,10397,43209,myelin sheath,C
4992,10397,5634,nucleus,C
4993,10397,48471,perinuclear region of cytoplasm,C
4994,10397,5886,plasma membrane,C
4995,10397,55038,recycling endosome membrane,C
4996,4750,5524,ATP binding,F
4997,4750,16301,kinase activity,F
4998,4750,46872,metal ion binding,F
4999,4750,5515,protein binding,F
5000,4750,4672,protein kinase activity,F
5001,4750,4713,protein tyrosine kinase activity,F
5002,4750,4702,"signal transducer, downstream of receptor, with serine/threonine kinase activity",F
5003,4750,7049,cell cycle,P
5004,4750,51301,cell division,P
5005,4750,60271,cilium assembly,P
5006,4750,18108,peptidyl-tyrosine phosphorylation,P
5007,4750,6468,protein phosphorylation,P
5008,4750,23014,signal transduction by protein phosphorylation,P
5009,4750,5813,centrosome,C
5010,4750,5737,cytoplasm,C
5011,4750,5634,nucleus,C
5012,4750,242,pericentriolar material,C
5013,6787,5524,ATP binding,F
5014,6787,30145,manganese ion binding,F
5015,6787,4674,protein serine/threonine kinase activity,F
5016,6787,4702,"signal transducer, downstream of receptor, with serine/threonine kinase activity",F
5017,6787,51301,cell division,P
5018,6787,6974,cellular response to DNA damage stimulus,P
5019,6787,278,mitotic cell cycle,P
5020,6787,45893,"positive regulation of transcription, DNA-templated",P
5021,6787,6468,protein phosphorylation,P
5022,6787,2000772,regulation of cellular senescence,P
5023,6787,1900062,regulation of replicative cell aging,P
5024,6787,2001020,regulation of response to DNA damage stimulus,P
5025,6787,23014,signal transduction by protein phosphorylation,P
5026,6787,5929,cilium,C
5027,6787,5737,cytoplasm,C
5028,6787,5737,cytoplasm,C
5029,10783,5524,ATP binding,F
5030,10783,19894,kinesin binding,F
5031,10783,287,magnesium ion binding,F
5032,10783,5515,protein binding,F
5033,10783,19901,protein kinase binding,F
5034,10783,4674,protein serine/threonine kinase activity,F
5035,10783,4674,protein serine/threonine kinase activity,F
5036,10783,4871,signal transducer activity,F
5037,10783,31572,G2 DNA damage checkpoint,P
5038,10783,6915,apoptotic process,P
5039,10783,7059,chromosome segregation,P
5040,10783,910,cytokinesis,P
5041,10783,7077,mitotic nuclear envelope disassembly,P
5042,10783,18105,peptidyl-serine phosphorylation,P
5043,10783,43123,positive regulation of I-kappaB kinase/NF-kappaB signaling,P
5044,10783,46777,protein autophosphorylation,P
5045,10783,6468,protein phosphorylation,P
5046,10783,2000772,regulation of cellular senescence,P
5047,10783,7346,regulation of mitotic cell cycle,P
5048,10783,30071,regulation of mitotic metaphase/anaphase transition,P
5049,10783,7165,signal transduction,P
5050,10783,51225,spindle assembly,P
5051,10783,5737,cytoplasm,C
5052,10783,5829,cytosol,C
5053,10783,5829,cytosol,C
5054,10783,43231,intracellular membrane-bounded organelle,C
5055,10783,5874,microtubule,C
5056,10783,5815,microtubule organizing center,C
5057,10783,16607,nuclear speck,C
5058,10783,5654,nucleoplasm,C
5059,10783,5634,nucleus,C
5060,10783,922,spindle pole,C
5061,4780,3677,DNA binding,F
5062,4780,1102,RNA polymerase II activating transcription factor binding,F
5063,4780,980,RNA polymerase II distal enhancer sequence-specific DNA binding,F
5064,4780,5515,protein binding,F
5065,4780,19904,protein domain specific binding,F
5066,4780,1221,transcription cofactor binding,F
5067,4780,3700,"transcription factor activity, sequence-specific DNA binding",F
5068,4780,44212,transcription regulatory region DNA binding,F
5069,4780,976,transcription regulatory region sequence-specific DNA binding,F
5070,4780,1205,"transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding",F
5071,4780,36499,PERK-mediated unfolded protein response,P
5072,4780,36499,PERK-mediated unfolded protein response,P
5073,4780,7568,aging,P
5074,4780,45454,cell redox homeostasis,P
5075,4780,35690,cellular response to drug,P
5076,4780,71498,cellular response to fluid shear stress,P
5077,4780,42149,cellular response to glucose starvation,P
5078,4780,70301,cellular response to hydrogen peroxide,P
5079,4780,71456,cellular response to hypoxia,P
5080,4780,71499,cellular response to laminar fluid shear stress,P
5081,4780,34599,cellular response to oxidative stress,P
5082,4780,34599,cellular response to oxidative stress,P
5083,4780,71356,cellular response to tumor necrosis factor,P
5084,4780,30968,endoplasmic reticulum unfolded protein response,P
5085,4780,6954,inflammatory response,P
5086,4780,10667,negative regulation of cardiac muscle cell apoptotic process,P
5087,4780,2000352,negative regulation of endothelial cell apoptotic process,P
5088,4780,1902037,negative regulation of hematopoietic stem cell differentiation,P
5089,4780,1903206,negative regulation of hydrogen peroxide-induced cell death,P
5090,4780,1902176,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,P
5091,4780,1904753,negative regulation of vascular associated smooth muscle cell migration,P
5092,4780,1903071,positive regulation of ER-associated ubiquitin-dependent protein catabolic process,P
5093,4780,45766,positive regulation of angiogenesis,P
5094,4780,30194,positive regulation of blood coagulation,P
5095,4780,43536,positive regulation of blood vessel endothelial cell migration,P
5096,4780,10628,positive regulation of gene expression,P
5097,4780,46326,positive regulation of glucose import,P
5098,4780,1903788,positive regulation of glutathione biosynthetic process,P
5099,4780,10976,positive regulation of neuron projection development,P
5100,4780,2000379,positive regulation of reactive oxygen species metabolic process,P
5101,4780,45944,positive regulation of transcription from RNA polymerase II promoter,P
5102,4780,45944,positive regulation of transcription from RNA polymerase II promoter,P
5103,4780,45944,positive regulation of transcription from RNA polymerase II promoter,P
5104,4780,36091,positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress,P
5105,4780,36003,positive regulation of transcription from RNA polymerase II promoter in response to stress,P
5106,4780,10499,proteasomal ubiquitin-independent protein catabolic process,P
5107,4780,43161,proteasome-mediated ubiquitin-dependent protein catabolic process,P
5108,4780,16567,protein ubiquitination,P
5109,4780,45995,regulation of embryonic development,P
5110,4780,2000121,regulation of removal of superoxide radicals,P
5111,4780,6366,transcription from RNA polymerase II promoter,P
5112,4780,5794,Golgi apparatus,C
5113,4780,5813,centrosome,C
5114,4780,785,chromatin,C
5115,4780,5737,cytoplasm,C
5116,4780,5829,cytosol,C
5117,4780,5654,nucleoplasm,C
5118,4780,5634,nucleus,C
5119,4780,5886,plasma membrane,C
5120,4780,32993,protein-DNA complex,C
5121,4814,5515,protein binding,F
5122,4814,7155,cell adhesion,P
5123,4814,1990384,hyaloid vascular plexus regression,P
5124,4814,7399,nervous system development,P
5125,4814,1954,positive regulation of cell-matrix adhesion,P
5126,4814,42246,tissue regeneration,P
5127,4814,16021,integral component of membrane,C
5128,4854,45296,cadherin binding,F
5129,4854,5509,calcium ion binding,F
5130,4854,19899,enzyme binding,F
5131,4854,5515,protein binding,F
5132,4854,4872,receptor activity,F
5133,4854,7220,Notch receptor processing,P
5134,4854,7219,Notch signaling pathway,P
5135,4854,48844,artery morphogenesis,P
5136,4854,30900,forebrain development,P
5137,4854,72104,glomerular capillary formation,P
5138,4854,45665,negative regulation of neuron differentiation,P
5139,4854,122,negative regulation of transcription from RNA polymerase II promoter,P
5140,4854,48663,neuron fate commitment,P
5141,4854,48661,positive regulation of smooth muscle cell proliferation,P
5142,4854,45944,positive regulation of transcription from RNA polymerase II promoter,P
5143,4854,6367,transcription initiation from RNA polymerase II promoter,P
5144,4854,139,Golgi membrane,C
5145,4854,15629,actin cytoskeleton,C
5146,4854,5829,cytosol,C
5147,4854,5829,cytosol,C
5148,4854,5789,endoplasmic reticulum membrane,C
5149,4854,5576,extracellular region,C
5150,4854,16021,integral component of membrane,C
5151,4854,5654,nucleoplasm,C
5152,4854,5654,nucleoplasm,C
5153,4854,5886,plasma membrane,C
5154,4854,43235,receptor complex,C
5155,50507,16174,NAD(P)H oxidase activity,F
5156,50507,9055,electron carrier activity,F
5157,50507,50660,flavin adenine dinucleotide binding,F
5158,50507,20037,heme binding,F
5159,50507,72341,modified amino acid binding,F
5160,50507,166,nucleotide binding,F
5161,50507,19826,oxygen sensor activity,F
5162,50507,5515,protein binding,F
5163,50507,16175,superoxide-generating NADPH oxidase activity,F
5164,50507,45453,bone resorption,P
5165,50507,55007,cardiac muscle cell differentiation,P
5166,50507,7569,cell aging,P
5167,50507,902,cell morphogenesis,P
5168,50507,71320,cellular response to cAMP,P
5169,50507,71480,cellular response to gamma radiation,P
5170,50507,71333,cellular response to glucose stimulus,P
5171,50507,71560,cellular response to transforming growth factor beta stimulus,P
5172,50507,10467,gene expression,P
5173,50507,50667,homocysteine metabolic process,P
5174,50507,6954,inflammatory response,P
5175,50507,8285,negative regulation of cell proliferation,P
5176,50507,55114,oxidation-reduction process,P
5177,50507,2000573,positive regulation of DNA biosynthetic process,P
5178,50507,70374,positive regulation of ERK1 and ERK2 cascade,P
5179,50507,43406,positive regulation of MAP kinase activity,P
5180,50507,43065,positive regulation of apoptotic process,P
5181,50507,51897,positive regulation of protein kinase B signaling,P
5182,50507,2000379,positive regulation of reactive oxygen species metabolic process,P
5183,50507,14911,positive regulation of smooth muscle cell migration,P
5184,50507,51496,positive regulation of stress fiber assembly,P
5185,50507,72593,reactive oxygen species metabolic process,P
5186,50507,1666,response to hypoxia,P
5187,50507,302,response to reactive oxygen species,P
5188,50507,42554,superoxide anion generation,P
5189,50507,6801,superoxide metabolic process,P
5190,50507,43020,NADPH oxidase complex,C
5191,50507,16324,apical plasma membrane,C
5192,50507,5789,endoplasmic reticulum membrane,C
5193,50507,5925,focal adhesion,C
5194,50507,16021,integral component of membrane,C
5195,50507,5739,mitochondrion,C
5196,50507,5730,nucleolus,C
5197,50507,5634,nucleus,C
5198,50507,48471,perinuclear region of cytoplasm,C
5199,50507,1725,stress fiber,C
5200,7101,42826,histone deacetylase binding,F
5201,7101,43565,sequence-specific DNA binding,F
5202,7101,3707,steroid hormone receptor activity,F
5203,7101,1077,"transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding",F
5204,7101,1078,"transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding",F
5205,7101,8270,zinc ion binding,F
5206,7101,2118,aggressive behavior,P
5207,7101,21764,amygdala development,P
5208,7101,21960,anterior commissure morphogenesis,P
5209,7101,1662,behavioral fear response,P
5210,7101,45165,cell fate commitment,P
5211,7101,21895,cerebral cortex neuron differentiation,P
5212,7101,21542,dentate gyrus development,P
5213,7101,30198,extracellular matrix organization,P
5214,7101,21872,forebrain generation of neurons,P
5215,7101,21819,layer formation in cerebral cortex,P
5216,7101,60291,long-term synaptic potentiation,P
5217,7101,43066,negative regulation of apoptotic process,P
5218,7101,48712,negative regulation of astrocyte differentiation,P
5219,7101,2000178,negative regulation of neural precursor cell proliferation,P
5220,7101,45665,negative regulation of neuron differentiation,P
5221,7101,122,negative regulation of transcription from RNA polymerase II promoter,P
5222,7101,7399,nervous system development,P
5223,7101,21772,olfactory bulb development,P
5224,7101,45766,positive regulation of angiogenesis,P
5225,7101,45787,positive regulation of cell cycle,P
5226,7101,2000179,positive regulation of neural precursor cell proliferation,P
5227,7101,2000648,positive regulation of stem cell proliferation,P
5228,7101,45944,positive regulation of transcription from RNA polymerase II promoter,P
5229,7101,90049,regulation of cell migration involved in sprouting angiogenesis,P
5230,7101,48814,regulation of dendrite morphogenesis,P
5231,7101,60164,regulation of timing of neuron differentiation,P
5232,7101,60041,retina development in camera-type eye,P
5233,7101,35176,social behavior,P
5234,7101,35019,somatic stem cell population maintenance,P
5235,7101,43401,steroid hormone mediated signaling pathway,P
5236,7101,6367,transcription initiation from RNA polymerase II promoter,P
5237,7101,7601,visual perception,P
5238,7101,5654,nucleoplasm,C
5239,59277,43237,laminin-1 binding,F
5240,59277,5515,protein binding,F
5241,59277,7411,axon guidance,P
5242,59277,16322,neuron remodeling,P
5243,59277,60668,regulation of branching involved in salivary gland morphogenesis by extracellular matrix-epithelial cell signaling,P
5244,59277,5604,basement membrane,C
5245,59277,5886,plasma membrane,C
5246,9891,5524,ATP binding,F
5247,9891,46872,metal ion binding,F
5248,9891,2039,p53 binding,F
5249,9891,5515,protein binding,F
5250,9891,4674,protein serine/threonine kinase activity,F
5251,9891,4674,protein serine/threonine kinase activity,F
5252,9891,7155,cell adhesion,P
5253,9891,6974,cellular response to DNA damage stimulus,P
5254,9891,35556,intracellular signal transduction,P
5255,9891,6468,protein phosphorylation,P
5256,9891,30155,regulation of cell adhesion,P
5257,9891,42127,regulation of cell proliferation,P
5258,9891,2000772,regulation of cellular senescence,P
5259,9891,35507,regulation of myosin-light-chain-phosphatase activity,P
5260,9891,1901796,regulation of signal transduction by p53 class mediator,P
5261,9891,5737,cytoplasm,C
5262,9891,1650,fibrillar center,C
5263,9891,15630,microtubule cytoskeleton,C
5264,9891,5654,nucleoplasm,C
5265,9891,5634,nucleus,C
5266,5015,978,RNA polymerase II core promoter proximal region sequence-specific DNA binding,F
5267,5015,8190,eukaryotic initiation factor 4E binding,F
5268,5015,5515,protein binding,F
5269,5015,1077,"transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding",F
5270,5015,7411,axon guidance,P
5271,5015,71542,dopaminergic neuron differentiation,P
5272,5015,71542,dopaminergic neuron differentiation,P
5273,5015,30900,forebrain development,P
5274,5015,30901,midbrain development,P
5275,5015,40019,positive regulation of embryonic development,P
5276,5015,2000543,positive regulation of gastrulation,P
5277,5015,45944,positive regulation of transcription from RNA polymerase II promoter,P
5278,5015,45893,"positive regulation of transcription, DNA-templated",P
5279,5015,90009,primitive streak formation,P
5280,5015,6461,protein complex assembly,P
5281,5015,40036,regulation of fibroblast growth factor receptor signaling pathway,P
5282,5015,8589,regulation of smoothened signaling pathway,P
5283,5015,6366,transcription from RNA polymerase II promoter,P
5284,5015,30426,growth cone,C
5285,5015,5634,nucleus,C
5286,5015,43234,protein complex,C
5287,64175,31418,L-ascorbic acid binding,F
5288,64175,5518,collagen binding,F
5289,64175,5506,iron ion binding,F
5290,64175,3674,molecular_function,F
5291,64175,19797,procollagen-proline 3-dioxygenase activity,F
5292,64175,19797,procollagen-proline 3-dioxygenase activity,F
5293,64175,32403,protein complex binding,F
5294,64175,60348,bone development,P
5295,64175,61077,chaperone-mediated protein folding,P
5296,64175,32963,collagen metabolic process,P
5297,64175,32963,collagen metabolic process,P
5298,64175,8285,negative regulation of cell proliferation,P
5299,64175,1901874,negative regulation of post-translational protein modification,P
5300,64175,55114,oxidation-reduction process,P
5301,64175,19511,peptidyl-proline hydroxylation,P
5302,64175,6457,protein folding,P
5303,64175,18126,protein hydroxylation,P
5304,64175,50821,protein stabilization,P
5305,64175,50708,regulation of protein secretion,P
5306,64175,5783,endoplasmic reticulum,C
5307,64175,5788,endoplasmic reticulum lumen,C
5308,64175,70062,extracellular exosome,C
5309,64175,32991,macromolecular complex,C
5310,64175,16020,membrane,C
5311,64175,5578,proteinaceous extracellular matrix,C
5312,23598,3677,DNA binding,F
5313,23598,978,RNA polymerase II core promoter proximal region sequence-specific DNA binding,F
5314,23598,3682,chromatin binding,F
5315,23598,46872,metal ion binding,F
5316,23598,1077,"transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding",F
5317,23598,30217,T cell differentiation,P
5318,23598,8584,male gonad development,P
5319,23598,45892,"negative regulation of transcription, DNA-templated",P
5320,23598,45944,positive regulation of transcription from RNA polymerase II promoter,P
5321,23598,6355,"regulation of transcription, DNA-templated",P
5322,23598,7283,spermatogenesis,P
5323,23598,6366,transcription from RNA polymerase II promoter,P
5324,23598,5654,nucleoplasm,C
5325,23598,5634,nucleus,C
5326,10298,5524,ATP binding,F
5327,10298,98641,cadherin binding involved in cell-cell adhesion,F
5328,10298,5515,protein binding,F
5329,10298,4672,protein kinase activity,F
5330,10298,4674,protein serine/threonine kinase activity,F
5331,10298,4702,"signal transducer, downstream of receptor, with serine/threonine kinase activity",F
5332,10298,6915,apoptotic process,P
5333,10298,16049,cell growth,P
5334,10298,16477,cell migration,P
5335,10298,8283,cell proliferation,P
5336,10298,98609,cell-cell adhesion,P
5337,10298,71407,cellular response to organic cyclic compound,P
5338,10298,7010,cytoskeleton organization,P
5339,10298,60996,dendritic spine development,P
5340,10298,278,mitotic cell cycle,P
5341,10298,6928,movement of cell or subcellular component,P
5342,10298,7165,signal transduction,P
5343,10298,23014,signal transduction by protein phosphorylation,P
5344,10298,5794,Golgi apparatus,C
5345,10298,5913,cell-cell adherens junction,C
5346,10298,5925,focal adhesion,C
5347,55193,3677,DNA binding,F
5348,55193,3682,chromatin binding,F
5349,55193,5515,protein binding,F
5350,55193,6338,chromatin remodeling,P
5351,55193,16569,covalent chromatin modification,P
5352,55193,278,mitotic cell cycle,P
5353,55193,8285,negative regulation of cell proliferation,P
5354,55193,6355,"regulation of transcription, DNA-templated",P
5355,55193,6351,"transcription, DNA-templated",P
5356,55193,90544,BAF-type complex,C
5357,55193,228,nuclear chromosome,C
5358,55193,5654,nucleoplasm,C
5359,7703,3677,DNA binding,F
5360,7703,3682,chromatin binding,F
5361,7703,5515,protein binding,F
5362,7703,3700,"transcription factor activity, sequence-specific DNA binding",F
5363,7703,8270,zinc ion binding,F
5364,7703,9952,anterior/posterior pattern specification,P
5365,7703,70301,cellular response to hydrogen peroxide,P
5366,7703,48704,embryonic skeletal system morphogenesis,P
5367,7703,16573,histone acetylation,P
5368,7703,1701,in utero embryonic development,P
5369,7703,2001234,negative regulation of apoptotic signaling pathway,P
5370,7703,122,negative regulation of transcription from RNA polymerase II promoter,P
5371,7703,6351,"transcription, DNA-templated",P
5372,7703,35102,PRC1 complex,C
5373,7703,31519,PcG protein complex,C
5374,7703,16604,nuclear body,C
5375,7703,790,nuclear chromatin,C
5376,7703,5654,nucleoplasm,C
5377,7703,5634,nucleus,C
5378,7703,1739,sex chromatin,C
5379,11235,47485,protein N-terminus binding,F
5380,11235,5515,protein binding,F
5381,11235,42803,protein homodimerization activity,F
5382,11235,19901,protein kinase binding,F
5383,11235,90168,Golgi reassembly,P
5384,11235,1525,angiogenesis,P
5385,11235,51683,establishment of Golgi localization,P
5386,11235,36481,intrinsic apoptotic signaling pathway in response to hydrogen peroxide,P
5387,11235,43066,negative regulation of apoptotic process,P
5388,11235,1903588,negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,P
5389,11235,90051,negative regulation of cell migration involved in sprouting angiogenesis,P
5390,11235,10629,negative regulation of gene expression,P
5391,11235,43406,positive regulation of MAP kinase activity,P
5392,11235,45747,positive regulation of Notch signaling pathway,P
5393,11235,30335,positive regulation of cell migration,P
5394,11235,30335,positive regulation of cell migration,P
5395,11235,8284,positive regulation of cell proliferation,P
5396,11235,10628,positive regulation of gene expression,P
5397,11235,90316,positive regulation of intracellular protein transport,P
5398,11235,33138,positive regulation of peptidyl-serine phosphorylation,P
5399,11235,71902,positive regulation of protein serine/threonine kinase activity,P
5400,11235,32874,positive regulation of stress-activated MAPK cascade,P
5401,11235,50821,protein stabilization,P
5402,11235,35023,regulation of Rho protein signal transduction,P
5403,11235,42542,response to hydrogen peroxide,P
5404,11235,43149,stress fiber assembly,P
5405,11235,44319,"wound healing, spreading of cells",P
5406,11235,5794,Golgi apparatus,C
5407,11235,5794,Golgi apparatus,C
5408,11235,139,Golgi membrane,C
5409,11235,5737,cytoplasm,C
5410,11235,5829,cytosol,C
5411,11235,70062,extracellular exosome,C
5412,11235,5886,plasma membrane,C
5413,149420,5524,ATP binding,F
5414,149420,5515,protein binding,F
5415,149420,4674,protein serine/threonine kinase activity,F
5416,149420,6468,protein phosphorylation,P
5417,149420,5654,nucleoplasm,C
5418,5170,4676,3-phosphoinositide-dependent protein kinase activity,F
5419,5170,5524,ATP binding,F
5420,5170,5158,insulin receptor binding,F
5421,5170,16301,kinase activity,F
5422,5170,16004,phospholipase activator activity,F
5423,5170,43274,phospholipase binding,F
5424,5170,5515,protein binding,F
5425,5170,19901,protein kinase binding,F
5426,5170,4674,protein serine/threonine kinase activity,F
5427,5170,4674,protein serine/threonine kinase activity,F
5428,5170,4674,protein serine/threonine kinase activity,F
5429,5170,4674,protein serine/threonine kinase activity,F
5430,5170,38095,Fc-epsilon receptor signaling pathway,P
5431,5170,31295,T cell costimulation,P
5432,5170,50852,T cell receptor signaling pathway,P
5433,5170,30036,actin cytoskeleton organization,P
5434,5170,32148,activation of protein kinase B activity,P
5435,5170,19722,calcium-mediated signaling,P
5436,5170,16477,cell migration,P
5437,5170,1990416,cellular response to brain-derived neurotrophic factor stimulus,P
5438,5170,71364,cellular response to epidermal growth factor stimulus,P
5439,5170,32869,cellular response to insulin stimulus,P
5440,5170,7173,epidermal growth factor receptor signaling pathway,P
5441,5170,97191,extrinsic apoptotic signaling pathway,P
5442,5170,48041,focal adhesion assembly,P
5443,5170,6972,hyperosmotic response,P
5444,5170,35556,intracellular signal transduction,P
5445,5170,35556,intracellular signal transduction,P
5446,5170,10667,negative regulation of cardiac muscle cell apoptotic process,P
5447,5170,43524,negative regulation of neuron apoptotic process,P
5448,5170,6469,negative regulation of protein kinase activity,P
5449,5170,34122,negative regulation of toll-like receptor signaling pathway,P
5450,5170,30512,negative regulation of transforming growth factor beta receptor signaling pathway,P
5451,5170,18105,peptidyl-serine phosphorylation,P
5452,5170,18107,peptidyl-threonine phosphorylation,P
5453,5170,48015,phosphatidylinositol-mediated signaling,P
5454,5170,30168,platelet activation,P
5455,5170,90004,positive regulation of establishment of protein localization to plasma membrane,P
5456,5170,10518,positive regulation of phospholipase activity,P
5457,5170,51281,positive regulation of release of sequestered calcium ion into cytosol,P
5458,5170,46777,protein autophosphorylation,P
5459,5170,6468,protein phosphorylation,P
5460,5170,43122,regulation of I-kappaB kinase/NF-kappaB signaling,P
5461,5170,10594,regulation of endothelial cell migration,P
5462,5170,43304,regulation of mast cell degranulation,P
5463,5170,6355,"regulation of transcription, DNA-templated",P
5464,5170,2223,stimulatory C-type lectin receptor signaling pathway,P
5465,5170,6351,"transcription, DNA-templated",P
5466,5170,3323,type B pancreatic cell development,P
5467,5170,42995,cell projection,C
5468,5170,5737,cytoplasm,C
5469,23037,7155,cell adhesion,P
5470,5170,5737,cytoplasm,C
5471,23037,5911,cell-cell junction,C
5472,23037,5737,cytoplasm,C
5473,5170,31410,cytoplasmic vesicle,C
5474,23037,5783,endoplasmic reticulum,C
5475,5170,5829,cytosol,C
5476,23037,5576,extracellular region,C
5477,23037,5634,nucleus,C
5478,5170,5925,focal adhesion,C
5479,5170,5622,intracellular,C
5480,5170,16020,membrane,C
5481,5170,5654,nucleoplasm,C
5482,5170,43204,perikaryon,C
5483,5170,5886,plasma membrane,C
5484,5170,5886,plasma membrane,C
5485,5170,14069,postsynaptic density,C
5486,5037,5524,ATP binding,F
5487,5037,3723,RNA binding,F
5488,5037,19899,enzyme binding,F
5489,5037,8429,phosphatidylethanolamine binding,F
5490,5037,5515,protein binding,F
5491,5037,19901,protein kinase binding,F
5492,5037,4867,serine-type endopeptidase inhibitor activity,F
5493,5037,165,MAPK cascade,P
5494,5037,10951,negative regulation of endopeptidase activity,P
5495,5037,5829,cytosol,C
5496,5037,70062,extracellular exosome,C
5497,5037,5634,nucleus,C
5498,5824,51117,ATPase binding,F
5499,5824,36105,peroxisome membrane class-1 targeting sequence binding,F
5500,5824,47485,protein N-terminus binding,F
5501,5824,5515,protein binding,F
5502,5824,61077,chaperone-mediated protein folding,P
5503,5824,72321,chaperone-mediated protein transport,P
5504,5824,72663,establishment of protein localization to peroxisome,P
5505,5824,1900131,negative regulation of lipid binding,P
5506,5824,16559,peroxisome fission,P
5507,5824,7031,peroxisome organization,P
5508,5824,7031,peroxisome organization,P
5509,5824,45046,protein import into peroxisome membrane,P
5510,5824,50821,protein stabilization,P
5511,5824,6625,protein targeting to peroxisome,P
5512,5824,6625,protein targeting to peroxisome,P
5513,5824,55085,transmembrane transport,P
5514,5824,31526,brush border membrane,C
5515,5824,5737,cytoplasm,C
5516,5824,5737,cytoplasm,C
5517,5824,5829,cytosol,C
5518,5824,5829,cytosol,C
5519,5824,5654,nucleoplasm,C
5520,5824,5778,peroxisomal membrane,C
5521,5824,5777,peroxisome,C
5522,5824,5777,peroxisome,C
5523,5824,43234,protein complex,C
5524,51588,3677,DNA binding,F
5525,51588,61665,SUMO ligase activity,F
5526,51588,19789,SUMO transferase activity,F
5527,51588,19789,SUMO transferase activity,F
5528,51588,19789,SUMO transferase activity,F
5529,51588,8022,protein C-terminus binding,F
5530,51588,5515,protein binding,F
5531,51588,3714,transcription corepressor activity,F
5532,51588,31625,ubiquitin protein ligase binding,F
5533,51588,8270,zinc ion binding,F
5534,51588,16055,Wnt signaling pathway,P
5535,51588,6303,double-strand break repair via nonhomologous end joining,P
5536,51588,32088,negative regulation of NF-kappaB transcription factor activity,P
5537,51588,122,negative regulation of transcription from RNA polymerase II promoter,P
5538,51588,45892,"negative regulation of transcription, DNA-templated",P
5539,51588,45892,"negative regulation of transcription, DNA-templated",P
5540,51588,10804,negative regulation of tumor necrosis factor-mediated signaling pathway,P
5541,51588,1902231,positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage,P
5542,51588,1902174,positive regulation of keratinocyte apoptotic process,P
5543,51588,33235,positive regulation of protein sumoylation,P
5544,51588,16925,protein sumoylation,P
5545,51588,16925,protein sumoylation,P
5546,51588,16925,protein sumoylation,P
5547,51588,16925,protein sumoylation,P
5548,51588,6351,"transcription, DNA-templated",P
5549,51588,16605,PML body,C
5550,51588,5737,cytoplasm,C
5551,51588,16363,nuclear matrix,C
5552,51588,5654,nucleoplasm,C
5553,51588,5634,nucleus,C
5554,51588,5634,nucleus,C
5555,51588,1990234,transferase complex,C
5556,23533,46935,1-phosphatidylinositol-3-kinase regulator activity,F
5557,23533,31683,G-protein beta/gamma-subunit complex binding,F
5558,23533,46934,"phosphatidylinositol-4,5-bisphosphate 3-kinase activity",F
5559,23533,7186,G-protein coupled receptor signaling pathway,P
5560,23533,7186,G-protein coupled receptor signaling pathway,P
5561,23533,14065,phosphatidylinositol 3-kinase signaling,P
5562,23533,14065,phosphatidylinositol 3-kinase signaling,P
5563,23533,6661,phosphatidylinositol biosynthetic process,P
5564,23533,46854,phosphatidylinositol phosphorylation,P
5565,23533,30168,platelet activation,P
5566,23533,43406,positive regulation of MAP kinase activity,P
5567,23533,43406,positive regulation of MAP kinase activity,P
5568,23533,51897,positive regulation of protein kinase B signaling,P
5569,23533,43551,regulation of phosphatidylinositol 3-kinase activity,P
5570,23533,5737,cytoplasm,C
5571,23533,5829,cytosol,C
5572,23533,5829,cytosol,C
5573,23533,16020,membrane,C
5574,23533,5815,microtubule organizing center,C
5575,23533,5634,nucleus,C
5576,23533,5942,phosphatidylinositol 3-kinase complex,C
5577,23533,5944,"phosphatidylinositol 3-kinase complex, class IB",C
5578,23533,5886,plasma membrane,C
5579,5286,16303,1-phosphatidylinositol-3-kinase activity,F
5580,5286,35005,1-phosphatidylinositol-4-phosphate 3-kinase activity,F
5581,5286,35005,1-phosphatidylinositol-4-phosphate 3-kinase activity,F
5582,5286,5524,ATP binding,F
5583,5286,35004,phosphatidylinositol 3-kinase activity,F
5584,5286,35091,phosphatidylinositol binding,F
5585,5286,48268,clathrin coat assembly,P
5586,5286,6897,endocytosis,P
5587,5286,7173,epidermal growth factor receptor signaling pathway,P
5588,5286,6887,exocytosis,P
5589,5286,8286,insulin receptor signaling pathway,P
5590,5286,61024,membrane organization,P
5591,5286,6661,phosphatidylinositol biosynthetic process,P
5592,5286,46854,phosphatidylinositol phosphorylation,P
5593,5286,36092,phosphatidylinositol-3-phosphate biosynthetic process,P
5594,5286,48015,phosphatidylinositol-mediated signaling,P
5595,5286,48008,platelet-derived growth factor receptor signaling pathway,P
5596,5286,14829,vascular smooth muscle contraction,P
5597,5286,5794,Golgi apparatus,C
5598,5286,30136,clathrin-coated vesicle,C
5599,5286,5737,cytoplasm,C
5600,5286,5829,cytosol,C
5601,5286,70062,extracellular exosome,C
5602,5286,16020,membrane,C
5603,5286,5634,nucleus,C
5604,5286,5942,phosphatidylinositol 3-kinase complex,C
5605,5286,5886,plasma membrane,C
5606,5286,31982,vesicle,C
5607,5292,5524,ATP binding,F
5608,5292,30145,manganese ion binding,F
5609,5292,5515,protein binding,F
5610,5292,4674,protein serine/threonine kinase activity,F
5611,5292,43024,ribosomal small subunit binding,F
5612,5292,8134,transcription factor binding,F
5613,5292,6915,apoptotic process,P
5614,5292,7049,cell cycle,P
5615,5292,8283,cell proliferation,P
5616,5292,30212,hyaluronan metabolic process,P
5617,5292,7275,multicellular organism development,P
5618,5292,43066,negative regulation of apoptotic process,P
5619,5292,43433,negative regulation of sequence-specific DNA binding transcription factor activity,P
5620,5292,60045,positive regulation of cardiac muscle cell proliferation,P
5621,5292,1905062,positive regulation of cardioblast proliferation,P
5622,5292,46777,protein autophosphorylation,P
5623,5292,6468,protein phosphorylation,P
5624,5292,7346,regulation of mitotic cell cycle,P
5625,5292,70561,vitamin D receptor signaling pathway,P
5626,5292,5737,cytoplasm,C
5627,5292,5829,cytosol,C
5628,5292,5730,nucleolus,C
5629,5292,5654,nucleoplasm,C
5630,5292,5634,nucleus,C
5631,5292,5886,plasma membrane,C
5632,22925,30246,carbohydrate binding,F
5633,22925,43274,phospholipase binding,F
5634,22925,4888,transmembrane signaling receptor activity,F
5635,22925,1816,cytokine production,P
5636,22925,1900139,negative regulation of arachidonic acid secretion,P
5637,22925,1900138,negative regulation of phospholipase A2 activity,P
5638,22925,90403,oxidative stress-induced premature senescence,P
5639,22925,43517,"positive regulation of DNA damage response, signal transduction by p53 class mediator",P
5640,22925,90238,positive regulation of arachidonic acid secretion,P
5641,22925,72593,reactive oxygen species metabolic process,P
5642,22925,6898,receptor-mediated endocytosis,P
5643,22925,90399,replicative senescence,P
5644,22925,7165,signal transduction,P
5645,22925,9986,cell surface,C
5646,22925,70062,extracellular exosome,C
5647,22925,5576,extracellular region,C
5648,22925,5887,integral component of plasma membrane,C
5649,22925,5886,plasma membrane,C
5650,22925,43235,receptor complex,C
5651,5315,5524,ATP binding,F
5652,5315,23026,MHC class II protein complex binding,F
5653,5315,3723,RNA binding,F
5654,5315,45296,cadherin binding,F
5655,5315,16301,kinase activity,F
5656,5315,287,magnesium ion binding,F
5657,5315,30955,potassium ion binding,F
5658,5315,5515,protein binding,F
5659,5315,4743,pyruvate kinase activity,F
5660,5315,4743,pyruvate kinase activity,F
5661,5315,4743,pyruvate kinase activity,F
5662,5315,61621,canonical glycolysis,P
5663,5315,32869,cellular response to insulin stimulus,P
5664,5315,43312,neutrophil degranulation,P
5665,5315,12501,programmed cell death,P
5666,5315,5929,cilium,C
5667,5315,5737,cytoplasm,C
5668,5315,5829,cytosol,C
5669,5315,5829,cytosol,C
5670,5315,5829,cytosol,C
5671,5315,70062,extracellular exosome,C
5672,5315,31012,extracellular matrix,C
5673,5315,5576,extracellular region,C
5674,5315,1903561,extracellular vesicle,C
5675,5315,1904813,ficolin-1-rich granule lumen,C
5676,5315,5739,mitochondrion,C
5677,5315,43209,myelin sheath,C
5678,5315,5634,nucleus,C
5679,5315,34774,secretory granule lumen,C
5680,5315,31982,vesicle,C
5681,5371,3677,DNA binding,F
5682,5371,46332,SMAD binding,F
5683,5371,32183,SUMO binding,F
5684,5371,5515,protein binding,F
5685,5371,42803,protein homodimerization activity,F
5686,5371,31625,ubiquitin protein ligase binding,F
5687,5371,8270,zinc ion binding,F
5688,5371,6977,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest",P
5689,5371,30578,PML body organization,P
5690,5371,7184,SMAD protein import into nucleus,P
5691,5371,6919,activation of cysteine-type endopeptidase activity involved in apoptotic process,P
5692,5371,60444,branching involved in mammary gland duct morphogenesis,P
5693,5371,7050,cell cycle arrest,P
5694,5371,45165,cell fate commitment,P
5695,5371,71353,cellular response to interleukin-4,P
5696,5371,90398,cellular senescence,P
5697,5371,32922,circadian regulation of gene expression,P
5698,5371,7182,common-partner SMAD protein phosphorylation,P
5699,5371,51607,defense response to virus,P
5700,5371,32469,endoplasmic reticulum calcium ion homeostasis,P
5701,5371,43153,entrainment of circadian clock by photoperiod,P
5702,5371,97191,extrinsic apoptotic signaling pathway,P
5703,5371,10761,fibroblast migration,P
5704,5371,45087,innate immune response,P
5705,5371,60333,interferon-gamma-mediated signaling pathway,P
5706,5371,42771,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,P
5707,5371,70059,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,P
5708,5371,8631,intrinsic apoptotic signaling pathway in response to oxidative stress,P
5709,5371,51457,maintenance of protein location in nucleus,P
5710,5371,30099,myeloid cell differentiation,P
5711,5371,16525,negative regulation of angiogenesis,P
5712,5371,30308,negative regulation of cell growth,P
5713,5371,8285,negative regulation of cell proliferation,P
5714,5371,50713,negative regulation of interleukin-1 beta secretion,P
5715,5371,2000059,negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process,P
5716,5371,45892,"negative regulation of transcription, DNA-templated",P
5717,5371,1902187,negative regulation of viral release from host cell,P
5718,5371,45345,positive regulation of MHC class I biosynthetic process,P
5719,5371,2001238,positive regulation of extrinsic apoptotic signaling pathway,P
5720,5371,48146,positive regulation of fibroblast proliferation,P
5721,5371,32206,positive regulation of telomere maintenance,P
5722,5371,45944,positive regulation of transcription from RNA polymerase II promoter,P
5723,5371,43161,proteasome-mediated ubiquitin-dependent protein catabolic process,P
5724,5371,6461,protein complex assembly,P
5725,5371,10522,regulation of calcium ion transport into cytosol,P
5726,5371,30155,regulation of cell adhesion,P
5727,5371,42752,regulation of circadian rhythm,P
5728,5371,2000779,regulation of double-strand break repair,P
5729,5371,1932,regulation of protein phosphorylation,P
5730,5371,1901796,regulation of signal transduction by p53 class mediator,P
5731,5371,6355,"regulation of transcription, DNA-templated",P
5732,5371,9411,response to UV,P
5733,5371,34097,response to cytokine,P
5734,5371,10332,response to gamma radiation,P
5735,5371,1666,response to hypoxia,P
5736,5371,48384,retinoic acid receptor signaling pathway,P
5737,5371,6351,"transcription, DNA-templated",P
5738,5371,7179,transforming growth factor beta receptor signaling pathway,P
5739,5371,16605,PML body,C
5740,5371,16605,PML body,C
5741,5371,16605,PML body,C
5742,5371,5737,cytoplasm,C
5743,5371,5829,cytosol,C
5744,5371,5829,cytosol,C
5745,5371,31901,early endosome membrane,C
5746,5371,42406,extrinsic component of endoplasmic reticulum membrane,C
5747,5371,792,heterochromatin,C
5748,5371,784,"nuclear chromosome, telomeric region",C
5749,5371,16363,nuclear matrix,C
5750,5371,31965,nuclear membrane,C
5751,5371,5730,nucleolus,C
5752,5371,5654,nucleoplasm,C
5753,5371,5654,nucleoplasm,C
5754,5371,5634,nucleus,C
5755,87178,175,3'-5'-exoribonuclease activity,F
5756,87178,3723,RNA binding,F
5757,87178,35198,miRNA binding,F
5758,87178,34046,poly(G) binding,F
5759,87178,8266,poly(U) RNA binding,F
5760,87178,4654,polyribonucleotide nucleotidyltransferase activity,F
5761,87178,5515,protein binding,F
5762,87178,6401,RNA catabolic process,P
5763,87178,35927,RNA import into mitochondrion,P
5764,87178,90503,"RNA phosphodiester bond hydrolysis, exonucleolytic",P
5765,87178,43631,RNA polyadenylation,P
5766,87178,35458,cellular response to interferon-beta,P
5767,87178,34599,cellular response to oxidative stress,P
5768,87178,97421,liver regeneration,P
5769,87178,6402,mRNA catabolic process,P
5770,87178,965,mitochondrial RNA 3'-end processing,P
5771,87178,964,mitochondrial RNA 5'-end processing,P
5772,87178,957,mitochondrial RNA catabolic process,P
5773,87178,958,mitochondrial mRNA catabolic process,P
5774,87178,97222,mitochondrial mRNA polyadenylation,P
5775,87178,70584,mitochondrion morphogenesis,P
5776,87178,71850,mitotic cell cycle arrest,P
5777,87178,45926,negative regulation of growth,P
5778,87178,71042,nuclear polyadenylation-dependent mRNA catabolic process,P
5779,87178,61014,positive regulation of mRNA catabolic process,P
5780,87178,2000627,positive regulation of miRNA catabolic process,P
5781,87178,962,positive regulation of mitochondrial RNA catabolic process,P
5782,87178,51260,protein homooligomerization,P
5783,87178,70207,protein homotrimerization,P
5784,87178,35928,rRNA import into mitochondrion,P
5785,87178,43457,regulation of cellular respiration,P
5786,87178,2000772,regulation of cellular senescence,P
5787,87178,51591,response to cAMP,P
5788,87178,60416,response to growth hormone,P
5789,87178,5737,cytoplasm,C
5790,87178,5829,cytosol,C
5791,87178,5789,endoplasmic reticulum membrane,C
5792,87178,45025,mitochondrial degradosome,C
5793,87178,5758,mitochondrial intermembrane space,C
5794,87178,5739,mitochondrion,C
5795,87178,5634,nucleus,C
5796,87178,42788,polysomal ribosome,C
5797,10654,5524,ATP binding,F
5798,10654,4631,phosphomevalonate kinase activity,F
5799,10654,4631,phosphomevalonate kinase activity,F
5800,10654,6695,cholesterol biosynthetic process,P
5801,10654,6695,cholesterol biosynthetic process,P
5802,10654,19287,"isopentenyl diphosphate biosynthetic process, mevalonate pathway",P
5803,10654,19287,"isopentenyl diphosphate biosynthetic process, mevalonate pathway",P
5804,10654,16310,phosphorylation,P
5805,10654,70723,response to cholesterol,P
5806,10654,16126,sterol biosynthetic process,P
5807,10654,5829,cytosol,C
5808,10654,5829,cytosol,C
5809,10654,70062,extracellular exosome,C
5810,10654,16020,membrane,C
5811,10654,5777,peroxisome,C
5812,25913,17151,DEAD/H-box RNA helicase binding,F
5813,25913,1990955,G-rich single-stranded DNA binding,F
5814,25913,98505,G-rich strand telomeric DNA binding,F
5815,25913,32357,oxidized purine DNA binding,F
5816,25913,5515,protein binding,F
5817,25913,43047,single-stranded telomeric DNA binding,F
5818,25913,43047,single-stranded telomeric DNA binding,F
5819,25913,10521,telomerase inhibitor activity,F
5820,25913,61821,telomeric D-loop binding,F
5821,25913,42162,telomeric DNA binding,F
5822,25913,61849,telomeric G-quadruplex DNA binding,F
5823,25913,32508,DNA duplex unwinding,P
5824,25913,70200,establishment of protein localization to telomere,P
5825,25913,51974,negative regulation of telomerase activity,P
5826,25913,32211,negative regulation of telomere maintenance via telomerase,P
5827,25913,32211,negative regulation of telomere maintenance via telomerase,P
5828,25913,1905776,positive regulation of DNA helicase activity,P
5829,25913,60383,positive regulation of DNA strand elongation,P
5830,25913,51096,positive regulation of helicase activity,P
5831,25913,51973,positive regulation of telomerase activity,P
5832,25913,51973,positive regulation of telomerase activity,P
5833,25913,32212,positive regulation of telomere maintenance via telomerase,P
5834,25913,32212,positive regulation of telomere maintenance via telomerase,P
5835,25913,1905774,regulation of DNA helicase activity,P
5836,25913,32210,regulation of telomere maintenance via telomerase,P
5837,25913,32202,telomere assembly,P
5838,25913,16233,telomere capping,P
5839,25913,16233,telomere capping,P
5840,25913,16233,telomere capping,P
5841,25913,7004,telomere maintenance via telomerase,P
5842,25913,61820,telomeric D-loop disassembly,P
5843,25913,781,"chromosome, telomeric region",C
5844,25913,784,"nuclear chromosome, telomeric region",C
5845,25913,783,nuclear telomere cap complex,C
5846,25913,5654,nucleoplasm,C
5847,25913,5634,nucleus,C
5848,25913,70187,shelterin complex,C
5849,25913,70187,shelterin complex,C
5850,25913,70187,shelterin complex,C
5851,5460,3677,DNA binding,F
5852,5460,3723,RNA binding,F
5853,5460,981,"RNA polymerase II transcription factor activity, sequence-specific DNA binding",F
5854,5460,35198,miRNA binding,F
5855,5460,5515,protein binding,F
5856,5460,43565,sequence-specific DNA binding,F
5857,5460,3700,"transcription factor activity, sequence-specific DNA binding",F
5858,5460,976,transcription regulatory region sequence-specific DNA binding,F
5859,5460,1227,"transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding",F
5860,5460,31625,ubiquitin protein ligase binding,F
5861,5460,9653,anatomical structure morphogenesis,P
5862,5460,1824,blastocyst development,P
5863,5460,1714,endodermal cell fate specification,P
5864,5460,42789,mRNA transcription from RNA polymerase II promoter,P
5865,5460,60965,negative regulation of gene silencing by miRNA,P
5866,5460,122,negative regulation of transcription from RNA polymerase II promoter,P
5867,5460,45944,positive regulation of transcription from RNA polymerase II promoter,P
5868,5460,9786,regulation of asymmetric cell division,P
5869,5460,10468,regulation of gene expression,P
5870,5460,6355,"regulation of transcription, DNA-templated",P
5871,5460,9611,response to wounding,P
5872,5460,35019,somatic stem cell population maintenance,P
5873,5460,35019,somatic stem cell population maintenance,P
5874,5460,35019,somatic stem cell population maintenance,P
5875,5460,6366,transcription from RNA polymerase II promoter,P
5876,5460,5737,cytoplasm,C
5877,5460,5829,cytosol,C
5878,5460,5739,mitochondrion,C
5879,5460,5654,nucleoplasm,C
5880,5460,5654,nucleoplasm,C
5881,5460,5634,nucleus,C
5882,5460,5634,nucleus,C
5883,5495,287,magnesium ion binding,F
5884,5495,30145,manganese ion binding,F
5885,5495,5515,protein binding,F
5886,5495,4722,protein serine/threonine phosphatase activity,F
5887,5495,6499,N-terminal protein myristoylation,P
5888,5495,43124,negative regulation of I-kappaB kinase/NF-kappaB signaling,P
5889,5495,42347,negative regulation of NF-kappaB import into nucleus,P
5890,5495,50687,negative regulation of defense response to virus,P
5891,5495,32688,negative regulation of interferon-beta production,P
5892,5495,35970,peptidyl-threonine dephosphorylation,P
5893,5495,6470,protein dephosphorylation,P
5894,5495,5829,cytosol,C
5895,5495,5829,cytosol,C
5896,5495,5829,cytosol,C
5897,5495,16020,membrane,C
5898,5495,5730,nucleolus,C
5899,8493,46872,metal ion binding,F
5900,8493,51019,mitogen-activated protein kinase binding,F
5901,8493,5515,protein binding,F
5902,8493,4722,protein serine/threonine phosphatase activity,F
5903,8493,86,G2/M transition of mitotic cell cycle,P
5904,8493,9267,cellular response to starvation,P
5905,8493,8285,negative regulation of cell proliferation,P
5906,8493,35970,peptidyl-threonine dephosphorylation,P
5907,8493,6470,protein dephosphorylation,P
5908,8493,9617,response to bacterium,P
5909,8493,9314,response to radiation,P
5910,8493,5634,nucleus,C
5911,55170,3682,chromatin binding,F
5912,55170,42393,histone binding,F
5913,55170,42054,histone methyltransferase activity,F
5914,55170,70612,histone methyltransferase activity (H2A-R3 specific),F
5915,55170,70611,histone methyltransferase activity (H3-R2 specific),F
5916,55170,44020,histone methyltransferase activity (H4-R3 specific),F
5917,55170,8469,histone-arginine N-methyltransferase activity,F
5918,55170,5515,protein binding,F
5919,55170,16274,protein-arginine N-methyltransferase activity,F
5920,55170,35242,protein-arginine omega-N asymmetric methyltransferase activity,F
5921,55170,35241,protein-arginine omega-N monomethyltransferase activity,F
5922,55170,6284,base-excision repair,P
5923,55170,16049,cell growth,P
5924,55170,90398,cellular senescence,P
5925,55170,34970,histone H3-R2 methylation,P
5926,55170,43985,histone H4-R3 methylation,P
5927,55170,16571,histone methylation,P
5928,55170,122,negative regulation of transcription from RNA polymerase II promoter,P
5929,55170,45892,"negative regulation of transcription, DNA-templated",P
5930,55170,19919,"peptidyl-arginine methylation, to asymmetrical-dimethyl arginine",P
5931,55170,6351,"transcription, DNA-templated",P
5932,55170,16032,viral process,P
5933,55170,5730,nucleolus,C
5934,55170,5654,nucleoplasm,C
5935,55170,5634,nucleus,C
5936,5583,5524,ATP binding,F
5937,5583,17160,Ral GTPase binding,F
5938,5583,4699,calcium-independent protein kinase C activity,F
5939,5583,19899,enzyme binding,F
5940,5583,46872,metal ion binding,F
5941,5583,4697,protein kinase C activity,F
5942,5583,35556,intracellular signal transduction,P
5943,5583,34351,negative regulation of glial cell apoptotic process,P
5944,5583,18105,peptidyl-serine phosphorylation,P
5945,5583,30168,platelet activation,P
5946,5583,50861,positive regulation of B cell receptor signaling pathway,P
5947,5583,51092,positive regulation of NF-kappaB transcription factor activity,P
5948,5583,60252,positive regulation of glial cell proliferation,P
5949,5583,45618,positive regulation of keratinocyte differentiation,P
5950,5583,10744,positive regulation of macrophage derived foam cell differentiation,P
5951,5583,1903078,positive regulation of protein localization to plasma membrane,P
5952,5583,70528,protein kinase C signaling,P
5953,5583,6468,protein phosphorylation,P
5954,5583,2000810,regulation of bicellular tight junction assembly,P
5955,5583,7165,signal transduction,P
5956,5583,5911,cell-cell junction,C
5957,5583,5737,cytoplasm,C
5958,5583,5829,cytosol,C
5959,5583,5829,cytosol,C
5960,5583,70062,extracellular exosome,C
5961,5583,5886,plasma membrane,C
5962,5580,5524,ATP binding,F
5963,5580,4699,calcium-independent protein kinase C activity,F
5964,5580,4699,calcium-independent protein kinase C activity,F
5965,5580,8047,enzyme activator activity,F
5966,5580,19899,enzyme binding,F
5967,5580,19899,enzyme binding,F
5968,5580,43560,insulin receptor substrate binding,F
5969,5580,19900,kinase binding,F
5970,5580,46872,metal ion binding,F
5971,5580,4715,non-membrane spanning protein tyrosine kinase activity,F
5972,5580,5515,protein binding,F
5973,5580,4697,protein kinase C activity,F
5974,5580,4697,protein kinase C activity,F
5975,5580,4672,protein kinase activity,F
5976,5580,19901,protein kinase binding,F
5977,5580,4674,protein serine/threonine kinase activity,F
5978,5580,4674,protein serine/threonine kinase activity,F
5979,5580,4674,protein serine/threonine kinase activity,F
5980,5580,42100,B cell proliferation,P
5981,5580,38096,Fc-gamma receptor signaling pathway involved in phagocytosis,P
5982,5580,7202,activation of phospholipase C activity,P
5983,5580,32147,activation of protein kinase activity,P
5984,5580,6915,apoptotic process,P
5985,5580,60326,cell chemotaxis,P
5986,5580,7049,cell cycle,P
5987,5580,1904385,cellular response to angiotensin,P
5988,5580,70301,cellular response to hydrogen peroxide,P
5989,5580,71447,cellular response to hydroperoxide,P
5990,5580,90398,cellular senescence,P
5991,5580,42742,defense response to bacterium,P
5992,5580,97194,execution phase of apoptosis,P
5993,5580,16572,histone phosphorylation,P
5994,5580,16064,immunoglobulin mediated immune response,P
5995,5580,60333,interferon-gamma-mediated signaling pathway,P
5996,5580,32613,interleukin-10 production,P
5997,5580,32615,interleukin-12 production,P
5998,5580,8631,intrinsic apoptotic signaling pathway in response to oxidative stress,P
5999,5580,43407,negative regulation of MAP kinase activity,P
6000,5580,30837,negative regulation of actin filament polymerization,P
6001,5580,51490,negative regulation of filopodium assembly,P
6002,5580,34351,negative regulation of glial cell apoptotic process,P
6003,5580,50728,negative regulation of inflammatory response,P
6004,5580,46627,negative regulation of insulin receptor signaling pathway,P
6005,5580,46627,negative regulation of insulin receptor signaling pathway,P
6006,5580,50732,negative regulation of peptidyl-tyrosine phosphorylation,P
6007,5580,90331,negative regulation of platelet aggregation,P
6008,5580,32091,negative regulation of protein binding,P
6009,5580,42119,neutrophil activation,P
6010,5580,43312,neutrophil degranulation,P
6011,5580,18105,peptidyl-serine phosphorylation,P
6012,5580,18107,peptidyl-threonine phosphorylation,P
6013,5580,18108,peptidyl-tyrosine phosphorylation,P
6014,5580,30168,platelet activation,P
6015,5580,2001235,positive regulation of apoptotic signaling pathway,P
6016,5580,2000304,positive regulation of ceramide biosynthetic process,P
6017,5580,32079,positive regulation of endodeoxyribonuclease activity,P
6018,5580,2000753,positive regulation of glucosylceramide catabolic process,P
6019,5580,1900163,positive regulation of phospholipid scramblase activity,P
6020,5580,35307,positive regulation of protein dephosphorylation,P
6021,5580,42307,positive regulation of protein import into nucleus,P
6022,5580,2001022,positive regulation of response to DNA damage stimulus,P
6023,5580,2000755,positive regulation of sphingomyelin catabolic process,P
6024,5580,32930,positive regulation of superoxide anion generation,P
6025,5580,6468,protein phosphorylation,P
6026,5580,50821,protein stabilization,P
6027,5580,32956,regulation of actin cytoskeleton organization,P
6028,5580,43488,regulation of mRNA stability,P
6029,5580,10469,regulation of receptor activity,P
6030,5580,7165,signal transduction,P
6031,5580,2223,stimulatory C-type lectin receptor signaling pathway,P
6032,5580,23021,termination of signal transduction,P
6033,5580,35578,azurophil granule lumen,C
6034,5580,5911,cell-cell junction,C
6035,5580,5737,cytoplasm,C
6036,5580,5829,cytosol,C
6037,5580,5829,cytosol,C
6038,5580,5783,endoplasmic reticulum,C
6039,5580,70062,extracellular exosome,C
6040,5580,5576,extracellular region,C
6041,5580,16363,nuclear matrix,C
6042,5580,5654,nucleoplasm,C
6043,5580,5634,nucleus,C
6044,5580,48471,perinuclear region of cytoplasm,C
6045,5580,5886,plasma membrane,C
6046,5580,5886,plasma membrane,C
6047,5629,50692,DBD domain binding,F
6048,5629,3677,DNA binding,F
6049,5629,50693,LBD domain binding,F
6050,5629,1046,core promoter sequence-specific DNA binding,F
6051,5629,16922,ligand-dependent nuclear receptor binding,F
6052,5629,5515,protein binding,F
6053,5629,3714,transcription corepressor activity,F
6054,5629,3705,"transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding",F
6055,5629,3700,"transcription factor activity, sequence-specific DNA binding",F
6056,5629,44212,transcription regulatory region DNA binding,F
6057,5629,1078,"transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding",F
6058,5629,90425,acinar cell differentiation,P
6059,5629,60414,aorta smooth muscle tissue morphogenesis,P
6060,5629,55009,atrial cardiac muscle tissue morphogenesis,P
6061,5629,7420,brain development,P
6062,5629,61114,branching involved in pancreas morphogenesis,P
6063,5629,55007,cardiac muscle cell differentiation,P
6064,5629,1709,cell fate determination,P
6065,5629,21707,cerebellar granule cell differentiation,P
6066,5629,7623,circadian rhythm,P
6067,5629,21542,dentate gyrus development,P
6068,5629,21516,dorsal spinal cord development,P
6069,5629,60059,embryonic retina morphogenesis in camera-type eye,P
6070,5629,60214,endocardium formation,P
6071,5629,2194,hepatocyte cell migration,P
6072,5629,70365,hepatocyte differentiation,P
6073,5629,72574,hepatocyte proliferation,P
6074,5629,1822,kidney development,P
6075,5629,2088,lens development in camera-type eye,P
6076,5629,70309,lens fiber cell morphogenesis,P
6077,5629,1889,liver development,P
6078,5629,30324,lung development,P
6079,5629,1946,lymphangiogenesis,P
6080,5629,60836,lymphatic endothelial cell differentiation,P
6081,5629,70858,negative regulation of bile acid biosynthetic process,P
6082,5629,8285,negative regulation of cell proliferation,P
6083,5629,43433,negative regulation of sequence-specific DNA binding transcription factor activity,P
6084,5629,122,negative regulation of transcription from RNA polymerase II promoter,P
6085,5629,45892,"negative regulation of transcription, DNA-templated",P
6086,5629,45892,"negative regulation of transcription, DNA-templated",P
6087,5629,45071,negative regulation of viral genome replication,P
6088,5629,21915,neural tube development,P
6089,5629,30182,neuron differentiation,P
6090,5629,97150,neuronal stem cell population maintenance,P
6091,5629,30910,olfactory placode formation,P
6092,5629,46619,optic placode formation involved in camera-type eye formation,P
6093,5629,43049,otic placode formation,P
6094,5629,31016,pancreas development,P
6095,5629,45787,positive regulation of cell cycle,P
6096,5629,1901978,positive regulation of cell cycle checkpoint,P
6097,5629,8284,positive regulation of cell proliferation,P
6098,5629,45737,positive regulation of cyclin-dependent protein serine/threonine kinase activity,P
6099,5629,10595,positive regulation of endothelial cell migration,P
6100,5629,1938,positive regulation of endothelial cell proliferation,P
6101,5629,2000979,positive regulation of forebrain neuron differentiation,P
6102,5629,60421,positive regulation of heart growth,P
6103,5629,2000179,positive regulation of neural precursor cell proliferation,P
6104,5629,60298,positive regulation of sarcomere organization,P
6105,5629,45944,positive regulation of transcription from RNA polymerase II promoter,P
6106,5629,45893,"positive regulation of transcription, DNA-templated",P
6107,5629,42752,regulation of circadian rhythm,P
6108,5629,10468,regulation of gene expression,P
6109,5629,60849,regulation of transcription involved in lymphatic endothelial cell fate commitment,P
6110,5629,31667,response to nutrient levels,P
6111,5629,60042,retina morphogenesis in camera-type eye,P
6112,5629,30240,skeletal muscle thin filament assembly,P
6113,5629,6351,"transcription, DNA-templated",P
6114,5629,48845,venous blood vessel morphogenesis,P
6115,5629,55010,ventricular cardiac muscle tissue morphogenesis,P
6116,5629,55005,ventricular cardiac myofibril assembly,P
6117,5629,60412,ventricular septum morphogenesis,P
6118,5629,5737,cytoplasm,C
6119,5629,5634,nucleus,C
6120,5629,5634,nucleus,C
6121,27339,42802,identical protein binding,F
6122,27339,5515,protein binding,F
6123,27339,61630,ubiquitin protein ligase activity,F
6124,27339,61630,ubiquitin protein ligase activity,F
6125,27339,34450,ubiquitin-ubiquitin ligase activity,F
6126,27339,34613,cellular protein localization,P
6127,27339,6303,double-strand break repair via nonhomologous end joining,P
6128,27339,349,generation of catalytic spliceosome for first transesterification step,P
6129,27339,1833,inner cell mass cell proliferation,P
6130,27339,8610,lipid biosynthetic process,P
6131,27339,398,"mRNA splicing, via spliceosome",P
6132,27339,398,"mRNA splicing, via spliceosome",P
6133,27339,398,"mRNA splicing, via spliceosome",P
6134,27339,45665,negative regulation of neuron differentiation,P
6135,27339,48711,positive regulation of astrocyte differentiation,P
6136,27339,48026,"positive regulation of mRNA splicing, via spliceosome",P
6137,27339,10498,proteasomal protein catabolic process,P
6138,27339,70534,protein K63-linked ubiquitination,P
6139,27339,209,protein polyubiquitination,P
6140,27339,72422,signal transduction involved in DNA damage checkpoint,P
6141,27339,245,spliceosomal complex assembly,P
6142,27339,244,spliceosomal tri-snRNP complex assembly,P
6143,27339,6283,transcription-coupled nucleotide-excision repair,P
6144,27339,5662,DNA replication factor A complex,C
6145,27339,974,Prp19 complex,C
6146,27339,71006,U2-type catalytic step 1 spliceosome,C
6147,27339,71013,catalytic step 2 spliceosome,C
6148,27339,5737,cytoplasm,C
6149,27339,5811,lipid particle,C
6150,27339,16020,membrane,C
6151,27339,16607,nuclear speck,C
6152,27339,5654,nucleoplasm,C
6153,27339,5634,nucleus,C
6154,27339,35861,site of double-strand break,C
6155,27339,5819,spindle,C
6156,5693,8233,peptidase activity,F
6157,5693,5515,protein binding,F
6158,5693,4298,threonine-type endopeptidase activity,F
6159,5693,38095,Fc-epsilon receptor signaling pathway,P
6160,5693,165,MAPK cascade,P
6161,5693,38061,NIK/NF-kappaB signaling,P
6162,5693,31146,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,P
6163,5693,50852,T cell receptor signaling pathway,P
6164,5693,60071,"Wnt signaling pathway, planar cell polarity pathway",P
6165,5693,31145,anaphase-promoting complex-dependent catabolic process,P
6166,5693,2479,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent",P
6167,5693,10972,negative regulation of G2/M transition of mitotic cell cycle,P
6168,5693,90090,negative regulation of canonical Wnt signaling pathway,P
6169,5693,51436,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,P
6170,5693,90263,positive regulation of canonical Wnt signaling pathway,P
6171,5693,51437,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,P
6172,5693,43161,proteasome-mediated ubiquitin-dependent protein catabolic process,P
6173,5693,16579,protein deubiquitination,P
6174,5693,209,protein polyubiquitination,P
6175,5693,6508,proteolysis,P
6176,5693,6521,regulation of cellular amino acid metabolic process,P
6177,5693,43488,regulation of mRNA stability,P
6178,5693,61418,regulation of transcription from RNA polymerase II promoter in response to hypoxia,P
6179,5693,6979,response to oxidative stress,P
6180,5693,2223,stimulatory C-type lectin receptor signaling pathway,P
6181,5693,55085,transmembrane transport,P
6182,5693,33209,tumor necrosis factor-mediated signaling pathway,P
6183,5693,16032,viral process,P
6184,5693,5813,centrosome,C
6185,5693,5829,cytosol,C
6186,5693,70062,extracellular exosome,C
6187,5693,5654,nucleoplasm,C
6188,5693,5654,nucleoplasm,C
6189,5693,5634,nucleus,C
6190,5693,502,proteasome complex,C
6191,5693,5839,proteasome core complex,C
6192,284119,3723,RNA binding,F
6193,284119,5515,protein binding,F
6194,284119,42134,rRNA primary transcript binding,F
6195,284119,6355,"regulation of transcription, DNA-templated",P
6196,284119,6363,termination of RNA polymerase I transcription,P
6197,284119,6363,termination of RNA polymerase I transcription,P
6198,284119,6361,transcription initiation from RNA polymerase I promoter,P
6199,284119,5901,caveola,C
6200,284119,5737,cytoplasm,C
6201,284119,5829,cytosol,C
6202,284119,5783,endoplasmic reticulum,C
6203,284119,43231,intracellular membrane-bounded organelle,C
6204,284119,45121,membrane raft,C
6205,284119,5739,mitochondrion,C
6206,284119,5654,nucleoplasm,C
6207,284119,5634,nucleus,C
6208,284119,5886,plasma membrane,C
6209,284119,43234,protein complex,C
6210,9232,981,"RNA polymerase II transcription factor activity, sequence-specific DNA binding",F
6211,9232,17124,SH3 domain binding,F
6212,9232,4869,cysteine-type endopeptidase inhibitor activity,F
6213,9232,30414,peptidase inhibitor activity,F
6214,9232,5515,protein binding,F
6215,9232,3700,"transcription factor activity, sequence-specific DNA binding",F
6216,9232,6281,DNA repair,P
6217,9232,31145,anaphase-promoting complex-dependent catabolic process,P
6218,9232,51301,cell division,P
6219,9232,51276,chromosome organization,P
6220,9232,45143,homologous chromosome segregation,P
6221,9232,10951,negative regulation of endopeptidase activity,P
6222,9232,42787,protein ubiquitination involved in ubiquitin-dependent protein catabolic process,P
6223,10213,61578,Lys63-specific deubiquitinase activity,F
6224,9232,6357,regulation of transcription from RNA polymerase II promoter,P
6225,10213,61133,endopeptidase activator activity,F
6226,9232,7283,spermatogenesis,P
6227,10213,46872,metal ion binding,F
6228,9232,6366,transcription from RNA polymerase II promoter,P
6229,9232,5737,cytoplasm,C
6230,10213,8237,metallopeptidase activity,F
6231,9232,5829,cytosol,C
6232,10213,70628,proteasome binding,F
6233,9232,5829,cytosol,C
6234,9232,5634,nucleus,C
6235,10213,5515,protein binding,F
6236,9232,5634,nucleus,C
6237,10213,38095,Fc-epsilon receptor signaling pathway,P
6238,10213,165,MAPK cascade,P
6239,10213,38061,NIK/NF-kappaB signaling,P
6240,10213,31146,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,P
6241,10213,50852,T cell receptor signaling pathway,P
6242,10213,60071,"Wnt signaling pathway, planar cell polarity pathway",P
6243,10213,31145,anaphase-promoting complex-dependent catabolic process,P
6244,10213,2479,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent",P
6245,10213,724,double-strand break repair via homologous recombination,P
6246,10213,6303,double-strand break repair via nonhomologous end joining,P
6247,10213,10972,negative regulation of G2/M transition of mitotic cell cycle,P
6248,10213,90090,negative regulation of canonical Wnt signaling pathway,P
6249,10213,51436,negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle,P
6250,10213,43312,neutrophil degranulation,P
6251,10213,90263,positive regulation of canonical Wnt signaling pathway,P
6252,10213,10950,positive regulation of endopeptidase activity,P
6253,10213,51437,positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition,P
6254,10213,43161,proteasome-mediated ubiquitin-dependent protein catabolic process,P
6255,10213,70536,protein K63-linked deubiquitination,P
6256,10213,70536,protein K63-linked deubiquitination,P
6257,10213,16579,protein deubiquitination,P
6258,10213,209,protein polyubiquitination,P
6259,10213,6521,regulation of cellular amino acid metabolic process,P
6260,10213,43488,regulation of mRNA stability,P
6261,10213,61136,regulation of proteasomal protein catabolic process,P
6262,10213,61418,regulation of transcription from RNA polymerase II promoter in response to hypoxia,P
6263,10213,45471,response to ethanol,P
6264,10213,2223,stimulatory C-type lectin receptor signaling pathway,P
6265,10213,55085,transmembrane transport,P
6266,10213,33209,tumor necrosis factor-mediated signaling pathway,P
6267,10213,6511,ubiquitin-dependent protein catabolic process,P
6268,10213,5829,cytosol,C
6269,10213,31597,cytosolic proteasome complex,C
6270,10213,70062,extracellular exosome,C
6271,10213,5576,extracellular region,C
6272,10213,1904813,ficolin-1-rich granule lumen,C
6273,10213,5654,nucleoplasm,C
6274,10213,5634,nucleus,C
6275,10213,22624,proteasome accessory complex,C
6276,10213,502,proteasome complex,C
6277,10213,502,proteasome complex,C
6278,10213,8541,"proteasome regulatory particle, lid subcomplex",C
6279,10213,34774,secretory granule lumen,C
6280,5885,3682,chromatin binding,F
6281,5885,5515,protein binding,F
6282,5885,32403,protein complex binding,F
6283,5885,1228,"transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding",F
6284,5885,6310,DNA recombination,P
6285,5885,6915,apoptotic process,P
6286,5885,51301,cell division,P
6287,5885,6302,double-strand break repair,P
6288,5885,10972,negative regulation of G2/M transition of mitotic cell cycle,P
6289,5885,45841,negative regulation of mitotic metaphase/anaphase transition,P
6290,5885,45876,positive regulation of sister chromatid cohesion,P
6291,5885,45944,positive regulation of transcription from RNA polymerase II promoter,P
6292,5885,71168,protein localization to chromatin,P
6293,5885,7131,reciprocal meiotic recombination,P
6294,5885,6357,regulation of transcription from RNA polymerase II promoter,P
6295,5885,7062,sister chromatid cohesion,P
6296,5885,6366,transcription from RNA polymerase II promoter,P
6297,5885,785,chromatin,C
6298,5885,5694,chromosome,C
6299,5885,775,"chromosome, centromeric region",C
6300,5885,8278,cohesin complex,C
6301,5885,5829,cytosol,C
6302,5885,16020,membrane,C
6303,5885,798,nuclear cohesin complex,C
6304,5885,5654,nucleoplasm,C
6305,5885,5654,nucleoplasm,C
6306,5894,5524,ATP binding,F
6307,5894,4709,MAP kinase kinase kinase activity,F
6308,5894,19899,enzyme binding,F
6309,5894,42802,identical protein binding,F
6310,5894,16301,kinase activity,F
6311,5894,46872,metal ion binding,F
6312,5894,31434,mitogen-activated protein kinase kinase binding,F
6313,5894,5515,protein binding,F
6314,5894,46982,protein heterodimerization activity,F
6315,5894,4672,protein kinase activity,F
6316,5894,4674,protein serine/threonine kinase activity,F
6317,5894,31267,small GTPase binding,F
6318,5894,165,MAPK cascade,P
6319,5894,186,activation of MAPKK activity,P
6320,5894,7190,activation of adenylate cyclase activity,P
6321,5894,6915,apoptotic process,P
6322,5894,30154,cell differentiation,P
6323,5894,8283,cell proliferation,P
6324,5894,71550,death-inducing signaling complex assembly,P
6325,5894,60324,face development,P
6326,5894,7507,heart development,P
6327,5894,35773,insulin secretion involved in cellular response to glucose stimulus,P
6328,5894,45104,intermediate filament cytoskeleton organization,P
6329,5894,34220,ion transmembrane transport,P
6330,5894,7275,multicellular organism development,P
6331,5894,43066,negative regulation of apoptotic process,P
6332,5894,8285,negative regulation of cell proliferation,P
6333,5894,43154,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,P
6334,5894,1902042,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,P
6335,5894,31333,negative regulation of protein complex assembly,P
6336,5894,9968,negative regulation of signal transduction,P
6337,5894,48011,neurotrophin TRK receptor signaling pathway,P
6338,5894,30168,platelet activation,P
6339,5894,70374,positive regulation of ERK1 and ERK2 cascade,P
6340,5894,33138,positive regulation of peptidyl-serine phosphorylation,P
6341,5894,45944,positive regulation of transcription from RNA polymerase II promoter,P
6342,5894,6468,protein phosphorylation,P
6343,5894,35023,regulation of Rho protein signal transduction,P
6344,5894,42981,regulation of apoptotic process,P
6345,5894,45595,regulation of cell differentiation,P
6346,5894,2000145,regulation of cell motility,P
6347,5894,1666,response to hypoxia,P
6348,5894,35994,response to muscle stretch,P
6349,5894,7165,signal transduction,P
6350,5894,35019,somatic stem cell population maintenance,P
6351,5894,2223,stimulatory C-type lectin receptor signaling pathway,P
6352,5894,48538,thymus development,P
6353,5894,30878,thyroid gland development,P
6354,5894,42060,wound healing,P
6355,5894,5794,Golgi apparatus,C
6356,5894,5737,cytoplasm,C
6357,5894,5737,cytoplasm,C
6358,5894,5829,cytosol,C
6359,5894,5829,cytosol,C
6360,5894,5741,mitochondrial outer membrane,C
6361,5894,16607,nuclear speck,C
6362,5894,5886,plasma membrane,C
6363,5894,5886,plasma membrane,C
6364,5894,5886,plasma membrane,C
6365,5894,31143,pseudopodium,C
6366,5925,3677,DNA binding,F
6367,5925,1102,RNA polymerase II activating transcription factor binding,F
6368,5925,50681,androgen receptor binding,F
6369,5925,1047,core promoter binding,F
6370,5925,97718,disordered domain specific binding,F
6371,5925,42802,identical protein binding,F
6372,5925,61676,importin-alpha family protein binding,F
6373,5925,19900,kinase binding,F
6374,5925,3674,molecular_function,F
6375,5925,51219,phosphoprotein binding,F
6376,5925,5515,protein binding,F
6377,5925,3713,transcription coactivator activity,F
6378,5925,3700,"transcription factor activity, sequence-specific DNA binding",F
6379,5925,8134,transcription factor binding,F
6380,5925,31625,ubiquitin protein ligase binding,F
6381,5925,82,G1/S transition of mitotic cell cycle,P
6382,5925,7265,Ras protein signal transduction,P
6383,5925,30521,androgen receptor signaling pathway,P
6384,5925,7050,cell cycle arrest,P
6385,5925,75,cell cycle checkpoint,P
6386,5925,51301,cell division,P
6387,5925,48667,cell morphogenesis involved in neuron differentiation,P
6388,5925,71466,cellular response to xenobiotic stimulus,P
6389,5925,6338,chromatin remodeling,P
6390,5925,16569,covalent chromatin modification,P
6391,5925,48565,digestive tract development,P
6392,5925,43353,enucleate erythrocyte differentiation,P
6393,5925,34349,glial cell apoptotic process,P
6394,5925,97284,hepatocyte apoptotic process,P
6395,5925,34088,maintenance of mitotic sister chromatid cohesion,P
6396,5925,7093,mitotic cell cycle checkpoint,P
6397,5925,45445,myoblast differentiation,P
6398,5925,2000134,negative regulation of G1/S transition of mitotic cell cycle,P
6399,5925,50680,negative regulation of epithelial cell proliferation,P
6400,5925,10629,negative regulation of gene expression,P
6401,5925,6469,negative regulation of protein kinase activity,P
6402,5925,43433,negative regulation of sequence-specific DNA binding transcription factor activity,P
6403,5925,45879,negative regulation of smoothened signaling pathway,P
6404,5925,7070,negative regulation of transcription from RNA polymerase II promoter during mitotic cell cycle,P
6405,5925,71930,negative regulation of transcription involved in G1/S transition of mitotic cell cycle,P
6406,5925,45892,"negative regulation of transcription, DNA-templated",P
6407,5925,45892,"negative regulation of transcription, DNA-templated",P
6408,5925,51402,neuron apoptotic process,P
6409,5925,42551,neuron maturation,P
6410,5925,31175,neuron projection development,P
6411,5925,45651,positive regulation of macrophage differentiation,P
6412,5925,45842,positive regulation of mitotic metaphase/anaphase transition,P
6413,5925,45944,positive regulation of transcription from RNA polymerase II promoter,P
6414,5925,2000679,positive regulation of transcription regulatory region DNA binding,P
6415,5925,45893,"positive regulation of transcription, DNA-templated",P
6416,5925,71459,"protein localization to chromosome, centromeric region",P
6417,5925,1558,regulation of cell growth,P
6418,5925,90230,regulation of centromere complex assembly,P
6419,5925,71922,regulation of cohesin loading,P
6420,5925,43550,regulation of lipid kinase activity,P
6421,5925,7346,regulation of mitotic cell cycle,P
6422,5925,83,regulation of transcription involved in G1/S transition of mitotic cell cycle,P
6423,5925,6355,"regulation of transcription, DNA-templated",P
6424,5925,31134,sister chromatid biorientation,P
6425,5925,35914,skeletal muscle cell differentiation,P
6426,5925,51146,striated muscle cell differentiation,P
6427,5925,1894,tissue homeostasis,P
6428,5925,6351,"transcription, DNA-templated",P
6429,5925,16032,viral process,P
6430,5925,16605,PML body,C
6431,5925,35189,Rb-E2F complex,C
6432,5925,35189,Rb-E2F complex,C
6433,5925,16514,SWI/SNF complex,C
6434,5925,785,chromatin,C
6435,5925,8024,cyclin/CDK positive transcription elongation factor complex,C
6436,5925,5654,nucleoplasm,C
6437,5925,5654,nucleoplasm,C
6438,5925,5634,nucleus,C
6439,5925,5634,nucleus,C
6440,5925,5819,spindle,C
6441,5948,16918,retinal binding,F
6442,5948,5501,retinoid binding,F
6443,5948,19841,retinol binding,F
6444,5948,5215,transporter activity,F
6445,5948,8544,epidermis development,P
6446,5948,1523,retinoid metabolic process,P
6447,5948,6810,transport,P
6448,5948,6776,vitamin A metabolic process,P
6449,5948,5829,cytosol,C
6450,9978,19788,NEDD8 transferase activity,F
6451,9978,97602,cullin family protein binding,F
6452,9978,16874,ligase activity,F
6453,9978,5515,protein binding,F
6454,9978,32403,protein complex binding,F
6455,9978,61630,ubiquitin protein ligase activity,F
6456,9978,61630,ubiquitin protein ligase activity,F
6457,9978,31625,ubiquitin protein ligase binding,F
6458,9978,4842,ubiquitin-protein transferase activity,F
6459,9978,4842,ubiquitin-protein transferase activity,F
6460,9978,4842,ubiquitin-protein transferase activity,F
6461,9978,34450,ubiquitin-ubiquitin ligase activity,F
6462,9978,8270,zinc ion binding,F
6463,9978,42769,"DNA damage response, detection of DNA damage",P
6464,9978,165,MAPK cascade,P
6465,9978,10265,SCF complex assembly,P
6466,9978,31146,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,P
6467,9978,31146,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,P
6468,9978,31146,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,P
6469,9978,16055,Wnt signaling pathway,P
6470,9978,70911,global genome nucleotide-excision repair,P
6471,9978,10972,negative regulation of G2/M transition of mitotic cell cycle,P
6472,9978,90090,negative regulation of canonical Wnt signaling pathway,P
6473,9978,715,"nucleotide-excision repair, DNA damage recognition",P
6474,9978,717,"nucleotide-excision repair, DNA duplex unwinding",P
6475,9978,33683,"nucleotide-excision repair, DNA incision",P
6476,9978,6295,"nucleotide-excision repair, DNA incision, 3'-to lesion",P
6477,9978,6296,"nucleotide-excision repair, DNA incision, 5'-to lesion",P
6478,9978,6294,"nucleotide-excision repair, preincision complex assembly",P
6479,9978,6293,"nucleotide-excision repair, preincision complex stabilization",P
6480,9978,43161,proteasome-mediated ubiquitin-dependent protein catabolic process,P
6481,9978,43161,proteasome-mediated ubiquitin-dependent protein catabolic process,P
6482,9978,6513,protein monoubiquitination,P
6483,9978,45116,protein neddylation,P
6484,9978,209,protein polyubiquitination,P
6485,9978,16567,protein ubiquitination,P
6486,9978,61418,regulation of transcription from RNA polymerase II promoter in response to hypoxia,P
6487,9978,6283,transcription-coupled nucleotide-excision repair,P
6488,9978,16032,viral process,P
6489,9978,31462,Cul2-RING ubiquitin ligase complex,C
6490,9978,31463,Cul3-RING ubiquitin ligase complex,C
6491,9978,31464,Cul4A-RING E3 ubiquitin ligase complex,C
6492,9978,31465,Cul4B-RING E3 ubiquitin ligase complex,C
6493,9978,31466,Cul5-RING ubiquitin ligase complex,C
6494,9978,31467,Cul7-RING ubiquitin ligase complex,C
6495,9978,19005,SCF ubiquitin ligase complex,C
6496,9978,19005,SCF ubiquitin ligase complex,C
6497,9978,30891,VCB complex,C
6498,9978,31461,cullin-RING ubiquitin ligase complex,C
6499,9978,5829,cytosol,C
6500,9978,5829,cytosol,C
6501,9978,5654,nucleoplasm,C
6502,9978,5654,nucleoplasm,C
6503,6041,5524,ATP binding,F
6504,6041,3723,RNA binding,F
6505,6041,4521,endoribonuclease activity,F
6506,6041,46872,metal ion binding,F
6507,6041,5515,protein binding,F
6508,6041,4672,protein kinase activity,F
6509,6041,19843,rRNA binding,F
6510,6041,43021,ribonucleoprotein complex binding,F
6511,6041,90502,"RNA phosphodiester bond hydrolysis, endonucleolytic",P
6512,6041,51607,defense response to virus,P
6513,6041,45444,fat cell differentiation,P
6514,6041,6397,mRNA processing,P
6515,6041,45071,negative regulation of viral genome replication,P
6516,6041,2001275,positive regulation of glucose import in response to insulin stimulus,P
6517,6041,45944,positive regulation of transcription from RNA polymerase II promoter,P
6518,6041,6468,protein phosphorylation,P
6519,6041,6364,rRNA processing,P
6520,6041,43488,regulation of mRNA stability,P
6521,6041,55085,transmembrane transport,P
6522,6041,60337,type I interferon signaling pathway,P
6523,6041,5575,cellular_component,C
6524,6041,5829,cytosol,C
6525,6041,5759,mitochondrial matrix,C
6526,6041,16363,nuclear matrix,C
6527,27330,5524,ATP binding,F
6528,27330,16301,kinase activity,F
6529,27330,287,magnesium ion binding,F
6530,27330,4672,protein kinase activity,F
6531,27330,4674,protein serine/threonine kinase activity,F
6532,27330,6978,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator",P
6533,27330,7417,central nervous system development,P
6534,27330,70373,negative regulation of ERK1 and ERK2 cascade,P
6535,27330,45992,negative regulation of embryonic development,P
6536,27330,2000381,negative regulation of mesoderm development,P
6537,27330,6468,protein phosphorylation,P
6538,27330,7165,signal transduction,P
6539,27330,5737,cytoplasm,C
6540,27330,5829,cytosol,C
6541,27330,1650,fibrillar center,C
6542,27330,5739,mitochondrion,C
6543,27330,5730,nucleolus,C
6544,27330,5654,nucleoplasm,C
6545,27330,5634,nucleus,C
6546,27330,5634,nucleus,C
6547,26156,3723,RNA binding,F
6548,26156,3723,RNA binding,F
6549,26156,45296,cadherin binding,F
6550,26156,3730,mRNA 3'-UTR binding,F
6551,26156,48027,mRNA 5'-UTR binding,F
6552,26156,470,maturation of LSU-rRNA,P
6553,26156,1649,osteoblast differentiation,P
6554,26156,42981,regulation of apoptotic process,P
6555,26156,2000772,regulation of cellular senescence,P
6556,26156,32880,regulation of protein localization,P
6557,26156,6412,translation,P
6558,26156,30686,90S preribosome,C
6559,26156,22625,cytosolic large ribosomal subunit,C
6560,26156,16020,membrane,C
6561,26156,5730,nucleolus,C
6562,861,5524,ATP binding,F
6563,861,977,RNA polymerase II regulatory region sequence-specific DNA binding,F
6564,861,977,RNA polymerase II regulatory region sequence-specific DNA binding,F
6565,861,1047,core promoter binding,F
6566,861,5515,protein binding,F
6567,861,975,regulatory region DNA binding,F
6568,861,1228,"transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding",F
6569,861,1228,"transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding",F
6570,861,2062,chondrocyte differentiation,P
6571,861,71425,hematopoietic stem cell proliferation,P
6572,861,30097,hemopoiesis,P
6573,861,1503,ossification,P
6574,861,48935,peripheral nervous system neuron development,P
6575,861,45766,positive regulation of angiogenesis,P
6576,861,30854,positive regulation of granulocyte differentiation,P
6577,861,32743,positive regulation of interleukin-2 production,P
6578,861,45944,positive regulation of transcription from RNA polymerase II promoter,P
6579,861,45944,positive regulation of transcription from RNA polymerase II promoter,P
6580,861,45893,"positive regulation of transcription, DNA-templated",P
6581,861,6366,transcription from RNA polymerase II promoter,P
6582,861,5829,cytosol,C
6583,861,43231,intracellular membrane-bounded organelle,C
6584,861,5654,nucleoplasm,C
6585,861,5634,nucleus,C
6586,10856,43531,ADP binding,F
6587,10856,5524,ATP binding,F
6588,10856,43141,ATP-dependent 5'-3' DNA helicase activity,F
6589,10856,4003,ATP-dependent DNA helicase activity,F
6590,10856,16887,ATPase activity,F
6591,10856,51117,ATPase binding,F
6592,10856,3678,DNA helicase activity,F
6593,10856,979,RNA polymerase II core promoter sequence-specific DNA binding,F
6594,10856,980,RNA polymerase II distal enhancer sequence-specific DNA binding,F
6595,10856,1094,TFIID-class transcription factor binding,F
6596,10856,31490,chromatin DNA binding,F
6597,10856,42802,identical protein binding,F
6598,10856,42802,identical protein binding,F
6599,10856,5515,protein binding,F
6600,10856,42803,protein homodimerization activity,F
6601,10856,51082,unfolded protein binding,F
6602,10856,32508,DNA duplex unwinding,P
6603,10856,6310,DNA recombination,P
6604,10856,6281,DNA repair,P
6605,10856,34644,cellular response to UV,P
6606,10856,71392,cellular response to estradiol stimulus,P
6607,10856,6338,chromatin remodeling,P
6608,10856,71169,establishment of protein localization to chromatin,P
6609,10856,43968,histone H2A acetylation,P
6610,10856,43967,histone H4 acetylation,P
6611,10856,71899,negative regulation of estrogen receptor binding,P
6612,10856,35066,positive regulation of histone acetylation,P
6613,10856,1904874,positive regulation of telomerase RNA localization to Cajal body,P
6614,10856,45944,positive regulation of transcription from RNA polymerase II promoter,P
6615,10856,6457,protein folding,P
6616,10856,40008,regulation of growth,P
6617,10856,6351,"transcription, DNA-templated",P
6618,10856,71733,transcriptional activation by promoter-enhancer looping,P
6619,10856,31011,Ino80 complex,C
6620,10856,71339,MLL1 complex,C
6621,10856,35267,NuA4 histone acetyltransferase complex,C
6622,10856,97255,R2TP complex,C
6623,10856,812,Swr1 complex,C
6624,10856,5813,centrosome,C
6625,10856,5829,cytosol,C
6626,10856,70062,extracellular exosome,C
6627,10856,5622,intracellular,C
6628,10856,30529,intracellular ribonucleoprotein complex,C
6629,10856,16020,membrane,C
6630,10856,5719,nuclear euchromatin,C
6631,10856,16363,nuclear matrix,C
6632,10856,5654,nucleoplasm,C
6633,10856,5654,nucleoplasm,C
6634,10856,5634,nucleus,C
6635,29843,70139,SUMO-specific endopeptidase activity,F
6636,29843,16929,SUMO-specific protease activity,F
6637,29843,16929,SUMO-specific protease activity,F
6638,29843,4175,endopeptidase activity,F
6639,29843,5515,protein binding,F
6640,29843,6919,activation of cysteine-type endopeptidase activity involved in apoptotic process,P
6641,29843,97190,apoptotic signaling pathway,P
6642,29843,32435,negative regulation of proteasomal ubiquitin-dependent protein catabolic process,P
6643,29843,45944,positive regulation of transcription from RNA polymerase II promoter,P
6644,29843,16926,protein desumoylation,P
6645,29843,16925,protein sumoylation,P
6646,29843,6508,proteolysis,P
6647,29843,10724,regulation of definitive erythrocyte differentiation,P
6648,29843,5737,cytoplasm,C
6649,29843,5925,focal adhesion,C
6650,29843,31965,nuclear membrane,C
6651,29843,5654,nucleoplasm,C
6652,29843,5634,nucleus,C
6653,29843,5634,nucleus,C
6654,59343,70139,SUMO-specific endopeptidase activity,F
6655,59343,16929,SUMO-specific protease activity,F
6656,59343,4175,endopeptidase activity,F
6657,59343,5515,protein binding,F
6658,59343,19904,protein domain specific binding,F
6659,59343,16055,Wnt signaling pathway,P
6660,59343,9950,dorsal/ventral axis specification,P
6661,59343,45444,fat cell differentiation,P
6662,59343,7507,heart development,P
6663,59343,60711,labyrinthine layer development,P
6664,59343,51028,mRNA transport,P
6665,59343,43518,"negative regulation of DNA damage response, signal transduction by p53 class mediator",P
6666,59343,35562,negative regulation of chromatin binding,P
6667,59343,32091,negative regulation of protein binding,P
6668,59343,31397,negative regulation of protein ubiquitination,P
6669,59343,1934,positive regulation of protein phosphorylation,P
6670,59343,31398,positive regulation of protein ubiquitination,P
6671,59343,45944,positive regulation of transcription from RNA polymerase II promoter,P
6672,59343,31648,protein destabilization,P
6673,59343,16926,protein desumoylation,P
6674,59343,16926,protein desumoylation,P
6675,59343,16925,protein sumoylation,P
6676,59343,15031,protein transport,P
6677,59343,32875,regulation of DNA endoreduplication,P
6678,59343,2000045,regulation of G1/S transition of mitotic cell cycle,P
6679,59343,30111,regulation of Wnt signaling pathway,P
6680,59343,60712,spongiotrophoblast layer development,P
6681,59343,60707,trophoblast giant cell differentiation,P
6682,59343,16605,PML body,C
6683,59343,31410,cytoplasmic vesicle,C
6684,59343,5829,cytosol,C
6685,59343,31965,nuclear membrane,C
6686,59343,5643,nuclear pore,C
6687,59343,5654,nucleoplasm,C
6688,57337,4930,G-protein coupled receptor activity,F
6689,57337,8234,cysteine-type peptidase activity,F
6690,57337,5515,protein binding,F
6691,57337,7188,adenylate cyclase-modulating G-protein coupled receptor signaling pathway,P
6692,57337,6508,proteolysis,P
6693,57337,5622,intracellular,C
6694,57337,5634,nucleus,C
6695,57337,5886,plasma membrane,C
6696,5054,2020,protease binding,F
6697,5054,5515,protein binding,F
6698,5054,5102,receptor binding,F
6699,5054,4867,serine-type endopeptidase inhibitor activity,F
6700,5054,4867,serine-type endopeptidase inhibitor activity,F
6701,5054,1525,angiogenesis,P
6702,5054,71222,cellular response to lipopolysaccharide,P
6703,5054,1300,chronological cell aging,P
6704,5054,7623,circadian rhythm,P
6705,5054,50829,defense response to Gram-negative bacterium,P
6706,5054,30198,extracellular matrix organization,P
6707,5054,42730,fibrinolysis,P
6708,5054,30195,negative regulation of blood coagulation,P
6709,5054,33629,negative regulation of cell adhesion mediated by integrin,P
6710,5054,30336,negative regulation of cell migration,P
6711,5054,10951,negative regulation of endopeptidase activity,P
6712,5054,2000352,negative regulation of endothelial cell apoptotic process,P
6713,5054,1902042,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,P
6714,5054,51918,negative regulation of fibrinolysis,P
6715,5054,10757,negative regulation of plasminogen activation,P
6716,5054,10757,negative regulation of plasminogen activation,P
6717,5054,14912,negative regulation of smooth muscle cell migration,P
6718,5054,2000098,negative regulation of smooth muscle cell-matrix adhesion,P
6719,5054,61044,negative regulation of vascular wound healing,P
6720,5054,61045,negative regulation of wound healing,P
6721,5054,2576,platelet degranulation,P
6722,5054,45766,positive regulation of angiogenesis,P
6723,5054,30194,positive regulation of blood coagulation,P
6724,5054,50729,positive regulation of inflammatory response,P
6725,5054,32757,positive regulation of interleukin-8 production,P
6726,5054,35491,positive regulation of leukotriene production involved in inflammatory response,P
6727,5054,90026,positive regulation of monocyte chemotaxis,P
6728,5054,48260,positive regulation of receptor-mediated endocytosis,P
6729,5054,45944,positive regulation of transcription from RNA polymerase II promoter,P
6730,5054,10469,regulation of receptor activity,P
6731,5054,70062,extracellular exosome,C
6732,5054,31012,extracellular matrix,C
6733,5054,5576,extracellular region,C
6734,5054,5576,extracellular region,C
6735,5054,5615,extracellular space,C
6736,5054,5886,plasma membrane,C
6737,5054,31093,platelet alpha granule lumen,C
6738,2810,45296,cadherin binding,F
6739,2810,42802,identical protein binding,F
6740,2810,51219,phosphoprotein binding,F
6741,2810,5515,protein binding,F
6742,2810,19904,protein domain specific binding,F
6743,2810,8426,protein kinase C inhibitor activity,F
6744,2810,19901,protein kinase binding,F
6745,2810,6977,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest",P
6746,2810,61436,establishment of skin barrier,P
6747,2810,8630,intrinsic apoptotic signaling pathway in response to DNA damage,P
6748,2810,31424,keratinization,P
6749,2810,3334,keratinocyte development,P
6750,2810,61024,membrane organization,P
6751,2810,43154,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,P
6752,2810,10839,negative regulation of keratinocyte proliferation,P
6753,2810,6469,negative regulation of protein kinase activity,P
6754,2810,71901,negative regulation of protein serine/threonine kinase activity,P
6755,2810,30307,positive regulation of cell growth,P
6756,2810,45606,positive regulation of epidermal cell differentiation,P
6757,2810,46827,positive regulation of protein export from nucleus,P
6758,2810,1900740,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,P
6759,2810,79,regulation of cyclin-dependent protein serine/threonine kinase activity,P
6760,2810,10482,regulation of epidermal cell division,P
6761,2810,1836,release of cytochrome c from mitochondria,P
6762,2810,7165,signal transduction,P
6763,2810,30659,cytoplasmic vesicle membrane,C
6764,2810,5829,cytosol,C
6765,2810,5829,cytosol,C
6766,2810,70062,extracellular exosome,C
6767,2810,5615,extracellular space,C
6768,2810,5739,mitochondrion,C
6769,2810,5634,nucleus,C
6770,150094,71889,14-3-3 protein binding,F
6771,150094,5524,ATP binding,F
6772,150094,5524,ATP binding,F
6773,150094,8140,cAMP response element binding protein binding,F
6774,150094,287,magnesium ion binding,F
6775,150094,287,magnesium ion binding,F
6776,150094,5515,protein binding,F
6777,150094,19901,protein kinase binding,F
6778,150094,4674,protein serine/threonine kinase activity,F
6779,150094,55007,cardiac muscle cell differentiation,P
6780,150094,7049,cell cycle,P
6781,150094,32870,cellular response to hormone stimulus,P
6782,150094,43153,entrainment of circadian clock by photoperiod,P
6783,150094,35556,intracellular signal transduction,P
6784,150094,35556,intracellular signal transduction,P
6785,150094,32792,negative regulation of CREB transcription factor activity,P
6786,150094,45721,negative regulation of gluconeogenesis,P
6787,150094,10868,negative regulation of triglyceride biosynthetic process,P
6788,150094,2000210,positive regulation of anoikis,P
6789,150094,46777,protein autophosphorylation,P
6790,150094,6468,protein phosphorylation,P
6791,150094,6468,protein phosphorylation,P
6792,150094,45595,regulation of cell differentiation,P
6793,150094,7346,regulation of mitotic cell cycle,P
6794,150094,10830,regulation of myotube differentiation,P
6795,150094,2028,regulation of sodium ion transport,P
6796,150094,48511,rhythmic process,P
6797,150094,5737,cytoplasm,C
6798,150094,5737,cytoplasm,C
6799,150094,5634,nucleus,C
6800,6446,5524,ATP binding,F
6801,6446,5246,calcium channel regulator activity,F
6802,6446,17081,chloride channel regulator activity,F
6803,6446,15459,potassium channel regulator activity,F
6804,6446,5515,protein binding,F
6805,6446,4674,protein serine/threonine kinase activity,F
6806,6446,4674,protein serine/threonine kinase activity,F
6807,6446,4712,protein serine/threonine/tyrosine kinase activity,F
6808,6446,17080,sodium channel regulator activity,F
6809,6446,6915,apoptotic process,P
6810,6446,6974,cellular response to DNA damage stimulus,P
6811,6446,35556,intracellular signal transduction,P
6812,6446,34220,ion transmembrane transport,P
6813,6446,7616,long-term memory,P
6814,6446,48812,neuron projection morphogenesis,P
6815,6446,18105,peptidyl-serine phosphorylation,P
6816,6446,32411,positive regulation of transporter activity,P
6817,6446,6468,protein phosphorylation,P
6818,6446,42981,regulation of apoptotic process,P
6819,6446,8217,regulation of blood pressure,P
6820,6446,50790,regulation of catalytic activity,P
6821,6446,1558,regulation of cell growth,P
6822,6446,30334,regulation of cell migration,P
6823,6446,42127,regulation of cell proliferation,P
6824,6446,60453,regulation of gastric acid secretion,P
6825,6446,51090,regulation of sequence-specific DNA binding transcription factor activity,P
6826,6446,70294,renal sodium ion absorption,P
6827,6446,6950,response to stress,P
6828,6446,6814,sodium ion transport,P
6829,6446,5737,cytoplasm,C
6830,6446,5829,cytosol,C
6831,6446,5829,cytosol,C
6832,6446,5789,endoplasmic reticulum membrane,C
6833,6446,5739,mitochondrion,C
6834,6446,16607,nuclear speck,C
6835,6446,5634,nucleus,C
6836,6446,5886,plasma membrane,C
6837,23309,1106,RNA polymerase II transcription corepressor activity,F
6838,23309,3682,chromatin binding,F
6839,23309,4407,histone deacetylase activity,F
6840,23309,5515,protein binding,F
6841,23309,44255,cellular lipid metabolic process,P
6842,23309,16575,histone deacetylation,P
6843,23309,122,negative regulation of transcription from RNA polymerase II promoter,P
6844,23309,6351,"transcription, DNA-templated",P
6845,23309,16580,Sin3 complex,C
6846,23309,805,X chromosome,C
6847,23309,1741,XY body,C
6848,23309,806,Y chromosome,C
6849,23309,30849,autosome,C
6850,23309,5737,cytoplasm,C
6851,23309,5654,nucleoplasm,C
6852,23309,5634,nucleus,C
6853,23411,43398,HLH domain binding,F
6854,23411,3950,NAD+ ADP-ribosyltransferase activity,F
6855,23411,70403,NAD+ binding,F
6856,23411,17136,NAD-dependent histone deacetylase activity,F
6857,23411,46969,NAD-dependent histone deacetylase activity (H3-K9 specific),F
6858,23411,34979,NAD-dependent protein deacetylase activity,F
6859,23411,34979,NAD-dependent protein deacetylase activity,F
6860,23411,34979,NAD-dependent protein deacetylase activity,F
6861,23411,43425,bHLH transcription factor binding,F
6862,23411,1046,core promoter sequence-specific DNA binding,F
6863,23411,19213,deacetylase activity,F
6864,23411,19899,enzyme binding,F
6865,23411,42393,histone binding,F
6866,23411,4407,histone deacetylase activity,F
6867,23411,4407,histone deacetylase activity,F
6868,23411,42802,identical protein binding,F
6869,23411,1990254,keratin filament binding,F
6870,23411,46872,metal ion binding,F
6871,23411,51019,mitogen-activated protein kinase binding,F
6872,23411,35257,nuclear hormone receptor binding,F
6873,23411,2039,p53 binding,F
6874,23411,8022,protein C-terminus binding,F
6875,23411,5515,protein binding,F
6876,23411,33558,protein deacetylase activity,F
6877,23411,33558,protein deacetylase activity,F
6878,23411,3714,transcription corepressor activity,F
6879,23411,3714,transcription corepressor activity,F
6880,23411,8134,transcription factor binding,F
6881,23411,1077,"transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding",F
6882,23411,6281,DNA repair,P
6883,23411,6260,DNA replication,P
6884,23411,731,DNA synthesis involved in DNA repair,P
6885,23411,70914,UV-damage excision repair,P
6886,23411,1525,angiogenesis,P
6887,23411,42595,behavioral response to starvation,P
6888,23411,7569,cell aging,P
6889,23411,1678,cellular glucose homeostasis,P
6890,23411,6974,cellular response to DNA damage stimulus,P
6891,23411,70301,cellular response to hydrogen peroxide,P
6892,23411,71456,cellular response to hypoxia,P
6893,23411,71479,cellular response to ionizing radiation,P
6894,23411,9267,cellular response to starvation,P
6895,23411,71356,cellular response to tumor necrosis factor,P
6896,23411,35356,cellular triglyceride homeostasis,P
6897,23411,42632,cholesterol homeostasis,P
6898,23411,6325,chromatin organization,P
6899,23411,6342,chromatin silencing,P
6900,23411,183,chromatin silencing at rDNA,P
6901,23411,183,chromatin silencing at rDNA,P
6902,23411,32922,circadian regulation of gene expression,P
6903,23411,32922,circadian regulation of gene expression,P
6904,23411,6343,establishment of chromatin silencing,P
6905,23411,55089,fatty acid homeostasis,P
6906,23411,70932,histone H3 deacetylation,P
6907,23411,70932,histone H3 deacetylation,P
6908,23411,1990619,histone H3-K9 deacetylation,P
6909,23411,61647,histone H3-K9 modification,P
6910,23411,16575,histone deacetylation,P
6911,23411,42771,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,P
6912,23411,33210,leptin-mediated signaling pathway,P
6913,23411,10934,macrophage cytokine production,P
6914,23411,30225,macrophage differentiation,P
6915,23411,6344,maintenance of chromatin silencing,P
6916,23411,6346,methylation-dependent chromatin silencing,P
6917,23411,7517,muscle organ development,P
6918,23411,43518,"negative regulation of DNA damage response, signal transduction by p53 class mediator",P
6919,23411,43124,negative regulation of I-kappaB kinase/NF-kappaB signaling,P
6920,23411,32088,negative regulation of NF-kappaB transcription factor activity,P
6921,23411,32007,negative regulation of TOR signaling,P
6922,23411,60766,negative regulation of androgen receptor signaling pathway,P
6923,23411,43066,negative regulation of apoptotic process,P
6924,23411,2000480,negative regulation of cAMP-dependent protein kinase activity,P
6925,23411,30308,negative regulation of cell growth,P
6926,23411,2000655,negative regulation of cellular response to testosterone stimulus,P
6927,23411,2000773,negative regulation of cellular senescence,P
6928,23411,45599,negative regulation of fat cell differentiation,P
6929,23411,10629,negative regulation of gene expression,P
6930,23411,51097,negative regulation of helicase activity,P
6931,23411,71441,negative regulation of histone H3-K14 acetylation,P
6932,23411,1900113,negative regulation of histone H3-K9 trimethylation,P
6933,23411,2000619,negative regulation of histone H4-K16 acetylation,P
6934,23411,1902166,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,P
6935,23411,1901215,negative regulation of neuron death,P
6936,23411,1902176,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,P
6937,23411,2000757,negative regulation of peptidyl-lysine acetylation,P
6938,23411,42326,negative regulation of phosphorylation,P
6939,23411,31393,negative regulation of prostaglandin biosynthetic process,P
6940,23411,1901984,negative regulation of protein acetylation,P
6941,23411,51898,negative regulation of protein kinase B signaling,P
6942,23411,43433,negative regulation of sequence-specific DNA binding transcription factor activity,P
6943,23411,43433,negative regulation of sequence-specific DNA binding transcription factor activity,P
6944,23411,122,negative regulation of transcription from RNA polymerase II promoter,P
6945,23411,122,negative regulation of transcription from RNA polymerase II promoter,P
6946,23411,45892,"negative regulation of transcription, DNA-templated",P
6947,23411,30512,negative regulation of transforming growth factor beta receptor signaling pathway,P
6948,23411,1542,ovulation from ovarian follicle,P
6949,23411,18394,peptidyl-lysine acetylation,P
6950,23411,34983,peptidyl-lysine deacetylation,P
6951,23411,45739,positive regulation of DNA repair,P
6952,23411,45348,positive regulation of MHC class II biosynthetic process,P
6953,23411,2821,positive regulation of adaptive immune response,P
6954,23411,1904179,positive regulation of adipose tissue development,P
6955,23411,45766,positive regulation of angiogenesis,P
6956,23411,43065,positive regulation of apoptotic process,P
6957,23411,43065,positive regulation of apoptotic process,P
6958,23411,2000481,positive regulation of cAMP-dependent protein kinase activity,P
6959,23411,8284,positive regulation of cell proliferation,P
6960,23411,2000774,positive regulation of cellular senescence,P
6961,23411,10875,positive regulation of cholesterol efflux,P
6962,23411,31937,positive regulation of chromatin silencing,P
6963,23411,43280,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,P
6964,23411,1902237,positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,P
6965,23411,1938,positive regulation of endothelial cell proliferation,P
6966,23411,51574,positive regulation of histone H3-K9 methylation,P
6967,23411,46628,positive regulation of insulin receptor signaling pathway,P
6968,23411,16239,positive regulation of macroautophagy,P
6969,23411,2000111,positive regulation of macrophage apoptotic process,P
6970,23411,14068,positive regulation of phosphatidylinositol 3-kinase signaling,P
6971,23411,1934,positive regulation of protein phosphorylation,P
6972,23411,51152,positive regulation of smooth muscle cell differentiation,P
6973,23411,45944,positive regulation of transcription from RNA polymerase II promoter,P
6974,23411,43161,proteasome-mediated ubiquitin-dependent protein catabolic process,P
6975,23411,6471,protein ADP-ribosylation,P
6976,23411,6476,protein deacetylation,P
6977,23411,6476,protein deacetylation,P
6978,23411,31648,protein destabilization,P
6979,23411,31648,protein destabilization,P
6980,23411,16567,protein ubiquitination,P
6981,23411,16567,protein ubiquitination,P
6982,23411,720,pyrimidine dimer repair by nucleotide-excision repair,P
6983,23411,6364,rRNA processing,P
6984,23411,70857,regulation of bile acid biosynthetic process,P
6985,23411,90335,regulation of brown fat cell differentiation,P
6986,23411,42127,regulation of cell proliferation,P
6987,23411,1900034,regulation of cellular response to heat,P
6988,23411,32071,regulation of endodeoxyribonuclease activity,P
6989,23411,10906,regulation of glucose metabolic process,P
6990,23411,10883,regulation of lipid storage,P
6991,23411,7346,regulation of mitotic cell cycle,P
6992,23411,35358,regulation of peroxisome proliferator activated receptor signaling pathway,P
6993,23411,33158,"regulation of protein import into nucleus, translocation",P
6994,23411,71900,regulation of protein serine/threonine kinase activity,P
6995,23411,34391,regulation of smooth muscle cell apoptotic process,P
6996,23411,42542,response to hydrogen peroxide,P
6997,23411,32868,response to insulin,P
6998,23411,44321,response to leptin,P
6999,23411,6979,response to oxidative stress,P
7000,23411,12,single strand break repair,P
7001,23411,7283,spermatogenesis,P
7002,23411,90400,stress-induced premature senescence,P
7003,23411,6366,transcription from RNA polymerase II promoter,P
7004,23411,6642,triglyceride mobilization,P
7005,23411,16032,viral process,P
7006,23411,50872,white fat cell differentiation,P
7007,23411,35098,ESC/E(Z) complex,C
7008,23411,16605,PML body,C
7009,23411,5677,chromatin silencing complex,C
7010,23411,5737,cytoplasm,C
7011,23411,5737,cytoplasm,C
7012,23411,5829,cytosol,C
7013,23411,5739,mitochondrion,C
7014,23411,790,nuclear chromatin,C
7015,23411,5635,nuclear envelope,C
7016,23411,5719,nuclear euchromatin,C
7017,23411,5720,nuclear heterochromatin,C
7018,23411,5637,nuclear inner membrane,C
7019,23411,5730,nucleolus,C
7020,23411,5730,nucleolus,C
7021,23411,5654,nucleoplasm,C
7022,23411,5654,nucleoplasm,C
7023,23411,5634,nucleus,C
7024,23411,33553,rDNA heterochromatin,C
7025,51548,3956,NAD(P)+-protein-arginine ADP-ribosyltransferase activity,F
7026,51548,3950,NAD+ ADP-ribosyltransferase activity,F
7027,51548,70403,NAD+ binding,F
7028,51548,17136,NAD-dependent histone deacetylase activity,F
7029,51548,46969,NAD-dependent histone deacetylase activity (H3-K9 specific),F
7030,51548,34979,NAD-dependent protein deacetylase activity,F
7031,51548,3682,chromatin binding,F
7032,51548,5515,protein binding,F
7033,51548,3714,transcription corepressor activity,F
7034,51548,8270,zinc ion binding,F
7035,51548,6284,base-excision repair,P
7036,51548,42593,glucose homeostasis,P
7037,51548,1990619,histone H3-K9 deacetylation,P
7038,51548,61647,histone H3-K9 modification,P
7039,51548,8285,negative regulation of cell proliferation,P
7040,51548,46325,negative regulation of glucose import,P
7041,51548,45820,negative regulation of glycolytic process,P
7042,51548,45892,"negative regulation of transcription, DNA-templated",P
7043,51548,1905555,positive regulation blood vessel branching,P
7044,51548,1902732,positive regulation of chondrocyte proliferation,P
7045,51548,31940,positive regulation of chromatin silencing at telomere,P
7046,51548,48146,positive regulation of fibroblast proliferation,P
7047,51548,2000648,positive regulation of stem cell proliferation,P
7048,51548,32206,positive regulation of telomere maintenance,P
7049,51548,1905549,positive regulation of telomeric heterochromatin assembly,P
7050,51548,1905564,positive regulation of vascular endothelial cell proliferation,P
7051,51548,3247,post-embryonic cardiac muscle cell growth involved in heart morphogenesis,P
7052,51548,6471,protein ADP-ribosylation,P
7053,51548,6471,protein ADP-ribosylation,P
7054,51548,31648,protein destabilization,P
7055,51548,10569,regulation of double-strand break repair via homologous recombination,P
7056,51548,31667,response to nutrient levels,P
7057,51548,5737,cytoplasm,C
7058,51548,5724,nuclear telomeric heterochromatin,C
7059,51548,5730,nucleolus,C
7060,51548,5654,nucleoplasm,C
7061,51548,5654,nucleoplasm,C
7062,51548,5634,nucleus,C
7063,51548,5634,nucleus,C
7064,6495,3677,DNA binding,F
7065,6495,978,RNA polymerase II core promoter proximal region sequence-specific DNA binding,F
7066,6495,978,RNA polymerase II core promoter proximal region sequence-specific DNA binding,F
7067,6495,3682,chromatin binding,F
7068,6495,5515,protein binding,F
7069,6495,43565,sequence-specific DNA binding,F
7070,6495,1223,transcription coactivator binding,F
7071,6495,3700,"transcription factor activity, sequence-specific DNA binding",F
7072,6495,3700,"transcription factor activity, sequence-specific DNA binding",F
7073,6495,44212,transcription regulatory region DNA binding,F
7074,6495,1077,"transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding",F
7075,6495,1077,"transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding",F
7076,6495,35909,aorta morphogenesis,P
7077,6495,6915,apoptotic process,P
7078,6495,1658,branching involved in ureteric bud morphogenesis,P
7079,6495,8283,cell proliferation,P
7080,6495,1905243,"cellular response to 3,3',5-triiodo-L-thyronine",P
7081,6495,90103,cochlea morphogenesis,P
7082,6495,48701,embryonic cranial skeleton morphogenesis,P
7083,6495,48704,embryonic skeletal system morphogenesis,P
7084,6495,30855,epithelial cell differentiation,P
7085,6495,21610,facial nerve morphogenesis,P
7086,6495,61197,fungiform papilla morphogenesis,P
7087,6495,48699,generation of neurons,P
7088,6495,48839,inner ear development,P
7089,6495,42472,inner ear morphogenesis,P
7090,6495,1822,kidney development,P
7091,6495,72172,mesonephric tubule formation,P
7092,6495,72075,metanephric mesenchyme development,P
7093,6495,42474,middle ear morphogenesis,P
7094,6495,51451,myoblast migration,P
7095,6495,61055,myotome development,P
7096,6495,90191,negative regulation of branching involved in ureteric bud morphogenesis,P
7097,6495,43524,negative regulation of neuron apoptotic process,P
7098,6495,122,negative regulation of transcription from RNA polymerase II promoter,P
7099,6495,48665,neuron fate specification,P
7100,6495,30910,olfactory placode formation,P
7101,6495,1759,organ induction,P
7102,6495,71599,otic vesicle development,P
7103,6495,3151,outflow tract morphogenesis,P
7104,6495,7389,pattern specification process,P
7105,6495,60037,pharyngeal system development,P
7106,6495,90190,positive regulation of branching involved in ureteric bud morphogenesis,P
7107,6495,2000729,positive regulation of mesenchymal cell proliferation involved in ureter development,P
7108,6495,72513,positive regulation of secondary heart field cardioblast proliferation,P
7109,6495,45944,positive regulation of transcription from RNA polymerase II promoter,P
7110,6495,45944,positive regulation of transcription from RNA polymerase II promoter,P
7111,6495,45893,"positive regulation of transcription, DNA-templated",P
7112,6495,72107,positive regulation of ureteric bud formation,P
7113,6495,34504,protein localization to nucleus,P
7114,6495,72095,regulation of branch elongation involved in ureteric bud branching,P
7115,6495,50678,regulation of epithelial cell proliferation,P
7116,6495,45664,regulation of neuron differentiation,P
7117,6495,32880,regulation of protein localization,P
7118,6495,2001014,regulation of skeletal muscle cell differentiation,P
7119,6495,14842,regulation of skeletal muscle satellite cell proliferation,P
7120,6495,8582,regulation of synaptic growth at neuromuscular junction,P
7121,6495,6355,"regulation of transcription, DNA-templated",P
7122,6495,7605,sensory perception of sound,P
7123,6495,7519,skeletal muscle tissue development,P
7124,6495,48538,thymus development,P
7125,6495,30878,thyroid gland development,P
7126,6495,6366,transcription from RNA polymerase II promoter,P
7127,6495,61551,trigeminal ganglion development,P
7128,6495,72193,ureter smooth muscle cell differentiation,P
7129,6495,1657,ureteric bud development,P
7130,6495,5737,cytoplasm,C
7131,6495,5730,nucleolus,C
7132,6495,5634,nucleus,C
7133,6495,5667,transcription factor complex,C
7134,64849,15137,citrate transmembrane transporter activity,F
7135,64849,15362,high-affinity sodium:dicarboxylate symporter activity,F
7136,64849,17153,sodium:dicarboxylate symporter activity,F
7137,64849,15141,succinate transmembrane transporter activity,F
7138,64849,15746,citrate transport,P
7139,64849,6814,sodium ion transport,P
7140,64849,71422,succinate transmembrane transport,P
7141,64849,70062,extracellular exosome,C
7142,64849,5887,integral component of plasma membrane,C
7143,64849,5886,plasma membrane,C
7144,9194,15129,lactate transmembrane transporter activity,F
7145,9194,8028,monocarboxylic acid transmembrane transporter activity,F
7146,9194,5477,pyruvate secondary active transmembrane transporter activity,F
7147,9194,50833,pyruvate transmembrane transporter activity,F
7148,9194,15293,symporter activity,F
7149,9194,35873,lactate transmembrane transport,P
7150,9194,1901475,pyruvate transmembrane transport,P
7151,9194,5887,integral component of plasma membrane,C
7152,9194,5886,plasma membrane,C
7153,6597,5524,ATP binding,F
7154,6597,70182,DNA polymerase binding,F
7155,6597,8094,DNA-dependent ATPase activity,F
7156,6597,1164,RNA polymerase I CORE element sequence-specific DNA binding,F
7157,6597,978,RNA polymerase II core promoter proximal region sequence-specific DNA binding,F
7158,6597,980,RNA polymerase II distal enhancer sequence-specific DNA binding,F
7159,6597,1105,RNA polymerase II transcription coactivator activity,F
7160,6597,30957,Tat protein binding,F
7161,6597,50681,androgen receptor binding,F
7162,6597,4386,helicase activity,F
7163,6597,70577,lysine-acetylated histone binding,F
7164,6597,31492,nucleosomal DNA binding,F
7165,6597,2039,p53 binding,F
7166,6597,47485,protein N-terminus binding,F
7167,6597,5515,protein binding,F
7168,6597,3713,transcription coactivator activity,F
7169,6597,3713,transcription coactivator activity,F
7170,6597,3714,transcription corepressor activity,F
7171,6597,8134,transcription factor binding,F
7172,6597,43044,ATP-dependent chromatin remodeling,P
7173,6597,1904837,beta-catenin-TCF complex assembly,P
7174,6597,6325,chromatin organization,P
7175,6597,6338,chromatin remodeling,P
7176,6597,6338,chromatin remodeling,P
7177,6597,6338,chromatin remodeling,P
7178,6597,16569,covalent chromatin modification,P
7179,6597,2000134,negative regulation of G1/S transition of mitotic cell cycle,P
7180,6597,60766,negative regulation of androgen receptor signaling pathway,P
7181,6597,30308,negative regulation of cell growth,P
7182,6597,122,negative regulation of transcription from RNA polymerase II promoter,P
7183,6597,7070,negative regulation of transcription from RNA polymerase II promoter during mitotic cell cycle,P
7184,6597,45892,"negative regulation of transcription, DNA-templated",P
7185,6597,45892,"negative regulation of transcription, DNA-templated",P
7186,6597,7399,nervous system development,P
7187,6597,3407,neural retina development,P
7188,6597,6337,nucleosome disassembly,P
7189,6597,43923,positive regulation by host of viral transcription,P
7190,6597,30177,positive regulation of Wnt signaling pathway,P
7191,6597,1902661,positive regulation of glucose mediated signaling pathway,P
7192,6597,1902895,positive regulation of pri-miRNA transcription from RNA polymerase II promoter,P
7193,6597,51091,positive regulation of sequence-specific DNA binding transcription factor activity,P
7194,6597,45944,positive regulation of transcription from RNA polymerase II promoter,P
7195,6597,45944,positive regulation of transcription from RNA polymerase II promoter,P
7196,6597,1901838,positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter,P
7197,6597,45893,"positive regulation of transcription, DNA-templated",P
7198,6597,6357,regulation of transcription from RNA polymerase II promoter,P
7199,6597,6351,"transcription, DNA-templated",P
7200,6597,16514,SWI/SNF complex,C
7201,6597,5615,extracellular space,C
7202,6597,16020,membrane,C
7203,6597,71565,nBAF complex,C
7204,6597,71564,npBAF complex,C
7205,6597,71564,npBAF complex,C
7206,6597,790,nuclear chromatin,C
7207,6597,5730,nucleolus,C
7208,6597,5654,nucleoplasm,C
7209,6597,5634,nucleus,C
7210,6597,43234,protein complex,C
7211,23049,5524,ATP binding,F
7212,23049,3723,RNA binding,F
7213,23049,46872,metal ion binding,F
7214,23049,5515,protein binding,F
7215,23049,4672,protein kinase activity,F
7216,23049,4674,protein serine/threonine kinase activity,F
7217,23049,4674,protein serine/threonine kinase activity,F
7218,23049,4674,protein serine/threonine kinase activity,F
7219,23049,42162,telomeric DNA binding,F
7220,23049,6281,DNA repair,P
7221,23049,6406,mRNA export from nucleus,P
7222,23049,184,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay",P
7223,23049,184,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay",P
7224,6598,3677,DNA binding,F
7225,23049,184,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay",P
7226,6598,1164,RNA polymerase I CORE element sequence-specific DNA binding,F
7227,23049,18105,peptidyl-serine phosphorylation,P
7228,6598,978,RNA polymerase II core promoter proximal region sequence-specific DNA binding,F
7229,6598,980,RNA polymerase II distal enhancer sequence-specific DNA binding,F
7230,23049,18105,peptidyl-serine phosphorylation,P
7231,6598,30957,Tat protein binding,F
7232,23049,46854,phosphatidylinositol phosphorylation,P
7233,6598,31492,nucleosomal DNA binding,F
7234,23049,46777,protein autophosphorylation,P
7235,6598,2039,p53 binding,F
7236,6598,5515,protein binding,F
7237,23049,32204,regulation of telomere maintenance,P
7238,6598,3713,transcription coactivator activity,F
7239,23049,6950,response to stress,P
7240,6598,3713,transcription coactivator activity,F
7241,23049,5737,cytoplasm,C
7242,6598,43044,ATP-dependent chromatin remodeling,P
7243,23049,5829,cytosol,C
7244,6598,15074,DNA integration,P
7245,6598,6281,DNA repair,P
7246,23049,5654,nucleoplasm,C
7247,6598,7049,cell cycle,P
7248,23049,5634,nucleus,C
7249,6598,30154,cell differentiation,P
7250,6598,6338,chromatin remodeling,P
7251,6598,6338,chromatin remodeling,P
7252,6598,16569,covalent chromatin modification,P
7253,6598,8285,negative regulation of cell proliferation,P
7254,6598,1900110,negative regulation of histone H3-K9 dimethylation,P
7255,6598,1900113,negative regulation of histone H3-K9 trimethylation,P
7256,6598,7399,nervous system development,P
7257,6598,6337,nucleosome disassembly,P
7258,6598,43923,positive regulation by host of viral transcription,P
7259,6598,1902661,positive regulation of glucose mediated signaling pathway,P
7260,6598,2000617,positive regulation of histone H3-K9 acetylation,P
7261,6598,90240,positive regulation of histone H4 acetylation,P
7262,6598,51091,positive regulation of sequence-specific DNA binding transcription factor activity,P
7263,6598,45944,positive regulation of transcription from RNA polymerase II promoter,P
7264,6598,1901838,positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter,P
7265,6598,1901838,positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter,P
7266,6598,2000618,regulation of histone H4-K16 acetylation,P
7267,6598,6357,regulation of transcription from RNA polymerase II promoter,P
7268,6598,39692,single stranded viral RNA replication via double stranded DNA intermediate,P
7269,6598,6351,"transcription, DNA-templated",P
7270,6598,16514,SWI/SNF complex,C
7271,6598,1650,fibrillar center,C
7272,6598,43231,intracellular membrane-bounded organelle,C
7273,6598,71565,nBAF complex,C
7274,6598,71564,npBAF complex,C
7275,6598,790,nuclear chromatin,C
7276,6598,5730,nucleolus,C
7277,6598,5654,nucleoplasm,C
7278,6598,5654,nucleoplasm,C
7279,6598,5634,nucleus,C
7280,6598,43234,protein complex,C
7281,64750,46332,SMAD binding,F
7282,64750,42802,identical protein binding,F
7283,64750,5515,protein binding,F
7284,64750,5160,transforming growth factor beta receptor binding,F
7285,64750,61630,ubiquitin protein ligase activity,F
7286,64750,4842,ubiquitin-protein transferase activity,F
7287,64750,4842,ubiquitin-protein transferase activity,F
7288,64750,4842,ubiquitin-protein transferase activity,F
7289,64750,30509,BMP signaling pathway,P
7290,64750,60071,"Wnt signaling pathway, planar cell polarity pathway",P
7291,64750,122,negative regulation of transcription from RNA polymerase II promoter,P
7292,64750,45892,"negative regulation of transcription, DNA-templated",P
7293,64750,30512,negative regulation of transforming growth factor beta receptor signaling pathway,P
7294,64750,30512,negative regulation of transforming growth factor beta receptor signaling pathway,P
7295,64750,90263,positive regulation of canonical Wnt signaling pathway,P
7296,64750,1901165,positive regulation of trophoblast cell migration,P
7297,64750,16579,protein deubiquitination,P
7298,64750,209,protein polyubiquitination,P
7299,64750,17015,regulation of transforming growth factor beta receptor signaling pathway,P
7300,64750,30579,ubiquitin-dependent SMAD protein catabolic process,P
7301,64750,6511,ubiquitin-dependent protein catabolic process,P
7302,64750,5829,cytosol,C
7303,64750,45121,membrane raft,C
7304,64750,16607,nuclear speck,C
7305,64750,5654,nucleoplasm,C
7306,64750,5634,nucleus,C
7307,64750,5886,plasma membrane,C
7308,64750,151,ubiquitin ligase complex,C
7309,6615,977,RNA polymerase II regulatory region sequence-specific DNA binding,F
7310,6615,19900,kinase binding,F
7311,6615,46872,metal ion binding,F
7312,6615,5515,protein binding,F
7313,6615,1078,"transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding",F
7314,6615,61314,Notch signaling involved in heart development,P
7315,6615,60536,cartilage morphogenesis,P
7316,6615,16477,cell migration,P
7317,6615,1837,epithelial to mesenchymal transition,P
7318,6615,1837,epithelial to mesenchymal transition,P
7319,6615,3198,epithelial to mesenchymal transition involved in endocardial cushion formation,P
7320,6615,31069,hair follicle morphogenesis,P
7321,6615,60972,left/right pattern formation,P
7322,6615,1707,mesoderm formation,P
7323,6615,43518,"negative regulation of DNA damage response, signal transduction by p53 class mediator",P
7324,6615,60806,negative regulation of cell differentiation involved in embryonic placenta development,P
7325,6615,1902230,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage,P
7326,6615,122,negative regulation of transcription from RNA polymerase II promoter,P
7327,6615,122,negative regulation of transcription from RNA polymerase II promoter,P
7328,6615,122,negative regulation of transcription from RNA polymerase II promoter,P
7329,6615,10957,negative regulation of vitamin D biosynthetic process,P
7330,6615,1649,osteoblast differentiation,P
7331,6615,60021,palate development,P
7332,6615,30335,positive regulation of cell migration,P
7333,6615,10718,positive regulation of epithelial to mesenchymal transition,P
7334,6615,10718,positive regulation of epithelial to mesenchymal transition,P
7335,6615,45893,"positive regulation of transcription, DNA-templated",P
7336,6615,2000810,regulation of bicellular tight junction assembly,P
7337,6615,60707,trophoblast giant cell differentiation,P
7338,6615,5737,cytoplasm,C
7339,6615,5737,cytoplasm,C
7340,6615,5634,nucleus,C
7341,6615,5634,nucleus,C
7342,8651,5159,insulin-like growth factor receptor binding,F
7343,8651,19210,kinase inhibitor activity,F
7344,8651,5515,protein binding,F
7345,8651,19901,protein kinase binding,F
7346,8651,4860,protein kinase inhibitor activity,F
7347,8651,7259,JAK-STAT cascade,P
7348,8651,71230,cellular response to amino acid stimulus,P
7349,8651,19221,cytokine-mediated signaling pathway,P
7350,8651,19221,cytokine-mediated signaling pathway,P
7351,8651,45444,fat cell differentiation,P
7352,8651,46426,negative regulation of JAK-STAT cascade,P
7353,8651,46426,negative regulation of JAK-STAT cascade,P
7354,8651,46426,negative regulation of JAK-STAT cascade,P
7355,8651,46627,negative regulation of insulin receptor signaling pathway,P
7356,8651,46627,negative regulation of insulin receptor signaling pathway,P
7357,8651,6469,negative regulation of protein kinase activity,P
7358,8651,45591,positive regulation of regulatory T cell differentiation,P
7359,8651,16567,protein ubiquitination,P
7360,8651,50707,regulation of cytokine secretion,P
7361,8651,40008,regulation of growth,P
7362,8651,60334,regulation of interferon-gamma-mediated signaling pathway,P
7363,8651,1932,regulation of protein phosphorylation,P
7364,8651,932,P-body,C
7365,8651,5737,cytoplasm,C
7366,8651,31410,cytoplasmic vesicle,C
7367,8651,5829,cytosol,C
7368,8651,5654,nucleoplasm,C
7369,6647,48365,Rac GTPase binding,F
7370,6647,51087,chaperone binding,F
7371,6647,5507,copper ion binding,F
7372,6647,42802,identical protein binding,F
7373,6647,5515,protein binding,F
7374,6647,42803,protein homodimerization activity,F
7375,6647,30346,protein phosphatase 2B binding,F
7376,6647,4784,superoxide dismutase activity,F
7377,6647,4784,superoxide dismutase activity,F
7378,6647,4784,superoxide dismutase activity,F
7379,6647,8270,zinc ion binding,F
7380,6647,187,activation of MAPK activity,P
7381,6647,8089,anterograde axonal transport,P
7382,6647,60088,auditory receptor cell stereocilium organization,P
7383,6647,7569,cell aging,P
7384,6647,6879,cellular iron ion homeostasis,P
7385,6647,71318,cellular response to ATP,P
7386,6647,71276,cellular response to cadmium ion,P
7387,6647,35865,cellular response to potassium ion,P
7388,6647,7566,embryo implantation,P
7389,6647,7566,embryo implantation,P
7390,6647,6749,glutathione metabolic process,P
7391,6647,60047,heart contraction,P
7392,6647,50665,hydrogen peroxide biosynthetic process,P
7393,6647,50665,hydrogen peroxide biosynthetic process,P
7394,6647,7626,locomotory behavior,P
7395,6647,46716,muscle cell cellular homeostasis,P
7396,6647,2262,myeloid cell homeostasis,P
7397,6647,45541,negative regulation of cholesterol biosynthetic process,P
7398,6647,43524,negative regulation of neuron apoptotic process,P
7399,6647,60052,neurofilament cytoskeleton organization,P
7400,6647,1541,ovarian follicle development,P
7401,6647,55114,oxidation-reduction process,P
7402,6647,32287,peripheral nervous system myelin maintenance,P
7403,6647,1890,placenta development,P
7404,6647,2576,platelet degranulation,P
7405,6647,43065,positive regulation of apoptotic process,P
7406,6647,43085,positive regulation of catalytic activity,P
7407,6647,1819,positive regulation of cytokine production,P
7408,6647,1902177,positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,P
7409,6647,32930,positive regulation of superoxide anion generation,P
7410,6647,72593,reactive oxygen species metabolic process,P
7411,6647,43087,regulation of GTPase activity,P
7412,6647,33081,regulation of T cell differentiation in thymus,P
7413,6647,8217,regulation of blood pressure,P
7414,6647,51881,regulation of mitochondrial membrane potential,P
7415,6647,40014,regulation of multicellular organism growth,P
7416,6647,46620,regulation of organ growth,P
7417,6647,45859,regulation of protein kinase activity,P
7418,6647,60087,relaxation of vascular smooth muscle,P
7419,6647,19430,removal of superoxide radicals,P
7420,6647,19430,removal of superoxide radicals,P
7421,6647,1975,response to amphetamine,P
7422,6647,46677,response to antibiotic,P
7423,6647,97332,response to antipsychotic drug,P
7424,6647,48678,response to axon injury,P
7425,6647,34465,response to carbon monoxide,P
7426,6647,46688,response to copper ion,P
7427,6647,42493,response to drug,P
7428,6647,45471,response to ethanol,P
7429,6647,9408,response to heat,P
7430,6647,42542,response to hydrogen peroxide,P
7431,6647,31667,response to nutrient levels,P
7432,6647,10033,response to organic substance,P
7433,6647,302,response to reactive oxygen species,P
7434,6647,303,response to superoxide,P
7435,6647,1895,retina homeostasis,P
7436,6647,8090,retrograde axonal transport,P
7437,6647,7605,sensory perception of sound,P
7438,6647,7283,spermatogenesis,P
7439,6647,42554,superoxide anion generation,P
7440,6647,6801,superoxide metabolic process,P
7441,6647,6801,superoxide metabolic process,P
7442,6647,48538,thymus development,P
7443,6647,19226,transmission of nerve impulse,P
7444,6647,1904115,axon cytoplasm,C
7445,6647,5737,cytoplasm,C
7446,6647,31410,cytoplasmic vesicle,C
7447,6647,5829,cytosol,C
7448,6647,5829,cytosol,C
7449,6647,32839,dendrite cytoplasm,C
7450,6647,31045,dense core granule,C
7451,6647,70062,extracellular exosome,C
7452,6647,31012,extracellular matrix,C
7453,6647,5576,extracellular region,C
7454,6647,5615,extracellular space,C
7455,6647,5764,lysosome,C
7456,6647,5758,mitochondrial intermembrane space,C
7457,6647,5759,mitochondrial matrix,C
7458,6647,5739,mitochondrion,C
7459,6647,43209,myelin sheath,C
7460,6647,43025,neuronal cell body,C
7461,6647,5654,nucleoplasm,C
7462,6647,5634,nucleus,C
7463,6647,5777,peroxisome,C
7464,6647,5777,peroxisome,C
7465,6647,5886,plasma membrane,C
7466,6647,43234,protein complex,C
7467,8470,3723,RNA binding,F
7468,8470,8093,cytoskeletal adaptor activity,F
7469,8470,5515,protein binding,F
7470,8470,5200,structural constituent of cytoskeleton,F
7471,8470,8307,structural constituent of muscle,F
7472,8470,7015,actin filament organization,P
7473,8470,8150,biological_process,P
7474,8470,7155,cell adhesion,P
7475,8470,61049,cell growth involved in cardiac muscle cell development,P
7476,8470,16477,cell migration,P
7477,8470,30018,Z disc,C
7478,8470,15629,actin cytoskeleton,C
7479,8470,16324,apical plasma membrane,C
7480,8470,5925,focal adhesion,C
7481,8470,30027,lamellipodium,C
7482,8470,5634,nucleus,C
7483,8470,48471,perinuclear region of cytoplasm,C
7484,6657,3677,DNA binding,F
7485,6657,3677,DNA binding,F
7486,6657,35198,miRNA binding,F
7487,6657,5515,protein binding,F
7488,6657,43565,sequence-specific DNA binding,F
7489,6657,3700,"transcription factor activity, sequence-specific DNA binding",F
7490,6657,3700,"transcription factor activity, sequence-specific DNA binding",F
7491,6657,44212,transcription regulatory region DNA binding,F
7492,6657,976,transcription regulatory region sequence-specific DNA binding,F
7493,6657,1077,"transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding",F
7494,6657,21984,adenohypophysis development,P
7495,6657,7050,cell cycle arrest,P
7496,6657,6325,chromatin organization,P
7497,6657,1714,endodermal cell fate specification,P
7498,6657,1654,eye development,P
7499,6657,30900,forebrain development,P
7500,6657,21781,glial cell fate commitment,P
7501,6657,48839,inner ear development,P
7502,6657,90090,negative regulation of canonical Wnt signaling pathway,P
7503,6657,50680,negative regulation of epithelial cell proliferation,P
7504,6657,45665,negative regulation of neuron differentiation,P
7505,6657,122,negative regulation of transcription from RNA polymerase II promoter,P
7506,6657,97150,neuronal stem cell population maintenance,P
7507,6657,1649,osteoblast differentiation,P
7508,6657,21983,pituitary gland development,P
7509,6657,43410,positive regulation of MAPK cascade,P
7510,6657,45597,positive regulation of cell differentiation,P
7511,6657,22409,positive regulation of cell-cell adhesion,P
7512,6657,45944,positive regulation of transcription from RNA polymerase II promoter,P
7513,6657,45893,"positive regulation of transcription, DNA-templated",P
7514,6657,43281,regulation of cysteine-type endopeptidase activity involved in apoptotic process,P
7515,6657,10468,regulation of gene expression,P
7516,6657,6355,"regulation of transcription, DNA-templated",P
7517,6657,6355,"regulation of transcription, DNA-templated",P
7518,6657,70848,response to growth factor,P
7519,6657,9611,response to wounding,P
7520,6657,35019,somatic stem cell population maintenance,P
7521,6657,35019,somatic stem cell population maintenance,P
7522,6657,35019,somatic stem cell population maintenance,P
7523,6657,42246,tissue regeneration,P
7524,6657,6366,transcription from RNA polymerase II promoter,P
7525,6657,5737,cytoplasm,C
7526,6657,5829,cytosol,C
7527,6657,5654,nucleoplasm,C
7528,6657,5654,nucleoplasm,C
7529,6657,5634,nucleus,C
7530,6657,5634,nucleus,C
7531,6657,5634,nucleus,C
7532,6657,5667,transcription factor complex,C
7533,10927,35064,methylated histone binding,F
7534,10927,5515,protein binding,F
7535,10927,16055,Wnt signaling pathway,P
7536,10927,16569,covalent chromatin modification,P
7537,10927,7276,gamete generation,P
7538,10927,51321,meiotic cell cycle,P
7539,10927,7275,multicellular organism development,P
7540,10927,30177,positive regulation of Wnt signaling pathway,P
7541,10927,9303,rRNA transcription,P
7542,10927,5829,cytosol,C
7543,10927,31965,nuclear membrane,C
7544,10927,5730,nucleolus,C
7545,10927,5654,nucleoplasm,C
7546,10927,5634,nucleus,C
7547,10927,5819,spindle,C
7548,6660,3677,DNA binding,F
7549,6660,5515,protein binding,F
7550,6660,3700,"transcription factor activity, sequence-specific DNA binding",F
7551,6660,55059,asymmetric neuroblast division,P
7552,6660,71560,cellular response to transforming growth factor beta stimulus,P
7553,6660,61036,positive regulation of cartilage development,P
7554,6660,32332,positive regulation of chondrocyte differentiation,P
7555,6660,2000741,positive regulation of mesenchymal stem cell differentiation,P
7556,6660,6355,"regulation of transcription, DNA-templated",P
7557,6660,6366,transcription from RNA polymerase II promoter,P
7558,6660,5634,nucleus,C
7559,6667,3677,DNA binding,F
7560,6667,71837,HMG box domain binding,F
7561,6667,978,RNA polymerase II core promoter proximal region sequence-specific DNA binding,F
7562,6667,978,RNA polymerase II core promoter proximal region sequence-specific DNA binding,F
7563,6667,977,RNA polymerase II regulatory region sequence-specific DNA binding,F
7564,6667,1103,RNA polymerase II repressing transcription factor binding,F
7565,6667,43425,bHLH transcription factor binding,F
7566,6667,1046,core promoter sequence-specific DNA binding,F
7567,6667,3690,double-stranded DNA binding,F
7568,6667,35035,histone acetyltransferase binding,F
7569,6667,42826,histone deacetylase binding,F
7570,6667,46872,metal ion binding,F
7571,6667,8022,protein C-terminus binding,F
7572,6667,5515,protein binding,F
7573,6667,42803,protein homodimerization activity,F
7574,6667,70491,repressing transcription factor binding,F
7575,6667,43565,sequence-specific DNA binding,F
7576,6667,982,"transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding",F
7577,6667,3700,"transcription factor activity, sequence-specific DNA binding",F
7578,6667,8134,transcription factor binding,F
7579,6667,44212,transcription regulatory region DNA binding,F
7580,6667,1077,"transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding",F
7581,6667,32869,cellular response to insulin stimulus,P
7582,6667,43923,positive regulation by host of viral transcription,P
7583,6667,1904828,positive regulation of hydrogen sulfide biosynthetic process,P
7584,6667,45944,positive regulation of transcription from RNA polymerase II promoter,P
7585,6667,45944,positive regulation of transcription from RNA polymerase II promoter,P
7586,6667,45944,positive regulation of transcription from RNA polymerase II promoter,P
7587,6667,45944,positive regulation of transcription from RNA polymerase II promoter,P
7588,6667,45893,"positive regulation of transcription, DNA-templated",P
7589,6667,100057,regulation of phenotypic switching by transcription from RNA polymerase II promoter,P
7590,6667,6355,"regulation of transcription, DNA-templated",P
7591,6667,48511,rhythmic process,P
7592,6667,42795,snRNA transcription from RNA polymerase II promoter,P
7593,6667,16032,viral process,P
7594,6667,5737,cytoplasm,C
7595,6667,790,nuclear chromatin,C
7596,6667,5654,nucleoplasm,C
7597,6667,5654,nucleoplasm,C
7598,6667,5634,nucleus,C
7599,6667,32993,protein-DNA complex,C
7600,6667,17053,transcriptional repressor complex,C
7601,8405,1085,RNA polymerase II transcription factor binding,F
7602,8405,5515,protein binding,F
7603,8405,31625,ubiquitin protein ligase binding,F
7604,8405,42593,glucose homeostasis,P
7605,8405,43433,negative regulation of sequence-specific DNA binding transcription factor activity,P
7606,8405,122,negative regulation of transcription from RNA polymerase II promoter,P
7607,8405,1902237,positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,P
7608,8405,2000676,positive regulation of type B pancreatic cell apoptotic process,P
7609,8405,43161,proteasome-mediated ubiquitin-dependent protein catabolic process,P
7610,8405,42787,protein ubiquitination involved in ubiquitin-dependent protein catabolic process,P
7611,8405,30162,regulation of proteolysis,P
7612,8405,31463,Cul3-RING ubiquitin ligase complex,C
7613,8405,19005,SCF ubiquitin ligase complex,C
7614,8405,5737,cytoplasm,C
7615,8405,16607,nuclear speck,C
7616,8405,5654,nucleoplasm,C
7617,8405,5634,nucleus,C
7618,6714,5524,ATP binding,F
7619,6714,42169,SH2 domain binding,F
7620,6714,5070,SH3/SH2 adaptor activity,F
7621,6714,45296,cadherin binding,F
7622,6714,71253,connexin binding,F
7623,6714,19899,enzyme binding,F
7624,6714,46875,ephrin receptor binding,F
7625,6714,30331,estrogen receptor binding,F
7626,6714,70851,growth factor receptor binding,F
7627,6714,20037,heme binding,F
7628,6714,51427,hormone receptor binding,F
7629,6714,5158,insulin receptor binding,F
7630,6714,5178,integrin binding,F
7631,6714,44325,ion channel binding,F
7632,6714,16301,kinase activity,F
7633,6714,19900,kinase binding,F
7634,6714,4715,non-membrane spanning protein tyrosine kinase activity,F
7635,6714,51219,phosphoprotein binding,F
7636,6714,8022,protein C-terminus binding,F
7637,6714,5515,protein binding,F
7638,6714,5080,protein kinase C binding,F
7639,6714,4672,protein kinase activity,F
7640,6714,4672,protein kinase activity,F
7641,6714,4713,protein tyrosine kinase activity,F
7642,6714,4713,protein tyrosine kinase activity,F
7643,6714,4713,protein tyrosine kinase activity,F
7644,6714,4713,protein tyrosine kinase activity,F
7645,6714,5102,receptor binding,F
7646,6714,97110,scaffold protein binding,F
7647,6714,31625,ubiquitin protein ligase binding,F
7648,6714,38128,ERBB2 signaling pathway,P
7649,6714,38096,Fc-gamma receptor signaling pathway involved in phagocytosis,P
7650,6714,31295,T cell costimulation,P
7651,6714,32148,activation of protein kinase B activity,P
7652,6714,34332,adherens junction organization,P
7653,6714,86098,angiotensin-activated signaling pathway involved in heart process,P
7654,6714,7411,axon guidance,P
7655,6714,45453,bone resorption,P
7656,6714,60444,branching involved in mammary gland duct morphogenesis,P
7657,6714,7049,cell cycle,P
7658,6714,8283,cell proliferation,P
7659,6714,71398,cellular response to fatty acid,P
7660,6714,71498,cellular response to fluid shear stress,P
7661,6714,71456,cellular response to hypoxia,P
7662,6714,32869,cellular response to insulin stimulus,P
7663,6714,71222,cellular response to lipopolysaccharide,P
7664,6714,71375,cellular response to peptide hormone stimulus,P
7665,6714,36120,cellular response to platelet-derived growth factor stimulus,P
7666,6714,71393,cellular response to progesterone stimulus,P
7667,6714,34614,cellular response to reactive oxygen species,P
7668,6714,7417,central nervous system development,P
7669,6714,35635,entry of bacterium into host cell,P
7670,6714,48013,ephrin receptor signaling pathway,P
7671,6714,7173,epidermal growth factor receptor signaling pathway,P
7672,6714,7173,epidermal growth factor receptor signaling pathway,P
7673,6714,30900,forebrain development,P
7674,6714,45087,innate immune response,P
7675,6714,7229,integrin-mediated signaling pathway,P
7676,6714,30520,intracellular estrogen receptor signaling pathway,P
7677,6714,35556,intracellular signal transduction,P
7678,6714,50900,leukocyte migration,P
7679,6714,2000811,negative regulation of anoikis,P
7680,6714,43066,negative regulation of apoptotic process,P
7681,6714,43154,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,P
7682,6714,2001237,negative regulation of extrinsic apoptotic signaling pathway,P
7683,6714,51895,negative regulation of focal adhesion assembly,P
7684,6714,2001243,negative regulation of intrinsic apoptotic signaling pathway,P
7685,6714,51902,negative regulation of mitochondrial depolarization,P
7686,6714,32463,negative regulation of protein homooligomerization,P
7687,6714,51974,negative regulation of telomerase activity,P
7688,6714,32211,negative regulation of telomere maintenance via telomerase,P
7689,6714,45892,"negative regulation of transcription, DNA-templated",P
7690,6714,48011,neurotrophin TRK receptor signaling pathway,P
7691,6714,48477,oogenesis,P
7692,6714,36035,osteoclast development,P
7693,6714,18105,peptidyl-serine phosphorylation,P
7694,6714,38083,peptidyl-tyrosine autophosphorylation,P
7695,6714,18108,peptidyl-tyrosine phosphorylation,P
7696,6714,18108,peptidyl-tyrosine phosphorylation,P
7697,6714,30168,platelet activation,P
7698,6714,48008,platelet-derived growth factor receptor signaling pathway,P
7699,6714,2000573,positive regulation of DNA biosynthetic process,P
7700,6714,70374,positive regulation of ERK1 and ERK2 cascade,P
7701,6714,43406,positive regulation of MAP kinase activity,P
7702,6714,43065,positive regulation of apoptotic process,P
7703,6714,90263,positive regulation of canonical Wnt signaling pathway,P
7704,6714,45737,positive regulation of cyclin-dependent protein serine/threonine kinase activity,P
7705,6714,50715,positive regulation of cytokine secretion,P
7706,6714,10634,positive regulation of epithelial cell migration,P
7707,6714,10907,positive regulation of glucose metabolic process,P
7708,6714,46628,positive regulation of insulin receptor signaling pathway,P
7709,6714,33625,positive regulation of integrin activation,P
7710,6714,2000394,positive regulation of lamellipodium morphogenesis,P
7711,6714,50731,positive regulation of peptidyl-tyrosine phosphorylation,P
7712,6714,43552,positive regulation of phosphatidylinositol 3-kinase activity,P
7713,6714,10641,positive regulation of platelet-derived growth factor receptor signaling pathway,P
7714,6714,71803,positive regulation of podosome assembly,P
7715,6714,31954,positive regulation of protein autophosphorylation,P
7716,6714,51897,positive regulation of protein kinase B signaling,P
7717,6714,1900182,positive regulation of protein localization to nucleus,P
7718,6714,10954,positive regulation of protein processing,P
7719,6714,71902,positive regulation of protein serine/threonine kinase activity,P
7720,6714,51057,positive regulation of small GTPase mediated signal transduction,P
7721,6714,14911,positive regulation of smooth muscle cell migration,P
7722,6714,45893,"positive regulation of transcription, DNA-templated",P
7723,6714,50847,progesterone receptor signaling pathway,P
7724,6714,50847,progesterone receptor signaling pathway,P
7725,6714,46777,protein autophosphorylation,P
7726,6714,31648,protein destabilization,P
7727,6714,45124,regulation of bone resorption,P
7728,6714,2001286,regulation of caveolin-mediated endocytosis,P
7729,6714,51726,regulation of cell cycle,P
7730,6714,60491,regulation of cell projection assembly,P
7731,6714,42127,regulation of cell proliferation,P
7732,6714,22407,regulation of cell-cell adhesion,P
7733,6714,2000641,regulation of early endosome to late endosome transport,P
7734,6714,10632,regulation of epithelial cell migration,P
7735,6714,33146,regulation of intracellular estrogen receptor signaling pathway,P
7736,6714,71801,regulation of podosome assembly,P
7737,6714,43393,regulation of protein binding,P
7738,6714,43114,regulation of vascular permeability,P
7739,6714,10447,response to acidic pH,P
7740,6714,42493,response to drug,P
7741,6714,51602,response to electrical stimulus,P
7742,6714,42542,response to hydrogen peroxide,P
7743,6714,70555,response to interleukin-1,P
7744,6714,9612,response to mechanical stimulus,P
7745,6714,51385,response to mineralocorticoid,P
7746,6714,31667,response to nutrient levels,P
7747,6714,9615,response to virus,P
7748,6714,7172,signal complex assembly,P
7749,6714,7165,signal transduction,P
7750,6714,16337,single organismal cell-cell adhesion,P
7751,6714,2223,stimulatory C-type lectin receptor signaling pathway,P
7752,6714,43149,stress fiber assembly,P
7753,6714,34446,substrate adhesion-dependent cell spreading,P
7754,6714,45056,transcytosis,P
7755,6714,7179,transforming growth factor beta receptor signaling pathway,P
7756,6714,60065,uterus development,P
7757,6714,48010,vascular endothelial growth factor receptor signaling pathway,P
7758,6714,5884,actin filament,C
7759,6714,5901,caveola,C
7760,6714,5737,cytoplasm,C
7761,6714,5829,cytosol,C
7762,6714,5829,cytosol,C
7763,6714,70062,extracellular exosome,C
7764,6714,31234,extrinsic component of cytoplasmic side of plasma membrane,C
7765,6714,5770,late endosome,C
7766,6714,5764,lysosome,C
7767,6714,5743,mitochondrial inner membrane,C
7768,6714,5739,mitochondrion,C
7769,6714,43005,neuron projection,C
7770,6714,5634,nucleus,C
7771,6714,48471,perinuclear region of cytoplasm,C
7772,6714,5886,plasma membrane,C
7773,6714,5886,plasma membrane,C
7774,6714,2102,podosome,C
7775,6714,14069,postsynaptic density,C
7776,6714,32587,ruffle membrane,C
7777,6720,3677,DNA binding,F
7778,6720,978,RNA polymerase II core promoter proximal region sequence-specific DNA binding,F
7779,6720,977,RNA polymerase II regulatory region sequence-specific DNA binding,F
7780,6720,4879,"RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding",F
7781,6720,3682,chromatin binding,F
7782,6720,5515,protein binding,F
7783,6720,32403,protein complex binding,F
7784,6720,46983,protein dimerization activity,F
7785,6720,19901,protein kinase binding,F
7786,6720,32810,sterol response element binding,F
7787,6720,3700,"transcription factor activity, sequence-specific DNA binding",F
7788,6720,1077,"transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding",F
7789,6720,7568,aging,P
7790,6720,71398,cellular response to fatty acid,P
7791,6720,9267,cellular response to starvation,P
7792,6720,8203,cholesterol metabolic process,P
7793,6720,7623,circadian rhythm,P
7794,6720,45444,fat cell differentiation,P
7795,6720,8286,insulin receptor signaling pathway,P
7796,6720,30522,intracellular receptor signaling pathway,P
7797,6720,8610,lipid biosynthetic process,P
7798,6720,6629,lipid metabolic process,P
7799,6720,30324,lung development,P
7800,6720,42789,mRNA transcription from RNA polymerase II promoter,P
7801,6720,46676,negative regulation of insulin secretion,P
7802,6720,122,negative regulation of transcription from RNA polymerase II promoter,P
7803,6720,45542,positive regulation of cholesterol biosynthetic process,P
7804,6720,31065,positive regulation of histone deacetylation,P
7805,6720,45944,positive regulation of transcription from RNA polymerase II promoter,P
7806,6720,45944,positive regulation of transcription from RNA polymerase II promoter,P
7807,6720,10867,positive regulation of triglyceride biosynthetic process,P
7808,6720,19217,regulation of fatty acid metabolic process,P
7809,6720,3062,regulation of heart rate by chemical signal,P
7810,6720,1903146,regulation of mitophagy,P
7811,6720,31647,regulation of protein stability,P
7812,6720,1903214,regulation of protein targeting to mitochondrion,P
7813,6720,6357,regulation of transcription from RNA polymerase II promoter,P
7814,6720,51591,response to cAMP,P
7815,6720,42493,response to drug,P
7816,6720,32094,response to food,P
7817,6720,33762,response to glucagon,P
7818,6720,9749,response to glucose,P
7819,6720,32570,response to progesterone,P
7820,6720,32526,response to retinoic acid,P
7821,6720,12507,ER to Golgi transport vesicle membrane,C
7822,6720,139,Golgi membrane,C
7823,6720,5737,cytoplasm,C
7824,6720,5829,cytosol,C
7825,6720,5789,endoplasmic reticulum membrane,C
7826,6720,16021,integral component of membrane,C
7827,6720,5635,nuclear envelope,C
7828,6720,5654,nucleoplasm,C
7829,6720,5634,nucleus,C
7830,6720,43234,protein complex,C
7831,6426,44547,DNA topoisomerase binding,F
7832,6426,3723,RNA binding,F
7833,6426,3723,RNA binding,F
7834,6426,50733,RS domain binding,F
7835,6426,3729,mRNA binding,F
7836,6426,5515,protein binding,F
7837,6426,43422,protein kinase B binding,F
7838,6426,6405,RNA export from nucleus,P
7839,6426,380,"alternative mRNA splicing, via spliceosome",P
7840,6426,60048,cardiac muscle contraction,P
7841,6426,1701,in utero embryonic development,P
7842,6426,97421,liver regeneration,P
7843,6426,31124,mRNA 3'-end processing,P
7844,6426,395,mRNA 5'-splice site recognition,P
7845,6426,6406,mRNA export from nucleus,P
7846,6426,6397,mRNA processing,P
7847,6426,6376,mRNA splice site selection,P
7848,6426,398,"mRNA splicing, via spliceosome",P
7849,6426,398,"mRNA splicing, via spliceosome",P
7850,6426,48709,oligodendrocyte differentiation,P
7851,6426,33120,positive regulation of RNA splicing,P
7852,6426,6369,termination of RNA polymerase II transcription,P
7853,6426,71013,catalytic step 2 spliceosome,C
7854,6426,5737,cytoplasm,C
7855,6426,35145,exon-exon junction complex,C
7856,6426,70062,extracellular exosome,C
7857,6426,16607,nuclear speck,C
7858,6426,5654,nucleoplasm,C
7859,6426,5654,nucleoplasm,C
7860,6426,5634,nucleus,C
7861,6777,979,RNA polymerase II core promoter sequence-specific DNA binding,F
7862,6777,3682,chromatin binding,F
7863,6777,35259,glucocorticoid receptor binding,F
7864,6777,5515,protein binding,F
7865,6777,46983,protein dimerization activity,F
7866,6777,19903,protein phosphatase binding,F
7867,6777,4713,protein tyrosine kinase activity,F
7868,6777,4871,signal transducer activity,F
7869,6777,3700,"transcription factor activity, sequence-specific DNA binding",F
7870,6777,1077,"transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding",F
7871,6777,6103,2-oxoglutarate metabolic process,P
7872,6777,7259,JAK-STAT cascade,P
7873,6777,60397,JAK-STAT cascade involved in growth hormone signaling pathway,P
7874,6777,60397,JAK-STAT cascade involved in growth hormone signaling pathway,P
7875,6777,48541,Peyer's patch development,P
7876,6777,33077,T cell differentiation in thymus,P
7877,6777,43029,T cell homeostasis,P
7878,6777,255,allantoin metabolic process,P
7879,6777,71364,cellular response to epidermal growth factor stimulus,P
7880,6777,71363,cellular response to growth factor stimulus,P
7881,6777,32870,cellular response to hormone stimulus,P
7882,6777,6101,citrate metabolic process,P
7883,6777,6600,creatine metabolic process,P
7884,6777,46449,creatinine metabolic process,P
7885,6777,46543,development of secondary female sexual characteristics,P
7886,6777,46544,development of secondary male sexual characteristics,P
7887,6777,6631,fatty acid metabolic process,P
7888,6777,7565,female pregnancy,P
7889,6777,6549,isoleucine metabolic process,P
7890,6777,7595,lactation,P
7891,6777,19915,lipid storage,P
7892,6777,1553,luteinization,P
7893,6777,97531,mast cell migration,P
7894,6777,1779,natural killer cell differentiation,P
7895,6777,43066,negative regulation of apoptotic process,P
7896,6777,45647,negative regulation of erythrocyte differentiation,P
7897,6777,6107,oxaloacetate metabolic process,P
7898,6777,18108,peptidyl-tyrosine phosphorylation,P
7899,6777,45579,positive regulation of B cell differentiation,P
7900,6777,42104,positive regulation of activated T cell proliferation,P
7901,6777,45648,positive regulation of erythrocyte differentiation,P
7902,6777,45588,positive regulation of gamma-delta T cell differentiation,P
7903,6777,50729,positive regulation of inflammatory response,P
7904,6777,45086,positive regulation of interleukin-2 biosynthetic process,P
7905,6777,45931,positive regulation of mitotic cell cycle,P
7906,6777,40018,positive regulation of multicellular organism growth,P
7907,6777,32825,positive regulation of natural killer cell differentiation,P
7908,6777,45954,positive regulation of natural killer cell mediated cytotoxicity,P
7909,6777,32819,positive regulation of natural killer cell proliferation,P
7910,6777,45944,positive regulation of transcription from RNA polymerase II promoter,P
7911,6777,42448,progesterone metabolic process,P
7912,6777,38161,prolactin signaling pathway,P
7913,6777,30856,regulation of epithelial cell differentiation,P
7914,6777,40014,regulation of multicellular organism growth,P
7915,6777,19218,regulation of steroid metabolic process,P
7916,6777,6357,regulation of transcription from RNA polymerase II promoter,P
7917,6777,32355,response to estradiol,P
7918,6777,70672,response to interleukin-15,P
7919,6777,70669,response to interleukin-2,P
7920,6777,70670,response to interleukin-4,P
7921,6777,6105,succinate metabolic process,P
7922,6777,19530,taurine metabolic process,P
7923,6777,6366,transcription from RNA polymerase II promoter,P
7924,6777,6573,valine metabolic process,P
7925,6777,5737,cytoplasm,C
7926,6777,5829,cytosol,C
7927,6777,5654,nucleoplasm,C
7928,6777,5634,nucleus,C
7929,282974,5524,ATP binding,F
7930,282974,46872,metal ion binding,F
7931,282974,4674,protein serine/threonine kinase activity,F
7932,282974,35556,intracellular signal transduction,P
7933,282974,18105,peptidyl-serine phosphorylation,P
7934,282974,5622,intracellular,C
7935,83931,5524,ATP binding,F
7936,83931,5515,protein binding,F
7937,83931,4674,protein serine/threonine kinase activity,F
7938,83931,5977,glycogen metabolic process,P
7939,83931,48286,lung alveolus development,P
7940,83931,60425,lung morphogenesis,P
7941,83931,35264,multicellular organism growth,P
7942,83931,43066,negative regulation of apoptotic process,P
7943,83931,6468,protein phosphorylation,P
7944,83931,43408,regulation of MAPK cascade,P
7945,83931,10468,regulation of gene expression,P
7946,83931,3016,respiratory system process,P
7947,83931,5829,cytosol,C
7948,83931,5654,nucleoplasm,C
7949,6850,5524,ATP binding,F
7950,6850,42169,SH2 domain binding,F
7951,6829,3723,RNA binding,F
7952,6850,35325,Toll-like receptor binding,F
7953,6829,3682,chromatin binding,F
7954,6850,5178,integrin binding,F
7955,6829,19899,enzyme binding,F
7956,6850,4715,non-membrane spanning protein tyrosine kinase activity,F
7957,6829,5515,protein binding,F
7958,6850,4715,non-membrane spanning protein tyrosine kinase activity,F
7959,6829,46982,protein heterodimerization activity,F
7960,6850,19902,phosphatase binding,F
7961,6829,6370,7-methylguanosine mRNA capping,P
7962,6850,1784,phosphotyrosine binding,F
7963,6829,6354,"DNA-templated transcription, elongation",P
7964,6850,5515,protein binding,F
7965,6829,7049,cell cycle,P
7966,6850,4672,protein kinase activity,F
7967,6829,6338,chromatin remodeling,P
7968,6850,4672,protein kinase activity,F
7969,6829,32785,"negative regulation of DNA-templated transcription, elongation",P
7970,6850,19901,protein kinase binding,F
7971,6829,1900364,negative regulation of mRNA polyadenylation,P
7972,6850,4674,protein serine/threonine kinase activity,F
7973,6829,122,negative regulation of transcription from RNA polymerase II promoter,P
7974,6850,4713,protein tyrosine kinase activity,F
7975,6829,32786,"positive regulation of DNA-templated transcription, elongation",P
7976,6850,4713,protein tyrosine kinase activity,F
7977,6829,16239,positive regulation of macroautophagy,P
7978,6850,4716,"signal transducer, downstream of receptor, with protein tyrosine kinase activity",F
7979,6829,45944,positive regulation of transcription from RNA polymerase II promoter,P
7980,6829,50434,positive regulation of viral transcription,P
7981,6850,50853,B cell receptor signaling pathway,P
7982,6829,10033,response to organic substance,P
7983,6850,50853,B cell receptor signaling pathway,P
7984,6829,39692,single stranded viral RNA replication via double stranded DNA intermediate,P
7985,6850,38095,Fc-epsilon receptor signaling pathway,P
7986,6829,6368,transcription elongation from RNA polymerase II promoter,P
7987,6850,38096,Fc-gamma receptor signaling pathway involved in phagocytosis,P
7988,6829,6368,transcription elongation from RNA polymerase II promoter,P
7989,6850,7257,activation of JUN kinase activity,P
7990,6829,6366,transcription from RNA polymerase II promoter,P
7991,6850,2250,adaptive immune response,P
7992,6829,32044,DSIF complex,C
7993,6850,2250,adaptive immune response,P
7994,6829,5654,nucleoplasm,C
7995,6850,1525,angiogenesis,P
7996,6829,5654,nucleoplasm,C
7997,6850,9887,animal organ morphogenesis,P
7998,6829,5634,nucleus,C
7999,6850,43366,beta selection,P
8000,6850,48514,blood vessel morphogenesis,P
8001,6850,8283,cell proliferation,P
8002,6850,71404,cellular response to low-density lipoprotein particle stimulus,P
8003,6850,71226,cellular response to molecule of fungal origin,P
8004,6850,38063,collagen-activated tyrosine kinase receptor signaling pathway,P
8005,6850,42742,defense response to bacterium,P
8006,6850,6954,inflammatory response,P
8007,6850,45087,innate immune response,P
8008,6850,45087,innate immune response,P
8009,6850,7229,integrin-mediated signaling pathway,P
8010,6850,7229,integrin-mediated signaling pathway,P
8011,6850,2366,leukocyte activation involved in immune response,P
8012,6850,7159,leukocyte cell-cell adhesion,P
8013,6850,19370,leukotriene biosynthetic process,P
8014,6850,1945,lymph vessel development,P
8015,6850,2281,macrophage activation involved in immune response,P
8016,6850,2281,macrophage activation involved in immune response,P
8017,6850,2283,neutrophil activation involved in immune response,P
8018,6850,2283,neutrophil activation involved in immune response,P
8019,6850,30593,neutrophil chemotaxis,P
8020,6850,18105,peptidyl-serine phosphorylation,P
8021,6850,38083,peptidyl-tyrosine autophosphorylation,P
8022,6850,30168,platelet activation,P
8023,6850,45579,positive regulation of B cell differentiation,P
8024,6850,46638,positive regulation of alpha-beta T cell differentiation,P
8025,6850,46641,positive regulation of alpha-beta T cell proliferation,P
8026,6850,45780,positive regulation of bone resorption,P
8027,6850,50850,positive regulation of calcium-mediated signaling,P
8028,6850,33630,positive regulation of cell adhesion mediated by integrin,P
8029,6850,33630,positive regulation of cell adhesion mediated by integrin,P
8030,6850,50715,positive regulation of cytokine secretion,P
8031,6850,45588,positive regulation of gamma-delta T cell differentiation,P
8032,6850,45425,positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process,P
8033,6850,45401,positive regulation of interleukin-3 biosynthetic process,P
8034,6850,43306,positive regulation of mast cell degranulation,P
8035,6850,1900086,positive regulation of peptidyl-tyrosine autophosphorylation,P
8036,6850,2092,positive regulation of receptor internalization,P
8037,6850,32481,positive regulation of type I interferon production,P
8038,6850,6468,protein phosphorylation,P
8039,6850,6468,protein phosphorylation,P
8040,6850,31623,receptor internalization,P
8041,6850,70372,regulation of ERK1 and ERK2 cascade,P
8042,6850,90237,regulation of arachidonic acid secretion,P
8043,6850,43313,regulation of neutrophil degranulation,P
8044,6850,50764,regulation of phagocytosis,P
8045,6850,10543,regulation of platelet activation,P
8046,6850,90330,regulation of platelet aggregation,P
8047,6850,90330,regulation of platelet aggregation,P
8048,6850,51090,regulation of sequence-specific DNA binding transcription factor activity,P
8049,6850,32928,regulation of superoxide anion generation,P
8050,6850,10803,regulation of tumor necrosis factor-mediated signaling pathway,P
8051,6850,2554,serotonin secretion by platelet,P
8052,6850,2223,stimulatory C-type lectin receptor signaling pathway,P
8053,6850,42991,transcription factor import into nucleus,P
8054,6850,7169,transmembrane receptor protein tyrosine kinase signaling pathway,P
8055,6850,16032,viral process,P
8056,6850,19815,B cell receptor complex,C
8057,6850,42101,T cell receptor complex,C
8058,6850,5737,cytoplasm,C
8059,6850,5829,cytosol,C
8060,6850,5829,cytosol,C
8061,6850,32009,early phagosome,C
8062,6850,31234,extrinsic component of cytoplasmic side of plasma membrane,C
8063,6850,5634,nucleus,C
8064,6850,5886,plasma membrane,C
8065,6850,43234,protein complex,C
8066,10460,5515,protein binding,F
8067,10460,51301,cell division,P
8068,10460,8283,cell proliferation,P
8069,10460,21987,cerebral cortex development,P
8070,10460,7091,metaphase/anaphase transition of mitotic cell cycle,P
8071,10460,1902850,microtubule cytoskeleton organization involved in mitosis,P
8072,10460,60236,regulation of mitotic spindle organization,P
8073,10460,5737,cytoplasm,C
8074,10460,15630,microtubule cytoskeleton,C
8075,10460,5815,microtubule organizing center,C
8076,10460,922,spindle pole,C
8077,6909,3677,DNA binding,F
8078,6909,978,RNA polymerase II core promoter proximal region sequence-specific DNA binding,F
8079,6909,5515,protein binding,F
8080,6909,43565,sequence-specific DNA binding,F
8081,6909,1078,"transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding",F
8082,6909,7219,Notch signaling pathway,P
8083,6909,35909,aorta morphogenesis,P
8084,6909,36302,atrioventricular canal development,P
8085,6909,48738,cardiac muscle tissue development,P
8086,6909,7569,cell aging,P
8087,6909,90398,cellular senescence,P
8088,6909,60560,developmental growth involved in morphogenesis,P
8089,6909,48596,embryonic camera-type eye morphogenesis,P
8090,6909,42733,embryonic digit morphogenesis,P
8091,6909,35050,embryonic heart tube development,P
8092,6909,3203,endocardial cushion morphogenesis,P
8093,6909,1947,heart looping,P
8094,6909,60596,mammary placode formation,P
8095,6909,7521,muscle cell fate determination,P
8096,6909,1901211,negative regulation of cardiac chamber formation,P
8097,6909,1901208,negative regulation of heart looping,P
8098,6909,122,negative regulation of transcription from RNA polymerase II promoter,P
8099,6909,45892,"negative regulation of transcription, DNA-templated",P
8100,6909,3151,outflow tract morphogenesis,P
8101,6909,3148,outflow tract septum morphogenesis,P
8102,6909,60021,palate development,P
8103,6909,60465,pharynx development,P
8104,6909,60045,positive regulation of cardiac muscle cell proliferation,P
8105,6909,8284,positive regulation of cell proliferation,P
8106,6909,8016,regulation of heart contraction,P
8107,6909,3256,regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation,P
8108,6909,6351,"transcription, DNA-templated",P
8109,6909,5634,nucleus,C
8110,6909,5667,transcription factor complex,C
8111,7014,98505,G-rich strand telomeric DNA binding,F
8112,7014,3691,double-stranded telomeric DNA binding,F
8113,7014,3691,double-stranded telomeric DNA binding,F
8114,7014,19899,enzyme binding,F
8115,7014,44877,macromolecular complex binding,F
8116,7014,8022,protein C-terminus binding,F
8117,7014,5515,protein binding,F
8118,7014,42803,protein homodimerization activity,F
8119,7014,3720,telomerase activity,F
8120,7014,42162,telomeric DNA binding,F
8121,7014,6278,RNA-dependent DNA biosynthetic process,P
8122,7014,7049,cell cycle,P
8123,7014,90398,cellular senescence,P
8124,7014,1903770,negative regulation of beta-galactosidase activity,P
8125,7014,2000773,negative regulation of cellular senescence,P
8126,7014,1905778,negative regulation of exonuclease activity,P
8127,7014,10629,negative regulation of gene expression,P
8128,7014,1904430,negative regulation of t-circle formation,P
8129,7014,1904430,negative regulation of t-circle formation,P
8130,7014,1904354,negative regulation of telomere capping,P
8131,7014,32205,negative regulation of telomere maintenance,P
8132,7014,32208,negative regulation of telomere maintenance via recombination,P
8133,7014,32208,negative regulation of telomere maintenance via recombination,P
8134,7014,32214,negative regulation of telomere maintenance via semi-conservative replication,P
8135,7014,32211,negative regulation of telomere maintenance via telomerase,P
8136,7014,32211,negative regulation of telomere maintenance via telomerase,P
8137,7014,32211,negative regulation of telomere maintenance via telomerase,P
8138,7014,1904357,negative regulation of telomere maintenance via telomere lengthening,P
8139,7014,1903824,negative regulation of telomere single strand break repair,P
8140,7014,1905839,negative regulation of telomeric D-loop disassembly,P
8141,7014,10628,positive regulation of gene expression,P
8142,7014,51000,positive regulation of nitric-oxide synthase activity,P
8143,7014,31848,protection from non-homologous end joining at telomere,P
8144,7014,31848,protection from non-homologous end joining at telomere,P
8145,7014,70198,"protein localization to chromosome, telomeric region",P
8146,7014,32204,regulation of telomere maintenance,P
8147,7014,32210,regulation of telomere maintenance via telomerase,P
8148,7014,32210,regulation of telomere maintenance via telomerase,P
8149,7014,16233,telomere capping,P
8150,7014,16233,telomere capping,P
8151,7014,16233,telomere capping,P
8152,7014,723,telomere maintenance,P
8153,7014,61820,telomeric D-loop disassembly,P
8154,7014,31627,telomeric loop formation,P
8155,7014,30870,Mre11 complex,C
8156,7014,781,"chromosome, telomeric region",C
8157,7014,16604,nuclear body,C
8158,7014,784,"nuclear chromosome, telomeric region",C
8159,7014,783,nuclear telomere cap complex,C
8160,7014,5654,nucleoplasm,C
8161,7014,5634,nucleus,C
8162,7014,70187,shelterin complex,C
8163,7014,70187,shelterin complex,C
8164,7014,70187,shelterin complex,C
8165,7015,3677,DNA binding,F
8166,7015,3723,RNA binding,F
8167,7015,3968,RNA-directed 5'-3' RNA polymerase activity,F
8168,7015,3964,RNA-directed DNA polymerase activity,F
8169,7015,3964,RNA-directed DNA polymerase activity,F
8170,7015,51087,chaperone binding,F
8171,7015,46872,metal ion binding,F
8172,7015,16779,nucleotidyltransferase activity,F
8173,7015,16779,nucleotidyltransferase activity,F
8174,7015,5515,protein binding,F
8175,7015,42803,protein homodimerization activity,F
8176,7015,42803,protein homodimerization activity,F
8177,7015,49,tRNA binding,F
8178,7015,70034,telomerase RNA binding,F
8179,7015,70034,telomerase RNA binding,F
8180,7015,3721,telomerase RNA reverse transcriptase activity,F
8181,7015,3721,telomerase RNA reverse transcriptase activity,F
8182,7015,3721,telomerase RNA reverse transcriptase activity,F
8183,7015,3721,telomerase RNA reverse transcriptase activity,F
8184,7015,3720,telomerase activity,F
8185,7015,3720,telomerase activity,F
8186,7015,3720,telomerase activity,F
8187,7015,3720,telomerase activity,F
8188,7015,42162,telomeric DNA binding,F
8189,7015,98680,template-free RNA nucleotidyltransferase,F
8190,7015,1223,transcription coactivator binding,F
8191,7015,71897,DNA biosynthetic process,P
8192,7015,22616,DNA strand elongation,P
8193,7015,32774,RNA biosynthetic process,P
8194,7015,6278,RNA-dependent DNA biosynthetic process,P
8195,7015,1904837,beta-catenin-TCF complex assembly,P
8196,7015,71456,cellular response to hypoxia,P
8197,7015,70200,establishment of protein localization to telomere,P
8198,7015,7005,mitochondrion organization,P
8199,7015,2000773,negative regulation of cellular senescence,P
8200,7015,2000773,negative regulation of cellular senescence,P
8201,7015,2000352,negative regulation of endothelial cell apoptotic process,P
8202,7015,2001240,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,P
8203,7015,10629,negative regulation of gene expression,P
8204,7015,60253,negative regulation of glial cell proliferation,P
8205,7015,43524,negative regulation of neuron apoptotic process,P
8206,7015,1903704,negative regulation of production of siRNA involved in RNA interference,P
8207,7015,1900087,positive regulation of G1/S transition of mitotic cell cycle,P
8208,7015,30177,positive regulation of Wnt signaling pathway,P
8209,7015,45766,positive regulation of angiogenesis,P
8210,7015,46326,positive regulation of glucose import,P
8211,7015,42635,positive regulation of hair cycle,P
8212,7015,51000,positive regulation of nitric-oxide synthase activity,P
8213,7015,1902895,positive regulation of pri-miRNA transcription from RNA polymerase II promoter,P
8214,7015,32092,positive regulation of protein binding,P
8215,7015,1904751,positive regulation of protein localization to nucleolus,P
8216,7015,2000648,positive regulation of stem cell proliferation,P
8217,7015,1903620,positive regulation of transdifferentiation,P
8218,7015,1904754,positive regulation of vascular associated smooth muscle cell migration,P
8219,7015,1904707,positive regulation of vascular smooth muscle cell proliferation,P
8220,7015,30422,production of siRNA involved in RNA interference,P
8221,7015,31647,regulation of protein stability,P
8222,7015,31647,regulation of protein stability,P
8223,7015,90399,replicative senescence,P
8224,7015,46686,response to cadmium ion,P
8225,7015,723,telomere maintenance,P
8226,7015,7004,telomere maintenance via telomerase,P
8227,7015,7004,telomere maintenance via telomerase,P
8228,7015,7004,telomere maintenance via telomerase,P
8229,7015,7004,telomere maintenance via telomerase,P
8230,7015,1172,"transcription, RNA-templated",P
8231,7015,16605,PML body,C
8232,7015,31379,RNA-directed RNA polymerase complex,C
8233,7015,1990572,TERT-RMRP complex,C
8234,7015,781,"chromosome, telomeric region",C
8235,7015,42645,mitochondrial nucleoid,C
8236,7015,784,"nuclear chromosome, telomeric region",C
8237,7015,783,nuclear telomere cap complex,C
8238,7015,5730,nucleolus,C
8239,7015,5730,nucleolus,C
8240,7015,5654,nucleoplasm,C
8241,7015,5654,nucleoplasm,C
8242,7015,5634,nucleus,C
8243,7015,5886,plasma membrane,C
8244,7015,333,telomerase catalytic core complex,C
8245,7015,333,telomerase catalytic core complex,C
8246,7015,333,telomerase catalytic core complex,C
8247,7015,5697,telomerase holoenzyme complex,C
8248,7015,5697,telomerase holoenzyme complex,C
8249,7015,5697,telomerase holoenzyme complex,C
8250,7023,3677,DNA binding,F
8251,7023,70888,E-box binding,F
8252,7023,978,RNA polymerase II core promoter proximal region sequence-specific DNA binding,F
8253,7023,42826,histone deacetylase binding,F
8254,7023,5515,protein binding,F
8255,7023,46982,protein heterodimerization activity,F
8256,7023,42803,protein homodimerization activity,F
8257,7023,43565,sequence-specific DNA binding,F
8258,7023,3713,transcription coactivator activity,F
8259,7023,3705,"transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding",F
8260,7023,44212,transcription regulatory region DNA binding,F
8261,7023,1077,"transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding",F
8262,7023,6978,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator",P
8263,7023,71549,cellular response to dexamethasone stimulus,P
8264,7023,43922,negative regulation by host of viral transcription,P
8265,7023,43922,negative regulation by host of viral transcription,P
8266,7023,43392,negative regulation of DNA binding,P
8267,7023,71157,negative regulation of cell cycle arrest,P
8268,7023,8285,negative regulation of cell proliferation,P
8269,7023,45736,negative regulation of cyclin-dependent protein serine/threonine kinase activity,P
8270,7023,45892,"negative regulation of transcription, DNA-templated",P
8271,7023,45892,"negative regulation of transcription, DNA-templated",P
8272,7023,43923,positive regulation by host of viral transcription,P
8273,7023,43065,positive regulation of apoptotic process,P
8274,7023,2001269,positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,P
8275,7023,45944,positive regulation of transcription from RNA polymerase II promoter,P
8276,7023,45893,"positive regulation of transcription, DNA-templated",P
8277,7023,6461,protein complex assembly,P
8278,7023,1901990,regulation of mitotic cell cycle phase transition,P
8279,7023,6366,transcription from RNA polymerase II promoter,P
8280,7023,5739,mitochondrion,C
8281,7023,5634,nucleus,C
8282,7023,17053,transcriptional repressor complex,C
8283,7027,3677,DNA binding,F
8284,7027,981,"RNA polymerase II transcription factor activity, sequence-specific DNA binding",F
8285,7027,5515,protein binding,F
8286,7027,19904,protein domain specific binding,F
8287,7027,3713,transcription coactivator activity,F
8288,7027,3700,"transcription factor activity, sequence-specific DNA binding",F
8289,7027,8134,transcription factor binding,F
8290,7027,6977,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest",P
8291,7027,8283,cell proliferation,P
8292,7027,70345,negative regulation of fat cell proliferation,P
8293,7027,1900740,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,P
8294,7027,45944,positive regulation of transcription from RNA polymerase II promoter,P
8295,7027,6357,regulation of transcription from RNA polymerase II promoter,P
8296,7027,6351,"transcription, DNA-templated",P
8297,7027,5829,cytosol,C
8298,7027,5739,mitochondrion,C
8299,7027,5654,nucleoplasm,C
8300,7027,5654,nucleoplasm,C
8301,7027,5634,nucleus,C
8302,7027,5667,transcription factor complex,C
8303,7041,70411,I-SMAD binding,F
8304,7041,48495,Roundabout binding,F
8305,7041,50681,androgen receptor binding,F
8306,7041,50681,androgen receptor binding,F
8307,7041,5515,protein binding,F
8308,7041,3713,transcription coactivator activity,F
8309,7041,3713,transcription coactivator activity,F
8310,7041,8270,zinc ion binding,F
8311,7041,16055,Wnt signaling pathway,P
8312,7041,30521,androgen receptor signaling pathway,P
8313,7041,7155,cell adhesion,P
8314,7041,45165,cell fate commitment,P
8315,7041,30855,epithelial cell differentiation,P
8316,7041,16331,morphogenesis of embryonic epithelium,P
8317,7041,8285,negative regulation of cell proliferation,P
8318,7041,45599,negative regulation of fat cell differentiation,P
8319,7041,30512,negative regulation of transforming growth factor beta receptor signaling pathway,P
8320,7041,10718,positive regulation of epithelial to mesenchymal transition,P
8321,7041,45893,"positive regulation of transcription, DNA-templated",P
8322,7041,45893,"positive regulation of transcription, DNA-templated",P
8323,7041,30511,positive regulation of transforming growth factor beta receptor signaling pathway,P
8324,7041,9408,response to heat,P
8325,7041,6366,transcription from RNA polymerase II promoter,P
8326,7041,30579,ubiquitin-dependent SMAD protein catabolic process,P
8327,7041,5737,cytoplasm,C
8328,7041,5856,cytoskeleton,C
8329,7041,31012,extracellular matrix,C
8330,7041,5925,focal adhesion,C
8331,7041,5622,intracellular,C
8332,7041,16363,nuclear matrix,C
8333,7098,3725,double-stranded RNA binding,F
8334,7098,3725,double-stranded RNA binding,F
8335,7098,42802,identical protein binding,F
8336,7098,5515,protein binding,F
8337,7098,4872,receptor activity,F
8338,7098,4888,transmembrane signaling receptor activity,F
8339,7098,7249,I-kappaB kinase/NF-kappaB signaling,P
8340,7098,7252,I-kappaB phosphorylation,P
8341,7098,2756,MyD88-independent toll-like receptor signaling pathway,P
8342,7098,35666,TRIF-dependent toll-like receptor signaling pathway,P
8343,7098,7250,activation of NF-kappaB-inducing kinase activity,P
8344,7098,97190,apoptotic signaling pathway,P
8345,7098,35690,cellular response to drug,P
8346,7098,71360,cellular response to exogenous dsRNA,P
8347,7098,35458,cellular response to interferon-beta,P
8348,7098,71346,cellular response to interferon-gamma,P
8349,7098,71260,cellular response to mechanical stimulus,P
8350,7098,42742,defense response to bacterium,P
8351,7098,51607,defense response to virus,P
8352,7098,9597,detection of virus,P
8353,7098,97191,extrinsic apoptotic signaling pathway,P
8354,7098,6972,hyperosmotic response,P
8355,7098,6954,inflammatory response,P
8356,7098,45087,innate immune response,P
8357,7098,8584,male gonad development,P
8358,7098,2282,microglial cell activation involved in immune response,P
8359,7098,70266,necroptotic process,P
8360,7098,97527,necroptotic signaling pathway,P
8361,7098,34128,negative regulation of MyD88-independent toll-like receptor signaling pathway,P
8362,7098,45671,negative regulation of osteoclast differentiation,P
8363,7098,46330,positive regulation of JNK cascade,P
8364,7098,42346,positive regulation of NF-kappaB import into nucleus,P
8365,7098,51092,positive regulation of NF-kappaB transcription factor activity,P
8366,7098,43065,positive regulation of apoptotic process,P
8367,7098,45080,positive regulation of chemokine biosynthetic process,P
8368,7098,32722,positive regulation of chemokine production,P
8369,7098,10628,positive regulation of gene expression,P
8370,7098,50729,positive regulation of inflammatory response,P
8371,7098,45356,positive regulation of interferon-alpha biosynthetic process,P
8372,7098,45359,positive regulation of interferon-beta biosynthetic process,P
8373,7098,45359,positive regulation of interferon-beta biosynthetic process,P
8374,7098,32728,positive regulation of interferon-beta production,P
8375,7098,45078,positive regulation of interferon-gamma biosynthetic process,P
8376,7098,32735,positive regulation of interleukin-12 production,P
8377,7098,32755,positive regulation of interleukin-6 production,P
8378,7098,32757,positive regulation of interleukin-8 production,P
8379,7098,34123,positive regulation of toll-like receptor signaling pathway,P
8380,7098,45944,positive regulation of transcription from RNA polymerase II promoter,P
8381,7098,32760,positive regulation of tumor necrosis factor production,P
8382,7098,34346,positive regulation of type III interferon production,P
8383,7098,2730,regulation of dendritic cell cytokine production,P
8384,7098,43330,response to exogenous dsRNA,P
8385,7098,7165,signal transduction,P
8386,7098,34138,toll-like receptor 3 signaling pathway,P
8387,7098,2224,toll-like receptor signaling pathway,P
8388,7098,139,Golgi membrane,C
8389,7098,9986,cell surface,C
8390,7098,5737,cytoplasm,C
8391,7098,5769,early endosome,C
8392,7098,36020,endolysosome membrane,C
8393,7098,5789,endoplasmic reticulum membrane,C
8394,7098,10008,endosome membrane,C
8395,7098,5887,integral component of plasma membrane,C
8396,7098,5622,intracellular,C
8397,7098,5765,lysosomal membrane,C
8398,7098,16020,membrane,C
8399,7114,3723,RNA binding,F
8400,7114,3785,actin monomer binding,F
8401,7114,19899,enzyme binding,F
8402,7114,5515,protein binding,F
8403,7114,7015,actin filament organization,P
8404,7114,7253,cytoplasmic sequestering of NF-kappaB,P
8405,7114,32088,negative regulation of NF-kappaB transcription factor activity,P
8406,7114,1901223,negative regulation of NIK/NF-kappaB signaling,P
8407,7114,1903026,negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding,P
8408,7114,2000483,negative regulation of interleukin-8 secretion,P
8409,7114,2576,platelet degranulation,P
8410,7114,2001171,positive regulation of ATP biosynthetic process,P
8411,7114,43536,positive regulation of blood vessel endothelial cell migration,P
8412,7114,43536,positive regulation of blood vessel endothelial cell migration,P
8413,7114,2001028,positive regulation of endothelial cell chemotaxis,P
8414,7114,1905273,"positive regulation of proton-transporting ATP synthase activity, rotational mechanism",P
8415,7114,1901222,regulation of NIK/NF-kappaB signaling,P
8416,7114,50727,regulation of inflammatory response,P
8417,7114,42989,sequestering of actin monomers,P
8418,7114,33209,tumor necrosis factor-mediated signaling pathway,P
8419,7114,5737,cytoplasm,C
8420,7114,5856,cytoskeleton,C
8421,7114,5829,cytosol,C
8422,7114,5576,extracellular region,C
8423,7114,5615,extracellular space,C
8424,7114,5622,intracellular,C
8425,7114,5634,nucleus,C
8426,7114,31093,platelet alpha granule lumen,C
8427,8741,5125,cytokine activity,F
8428,8741,5102,receptor binding,F
8429,8741,5164,tumor necrosis factor receptor binding,F
8430,8741,6955,immune response,P
8431,8741,8284,positive regulation of cell proliferation,P
8432,8741,48298,positive regulation of isotype switching to IgA isotypes,P
8433,8741,43488,regulation of mRNA stability,P
8434,8741,7165,signal transduction,P
8435,8741,33209,tumor necrosis factor-mediated signaling pathway,P
8436,8741,5737,cytoplasm,C
8437,8741,5829,cytosol,C
8438,8741,70062,extracellular exosome,C
8439,8741,5576,extracellular region,C
8440,8741,5615,extracellular space,C
8441,8741,16020,membrane,C
8442,8741,5654,nucleoplasm,C
8443,9966,5125,cytokine activity,F
8444,9966,5102,receptor binding,F
8445,9966,5164,tumor necrosis factor receptor binding,F
8446,9966,7250,activation of NF-kappaB-inducing kinase activity,P
8447,9966,6919,activation of cysteine-type endopeptidase activity involved in apoptotic process,P
8448,9966,6915,apoptotic process,P
8449,9966,42107,cytokine metabolic process,P
8450,9966,6955,immune response,P
8451,9966,7165,signal transduction,P
8452,9966,33209,tumor necrosis factor-mediated signaling pathway,P
8453,9966,5615,extracellular space,C
8454,9966,16021,integral component of membrane,C
8455,9966,5887,integral component of plasma membrane,C
8456,9966,5622,intracellular,C
8457,9966,5886,plasma membrane,C
8458,9966,5886,plasma membrane,C
8459,7150,5524,ATP binding,F
8460,7150,3677,DNA binding,F
8461,7150,3677,DNA binding,F
8462,7150,3917,DNA topoisomerase type I activity,F
8463,7150,3917,DNA topoisomerase type I activity,F
8464,7150,3723,RNA binding,F
8465,7150,3682,chromatin binding,F
8466,7150,1046,core promoter sequence-specific DNA binding,F
8467,7150,3690,double-stranded DNA binding,F
8468,7150,5515,protein binding,F
8469,7150,19904,protein domain specific binding,F
8470,7150,4674,protein serine/threonine kinase activity,F
8471,7150,3697,single-stranded DNA binding,F
8472,7150,97100,supercoiled DNA binding,F
8473,7150,6260,DNA replication,P
8474,7150,6265,DNA topological change,P
8475,7150,6265,DNA topological change,P
8476,7150,6338,chromatin remodeling,P
8477,7150,7059,chromosome segregation,P
8478,7150,32922,circadian regulation of gene expression,P
8479,7150,7623,circadian rhythm,P
8480,7150,40016,embryonic cleavage,P
8481,7150,18105,peptidyl-serine phosphorylation,P
8482,7150,16310,phosphorylation,P
8483,7150,12501,programmed cell death,P
8484,7150,16925,protein sumoylation,P
8485,7150,42493,response to drug,P
8486,7150,16032,viral process,P
8487,7150,9330,DNA topoisomerase complex (ATP-hydrolyzing),C
8488,7150,932,P-body,C
8489,7150,1650,fibrillar center,C
8490,7150,228,nuclear chromosome,C
8491,7150,5730,nucleolus,C
8492,7150,5730,nucleolus,C
8493,7150,5654,nucleoplasm,C
8494,7150,5654,nucleoplasm,C
8495,7150,5654,nucleoplasm,C
8496,7150,5634,nucleus,C
8497,7150,43204,perikaryon,C
8498,7150,32993,protein-DNA complex,C
8499,7150,31298,replication fork protection complex,C
8500,8626,3677,DNA binding,F
8501,8626,97371,MDM2/MDM4 family protein binding,F
8502,8626,50699,WW domain binding,F
8503,8626,3682,chromatin binding,F
8504,8626,3684,damaged DNA binding,F
8505,8626,3690,double-stranded DNA binding,F
8506,8626,42802,identical protein binding,F
8507,8626,46872,metal ion binding,F
8508,8626,2039,p53 binding,F
8509,8626,2039,p53 binding,F
8510,8626,5515,protein binding,F
8511,8626,43565,sequence-specific DNA binding,F
8512,8626,3700,"transcription factor activity, sequence-specific DNA binding",F
8513,8626,3700,"transcription factor activity, sequence-specific DNA binding",F
8514,8626,989,"transcription factor activity, transcription factor binding",F
8515,8626,44212,transcription regulatory region DNA binding,F
8516,8626,1077,"transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding",F
8517,8626,6978,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator",P
8518,8626,7219,Notch signaling pathway,P
8519,8626,6915,apoptotic process,P
8520,8626,34644,cellular response to UV,P
8521,8626,6338,chromatin remodeling,P
8522,8626,60197,cloacal septation,P
8523,8626,7499,ectoderm and mesoderm interaction,P
8524,8626,30326,embryonic limb morphogenesis,P
8525,8626,10481,epidermal cell division,P
8526,8626,2064,epithelial cell development,P
8527,8626,1736,establishment of planar polarity,P
8528,8626,61436,establishment of skin barrier,P
8529,8626,48807,female genitalia morphogenesis,P
8530,8626,31069,hair follicle morphogenesis,P
8531,8626,42771,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,P
8532,8626,30216,keratinocyte differentiation,P
8533,8626,43616,keratinocyte proliferation,P
8534,8626,31571,mitotic G1 DNA damage checkpoint,P
8535,8626,10259,multicellular organism aging,P
8536,8626,43066,negative regulation of apoptotic process,P
8537,8626,33147,negative regulation of intracellular estrogen receptor signaling pathway,P
8538,8626,45617,negative regulation of keratinocyte differentiation,P
8539,8626,2000381,negative regulation of mesoderm development,P
8540,8626,122,negative regulation of transcription from RNA polymerase II promoter,P
8541,8626,45892,"negative regulation of transcription, DNA-templated",P
8542,8626,51402,neuron apoptotic process,P
8543,8626,42475,odontogenesis of dentin-containing tooth,P
8544,8626,30859,polarized epithelial cell differentiation,P
8545,8626,45747,positive regulation of Notch signaling pathway,P
8546,8626,2000271,positive regulation of fibroblast apoptotic process,P
8547,8626,10838,positive regulation of keratinocyte proliferation,P
8548,8626,2053,positive regulation of mesenchymal cell proliferation,P
8549,8626,45669,positive regulation of osteoblast differentiation,P
8550,8626,1900740,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,P
8551,8626,1904674,positive regulation of somatic stem cell population maintenance,P
8552,8626,45944,positive regulation of transcription from RNA polymerase II promoter,P
8553,8626,45893,"positive regulation of transcription, DNA-templated",P
8554,8626,45893,"positive regulation of transcription, DNA-templated",P
8555,8626,45893,"positive regulation of transcription, DNA-templated",P
8556,8626,36342,post-anal tail morphogenesis,P
8557,8626,60513,prostatic bud formation,P
8558,8626,51289,protein homotetramerization,P
8559,8626,9954,proximal/distal pattern formation,P
8560,8626,42981,regulation of apoptotic process,P
8561,8626,43281,regulation of cysteine-type endopeptidase activity involved in apoptotic process,P
8562,8626,10482,regulation of epidermal cell division,P
8563,8626,43523,regulation of neuron apoptotic process,P
8564,8626,1901796,regulation of signal transduction by p53 class mediator,P
8565,8626,1302,replicative cell aging,P
8566,8626,10165,response to X-ray,P
8567,8626,10332,response to gamma radiation,P
8568,8626,1501,skeletal system development,P
8569,8626,43589,skin morphogenesis,P
8570,8626,48745,smooth muscle tissue development,P
8571,8626,7283,spermatogenesis,P
8572,8626,60529,squamous basal epithelial stem cell differentiation involved in prostate gland acinus development,P
8573,8626,48485,sympathetic nervous system development,P
8574,8626,6366,transcription from RNA polymerase II promoter,P
8575,8626,60157,urinary bladder development,P
8576,8626,5794,Golgi apparatus,C
8577,8626,5737,cytoplasm,C
8578,8626,5829,cytosol,C
8579,8626,5829,cytosol,C
8580,8626,30425,dendrite,C
8581,8626,5739,mitochondrion,C
8582,8626,790,nuclear chromatin,C
8583,8626,5654,nucleoplasm,C
8584,8626,5654,nucleoplasm,C
8585,8626,5634,nucleus,C
8586,8626,5634,nucleus,C
8587,8626,5791,rough endoplasmic reticulum,C
8588,8626,5667,transcription factor complex,C
8589,7175,3723,RNA binding,F
8590,7175,3682,chromatin binding,F
8591,7175,70840,dynein complex binding,F
8592,7175,31072,heat shock protein binding,F
8593,7175,3729,mRNA binding,F
8594,7175,51019,mitogen-activated protein kinase binding,F
8595,7175,3674,molecular_function,F
8596,7175,5487,nucleocytoplasmic transporter activity,F
8597,7175,43495,protein anchor,F
8598,7175,5515,protein binding,F
8599,7175,42803,protein homodimerization activity,F
8600,7175,5215,transporter activity,F
8601,7175,15631,tubulin binding,F
8602,7175,189,MAPK import into nucleus,P
8603,7175,6405,RNA export from nucleus,P
8604,7175,6404,RNA import into nucleus,P
8605,7175,8150,biological_process,P
8606,7175,51301,cell division,P
8607,7175,34605,cellular response to heat,P
8608,7175,35457,cellular response to interferon-alpha,P
8609,7175,31047,gene silencing by RNA,P
8610,7175,75733,intracellular transport of virus,P
8611,7175,6406,mRNA export from nucleus,P
8612,7175,31990,mRNA export from nucleus in response to heat stress,P
8613,7175,7077,mitotic nuclear envelope disassembly,P
8614,7175,7094,mitotic spindle assembly checkpoint,P
8615,7175,46832,negative regulation of RNA export from nucleus,P
8616,7175,46832,negative regulation of RNA export from nucleus,P
8617,7175,122,negative regulation of transcription from RNA polymerase II promoter,P
8618,7175,45947,negative regulation of translational initiation,P
8619,7175,43578,nuclear matrix organization,P
8620,7175,51292,nuclear pore complex assembly,P
8621,7175,6999,nuclear pore organization,P
8622,7175,6999,nuclear pore organization,P
8623,7175,31453,positive regulation of heterochromatin assembly,P
8624,7175,90316,positive regulation of intracellular protein transport,P
8625,7175,90267,positive regulation of mitotic cell cycle spindle assembly checkpoint,P
8626,7175,46827,positive regulation of protein export from nucleus,P
8627,7175,42307,positive regulation of protein import into nucleus,P
8628,7175,6611,protein export from nucleus,P
8629,7175,6606,protein import into nucleus,P
8630,7175,6606,protein import into nucleus,P
8631,7175,16925,protein sumoylation,P
8632,7175,1900034,regulation of cellular response to heat,P
8633,7175,10827,regulation of glucose transport,P
8634,7175,10793,regulation of mRNA export from nucleus,P
8635,7175,10965,regulation of mitotic sister chromatid separation,P
8636,7175,1901673,regulation of mitotic spindle assembly,P
8637,7175,46825,regulation of protein export from nucleus,P
8638,7175,42306,regulation of protein import into nucleus,P
8639,7175,31647,regulation of protein stability,P
8640,7175,70849,response to epidermal growth factor,P
8641,7175,6409,tRNA export from nucleus,P
8642,7175,16032,viral process,P
8643,7175,19083,viral transcription,P
8644,7175,5575,cellular_component,C
8645,7175,5737,cytoplasm,C
8646,7175,5868,cytoplasmic dynein complex,C
8647,7175,19898,extrinsic component of membrane,C
8648,7175,776,kinetochore,C
8649,7175,776,kinetochore,C
8650,7175,776,kinetochore,C
8651,7175,72686,mitotic spindle,C
8652,7175,5635,nuclear envelope,C
8653,7175,42405,nuclear inclusion body,C
8654,7175,31965,nuclear membrane,C
8655,7175,34399,nuclear periphery,C
8656,7175,5643,nuclear pore,C
8657,7175,44615,nuclear pore nuclear basket,C
8658,7175,5654,nucleoplasm,C
8659,7175,5634,nucleus,C
8660,7157,5524,ATP binding,F
8661,7157,3677,DNA binding,F
8662,7157,3677,DNA binding,F
8663,7157,977,RNA polymerase II regulatory region sequence-specific DNA binding,F
8664,7157,981,"RNA polymerase II transcription factor activity, sequence-specific DNA binding",F
8665,7157,1085,RNA polymerase II transcription factor binding,F
8666,7157,51087,chaperone binding,F
8667,7157,3682,chromatin binding,F
8668,7157,5507,copper ion binding,F
8669,7157,1046,core promoter sequence-specific DNA binding,F
8670,7157,1046,core promoter sequence-specific DNA binding,F
8671,7157,3684,damaged DNA binding,F
8672,7157,97718,disordered domain specific binding,F
8673,7157,19899,enzyme binding,F
8674,7157,35035,histone acetyltransferase binding,F
8675,7157,42826,histone deacetylase binding,F
8676,7157,42802,identical protein binding,F
8677,7157,42802,identical protein binding,F
8678,7157,3730,mRNA 3'-UTR binding,F
8679,7157,2039,p53 binding,F
8680,7157,2039,p53 binding,F
8681,7157,2020,protease binding,F
8682,7157,47485,protein N-terminus binding,F
8683,7157,5515,protein binding,F
8684,7157,46982,protein heterodimerization activity,F
8685,7157,19901,protein kinase binding,F
8686,7157,51721,protein phosphatase 2A binding,F
8687,7157,19903,protein phosphatase binding,F
8688,7157,43621,protein self-association,F
8689,7157,30971,receptor tyrosine kinase binding,F
8690,7157,990,"transcription factor activity, core RNA polymerase binding",F
8691,7157,3700,"transcription factor activity, sequence-specific DNA binding",F
8692,7157,8134,transcription factor binding,F
8693,7157,44212,transcription regulatory region DNA binding,F
8694,7157,1228,"transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding",F
8695,7157,31625,ubiquitin protein ligase binding,F
8696,7157,8270,zinc ion binding,F
8697,7157,30330,"DNA damage response, signal transduction by p53 class mediator",P
8698,7157,30330,"DNA damage response, signal transduction by p53 class mediator",P
8699,7157,6977,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest",P
8700,7157,6977,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest",P
8701,7157,6978,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator",P
8702,7157,6978,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator",P
8703,7157,733,DNA strand renaturation,P
8704,7157,6983,ER overload response,P
8705,7157,7265,Ras protein signal transduction,P
8706,7157,6914,autophagy,P
8707,7157,6284,base-excision repair,P
8708,7157,7569,cell aging,P
8709,7157,7050,cell cycle arrest,P
8710,7157,7050,cell cycle arrest,P
8711,7157,30154,cell differentiation,P
8712,7157,8283,cell proliferation,P
8713,7157,6974,cellular response to DNA damage stimulus,P
8714,7157,34644,cellular response to UV,P
8715,7157,34644,cellular response to UV,P
8716,7157,72717,cellular response to actinomycin D,P
8717,7157,35690,cellular response to drug,P
8718,7157,71480,cellular response to gamma radiation,P
8719,7157,42149,cellular response to glucose starvation,P
8720,7157,71456,cellular response to hypoxia,P
8721,7157,71479,cellular response to ionizing radiation,P
8722,7157,31497,chromatin assembly,P
8723,7157,48512,circadian behavior,P
8724,7157,8340,determination of adult lifespan,P
8725,7157,43153,entrainment of circadian clock by photoperiod,P
8726,7157,97193,intrinsic apoptotic signaling pathway,P
8727,7157,72332,intrinsic apoptotic signaling pathway by p53 class mediator,P
8728,7157,42771,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,P
8729,7157,42771,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,P
8730,7157,31571,mitotic G1 DNA damage checkpoint,P
8731,7157,7275,multicellular organism development,P
8732,7157,43066,negative regulation of apoptotic process,P
8733,7157,30308,negative regulation of cell growth,P
8734,7157,8285,negative regulation of cell proliferation,P
8735,7157,8285,negative regulation of cell proliferation,P
8736,7157,8285,negative regulation of cell proliferation,P
8737,7157,48147,negative regulation of fibroblast proliferation,P
8738,7157,51097,negative regulation of helicase activity,P
8739,7157,51974,negative regulation of telomerase activity,P
8740,7157,122,negative regulation of transcription from RNA polymerase II promoter,P
8741,7157,122,negative regulation of transcription from RNA polymerase II promoter,P
8742,7157,45892,"negative regulation of transcription, DNA-templated",P
8743,7157,45892,"negative regulation of transcription, DNA-templated",P
8744,7157,45892,"negative regulation of transcription, DNA-templated",P
8745,7157,6289,nucleotide-excision repair,P
8746,7157,97252,oligodendrocyte apoptotic process,P
8747,7157,90403,oxidative stress-induced premature senescence,P
8748,7157,48015,phosphatidylinositol-mediated signaling,P
8749,7157,43065,positive regulation of apoptotic process,P
8750,7157,71158,positive regulation of cell cycle arrest,P
8751,7157,71158,positive regulation of cell cycle arrest,P
8752,7157,1900119,positive regulation of execution phase of apoptosis,P
8753,7157,10628,positive regulation of gene expression,P
8754,7157,10628,positive regulation of gene expression,P
8755,7157,31065,positive regulation of histone deacetylation,P
8756,7157,2001244,positive regulation of intrinsic apoptotic signaling pathway,P
8757,7157,43525,positive regulation of neuron apoptotic process,P
8758,7157,50731,positive regulation of peptidyl-tyrosine phosphorylation,P
8759,7157,46827,positive regulation of protein export from nucleus,P
8760,7157,1900740,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,P
8761,7157,32461,positive regulation of protein oligomerization,P
8762,7157,2000379,positive regulation of reactive oxygen species metabolic process,P
8763,7157,90200,positive regulation of release of cytochrome c from mitochondria,P
8764,7157,70245,positive regulation of thymocyte apoptotic process,P
8765,7157,45944,positive regulation of transcription from RNA polymerase II promoter,P
8766,7157,45944,positive regulation of transcription from RNA polymerase II promoter,P
8767,7157,45944,positive regulation of transcription from RNA polymerase II promoter,P
8768,7157,1990440,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,P
8769,7157,45893,"positive regulation of transcription, DNA-templated",P
8770,7157,45893,"positive regulation of transcription, DNA-templated",P
8771,7157,43161,proteasome-mediated ubiquitin-dependent protein catabolic process,P
8772,7157,6461,protein complex assembly,P
8773,7157,16579,protein deubiquitination,P
8774,7157,51289,protein homotetramerization,P
8775,7157,8104,protein localization,P
8776,7157,51262,protein tetramerization,P
8777,7157,42981,regulation of apoptotic process,P
8778,7157,42981,regulation of apoptotic process,P
8779,7157,1902749,regulation of cell cycle G2/M phase transition,P
8780,7157,46902,regulation of mitochondrial membrane permeability,P
8781,7157,1901796,regulation of signal transduction by p53 class mediator,P
8782,7157,6355,"regulation of transcription, DNA-templated",P
8783,7157,6355,"regulation of transcription, DNA-templated",P
8784,7157,90399,replicative senescence,P
8785,7157,10165,response to X-ray,P
8786,7157,46677,response to antibiotic,P
8787,7157,10332,response to gamma radiation,P
8788,7157,72331,signal transduction by p53 class mediator,P
8789,7157,6366,transcription from RNA polymerase II promoter,P
8790,7157,16032,viral process,P
8791,7157,16605,PML body,C
8792,7157,5737,cytoplasm,C
8793,7157,5829,cytosol,C
8794,7157,5829,cytosol,C
8795,7157,5783,endoplasmic reticulum,C
8796,7157,5622,intracellular,C
8797,7157,5759,mitochondrial matrix,C
8798,7157,5739,mitochondrion,C
8799,7157,16604,nuclear body,C
8800,7157,790,nuclear chromatin,C
8801,7157,16363,nuclear matrix,C
8802,7157,5730,nucleolus,C
8803,7157,5654,nucleoplasm,C
8804,7157,5654,nucleoplasm,C
8805,7157,5634,nucleus,C
8806,7157,43234,protein complex,C
8807,7157,43234,protein complex,C
8808,7157,5657,replication fork,C
8809,7157,5669,transcription factor TFIID complex,C
8810,10155,3677,DNA binding,F
8811,10155,35851,Krueppel-associated box domain binding,F
8812,10155,3723,RNA binding,F
8813,10155,1105,RNA polymerase II transcription coactivator activity,F
8814,10155,3682,chromatin binding,F
8815,10155,70087,chromo shadow domain binding,F
8816,10155,1990841,promoter-specific chromatin binding,F
8817,10155,5515,protein binding,F
8818,10155,4672,protein kinase activity,F
8819,10155,43565,sequence-specific DNA binding,F
8820,10155,3714,transcription corepressor activity,F
8821,10155,3700,"transcription factor activity, sequence-specific DNA binding",F
8822,10155,31625,ubiquitin protein ligase binding,F
8823,10155,4842,ubiquitin-protein transferase activity,F
8824,10155,8270,zinc ion binding,F
8825,10155,43045,DNA methylation involved in embryo development,P
8826,10155,6281,DNA repair,P
8827,10155,7265,Ras protein signal transduction,P
8828,10155,60028,convergent extension involved in axis elongation,P
8829,10155,16569,covalent chromatin modification,P
8830,10155,7566,embryo implantation,P
8831,10155,60669,embryonic placenta morphogenesis,P
8832,10155,1837,epithelial to mesenchymal transition,P
8833,10155,45087,innate immune response,P
8834,10155,1901536,negative regulation of DNA demethylation,P
8835,10155,45869,negative regulation of single stranded viral RNA replication via double stranded DNA intermediate,P
8836,10155,122,negative regulation of transcription from RNA polymerase II promoter,P
8837,10155,45892,"negative regulation of transcription, DNA-templated",P
8838,10155,1902187,negative regulation of viral release from host cell,P
8839,10155,43388,positive regulation of DNA binding,P
8840,10155,45739,positive regulation of DNA repair,P
8841,10155,90309,positive regulation of methylation-dependent chromatin silencing,P
8842,10155,42993,positive regulation of transcription factor import into nucleus,P
8843,10155,45944,positive regulation of transcription from RNA polymerase II promoter,P
8844,10155,45893,"positive regulation of transcription, DNA-templated",P
8845,10155,46777,protein autophosphorylation,P
8846,10155,51259,protein oligomerization,P
8847,10155,16925,protein sumoylation,P
8848,10155,16925,protein sumoylation,P
8849,10155,16567,protein ubiquitination,P
8850,10155,2000653,regulation of genetic imprinting,P
8851,10155,6367,transcription initiation from RNA polymerase II promoter,P
8852,10155,90575,RNA polymerase II transcription factor complex,C
8853,10155,5719,nuclear euchromatin,C
8854,10155,5720,nuclear heterochromatin,C
8855,10155,5654,nucleoplasm,C
8856,10155,5654,nucleoplasm,C
8857,10155,5634,nucleus,C
8858,10155,5634,nucleus,C
8859,79054,5262,calcium channel activity,F
8860,79054,5515,protein binding,F
8861,79054,42803,protein homodimerization activity,F
8862,79054,70588,calcium ion transmembrane transport,P
8863,79054,6874,cellular calcium ion homeostasis,P
8864,79054,16048,detection of temperature stimulus,P
8865,79054,51289,protein homotetramerization,P
8866,79054,70207,protein homotrimerization,P
8867,79054,9409,response to cold,P
8868,79054,50955,thermoception,P
8869,79054,5789,endoplasmic reticulum membrane,C
8870,79054,9897,external side of plasma membrane,C
8871,79054,16021,integral component of membrane,C
8872,79054,45121,membrane raft,C
8873,79054,5886,plasma membrane,C
8874,79054,5886,plasma membrane,C
8875,7295,3723,RNA binding,F
8876,7295,16671,"oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor",F
8877,7295,15037,peptide disulfide oxidoreductase activity,F
8878,7295,5515,protein binding,F
8879,7295,15035,protein disulfide oxidoreductase activity,F
8880,7295,47134,protein-disulfide reductase activity,F
8881,7295,4791,thioredoxin-disulfide reductase activity,F
8882,7295,32148,activation of protein kinase B activity,P
8883,7295,8283,cell proliferation,P
8884,7295,45454,cell redox homeostasis,P
8885,7295,7267,cell-cell signaling,P
8886,7295,98869,cellular oxidant detoxification,P
8887,7295,6662,glycerol ether metabolic process,P
8888,7295,6928,movement of cell or subcellular component,P
8889,7295,1903206,negative regulation of hydrogen peroxide-induced cell death,P
8890,7295,46826,negative regulation of protein export from nucleus,P
8891,7295,122,negative regulation of transcription from RNA polymerase II promoter,P
8892,7295,15949,nucleobase-containing small molecule interconversion,P
8893,7295,55114,oxidation-reduction process,P
8894,7295,43388,positive regulation of DNA binding,P
8895,7295,33138,positive regulation of peptidyl-serine phosphorylation,P
8896,7295,51897,positive regulation of protein kinase B signaling,P
8897,7295,30091,protein repair,P
8898,7295,33158,"regulation of protein import into nucleus, translocation",P
8899,7295,9314,response to radiation,P
8900,7295,302,response to reactive oxygen species,P
8901,7295,7165,signal transduction,P
8902,7295,6351,"transcription, DNA-templated",P
8903,7295,5737,cytoplasm,C
8904,7295,5829,cytosol,C
8905,7295,5829,cytosol,C
8906,7295,70062,extracellular exosome,C
8907,7295,5739,mitochondrion,C
8908,7295,5634,nucleus,C
8909,10628,4857,enzyme inhibitor activity,F
8910,10628,5515,protein binding,F
8911,10628,31625,ubiquitin protein ligase binding,F
8912,10628,7049,cell cycle,P
8913,10628,71228,cellular response to tumor cell,P
8914,10628,30216,keratinocyte differentiation,P
8915,10628,43086,negative regulation of catalytic activity,P
8916,10628,51782,negative regulation of cell division,P
8917,10628,122,negative regulation of transcription from RNA polymerase II promoter,P
8918,10628,48008,platelet-derived growth factor receptor signaling pathway,P
8919,10628,43065,positive regulation of apoptotic process,P
8920,10628,6606,protein import into nucleus,P
8921,10628,42127,regulation of cell proliferation,P
8922,10628,51592,response to calcium ion,P
8923,10628,42493,response to drug,P
8924,10628,32355,response to estradiol,P
8925,10628,9749,response to glucose,P
8926,10628,42542,response to hydrogen peroxide,P
8927,10628,9612,response to mechanical stimulus,P
8928,10628,32570,response to progesterone,P
8929,10628,6351,"transcription, DNA-templated",P
8930,10628,5737,cytoplasm,C
8931,10628,5829,cytosol,C
8932,10628,5758,mitochondrial intermembrane space,C
8933,10628,5634,nucleus,C
8934,80019,5515,protein binding,F
8935,80019,43130,ubiquitin binding,F
8936,7297,5524,ATP binding,F
8937,7297,5131,growth hormone receptor binding,F
8938,7297,4715,non-membrane spanning protein tyrosine kinase activity,F
8939,7297,4715,non-membrane spanning protein tyrosine kinase activity,F
8940,7297,5515,protein binding,F
8941,7297,4713,protein tyrosine kinase activity,F
8942,7297,4713,protein tyrosine kinase activity,F
8943,7297,31702,type 1 angiotensin receptor binding,F
8944,7297,30154,cell differentiation,P
8945,7297,16477,cell migration,P
8946,7297,45087,innate immune response,P
8947,7297,35556,intracellular signal transduction,P
8948,7297,38083,peptidyl-tyrosine autophosphorylation,P
8949,7297,6468,protein phosphorylation,P
8950,7297,42127,regulation of cell proliferation,P
8951,7297,60338,regulation of type I interferon-mediated signaling pathway,P
8952,7297,7169,transmembrane receptor protein tyrosine kinase signaling pathway,P
8953,7297,60337,type I interferon signaling pathway,P
8954,7297,5737,cytoplasm,C
8955,7297,5856,cytoskeleton,C
8956,7297,5829,cytosol,C
8957,7297,70062,extracellular exosome,C
8958,7297,31234,extrinsic component of cytoplasmic side of plasma membrane,C
8959,7297,5634,nucleus,C
8960,27287,5515,protein binding,F
8961,27287,43565,sequence-specific DNA binding,F
8962,27287,7275,multicellular organism development,P
8963,27287,6355,"regulation of transcription, DNA-templated",P
8964,27287,5634,nucleus,C
8965,7398,4197,cysteine-type endopeptidase activity,F
8966,7398,8233,peptidase activity,F
8967,7398,5515,protein binding,F
8968,7398,4843,thiol-dependent ubiquitin-specific protease activity,F
8969,7398,4843,thiol-dependent ubiquitin-specific protease activity,F
8970,7398,42769,"DNA damage response, detection of DNA damage",P
8971,7398,36297,interstrand cross-link repair,P
8972,7398,35520,monoubiquitinated protein deubiquitination,P
8973,7398,16579,protein deubiquitination,P
8974,7398,6282,regulation of DNA repair,P
8975,7398,9411,response to UV,P
8976,7398,1501,skeletal system development,P
8977,7398,6511,ubiquitin-dependent protein catabolic process,P
8978,7398,5654,nucleoplasm,C
8979,7398,5654,nucleoplasm,C
8980,7398,5634,nucleus,C
8981,7422,42056,chemoattractant activity,F
8982,7422,5125,cytokine activity,F
8983,7422,5125,cytokine activity,F
8984,7422,50840,extracellular matrix binding,F
8985,7422,1968,fibronectin binding,F
8986,7422,8083,growth factor activity,F
8987,7422,8083,growth factor activity,F
8988,7422,8201,heparin binding,F
8989,7422,8201,heparin binding,F
8990,7422,42802,identical protein binding,F
8991,7422,5161,platelet-derived growth factor receptor binding,F
8992,7422,5515,protein binding,F
8993,7422,46982,protein heterodimerization activity,F
8994,7422,42803,protein homodimerization activity,F
8995,7422,48018,receptor agonist activity,F
8996,7422,43183,vascular endothelial growth factor receptor 1 binding,F
8997,7422,43184,vascular endothelial growth factor receptor 2 binding,F
8998,7422,5172,vascular endothelial growth factor receptor binding,F
8999,7422,38190,VEGF-activated neuropilin signaling pathway,P
9000,7422,32147,activation of protein kinase activity,P
9001,7422,1525,angiogenesis,P
9002,7422,48844,artery morphogenesis,P
9003,7422,1569,branching involved in blood vessel morphogenesis,P
9004,7422,48754,branching morphogenesis of an epithelial tube,P
9005,7422,48593,camera-type eye morphogenesis,P
9006,7422,48739,cardiac muscle fiber development,P
9007,7422,60948,cardiac vascular smooth muscle cell development,P
9008,7422,48469,cell maturation,P
9009,7422,2042,cell migration involved in sprouting angiogenesis,P
9010,7422,71456,cellular response to hypoxia,P
9011,7422,35924,cellular response to vascular endothelial growth factor stimulus,P
9012,7422,71679,commissural neuron axon guidance,P
9013,7422,60982,coronary artery morphogenesis,P
9014,7422,3169,coronary vein morphogenesis,P
9015,7422,71542,dopaminergic neuron differentiation,P
9016,7422,35767,endothelial cell chemotaxis,P
9017,7422,30855,epithelial cell differentiation,P
9018,7422,42462,eye photoreceptor cell development,P
9019,7422,40007,growth,P
9020,7422,3007,heart morphogenesis,P
9021,7422,1701,in utero embryonic development,P
9022,7422,50930,induction of positive chemotaxis,P
9023,7422,50930,induction of positive chemotaxis,P
9024,7422,1822,kidney development,P
9025,7422,7595,lactation,P
9026,7422,30324,lung development,P
9027,7422,36303,lymph vessel morphogenesis,P
9028,7422,30225,macrophage differentiation,P
9029,7422,60749,mammary gland alveolus development,P
9030,7422,7498,mesoderm development,P
9031,7422,30224,monocyte differentiation,P
9032,7422,97475,motor neuron migration,P
9033,7422,43066,negative regulation of apoptotic process,P
9034,7422,43154,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,P
9035,7422,122,negative regulation of transcription from RNA polymerase II promoter,P
9036,7422,7399,nervous system development,P
9037,7422,3151,outflow tract morphogenesis,P
9038,7422,1541,ovarian follicle development,P
9039,7422,2576,platelet degranulation,P
9040,7422,50918,positive chemotaxis,P
9041,7422,32793,positive regulation of CREB transcription factor activity,P
9042,7422,43406,positive regulation of MAP kinase activity,P
9043,7422,45766,positive regulation of angiogenesis,P
9044,7422,45766,positive regulation of angiogenesis,P
9045,7422,48842,positive regulation of axon extension involved in axon guidance,P
9046,7422,43536,positive regulation of blood vessel endothelial cell migration,P
9047,7422,90190,positive regulation of branching involved in ureteric bud morphogenesis,P
9048,7422,45785,positive regulation of cell adhesion,P
9049,7422,51781,positive regulation of cell division,P
9050,7422,30335,positive regulation of cell migration,P
9051,7422,90050,positive regulation of cell migration involved in sprouting angiogenesis,P
9052,7422,8284,positive regulation of cell proliferation,P
9053,7422,8284,positive regulation of cell proliferation,P
9054,7422,38091,positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway,P
9055,7422,51272,positive regulation of cellular component movement,P
9056,7422,38033,positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway,P
9057,7422,10595,positive regulation of endothelial cell migration,P
9058,7422,1938,positive regulation of endothelial cell proliferation,P
9059,7422,1938,positive regulation of endothelial cell proliferation,P
9060,7422,50679,positive regulation of epithelial cell proliferation,P
9061,7422,51894,positive regulation of focal adhesion assembly,P
9062,7422,10628,positive regulation of gene expression,P
9063,7422,1901727,positive regulation of histone deacetylase activity,P
9064,7422,2687,positive regulation of leukocyte migration,P
9065,7422,60754,positive regulation of mast cell chemotaxis,P
9066,7422,2053,positive regulation of mesenchymal cell proliferation,P
9067,7422,2052,positive regulation of neuroblast proliferation,P
9068,7422,1900745,positive regulation of p38MAPK cascade,P
9069,7422,33138,positive regulation of peptidyl-serine phosphorylation,P
9070,7422,1900086,positive regulation of peptidyl-tyrosine autophosphorylation,P
9071,7422,50731,positive regulation of peptidyl-tyrosine phosphorylation,P
9072,7422,50927,positive regulation of positive chemotaxis,P
9073,7422,31954,positive regulation of protein autophosphorylation,P
9074,7422,31334,positive regulation of protein complex assembly,P
9075,7422,90037,positive regulation of protein kinase C signaling,P
9076,7422,1903572,positive regulation of protein kinase D signaling,P
9077,7422,1934,positive regulation of protein phosphorylation,P
9078,7422,2092,positive regulation of receptor internalization,P
9079,7422,1902336,positive regulation of retinal ganglion cell axon guidance,P
9080,7422,45944,positive regulation of transcription from RNA polymerase II promoter,P
9081,7422,45944,positive regulation of transcription from RNA polymerase II promoter,P
9082,7422,61419,positive regulation of transcription from RNA polymerase II promoter in response to hypoxia,P
9083,7422,30949,positive regulation of vascular endothelial growth factor receptor signaling pathway,P
9084,7422,31077,post-embryonic camera-type eye development,P
9085,7422,60319,primitive erythrocyte differentiation,P
9086,7422,30823,regulation of cGMP metabolic process,P
9087,7422,8360,regulation of cell shape,P
9088,7422,90259,regulation of retinal ganglion cell axon guidance,P
9089,7422,6357,regulation of transcription from RNA polymerase II promoter,P
9090,7422,61418,regulation of transcription from RNA polymerase II promoter in response to hypoxia,P
9091,7422,1666,response to hypoxia,P
9092,7422,43129,surfactant homeostasis,P
9093,7422,35148,tube formation,P
9094,7422,48010,vascular endothelial growth factor receptor signaling pathway,P
9095,7422,48010,vascular endothelial growth factor receptor signaling pathway,P
9096,7422,1570,vasculogenesis,P
9097,7422,9986,cell surface,C
9098,7422,5737,cytoplasm,C
9099,7422,5576,extracellular region,C
9100,7422,5615,extracellular space,C
9101,7422,5615,extracellular space,C
9102,7422,16020,membrane,C
9103,7422,31093,platelet alpha granule lumen,C
9104,7422,5578,proteinaceous extracellular matrix,C
9105,7422,30141,secretory granule,C
9106,51384,5109,frizzled binding,F
9107,51384,16055,Wnt signaling pathway,P
9108,51384,16055,Wnt signaling pathway,P
9109,51384,46849,bone remodeling,P
9110,51384,60317,cardiac epithelial to mesenchymal transition,P
9111,51384,45165,cell fate commitment,P
9112,51384,30216,keratinocyte differentiation,P
9113,51384,43616,keratinocyte proliferation,P
9114,51384,60548,negative regulation of cell death,P
9115,51384,30182,neuron differentiation,P
9116,51384,3408,optic cup formation involved in camera-type eye development,P
9117,51384,90403,oxidative stress-induced premature senescence,P
9118,51384,46330,positive regulation of JNK cascade,P
9119,51384,10628,positive regulation of gene expression,P
9120,51384,14068,positive regulation of phosphatidylinositol 3-kinase signaling,P
9121,51384,90399,replicative senescence,P
9122,51384,5737,cytoplasm,C
9123,51384,5576,extracellular region,C
9124,51384,5615,extracellular space,C
9125,51384,5578,proteinaceous extracellular matrix,C
9126,7472,5125,cytokine activity,F
9127,7472,5109,frizzled binding,F
9128,7472,5515,protein binding,F
9129,7472,48018,receptor agonist activity,F
9130,7472,48018,receptor agonist activity,F
9131,7472,16055,Wnt signaling pathway,P
9132,7472,16055,Wnt signaling pathway,P
9133,7472,55009,atrial cardiac muscle tissue morphogenesis,P
9134,7472,60070,canonical Wnt signaling pathway,P
9135,7472,60070,canonical Wnt signaling pathway,P
9136,7472,1904954,canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,P
9137,7472,60317,cardiac epithelial to mesenchymal transition,P
9138,7472,45165,cell fate commitment,P
9139,7472,33278,cell proliferation in midbrain,P
9140,7472,7267,cell-cell signaling,P
9141,7472,71300,cellular response to retinoic acid,P
9142,7472,71560,cellular response to transforming growth factor beta stimulus,P
9143,7472,61072,iris morphogenesis,P
9144,7472,60716,labyrinthine layer blood vessel development,P
9145,7472,2088,lens development in camera-type eye,P
9146,7472,30324,lung development,P
9147,7472,60492,lung induction,P
9148,7472,61180,mammary gland epithelium development,P
9149,7472,1904948,midbrain dopaminergic neuron differentiation,P
9150,7472,22008,neurogenesis,P
9151,7472,30182,neuron differentiation,P
9152,7472,90263,positive regulation of canonical Wnt signaling pathway,P
9153,7472,60045,positive regulation of cardiac muscle cell proliferation,P
9154,7472,8284,positive regulation of cell proliferation,P
9155,7472,1938,positive regulation of endothelial cell proliferation,P
9156,7472,60501,positive regulation of epithelial cell proliferation involved in lung morphogenesis,P
9157,7472,48146,positive regulation of fibroblast proliferation,P
9158,7472,2053,positive regulation of mesenchymal cell proliferation,P
9159,7472,50769,positive regulation of neurogenesis,P
9160,7472,51091,positive regulation of sequence-specific DNA binding transcription factor activity,P
9161,7472,45944,positive regulation of transcription from RNA polymerase II promoter,P
9162,7472,1990909,Wnt signalosome,C
9163,7472,5737,cytoplasm,C
9164,7472,31012,extracellular matrix,C
9165,7472,5576,extracellular region,C
9166,7472,5576,extracellular region,C
9167,7472,5615,extracellular space,C
9168,7472,5886,plasma membrane,C
9169,7472,5578,proteinaceous extracellular matrix,C
9170,7486,43138,3'-5' DNA helicase activity,F
9171,7486,8408,3'-5' exonuclease activity,F
9172,7486,70337,3'-flap-structured DNA binding,F
9173,7486,5524,ATP binding,F
9174,7486,43140,ATP-dependent 3'-5' DNA helicase activity,F
9175,7486,4003,ATP-dependent DNA helicase activity,F
9176,7486,16887,ATPase activity,F
9177,7486,3677,DNA binding,F
9178,7486,3678,DNA helicase activity,F
9179,7486,3678,DNA helicase activity,F
9180,7486,51880,G-quadruplex DNA binding,F
9181,7486,403,Y-form DNA binding,F
9182,7486,405,bubble DNA binding,F
9183,7486,3682,chromatin binding,F
9184,7486,4527,exonuclease activity,F
9185,7486,4527,exonuclease activity,F
9186,7486,61749,forked DNA-dependent helicase activity,F
9187,7486,400,four-way junction DNA binding,F
9188,7486,9378,four-way junction helicase activity,F
9189,7486,4386,helicase activity,F
9190,7486,287,magnesium ion binding,F
9191,7486,30145,manganese ion binding,F
9192,7486,32357,oxidized purine DNA binding,F
9193,7486,5515,protein binding,F
9194,7486,32403,protein complex binding,F
9195,7486,42803,protein homodimerization activity,F
9196,7486,61821,telomeric D-loop binding,F
9197,7486,61849,telomeric G-quadruplex DNA binding,F
9198,7486,32508,DNA duplex unwinding,P
9199,7486,6259,DNA metabolic process,P
9200,7486,6260,DNA replication,P
9201,7486,6260,DNA replication,P
9202,7486,6260,DNA replication,P
9203,7486,731,DNA synthesis involved in DNA repair,P
9204,7486,731,DNA synthesis involved in DNA repair,P
9205,7486,44806,G-quadruplex DNA unwinding,P
9206,7486,44806,G-quadruplex DNA unwinding,P
9207,7486,7568,aging,P
9208,7486,6284,base-excision repair,P
9209,7486,7420,brain development,P
9210,7486,7569,cell aging,P
9211,7486,6974,cellular response to DNA damage stimulus,P
9212,7486,71480,cellular response to gamma radiation,P
9213,7486,9267,cellular response to starvation,P
9214,7486,6302,double-strand break repair,P
9215,7486,724,double-strand break repair via homologous recombination,P
9216,7486,10259,multicellular organism aging,P
9217,7486,90305,nucleic acid phosphodiester bond hydrolysis,P
9218,7486,32066,nucleolus to nucleoplasm transport,P
9219,7486,51345,positive regulation of hydrolase activity,P
9220,7486,98530,positive regulation of strand invasion,P
9221,7486,42981,regulation of apoptotic process,P
9222,7486,40009,regulation of growth rate,P
9223,7486,1901796,regulation of signal transduction by p53 class mediator,P
9224,7486,31297,replication fork processing,P
9225,7486,31297,replication fork processing,P
9226,7486,1302,replicative cell aging,P
9227,7486,10225,response to UV-C,P
9228,7486,6979,response to oxidative stress,P
9229,7486,732,strand displacement,P
9230,7486,90656,t-circle formation,P
9231,7486,723,telomere maintenance,P
9232,7486,723,telomere maintenance,P
9233,7486,61820,telomeric D-loop disassembly,P
9234,7486,61820,telomeric D-loop disassembly,P
9235,7486,61820,telomeric D-loop disassembly,P
9236,7486,32389,MutLalpha complex,C
9237,7486,5813,centrosome,C
9238,7486,5694,chromosome,C
9239,7486,781,"chromosome, telomeric region",C
9240,7486,5737,cytoplasm,C
9241,7486,43005,neuron projection,C
9242,7486,16607,nuclear speck,C
9243,7486,5730,nucleolus,C
9244,7486,5654,nucleoplasm,C
9245,7486,5654,nucleoplasm,C
9246,7486,5657,replication fork,C
9247,7490,70742,C2H2 zinc finger domain binding,F
9248,7490,3723,RNA binding,F
9249,7490,10385,double-stranded methylated DNA binding,F
9250,7490,44729,hemi-methylated DNA-binding,F
9251,7490,5515,protein binding,F
9252,7490,43565,sequence-specific DNA binding,F
9253,7490,3700,"transcription factor activity, sequence-specific DNA binding",F
9254,7490,3700,"transcription factor activity, sequence-specific DNA binding",F
9255,7490,44212,transcription regulatory region DNA binding,F
9256,7490,1077,"transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding",F
9257,7490,8270,zinc ion binding,F
9258,7490,8380,RNA splicing,P
9259,7490,35802,adrenal cortex formation,P
9260,7490,30325,adrenal gland development,P
9261,7490,1658,branching involved in ureteric bud morphogenesis,P
9262,7490,43010,camera-type eye development,P
9263,7490,60923,cardiac muscle cell fate commitment,P
9264,7490,71320,cellular response to cAMP,P
9265,7490,71371,cellular response to gonadotropin stimulus,P
9266,7490,60539,diaphragm development,P
9267,7490,30855,epithelial cell differentiation,P
9268,7490,7281,germ cell development,P
9269,7490,32836,glomerular basement membrane development,P
9270,7490,72112,glomerular visceral epithelial cell differentiation,P
9271,7490,72112,glomerular visceral epithelial cell differentiation,P
9272,7490,32835,glomerulus development,P
9273,7490,8406,gonad development,P
9274,7490,7507,heart development,P
9275,7490,1822,kidney development,P
9276,7490,30539,male genitalia development,P
9277,7490,8584,male gonad development,P
9278,7490,60231,mesenchymal to epithelial transition,P
9279,7490,72284,metanephric S-shaped body morphogenesis,P
9280,7490,72207,metanephric epithelium development,P
9281,7490,72075,metanephric mesenchyme development,P
9282,7490,43066,negative regulation of apoptotic process,P
9283,7490,30308,negative regulation of cell growth,P
9284,7490,8285,negative regulation of cell proliferation,P
9285,7490,2000195,negative regulation of female gonad development,P
9286,7490,72302,negative regulation of metanephric glomerular mesangial cell proliferation,P
9287,7490,122,negative regulation of transcription from RNA polymerase II promoter,P
9288,7490,45892,"negative regulation of transcription, DNA-templated",P
9289,7490,60421,positive regulation of heart growth,P
9290,7490,2000020,positive regulation of male gonad development,P
9291,7490,2001076,positive regulation of metanephric ureteric bud development,P
9292,7490,45944,positive regulation of transcription from RNA polymerase II promoter,P
9293,7490,45893,"positive regulation of transcription, DNA-templated",P
9294,7490,45893,"positive regulation of transcription, DNA-templated",P
9295,7490,72166,posterior mesonephric tubule development,P
9296,7490,3156,regulation of animal organ formation,P
9297,7490,6357,regulation of transcription from RNA polymerase II promoter,P
9298,7490,6355,"regulation of transcription, DNA-templated",P
9299,7490,6355,"regulation of transcription, DNA-templated",P
9300,7490,7530,sex determination,P
9301,7490,7356,thorax and anterior abdomen determination,P
9302,7490,9888,tissue development,P
9303,7490,6366,transcription from RNA polymerase II promoter,P
9304,7490,1657,ureteric bud development,P
9305,7490,1570,vasculogenesis,P
9306,7490,61032,visceral serous pericardium development,P
9307,7490,5737,cytoplasm,C
9308,7490,5829,cytosol,C
9309,7490,16607,nuclear speck,C
9310,7490,5730,nucleolus,C
9311,7490,5654,nucleoplasm,C
9312,7490,5634,nucleus,C
9313,54739,8270,zinc ion binding,F
9314,54739,6915,apoptotic process,P
9315,54739,31333,negative regulation of protein complex assembly,P
9316,54739,35456,response to interferon-beta,P
9317,54739,60337,type I interferon signaling pathway,P
9318,54739,5829,cytosol,C
9319,54739,5739,mitochondrion,C
9320,54739,5634,nucleus,C
9321,11059,5515,protein binding,F
9322,11059,61630,ubiquitin protein ligase activity,F
9323,11059,4842,ubiquitin-protein transferase activity,F
9324,11059,7417,central nervous system development,P
9325,11059,34220,ion transmembrane transport,P
9326,11059,45892,"negative regulation of transcription, DNA-templated",P
9327,11059,43161,proteasome-mediated ubiquitin-dependent protein catabolic process,P
9328,11059,16567,protein ubiquitination,P
9329,11059,16567,protein ubiquitination,P
9330,11059,7165,signal transduction,P
9331,11059,46718,viral entry into host cell,P
9332,11059,5829,cytosol,C
9333,11059,70062,extracellular exosome,C
9334,11059,5634,nucleus,C
9335,11059,5886,plasma membrane,C
9336,11059,151,ubiquitin ligase complex,C
9337,10413,979,RNA polymerase II core promoter sequence-specific DNA binding,F
9338,10413,33613,activating transcription factor binding,F
9339,10413,3682,chromatin binding,F
9340,10413,70064,proline-rich region binding,F
9341,10413,8022,protein C-terminus binding,F
9342,10413,5515,protein binding,F
9343,10413,46982,protein heterodimerization activity,F
9344,10413,3713,transcription coactivator activity,F
9345,10413,3713,transcription coactivator activity,F
9346,10413,3714,transcription corepressor activity,F
9347,10413,1076,"transcription factor activity, RNA polymerase II transcription factor binding",F
9348,10413,44212,transcription regulatory region DNA binding,F
9349,10413,60449,bud elongation involved in lung branching,P
9350,10413,902,cell morphogenesis,P
9351,10413,8283,cell proliferation,P
9352,10413,6974,cellular response to DNA damage stimulus,P
9353,10413,71480,cellular response to gamma radiation,P
9354,10413,71300,cellular response to retinoic acid,P
9355,10413,60242,contact inhibition,P
9356,10413,3143,embryonic heart tube morphogenesis,P
9357,10413,35329,hippo signaling,P
9358,10413,30216,keratinocyte differentiation,P
9359,10413,48368,lateral mesoderm development,P
9360,10413,60487,lung epithelial cell differentiation,P
9361,10413,30857,negative regulation of epithelial cell differentiation,P
9362,10413,2001237,negative regulation of extrinsic apoptotic signaling pathway,P
9363,10413,1903507,negative regulation of nucleic acid-templated transcription,P
9364,10413,2000737,negative regulation of stem cell differentiation,P
9365,10413,30903,notochord development,P
9366,10413,48339,paraxial mesoderm development,P
9367,10413,90263,positive regulation of canonical Wnt signaling pathway,P
9368,10413,8284,positive regulation of cell proliferation,P
9369,10413,46622,positive regulation of organ growth,P
9370,10413,1902459,positive regulation of stem cell population maintenance,P
9371,10413,45944,positive regulation of transcription from RNA polymerase II promoter,P
9372,10413,45893,"positive regulation of transcription, DNA-templated",P
9373,10413,45893,"positive regulation of transcription, DNA-templated",P
9374,10413,6461,protein complex assembly,P
9375,10413,6461,protein complex assembly,P
9376,10413,10837,regulation of keratinocyte proliferation,P
9377,10413,72307,regulation of metanephric nephron tubule epithelial cell differentiation,P
9378,10413,50767,regulation of neurogenesis,P
9379,10413,72091,regulation of stem cell proliferation,P
9380,10413,35019,somatic stem cell population maintenance,P
9381,10413,6367,transcription initiation from RNA polymerase II promoter,P
9382,10413,1570,vasculogenesis,P
9383,10413,71148,TEAD-1-YAP complex,C
9384,10413,71149,TEAD-2-YAP complex,C
9385,10413,5737,cytoplasm,C
9386,10413,5829,cytosol,C
9387,10413,16020,membrane,C
9388,10413,5654,nucleoplasm,C
9389,10413,5634,nucleus,C
9390,83719,46872,metal ion binding,F
9391,83719,2000774,positive regulation of cellular senescence,P
9392,83719,5730,nucleolus,C
9393,7538,71889,14-3-3 protein binding,F
9394,7538,17091,AU-rich element binding,F
9395,7538,17091,AU-rich element binding,F
9396,7538,19957,C-C chemokine binding,F
9397,7538,3677,DNA binding,F
9398,7538,3723,RNA binding,F
9399,7538,70063,RNA polymerase binding,F
9400,7538,19899,enzyme binding,F
9401,7538,31072,heat shock protein binding,F
9402,7538,35925,mRNA 3'-UTR AU-rich region binding,F
9403,7538,3729,mRNA binding,F
9404,7538,46872,metal ion binding,F
9405,7538,5515,protein binding,F
9406,7538,19901,protein kinase binding,F
9407,7538,3727,single-stranded RNA binding,F
9408,7538,61158,3'-UTR-mediated mRNA destabilization,P
9409,7538,61158,3'-UTR-mediated mRNA destabilization,P
9410,7538,70935,3'-UTR-mediated mRNA stabilization,P
9411,7538,165,MAPK cascade,P
9412,7538,165,MAPK cascade,P
9413,7538,71364,cellular response to epidermal growth factor stimulus,P
9414,7538,44344,cellular response to fibroblast growth factor stimulus,P
9415,7538,71385,cellular response to glucocorticoid stimulus,P
9416,7538,97011,cellular response to granulocyte macrophage colony-stimulating factor stimulus,P
9417,7538,71222,cellular response to lipopolysaccharide,P
9418,7538,71222,cellular response to lipopolysaccharide,P
9419,7538,71356,cellular response to tumor necrosis factor,P
9420,7538,6402,mRNA catabolic process,P
9421,7538,51028,mRNA transport,P
9422,7538,35278,miRNA mediated inhibition of translation,P
9423,7538,45647,negative regulation of erythrocyte differentiation,P
9424,7538,45085,negative regulation of interleukin-2 biosynthetic process,P
9425,7538,1904246,negative regulation of polynucleotide adenylyltransferase activity,P
9426,7538,122,negative regulation of transcription from RNA polymerase II promoter,P
9427,7538,32897,negative regulation of viral transcription,P
9428,7538,288,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay",P
9429,7538,31086,"nuclear-transcribed mRNA catabolic process, deadenylation-independent decay",P
9430,7538,289,nuclear-transcribed mRNA poly(A) tail shortening,P
9431,7538,38066,p38MAPK cascade,P
9432,7538,1901835,positive regulation of deadenylation-independent decapping of nuclear-transcribed mRNA,P
9433,7538,45600,positive regulation of fat cell differentiation,P
9434,7538,2000637,positive regulation of gene silencing by miRNA,P
9435,7538,1904582,positive regulation of intracellular mRNA localization,P
9436,7538,1900153,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay",P
9437,7538,1900153,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay",P
9438,7538,60213,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening,P
9439,7538,1902172,regulation of keratinocyte apoptotic process,P
9440,7538,45616,regulation of keratinocyte differentiation,P
9441,7538,10837,regulation of keratinocyte proliferation,P
9442,7538,43488,regulation of mRNA stability,P
9443,7538,43488,regulation of mRNA stability,P
9444,7538,43488,regulation of mRNA stability,P
9445,7538,32680,regulation of tumor necrosis factor production,P
9446,7538,42594,response to starvation,P
9447,7538,9611,response to wounding,P
9448,7538,9611,response to wounding,P
9449,7538,30014,CCR4-NOT complex,C
9450,7538,98745,Dcp1-Dcp2 complex,C
9451,7538,932,P-body,C
9452,7538,70578,RISC-loading complex,C
9453,7538,5737,cytoplasm,C
9454,7538,10494,cytoplasmic stress granule,C
9455,7538,5829,cytosol,C
9456,7538,5829,cytosol,C
9457,7538,178,exosome (RNase complex),C
9458,7538,30529,intracellular ribonucleoprotein complex,C
9459,7538,5634,nucleus,C
9460,7538,1990904,ribonucleoprotein complex,C
9461,64393,3723,RNA binding,F
9462,64393,3723,RNA binding,F
9463,64393,2039,p53 binding,F
9464,64393,5515,protein binding,F
9465,64393,8270,zinc ion binding,F
9466,64393,6974,cellular response to DNA damage stimulus,P
9467,64393,72332,intrinsic apoptotic signaling pathway by p53 class mediator,P
9468,64393,43065,positive regulation of apoptotic process,P
9469,64393,15031,protein transport,P
9470,64393,40008,regulation of growth,P
9471,64393,5730,nucleolus,C
9472,64393,5654,nucleoplasm,C
9473,64393,5886,plasma membrane,C
9474,7707,978,RNA polymerase II core promoter proximal region sequence-specific DNA binding,F
9475,7707,46872,metal ion binding,F
9476,7707,5515,protein binding,F
9477,7707,43565,sequence-specific DNA binding,F
9478,7707,1078,"transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding",F
9479,7707,6968,cellular defense response,P
9480,7707,7276,gamete generation,P
9481,7707,10629,negative regulation of gene expression,P
9482,7707,122,negative regulation of transcription from RNA polymerase II promoter,P
9483,7707,45892,"negative regulation of transcription, DNA-templated",P
9484,7707,45944,positive regulation of transcription from RNA polymerase II promoter,P
9485,7707,6461,protein complex assembly,P
9486,7707,21762,substantia nigra development,P
9487,7707,6366,transcription from RNA polymerase II promoter,P
9488,7707,5794,Golgi apparatus,C
9489,7707,5634,nucleus,C